Basket Home Your Account Contact/Consultation

Market Surveys Globaldata Pharmaceuticals Health

TitleYearPrice

India Orthopedic Devices Market Outlook to 2016

Market size and company share data for seven orthopedic devices market categories – Orthobiologics, Joint Reconstruction, Spinal S
2010 2.500,00$

Type 2 Diabetes - Pipeline Assessment and Market Forecasts to 2017

Annualized global type 2 diabetes therapeutics market revenue data from 2001 to 2009, forecast for eight years to 2017. / Geogra
2010 2.000,00$

Endometriosis - Pipeline Assessment and Market Forecasts to 2017

Annualized global endometriosis market revenues data from 2001 to 2009, forecast for eight years to 2017. / Pipeline analysis da
2010 2.000,00$

Women’s Infertility - Pipeline Assessment and Market Forecasts to 2017

Annualized global women’s infertility therapeutics market revenue data from 2001 to 2009, forecast for eight years to 2017. / Ge
2010 2.000,00$

Urinary Incontinence - Pipeline Assessment and Market Forecasts to 2017

Annualized global UI therapeutics market revenues data from 2001 to 2009, forecast for eight years to 2017. / Geographies covered
2010 2.000,00$

Hologic Acquires Sentinelle Medical: A Move to Increase Presence in Breast Cancer Market

Introduction / / GlobalData’s report, “Hologic to Acquire Sentinelle Medical: A Move to Increase Presence in Breast Cancer Market
2010 500,00$

Peripheral Vascular Devices Market in Japan

Introduction / / GlobalData’s report, “Peripheral Vascular Devices Market in Japan” provides key data, information and analysis o
2010 500,00$

Dental Lasers: A Market Snapshot

Introduction / / GlobalData’s report, “Dental Lasers: A Market Snapshot” provides key data, information and analysis on the globa
2010 500,00$

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – AUGUST 2010

Introduction / / "GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – August 2010” r
2010 1.000,00$

Neurostimulation Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Neurostimulation Devices – Global Pipeline Analysis, Opportunity Assessment and Market
2010 3.500,00$

Interventional Cardiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Interventional Cardiology Devices - Global Pipeline Analysis, Opportunity Assessment a
2010 3.500,00$

Hansen Medical Enters into an Agreement with Siemens Healthcare: A Move to Increase Market Penetration

Introduction / / GlobalData’s report, “Hansen Medical Enters into an Agreement with Siemens Healthcare: A Move to Increase Market
2010 500,00$

Boston Scientific Invests in Cameron Health: A Move to Gain from New Technology

Introduction / / GlobalData’s report, “Boston Scientific Invests in Cameron Health: A Move to Gain from New Technology”” provides
2010 500,00$

Medtronic Enters into Licensing Agreement with AGA Medical Holdings: A Move to Benefit from Huge Market Opportunity in Structural Heart Defects and Vascular Abnormalities

Introduction / / GlobalData’s report, “Medtronic Enters into Licensing Agreement with AGA Medical Holdings: A Move to Benefit fro
2010 500,00$

Brazil Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical devices report, “Brazil Orthopedic Devices Market Outlook to 2016” provides key market data
2010 2.500,00$

Medical Equipment Monthly Deals Analysis: M&A and Investments Trends - August 2010

Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis: M&A and Investments Trends – August 2010” report is an e
2010 1.000,00$

Germany Opthalmic Devices Market Outlook to 2016

Introduction / / GlobalData's medical devices report, “Germany Opthalmic Devices Market Outlook to 2016” provides key market data
2010 2.500,00$

France Opthalmic Devices Market Outlook to 2016

Introduction / / GlobalData's medical devices report, “France Opthalmic Devices Market Outlook to 2016” provides key market data
2010 2.500,00$

Italy Opthalmic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical devices report, “Italy Opthalmic Devices Market Outlook to 2016” provides key market data o
2010 2.500,00$

Spain Opthalmic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical devices report, “Spain Opthalmic Devices Market Outlook to 2016” provides key market data o
2010 2.500,00$

Netherlands Opthalmic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical devices report, “Netherlands Opthalmic Devices Market Outlook to 2016” provides key market
2010 2.500,00$

United Kingdom Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s medical devices report, “United Kingdom Surgical Equipment Market Outlook to 2016” provides key mar
2010 2.500,00$

Japan Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s medical devices report, “Japan Surgical Equipment Market Outlook to 2016” provides key market data
2010 2.500,00$

India Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s medical devices report, “India Surgical Equipment Market Outlook to 2016” provides key market data
2010 2.500,00$

Spain Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s medical devices report, “Spain Surgical Equipment Market Outlook to 2016” provides key market data
2010 2.500,00$

Belgium Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s medical devices report, “Belgium Surgical Equipment Market Outlook to 2016” provides key market dat
2010 2.500,00$

Argentina Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s medical devices report, “Argentina Surgical Equipment Market Outlook to 2016” provides key market d
2010 2.500,00$

Taiwan Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s medical devices report, “Taiwan Surgical Equipment Market Outlook to 2016” provides key market data
2010 2.500,00$

South Africa Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s medical devices report, “South Africa Surgical Equipment Market Outlook to 2016” provides key marke
2010 2.500,00$

Israel Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s medical devices report, “Israel Surgical Equipment Market Outlook to 2016” provides key market data
2010 2.500,00$

Wound Care Management: Innovations and Trends

Introduction / / GlobalData’s report, “Wound Care Management: Innovations and Trends” provides key data, information and analysis
2010 500,00$

Erectile Dysfunction - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData’s pharmaceutical and healthcare report, “Erectile Dysfunction - Pipeline Assessment and Market Foreca
2010 2.000,00$

Cystic Fibrosis – Pipeline Assessment and Market Forecasts to 2017

Annualized global cystic fibrosis market revenues data from 2001 to 2009, forecast forward for eight years to 2017. / Pipeline a
2010 2.000,00$

Dental Devices Market Outlook in Argentina to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Argentina to 2016 - Dental Chairs and Equi
2010 2.500,00$

Dental Devices Market Outlook in Australia to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Australia to 2016 - Dental Chairs and Equi
2010 2.500,00$

Dental Devices Market Outlook in Belgium to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Belgium to 2016 - Dental Chairs and Equipm
2010 2.500,00$

Dental Devices Market Outlook in Brazil to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Brazil to 2016 - Dental Chairs and Equipme
2010 2.500,00$

Dental Devices Market Outlook in Canada to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Canada to 2016 - Dental Chairs and Equipme
2010 2.500,00$

Dental Devices Market Outlook in China to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in China to 2016 - Dental Chairs and Equipmen
2010 2.500,00$

Dental Devices Market Outlook in France to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in France to 2016 - Dental Chairs and Equipme
2010 2.500,00$

Dental Devices Market Outlook in Germany to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Germany to 2016 - Dental Chairs and Equipm
2010 2.500,00$

Dental Devices Market Outlook in India to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in India to 2016 - Dental Chairs and Equipmen
2010 2.500,00$

Dental Devices Market Outlook in Israel to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Israel to 2016 - Dental Chairs and Equipme
2010 2.500,00$

Dental Devices Market Outlook in Italy to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Italy to 2016 - Dental Chairs and Equipmen
2010 2.500,00$

Dental Devices Market Outlook in Japan to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Japan to 2016 - Dental Chairs and Equipmen
2010 2.500,00$

Dental Devices Market Outlook in Mexico to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Mexico to 2016 - Dental Chairs and Equipme
2010 2.500,00$

Dental Devices Market Outlook in Netherlands to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Netherlands to 2016 - Dental Chairs and Eq
2010 2.500,00$

Dental Devices Market Outlook in Republic of Korea to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Republic of Korea to 2016 - Dental Chairs
2010 2.500,00$

Dental Devices Market Outlook in South Africa to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in South Africa to 2016 - Dental Chairs and E
2010 2.500,00$

Dental Devices Market Outlook in Spain to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Introduction / / GlobalData’s medical devices report, “Dental Devices Market Outlook in Spain to 2016 - Dental Chairs and Equipme
2010 2.500,00$

Dental Devices Market Outlook in Taiwan to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Taiwan to 2016 - Dental Chairs and Equipme
2010 2.500,00$

Dental Devices Market Outlook in the UK to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in the UK to 2016 - Dental Chairs and Equipme
2010 2.500,00$

Dental Devices Market Outlook in the US to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in the US to 2016 - Dental Chairs and Equipme
2010 2.500,00$

Drug Delivery Devices Market Outlook in Argentina to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Argentina to 2016 - Inhalation Syst
2010 2.500,00$

Drug Delivery Devices Market Outlook in Australia to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Australia to 2016 - Inhalation Syst
2010 2.500,00$

Drug Delivery Devices Market Outlook in Belgium to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Belgium to 2016 - Inhalation System
2010 2.500,00$

Drug Delivery Devices Market Outlook in Brazil to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Brazil to 2016 - Inhalation Systems
2010 2.500,00$

Drug Delivery Devices Market Outlook in Canada to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Canada to 2016 - Inhalation Systems
2010 2.500,00$

Drug Delivery Devices Market Outlook in China to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in China to 2016 - Inhalation Systems,
2010 2.500,00$

Drug Delivery Devices Market Outlook in France to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in France to 2016 - Inhalation Systems
2010 2.500,00$

Drug Delivery Devices Market Outlook in Germany to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Germany to 2016 - Inhalation System
2010 2.500,00$

Drug Delivery Devices Market Outlook in India to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in India to 2016 - Inhalation Systems,
2010 2.500,00$

Drug Delivery Devices Market Outlook in Israel to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Israel to 2016 - Inhalation Systems
2010 2.500,00$

Drug Delivery Devices Market Outlook in Italy to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Italy to 2016 - Inhalation Systems,
2010 2.500,00$

Drug Delivery Devices Market Outlook in Japan to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Japan to 2016 - Inhalation Systems,
2010 2.500,00$

Drug Delivery Devices Market Outlook in Mexico to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Mexico to 2016 - Inhalation Systems
2010 2.500,00$

Drug Delivery Devices Market Outlook in Netherlands to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Netherlands to 2016 - Inhalation Sy
2010 2.500,00$

Drug Delivery Devices Market Outlook in Republic of Korea to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Republic of Korea to 2016 - Inhalat
2010 2.500,00$

Drug Delivery Devices Market Outlook in South Africa to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in South Africa to 2016 - Inhalation S
2010 2.500,00$

Drug Delivery Devices Market Outlook in Spain to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Spain to 2016 - Inhalation Systems,
2010 2.500,00$

Drug Delivery Devices Market Outlook in Taiwan to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Taiwan to 2016 - Inhalation Systems
2010 2.500,00$

Drug Delivery Devices Market Outlook in the UK to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in the UK to 2016 - Inhalation Systems
2010 2.500,00$

Drug Delivery Devices Market Outlook in the US to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in the US to 2016 - Inhalation Systems
2010 2.500,00$

Endoscopy Devices Market Outlook in Argentina to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Argentina to 2016 - Endoscopy Visualiza
2010 2.500,00$

Endoscopy Devices Market Outlook in Australia to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Australia to 2016 - Endoscopy Visualiza
2010 2.500,00$

Endoscopy Devices Market Outlook in Belgium to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Belgium to 2016 - Endoscopy Visualizati
2010 2.500,00$

Endoscopy Devices Market Outlook in Brazil to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Brazil to 2016 - Endoscopy Visualizatio
2010 2.500,00$

Endoscopy Devices Market Outlook in Canada to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Canada to 2016 - Endoscopy Visualizatio
2010 2.500,00$

Endoscopy Devices Market Outlook in China to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in China to 2016 - Endoscopy Visualization
2010 2.500,00$

Endoscopy Devices Market Outlook in France to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in France to 2016 - Endoscopy Visualizatio
2010 2.500,00$

Endoscopy Devices Market Outlook in Germany to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Germany to 2016 - Endoscopy Visualizati
2010 2.500,00$

Endoscopy Devices Market Outlook in India to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in India to 2016 - Endoscopy Visualization
2010 2.500,00$

Endoscopy Devices Market Outlook in Israel to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Israel to 2016 - Endoscopy Visualizatio
2010 2.500,00$

Endoscopy Devices Market Outlook in Italy to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Italy to 2016 - Endoscopy Visualization
2010 2.500,00$

Endoscopy Devices Market Outlook in Japan to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Japan to 2016 - Endoscopy Visualization
2010 2.500,00$

Endoscopy Devices Market Outlook in Mexico to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Mexico to 2016 - Endoscopy Visualizatio
2010 2.500,00$

Endoscopy Devices Market Outlook in Netherlands to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Netherlands to 2016 - Endoscopy Visuali
2010 2.500,00$

Endoscopy Devices Market Outlook in Republic of Korea to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Republic of Korea to 2016 - Endoscopy V
2010 2.500,00$

Endoscopy Devices Market Outlook in South Africa to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in South Africa to 2016 - Endoscopy Visual
2010 2.500,00$

Endoscopy Devices Market Outlook in Spain to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Spain to 2016 - Endoscopy Visualization
2010 2.500,00$

Endoscopy Devices Market Outlook in Taiwan to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Taiwan to 2016 - Endoscopy Visualizatio
2010 2.500,00$

Endoscopy Devices Market Outlook in the UK to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in the UK to 2016 - Endoscopy Visualizatio
2010 2.500,00$

Endoscopy Devices Market Outlook in the US to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in the US to 2016 - Endoscopy Visualizatio
2010 2.500,00$

ENT Devices Market Outlook in Argentina to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Argentina to 2016 - Hearing Aid Devices and I
2010 2.500,00$

ENT Devices Market Outlook in Australia to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Australia to 2016 - Hearing Aid Devices and I
2010 2.500,00$

ENT Devices Market Outlook in Belgium to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Belgium to 2016 - Hearing Aid Devices and Imp
2010 2.500,00$

ENT Devices Market Outlook in Brazil to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Brazil to 2016 - Hearing Aid Devices and Impl
2010 2.500,00$

ENT Devices Market Outlook in Canada to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Canada to 2016 - Hearing Aid Devices and Impl
2010 2.500,00$

ENT Devices Market Outlook in China to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in China to 2016 - Hearing Aid Devices and Impla
2010 2.500,00$

ENT Devices Market Outlook in Franceto 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Franceto 2016 - Hearing Aid Devices and Impla
2010 2.500,00$

ENT Devices Market Outlook in Germany to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Germany to 2016 - Hearing Aid Devices and Imp
2010 2.500,00$

ENT Devices Market Outlook in India to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in India to 2016 - Hearing Aid Devices and Impla
2010 2.500,00$

ENT Devices Market Outlook in Israel to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Israel to 2016 - Hearing Aid Devices and Impl
2010 2.500,00$

ENT Devices Market Outlook in Italy to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Italy to 2016 - Hearing Aid Devices and Impla
2010 2.500,00$

ENT Devices Market Outlook in Japan to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Japan to 2016 - Hearing Aid Devices and Impla
2010 2.500,00$

ENT Devices Market Outlook in Mexico to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Mexico to 2016 - Hearing Aid Devices and Impl
2010 2.500,00$

ENT Devices Market Outlook in Netherlands to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Netherlands to 2016 - Hearing Aid Devices and
2010 2.500,00$

ENT Devices Market Outlook in Republic of Korea to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Republic of Korea to 2016 - Hearing Aid Devic
2010 2.500,00$

ENT Devices Market Outlook in South Africa to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in South Africa to 2016 - Hearing Aid Devices an
2010 2.500,00$

ENT Devices Market Outlook in Spain to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Spain to 2016 - Hearing Aid Devices and Impla
2010 2.500,00$

ENT Devices Market Outlook in Taiwan to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Taiwan to 2016 - Hearing Aid Devices and Impl
2010 2.500,00$

ENT Devices Market Outlook in the UK to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in the UK to 2016 - Hearing Aid Devices and Impl
2010 2.500,00$

ENT Devices Market Outlook in the US to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices

Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in the US to 2016 - Hearing Aid Devices and Impl
2010 2.500,00$

Hospital Supplies Market Outlook in Argentina to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Argentina to 2016 - Disposable Hospital
2010 2.500,00$

Hospital Supplies Market Outlook in Australia to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Australia to 2016 - Disposable Hospital
2010 2.500,00$

Hospital Supplies Market Outlook in Belgium to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Belgium to 2016 - Disposable Hospital S
2010 2.500,00$

Hospital Supplies Market Outlook in Brazil to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Brazil to 2016 - Disposable Hospital Su
2010 2.500,00$

Hospital Supplies Market Outlook in Canada to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Canada to 2016 - Disposable Hospital Su
2010 2.500,00$

Hospital Supplies Market Outlook in China to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in China to 2016 - Disposable Hospital Sup
2010 2.500,00$

Hospital Supplies Market Outlook in France to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in France to 2016 - Disposable Hospital Su
2010 2.500,00$

Hospital Supplies Market Outlook in Germany to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Germany to 2016 - Disposable Hospital S
2010 2.500,00$

Hospital Supplies Market Outlook in India to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in India to 2016 - Disposable Hospital Sup
2010 2.500,00$

Hospital Supplies Market Outlook in Israel to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Israel to 2016 - Disposable Hospital Su
2010 2.500,00$

Hospital Supplies Market Outlook in Italy to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Italy to 2016 - Disposable Hospital Sup
2010 2.500,00$

Hospital Supplies Market Outlook in Japan to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Japan to 2016 - Disposable Hospital Sup
2010 2.500,00$

Hospital Supplies Market Outlook in Mexico to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Mexico to 2016 - Disposable Hospital Su
2010 2.500,00$

Hospital Supplies Market Outlook in Netherlands to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Netherlands to 2016 - Disposable Hospit
2010 2.500,00$

Hospital Supplies Market Outlook in Republic of Korea to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Republic of Korea to 2016 - Disposable
2010 2.500,00$

Hospital Supplies Market Outlook in South Africa to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in South Africa to 2016 - Disposable Hospi
2010 2.500,00$

Hospital Supplies Market Outlook in Spain to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Spain to 2016 - Disposable Hospital Sup
2010 2.500,00$

Hospital Supplies Market Outlook in Taiwan to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Taiwan to 2016 - Disposable Hospital Su
2010 2.500,00$

Hospital Supplies Market Outlook in the UK to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in the UK to 2016 - Disposable Hospital Su
2010 2.500,00$

Hospital Supplies Market Outlook in the US to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in the US to 2016 - Disposable Hospital Su
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in Argentina to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Argentina to 2016 - Incont
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in Australia to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Australia to 2016 - Incont
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in Belgium to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Belgium to 2016 - Incontin
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in Brazil to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Brazil to 2016 - Incontine
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in Canada to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Canada to 2016 - Incontine
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in China to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in China to 2016 - Incontinen
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in France to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in France to 2016 - Incontine
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in Germany to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Germany to 2016 - Incontin
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in India to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in India to 2016 - Incontinen
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in Israel to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Israel to 2016 - Incontine
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in Italy to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Italy to 2016 - Incontinen
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in Japan to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Japan to 2016 - Incontinen
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in Mexico to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Mexico to 2016 - Incontine
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in Netherlands to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Netherlands to 2016 - Inco
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in Republic of Korea to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Republic of Korea to 2016
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in South Africa to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in South Africa to 2016 - Inc
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in Spain to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Spain to 2016 - Incontinen
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in Taiwan to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Taiwan to 2016 - Incontine
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in the UK to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in the UK to 2016 - Incontine
2010 2.500,00$

Nephrology and Urology Devices Market Outlook in the US to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others

Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in the US to 2016 - Incontine
2010 2.500,00$

Neurology Devices Market Outlook in Argentina to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Argentina to 2016 - Neurostimulation De
2010 2.500,00$

Neurology Devices Market Outlook in Australia to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Australia to 2016 - Neurostimulation De
2010 2.500,00$

Neurology Devices Market Outlook in Belgium to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Belgium to 2016 - Neurostimulation Devi
2010 2.500,00$

Neurology Devices Market Outlook in Brazil to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Brazil to 2016 - Neurostimulation Devic
2010 2.500,00$

Neurology Devices Market Outlook in Canada to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Canada to 2016 - Neurostimulation Devic
2010 2.500,00$

Neurology Devices Market Outlook in China to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in China to 2016 - Neurostimulation Device
2010 2.500,00$

Neurology Devices Market Outlook in France to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in France to 2016 - Neurostimulation Devic
2010 2.500,00$

Neurology Devices Market Outlook in Germany to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Germany to 2016 - Neurostimulation Devi
2010 2.500,00$

Neurology Devices Market Outlook in India to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in India to 2016 - Neurostimulation Device
2010 2.500,00$

Neurology Devices Market Outlook in Israel to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Israel to 2016 - Neurostimulation Devic
2010 2.500,00$

Neurology Devices Market Outlook in Italy to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Italy to 2016 - Neurostimulation Device
2010 2.500,00$

Neurology Devices Market Outlook in Japan to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Japan to 2016 - Neurostimulation Device
2010 2.500,00$

Neurology Devices Market Outlook in Mexico to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Mexico to 2016 - Neurostimulation Devic
2010 2.500,00$

Neurology Devices Market Outlook in Netherlands to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Netherlands to 2016 - Neurostimulation
2010 2.500,00$

Neurology Devices Market Outlook in Republic of Korea to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Republic of Korea to 2016 - Neurostimul
2010 2.500,00$

Neurology Devices Market Outlook in South Africa to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in South Africa to 2016 - Neurostimulation
2010 2.500,00$

Neurology Devices Market Outlook in Spain to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Spain to 2016 - Neurostimulation Device
2010 2.500,00$

Neurology Devices Market Outlook in Taiwan to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Taiwan to 2016 - Neurostimulation Devic
2010 2.500,00$

Neurology Devices Market Outlook in the UK to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in the UK to 2016 - Neurostimulation Devic
2010 2.500,00$

Neurology Devices Market Outlook in the US to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in the US to 2016 - Neurostimulation Devic
2010 2.500,00$

Ophthalmic Devices Market Outlook in Argentina to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others

Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in Argentina to 2016 - Vision Care, Catar
2010 2.500,00$

Ophthalmic Devices Market Outlook in Australia to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others

Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in Australia to 2016 - Vision Care, Catar
2010 2.500,00$

Ophthalmic Devices Market Outlook in Belgium to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others

Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in Belgium to 2016 - Vision Care, Catarac
2010 2.500,00$

Ophthalmic Devices Market Outlook in Brazil to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others

Introduction / / GlobalData’s medical device report, "Ophthalmic Devices Market Outlook in Brazil to 2016 - Vision Care, Cataract
2010 2.500,00$

Ophthalmic Devices Market Outlook in Canada to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others

Introduction / / GlobalData's medical device report, “Ophthalmic Devices Market Outlook in Canada to 2016 - Vision Care, Cataract
2010 2.500,00$

Ophthalmic Devices Market Outlook in China to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others

Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in China to 2016 - Vision Care, Cataract
2010 2.500,00$

Ophthalmic Devices Market Outlook in India to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others

Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in India to 2016 - Vision Care, Cataract
2010 2.500,00$

Ophthalmic Devices Market Outlook in Israel to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others

Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in Israel to 2016 - Vision Care, Cataract
2010 2.500,00$

Ophthalmic Devices Market Outlook in Japan to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others

Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in Japan to 2016 - Vision Care, Cataract
2010 2.500,00$

Ophthalmic Devices Market Outlook in Mexico to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others

Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in Mexico to 2016 - Vision Care, Cataract
2010 2.500,00$

Ophthalmic Devices Market Outlook in Republic of Korea to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others

Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in Republic of Korea to 2016 - Vision Car
2010 2.500,00$

Ophthalmic Devices Market Outlook in South Africa to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others

Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in South Africa to 2016 - Vision Care, Ca
2010 2.500,00$

Ophthalmic Devices Market Outlook in Taiwan to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others

Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in Taiwan to 2016 - Vision Care, Cataract
2010 2.500,00$

Ophthalmic Devices Market Outlook in the UK to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others

Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in the UK to 2016 - Vision Care, Cataract
2010 2.500,00$

Ophthalmic Devices Market Outlook in the United States (US) to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others

Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in the United States (US) to 2016 - Visio
2010 2.500,00$

Surgical Equipment Market Outlook in Republic of Korea to 2016 - Surgical Sutures, Hand Instruments and Radiofrequency (RF) Generator and Accessories

Introduction / / GlobalData’s medical device report, “Surgical Equipment Market Outlook in Republic of Korea to 2016 - Surgical S
2010 2.500,00$

Surgical Equipment Market Outlook in the US to 2016 - Surgical Sutures, Hand Instruments and Radiofrequency (RF) Generator and Accessories

Introduction / / GlobalData’s medical device report, “Surgical Equipment Market Outlook in the US to 2016 - Surgical Sutures, Han
2010 2.500,00$

Wound Care Management Market Outlook in Republic of Korea to 2016 - Advanced Wound Management, Negative Pressure Wound Therapy (NPWT), Wound Closure Devices, Pressure Relief Devices and Others

Introduction / / GlobalData’s medical device report, “Wound Care Management Market Outlook in Republic of Korea to 2016 - Advance
2010 2.500,00$

Healthcare IT Market Outlook in Australia to 2016 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Australia to 2016 - Hospital Information
2010 2.500,00$

Healthcare IT Market Outlook in Brazil to 2016 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Brazil to 2016 - Hospital Information S
2010 2.500,00$

Healthcare IT Market Outlook in Canada to 2016 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Canada to 2016 - Hospital Information Sy
2010 2.500,00$

Healthcare IT Market Outlook in China to 2016 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in China to 2016 - Hospital Information Sys
2010 2.500,00$

Healthcare IT Market Outlook in France to 2016 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in France to 2016 - Hospital Information Sy
2010 2.500,00$

Healthcare IT Market Outlook in Germany to 2016 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Germany to 2016 - Hospital Information S
2010 2.500,00$

Healthcare IT Market Outlook in India to 2016 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in India to 2016 - Hospital Information Sys
2010 2.500,00$

Healthcare IT Market Outlook in Israel to 2016 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Israel to 2016 - Hospital Information Sy
2010 2.500,00$

Healthcare IT Market Outlook in Italy to 2016 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Italy to 2016 - Hospital Information Sys
2010 2.500,00$

Healthcare IT Market Outlook in Japan to 2016 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Japan to 2016 - Hospital Information Sys
2010 2.500,00$

Healthcare IT Market Outlook in New Zealand to 2016 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in New Zealand to 2016 - Hospital Informati
2010 2.500,00$

Healthcare IT Market Outlook in Spain to 2016 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Spain to 2016 - Hospital Information Sys
2010 2.500,00$

Healthcare IT Market Outlook in Sweden to 2016 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Sweden to 2016 - Hospital Information Sy
2010 2.500,00$

Healthcare IT Market Outlook in the UK to 2016 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in the UK to 2016 - Hospital Information Sy
2010 2.500,00$

Healthcare IT Market Outlook in the US to 2016 - Hospital Information Systems and Medical Imaging Information Systems

Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in the US to 2016 - Hospital Information Sy
2010 2.500,00$

Chronic Kidney Disease - Pipeline Assessment and Market Forecasts to 2016

Annualized global chronic kidney disease market revenues data from 2001 to 2009, forecast forward for 7 years to 2016. / Pipeline
2010 2.000,00$

Ambu A/S Market Share Analysis

Introduction / / GlobalData’s new report, “Ambu A/S Market Share Analysis” provides in-depth information on Ambu’s market posit
2010 1.000,00$

Boston Scientific Corporation Market Share Analysis

Introduction / / GlobalData’s new report, “Boston Scientific Corporation Market Share Analysis” provides in-depth information o
2010 1.000,00$

Baxter International Inc. Market Share Analysis

Introduction / / GlobalData’s new report, “Baxter International Inc. Market Share Analysis” provides in-depth information on Ba
2010 1.000,00$

Rossmax International Ltd. Market Share Analysis

Introduction / / GlobalData’s new report, “Rossmax International Ltd. Market Share Analysis” provides in-depth information on Ros
2010 1.000,00$

BPL Healthcare Business Group Market Share Analysis

Introduction / / GlobalData’s new report, “BPL Healthcare Business Group Market Share Analysis” provides in-depth information o
2010 1.000,00$

TOSHIBA Medical Systems Corporation Market Share Analysis

Introduction / / GlobalData’s new report, “TOSHIBA Medical Systems Corporation Market Share Analysis” provides in-depth informati
2010 1.000,00$

SonoSite, Inc. Market Share Analysis

Introduction / / GlobalData’s new report, “SonoSite, Inc. Market Share Analysis” provides in-depth information on SonoSite’s mark
2010 1.000,00$

Nihon Kohden Corporation Market Share Analysis

Introduction / / GlobalData’s new report, “Nihon Kohden Corporation Market Share Analysis” provides in-depth information on Nihon
2010 1.000,00$

Fukuda Denshi Co., Ltd. Market Share Analysis

Introduction / / GlobalData’s new report, “Fukuda Denshi Co., Ltd. Market Share Analysis” provides in-depth information on Fukuda
2010 1.000,00$

Beijing Wandong Medical Equipment Co., Ltd. Market Share Analysis

Introduction / / GlobalData’s new report, “Beijing Wandong Medical Equipment Co., Ltd. Market Share Analysis” provides in-depth
2010 1.000,00$

Philips Respironics, Inc. Market Share Analysis

Introduction / / GlobalData’s new report, “Philips Respironics, Inc. Market Share Analysis” provides in-depth information on Phil
2010 1.000,00$

Canada Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Canada Orthopedic Devices Market Outlook to 2016” provides key market
2010 2.500,00$

Hip and Knee Implants - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s Orthopedic Devices report, “Hip and Knee Implants - Global Pipeline Analysis, Opportunity Assessmen
2010 3.500,00$

Germany Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Germany Orthopedic Devices Market Outlook to 2016” provides key market d
2010 2.500,00$

France Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “France Orthopedic Devices Market Outlook to 2016” provides key market da
2010 2.500,00$

Italy Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Italy Orthopedic Devices Market Outlook to 2016” provides key market dat
2010 2.500,00$

Spain Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Spain Orthopedic Devices Market Outlook to 2016” provides key market dat
2010 2.500,00$

Australia Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Australia Orthopedic Devices Market Outlook to 2016” provides key mark
2010 2.500,00$

Netherlands Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Netherlands Orthopedic Devices Market Outlook to 2016” provides key mark
2010 2.500,00$

Belgium Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Belgium Orthopedic Devices Market Outlook to 2016” provides key market
2010 2.500,00$

Argentina Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Argentina Orthopedic Devices Market Outlook to 2016” provides key mark
2010 2.500,00$

Mexico Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Mexico Orthopedic Devices Market Outlook to 2016” provides key market da
2010 2.500,00$

Republic of Korea Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Republic of Korea Orthopedic Devices Market Outlook to 2016” provides ke
2010 2.500,00$

Taiwan Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Taiwan Orthopedic Devices Market Outlook to 2016” provides key market da
2010 2.500,00$

South Africa Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “South Africa Orthopedic Devices Market Outlook to 2016” provides key mar
2010 2.500,00$

Israel Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Israel Orthopedic Devices Market Outlook to 2016” provides key market da
2010 2.500,00$

United Kingdom Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “The UK Orthopedic Devices Market Outlook to 2016” provides key market da
2010 2.500,00$

Japan Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Japan Orthopedic Devices Market Outlook to 2016” provides key market dat
2010 2.500,00$

China Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “China Orthopedic Devices Market Outlook to 2016” provides key market dat
2010 2.500,00$

United States Orthopedic Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “US Orthopedic Devices Market Outlook to 2016” provides key market data o
2010 2.500,00$

Argentina Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s new report, “Argentina Wound Care Management Market Outlook to 2016” provides key market data on
2010 2.500,00$

Medical Equipment Monthly Deals Analysis: M&A and Investments Trends - July 2010

Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis: M&A and Investments Trends – July 2010” report is an ess
2010 1.000,00$

Medical Equipment Quarterly Deals Analysis: M&A and Investments Trends - Q2 2010

Introduction / / GlobalData's “Medical Equipment Quarterly Deals Analysis: M&A and Investments Trends - Q2 2010” report is an ess
2010 1.500,00$

United States In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “US In Vitro Diagnostics Market Outlook to 2016” provides key market data on the US In
2010 2.500,00$

United Kingdom In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “UK In Vitro Diagnostics Market Outlook to 2016” provides key market data on the UK In
2010 2.500,00$

Canada In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “Canada In Vitro Diagnostics Market Outlook to 2016” provides key market data on the
2010 2.500,00$

Italy In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “Italy In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Ita
2010 2.500,00$

Spain In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, "Spain In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Spa
2010 2.500,00$

Brazil In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “Brazil In Vitro Diagnostics Market Outlook to 2016” provides key market data on the
2010 2.500,00$

Netherlands In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “Netherlands In Vitro Diagnostics Market Outlook to 2016” provides key market data on t
2010 2.500,00$

Belgium In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “Belgium In Vitro Diagnostics Market Outlook to 2016” provides key market data on the
2010 2.500,00$

Republic of Korea In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “Republic of Korea In Vitro Diagnostics Market Outlook to 2016” provides key market dat
2010 2.500,00$

Israel Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Israel Anesthesia and Respiratory Devices Market Outlook to 2016” provid
2010 2.500,00$

Israel Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s new report, “Israel Wound Care Management Market Outlook to 2016” provides key market data on the I
2010 2.500,00$

Israel In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “Israel In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Is
2010 2.500,00$

China Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s new report, “China Surgical Equipment Market Outlook to 2016” provides key market data on the China
2010 2.500,00$

Canada Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s new report, “Canada Surgical Equipment Market Outlook to 2016” provides key market data on the Cana
2010 2.500,00$

Germany Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s new report, “Germany Surgical Equipment Market Outlook to 2016” provides key market data on the Ger
2010 2.500,00$

France Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s new report, “France Surgical Equipment Market Outlook to 2016” provides key market data on the Fran
2010 2.500,00$

Italy Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s new report, “Italy Surgical Equipment Market Outlook to 2016” provides key market data on the Italy
2010 2.500,00$

Australia Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s new report, “Australia Surgical Equipment Market Outlook to 2016” provides key market data on the
2010 2.500,00$

Brazil Surgical Equipment Market Outlook to 2016

Introduction / / GlobalData’s new report, “Brazil Surgical Equipment Market Outlook to 2016” provides key market data on the Br
2010 2.500,00$

Insulin Pumps - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s medical equipment report, “Insulin Pumps – Global Pipeline Analysis, Opportunity Assessment and Mar
2010 3.500,00$

Hormone Replacement Therapy in Menopause - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData's has released its pharmaceutical and healthcare report, “Hormone Replacement Therapy in Menopause -
2010 2.000,00$

3M Health Care Market Share Analysis

Introduction / / GlobalData’s medical devices report, “3M Healthcare Market Share Analysis” provides in-depth information on 3M H
2010 1.000,00$

Draegerwerk AG & Co. KGaA Market Share Analysis

Introduction / / GlobalData’s medical devices report, “Draegerwerk AG & Co. KGaA Market Share Analysis” provides in-depth informa
2010 1.000,00$

Coloplast A/S Market Share Analysis

Introduction / / GlobalData’s medical devices report, “Coloplast A/S Market Share Analysis” provides in-depth information on Colo
2010 1.000,00$

Cordis Corporation Market Share Analysis

Introduction / / GlobalData’s medical devices report, “Cordis Corporation Market Share Analysis” provides in-depth information on
2010 1.000,00$

Larsen & Toubro Medical Equipment & Systems Market Share Analysis

Introduction / / GlobalData’s medical devices report, “Larsen & Toubro Medical Equipment & Systems (L&T Medical) Market Share Ana
2010 1.000,00$

Spain Patient Monitoring Market Outlook to 2016

Introduction / / GlobalData’s new report, “Spain Patient Monitoring Market Outlook to 2016” provides key market data on the Spain
2010 2.500,00$

Abbott Laboratories Market Share Analysis

Introduction / / GlobalData’s medical devices report, “Abbott Laboratories Market Share Analysis” provides in-depth information o
2010 1.000,00$

Molnlycke Health Care AB Market Share Analysis

Introduction / / GlobalData’s medical devices report, “Molnlycke Health Care AB Market Share Analysis” provides in-depth informat
2010 1.000,00$

Respiratory Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s medical equipment report, “Respiratory Devices – Global Pipeline Analysis, Opportunity Assessment a
2010 3.500,00$

BSN medical GmbH Market Share Analysis

Introduction / / GlobalData’s medical devices report, “BSN medical GmbH Market Share Analysis” provides in-depth information on B
2010 1.000,00$

Sectra AB Market Share Analysis

Introduction / / GlobalData’s medical devices report, “Spectra AB. Market Share Analysis” provides in-depth information on Spectr
2010 1.000,00$

Animas Corporation Market Share Analysis

Introduction / / GlobalData’s medical devices report, “Animas Corporation Market Share Analysis” provides in-depth information on
2010 1.000,00$

OSI Systems, Inc. Market Share Analysis

Introduction / / GlobalData’s medical devices report, “OSI Systems, Inc. Market Share Analysis” provides in-depth information on
2010 1.000,00$

Medison Co., Ltd. Market Share Analysis

Introduction / / GlobalData’s medical devices report, “Medison Co., Ltd. Market Share Analysis” provides in-depth information on
2010 1.000,00$

CooperVision, Inc. Market Share Analysis

Introduction / / GlobalData’s medical devices report, “CooperVision, Inc. Market Share Analysis” provides in-depth information on
2010 1.000,00$

Anthogyr S.A. Market Share Analysis

Introduction / / GlobalData’s medical devices report, “Anthogyr S.A. Market Share Analysis” provides in-depth information on Anth
2010 1.000,00$

Covidien plc Market Share Analysis

Introduction / / GlobalData’s medical devices report, “Covidien plc Market Share Analysis” provides in-depth information on Covid
2010 1.000,00$

Mindray Medical International Limited Market Share Analysis

Introduction / / GlobalData’s medical devices report, “Mindray Medical International Market Share Analysis” provides in-depth inf
2010 1.000,00$

Dameca a/s Market Share Analysis

Introduction / / GlobalData’s medical devices report, “Dameca a/s Market Share Analysis” provides in-depth information on Dameca’
2010 1.000,00$

United States Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s new report, “US Wound Care Management Market Outlook to 2016” provides key market data on the US wo
2010 2.500,00$

United Kingdom Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s new report, “UK Wound Care Management Market Outlook to 2016” provides key market data on the UK wo
2010 2.500,00$

Japan Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s new report, “Japan Wound Care Management Market Outlook to 2016” provides key market data on the Ja
2010 2.500,00$

India Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s new report, “India Wound Care Management Market Outlook to 2016” provides key market data on the In
2010 2.500,00$

France Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s new report, “France Wound Care Management Market Outlook to 2016” provides key market data on the F
2010 2.500,00$

Australia Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s new report, “Australia Wound Care Management Market Outlook to 2016” provides key market data on th
2010 2.500,00$

South Africa Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s new report, “South Africa Wound Care Management Market Outlook to 2016” provides key market data on
2010 2.500,00$

Japan In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “Japan In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Jap
2010 3.500,00$

India In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “India In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Ind
2010 3.500,00$

China In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “China In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Chi
2010 3.500,00$

Germany In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “Germany In Vitro Diagnostics Market Outlook to 2016” provides key market data on the G
2010 3.500,00$

France In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “France In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Fr
2010 3.500,00$

Australia In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “Australia In Vitro Diagnostics Market Outlook to 2016” provides key market data on the
2010 3.500,00$

Argentina In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “Argentina In Vitro Diagnostics Market Outlook to 2016” provides key market data on the
2010 3.500,00$

Mexico In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “Mexico In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Me
2010 3.500,00$

Taiwan In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “Taiwan In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Ta
2010 3.500,00$

South Africa In Vitro Diagnostics Market Outlook to 2016

Introduction / / GlobalData’s new report, “South Africa In Vitro Diagnostics Market Outlook to 2016” provides key market data on
2010 3.500,00$

Diabetes Care Devices: Emerging Countries (China, India, Brazil) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Diabetes Care Devices - Emerging Countries Opportunity Assessment, Competitive Landsca
2010 3.500,00$

Picture Archiving and Communication Systems (PACS) - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Picture Archiving and Communication Systems (PACS) - Global Opportunity Assessment, Co
2010 3.500,00$

Hemophilia - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Hemophilia - Pipeline Assessment a
2010 2.000,00$

Allergic Rhinitis - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released a new report, “Allergic Rhinitis - Pipeline Assessm
2010 2.000,00$

Migraine - Pipeline Assessment and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Migraine - Pipeline Assessment and Market Forecast
2010 2.000,00$

Idiopathic Pulmonary Fibrosis - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData’s pharmaceutical and healthcare report, “Idiopathic Pulmonary Fibrosis - Pipeline Assessment and Ma
2010 2.000,00$

Acne - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist, has released a new report, “Acne - Pipeline Assessment and Marke
2010 2.000,00$

US Patient Monitoring Devices Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s medical equipment report, “US Patient Monitoring Pipeline Analysis, Opportunity Assessment and Ma
2010 3.500,00$

Mergers, Acquisitions and Partnerships in the Medical Devices Industry - Inorganic Growth Driven by the Strategic Need to Hold a Diversified Portfolio

Introduction / / Investments in the global medical devices industry exceeded $73 billion in 2009. In the same year, $18.7 billi
2010 3.500,00$

United States Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “US Anesthesia and Respiratory Devices Market Outlook to 2016” provides
2010 2.500,00$

Japan Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Japan Anesthesia and Respiratory Devices Market Outlook to 2016” provi
2010 2.500,00$

China Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “China Anesthesia and Respiratory Devices Market Outlook to 2016” provi
2010 2.500,00$

Australia Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Australia Anesthesia and Respiratory Devices Market Outlook to 2016” p
2010 2.500,00$

Netherlands Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Netherlands Anesthesia and Respiratory Devices Market Outlook to 2016”
2010 2.500,00$

Belgium Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Belgium Anesthesia and Respiratory Devices Market Outlook to 2016” pro
2010 2.500,00$

Mexico Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Mexico Anesthesia and Respiratory Devices Market Outlook to 2016” prov
2010 2.500,00$

South Africa Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “South Africa Anesthesia and Respiratory Devices Market Outlook to 2016
2010 2.500,00$

China Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “China Wound Care Management Market Outlook to 2016” provides key marke
2010 2.500,00$

Canada Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Canada Wound Care Management Market Outlook to 2016” provides key mark
2010 2.500,00$

Germany Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Germany Wound Care Management Market Outlook to 2016” provides key mar
2010 2.500,00$

Italy Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Italy Wound Care Management Market Outlook to 2016” provides key marke
2010 2.500,00$

Spain Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Spain Wound Care Management Market Outlook to 2016” provides key marke
2010 2.500,00$

Brazil Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Brazil Wound Care Management Market Outlook to 2016” provides key mark
2010 2.500,00$

Netherlands Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Netherlands Wound Care Management Market Outlook to 2016” provides key
2010 2.500,00$

Belgium Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Belgium Wound Care Management Market Outlook to 2016” provides key mar
2010 2.500,00$

Mexico Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Mexico Wound Care Management Market Outlook to 2016” provides key mark
2010 2.500,00$

Taiwan Wound Care Management Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Taiwan Wound Care Management Market Outlook to 2016” provides key mark
2010 2.500,00$

Viscosupplementation - A European Market Snapshot

Introduction / / GlobalData’s report, “Viscosupplementation: A European Market Snapshot” provides key data, information and ana
2010 500,00$

Antimicrobial Coatings for Medical Devices: An Overview

Introduction / / GlobalData’s report, “Antimicrobial Coatings for Medical Devices” provides key data, information and analysis
2010 500,00$

Periodontal Disease - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist’s new report, “Periodontal Disease - Pipeline Assessment and Mark
2010 2.000,00$

Neuropathic Pain - Pipeline Assessment and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Neuropathic Pain - Pipeline Assessment and Market
2010 2.000,00$

Herpes Simplex - Pipeline Assessment and Market Forecasts to 2017

Introduction / / GlobalData, the industry analysis specialist’s new report, “Herpes Simplex - Pipeline Assessment and Market Fo
2010 2.000,00$

HIV-AIDS – Pipeline Assessment and Market Forecasts to 2016

Annualized global HIV/AIDS market revenues data from 2001 to 2009, forecast for seven years to 2016. / Pipeline analysis data pr
2010 2.000,00$

Hepatitis C (HCV) – Pipeline Assessment and Market Forecasts to 2016

Annualized global hepatitis C market revenues data from 2000 to 2009, forecast for seven years to 2016. / Pipeline analysis data
2010 2.000,00$

Dyslipidemia – Pipeline Assessment and Market Forecasts to 2016

Annualized global dyslipidemia market revenues data from 2001 to 2009, forecast forward for 7 years to 2016. / Pipeline analysis
2010 2.000,00$

Pulmonary Arterial Hypertension (PAH) - Pipeline Assessment and Market Forecasts to 2016

Annualized global PAH market revenues data from 2005 to 2009, forecast forward for seven years to 2016. / Geographic markets cov
2010 2.000,00$

Parkinson's Disease – Pipeline Assessment and Market Forecasts to 2016

Annualized global Parkinson’s disease market revenues data from 2001 to 2009, forecast forward for 7 years to 2016. / Pipeline a
2010 2.000,00$

Type 1 Diabetes - Drug Pipeline Assessment and Market Forecasts to 2017

Annualized global type 1 diabetes market revenues data from data from 2001 to 2009, forecast for eight years to 2017. / Pipeline
2010 2.000,00$

Global Coronary Stents Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s medical equipment report, “Global Coronary Stents Equipment Pipeline Analysis, Opportunity Assessme
2010 3.500,00$

Dehaier Medical Systems Signs Distribution Agreement with HEYER Medical: A Move to Expand Product Offerings

Introduction / / GlobalData’s report, “Dehaier Medical Systems Signs Distribution Agreement with HEYER Medical: A Move to Expand
2010 500,00$

Japan Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Japan Diagnostic Imaging Market Outlook to 2016” provides key market dat
2010 2.500,00$

Germany Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Germany Diagnostic Imaging Market Outlook to 2016” provides key market d
2010 2.500,00$

France Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “France Diagnostic Imaging Market Outlook to 2016” provides key market da
2010 2.500,00$

Spain Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Spain Diagnostic Imaging Market Outlook to 2016” provides key market dat
2010 2.500,00$

Australia Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Australia Diagnostic Imaging Market Outlook to 2016” provides key market
2010 2.500,00$

Belgium Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Brazil Diagnostic Imaging Market Outlook to 2016” provides key market da
2010 2.500,00$

Argentina Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Argentina Diagnostic Imaging Market Outlook to 2016” provides key market
2010 2.500,00$

Republic of Korea Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Republic of Korea Diagnostic Imaging Market Outlook to 2016” provides ke
2010 2.500,00$

South Africa Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “South Africa Diagnostic Imaging Market Outlook to 2016” provides key mar
2010 2.500,00$

Israel Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Israel Diagnostic Imaging Market Outlook to 2016” provides key market da
2010 2.500,00$

United Kingdom Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “UK Anesthesia and Respiratory Devices Market Outlook to 2016” provides k
2010 2.500,00$

India Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “India Anesthesia and Respiratory Devices Market Outlook to 2016” provide
2010 2.500,00$

Canada Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Canada Anesthesia and Respiratory Devices Market Outlook to 2016” provid
2010 2.500,00$

Germany Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Germany Anesthesia and Respiratory Devices Market Outlook to 2016” provi
2010 2.500,00$

France Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “France Anesthesia and Respiratory Devices Market Outlook to 2016” provid
2010 2.500,00$

Italy Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Italy Anesthesia and Respiratory Devices Market Outlook to 2016” provide
2010 2.500,00$

Spain Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Spain Anesthesia and Respiratory Devices Market Outlook to 2016” provide
2010 2.500,00$

Brazil Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Brazil Anesthesia and Respiratory Devices Market Outlook to 2016” provid
2010 2.500,00$

Argentina Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Argentina Anesthesia and Respiratory Devices Market Outlook to 2016” pro
2010 2.500,00$

Republic of Korea Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Republic of Korea Anesthesia and Respiratory Devices Market Outlook to 2
2010 2.500,00$

Taiwan Anesthesia and Respiratory Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Taiwan Anesthesia and Respiratory Devices Market Outlook to 2016” provid
2010 2.500,00$

Medical Equipment Monthly Deals Analysis: M&A and Investments Trends - June 2010

Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis: M&A and Investments Trends – June 2010” report is an ess
2010 1.000,00$

Economic Benefits and the Drive for Going Green Bolstering Medical Device Reprocessing

Introduction / / GlobalData’s report, “Economic Benefits and the Drive for Going Green Bolstering Medical Device Reprocessing” pr
2010 500,00$

Arigene Co., Ltd. (67850) - Strategic Analysis Review

This comprehensive SWOT profile of Arigene Co., Ltd. provides you an in-depth strategic analysis of the company’s businesses and o
2010 250,00$

DALTON CORPORATION - Strategic Analysis Review

This comprehensive SWOT profile of DALTON CORPORATION provides you an in-depth strategic analysis of the company’s businesses and
2010 125,00$

Attwell Capital Inc. (AT.H) - Strategic Analysis Review

This comprehensive SWOT profile of Attwell Capital Inc. provides you an in-depth strategic analysis of the company’s businesses an
2010 250,00$

Chemipal Ltd. (CMPL) - Strategic Analysis Review

This comprehensive SWOT profile of Chemipal Ltd. provides you an in-depth strategic analysis of the company’s businesses and opera
2010 250,00$

DIO Corporation (39840) - Strategic Analysis Review

This comprehensive SWOT profile of DIO Corporation provides you an in-depth strategic analysis of the company’s businesses and ope
2010 250,00$

Lilama 69-1 JSC (L61) - Strategic Analysis Review

This comprehensive SWOT profile of Lilama 69-1 JSC provides you an in-depth strategic analysis of the company’s businesses and ope
2010 250,00$

HOSHI IRYO-SANKI CO., LTD (7634) - Strategic Analysis Review

This comprehensive SWOT profile of HOSHI IRYO-SANKI CO., LTD provides you an in-depth strategic analysis of the company’s business
2010 250,00$

PositiveID Corporation (PSID) - Strategic Analysis Review

PositiveID Corporation is a company which operates in two main divisions: HealthID and ID Security. The company's HealthID busines
2010 250,00$

New Mexico Software Inc. - Strategic Analysis Review

This comprehensive SWOT profile of New Mexico Software Inc. provides you an in-depth strategic analysis of the company’s businesse
2010 125,00$

PT. Millennium Pharmacon International TBK (SDPC) - Strategic Analysis Review

This comprehensive SWOT profile of PT. Millennium Pharmacon International TBK provides you an in-depth strategic analysis of the c
2010 125,00$

J.L.Morison, Sons & Jones (Ceylon) PLC (MORI) - Strategic Analysis Review

This comprehensive SWOT profile of J.L.Morison, Sons & Jones (Ceylon) PLC provides you an in-depth strategic analysis of the compa
2010 250,00$

In House Productions Limited (526610) - Strategic Analysis Review

This comprehensive SWOT profile of In House Productions Limited provides you an in-depth strategic analysis of the company’s busin
2010 250,00$

Jacques Bogart SA (JBOG) - Strategic Analysis Review

This comprehensive SWOT profile of Jacques Bogart SA provides you an in-depth strategic analysis of the company’s businesses and o
2010 250,00$

Incomex Paraguay SAECA (ICO) - Strategic Analysis Review

This comprehensive SWOT profile of Incomex Paraguay SAECA provides you an in-depth strategic analysis of the company’s businesses
2010 250,00$

Indbank Merchant Banking Services Ltd (511473) - Strategic Analysis Review

This comprehensive SWOT profile of Indbank Merchant Banking Services Ltd provides you an in-depth strategic analysis of the compan
2010 250,00$

Carematrix Corporation (CMDCQ) - Strategic Analysis Review

This comprehensive SWOT profile of Carematrix Corporation provides you an in-depth strategic analysis of the company’s businesses
2010 250,00$

Audiotech Healthcare Corporation (AUD) - Strategic Analysis Review

This comprehensive SWOT profile of Audiotech Healthcare Corporation provides you an in-depth strategic analysis of the company’s b
2010 250,00$

Cassius Ventures Ltd. (CZ.P) - Strategic Analysis Review

This comprehensive SWOT profile of Cassius Ventures Ltd. provides you an in-depth strategic analysis of the company’s businesses a
2010 250,00$

Karver International, Inc. - Strategic Analysis Review

Karver International, Inc. (Karver), formerly Medeorex, Inc. is a development stage pharmaceutical companyengaged in rendering hea
2010 250,00$

Dental Patient Care America Inc (DPAT) - Strategic Analysis Review

This comprehensive SWOT profile of Dental Patient Care America Inc provides you an in-depth strategic analysis of the company’s bu
2010 250,00$

Bellmore Corp (BLMR) - Strategic Analysis Review

This comprehensive SWOT profile of Bellmore Corp provides you an in-depth strategic analysis of the company’s businesses and opera
2010 250,00$

Latvijas Zoovetapgade AS (ZOV1R) - Strategic Analysis Review

Latvijas Zoovetapgade AS (Latvijas Zoovetapgade JSC) is a veterinary preparations provider based in Latvia. The company is princip
2010 250,00$

Chemeq Limited - Strategic Analysis Review

This comprehensive SWOT profile of Chemeq Limited provides you an in-depth strategic analysis of the company’s businesses and oper
2010 250,00$

Chengdu Huasun Group Inc.,Ltd. (790) - Strategic Analysis Review

This comprehensive SWOT profile of Chengdu Huasun Group Inc.,Ltd. provides you an in-depth strategic analysis of the company’s bus
2010 250,00$

Let''s Talk Recovery Inc. (LKRV) - Strategic Analysis Review

Let's Talk Recovery, Inc. is a publicly traded company offering dynamic, socially responsible solutions to the rapidly growing rec
2010 125,00$

Mangalam Drugs and Organics Limited (532637) - Strategic Analysis Review

This comprehensive SWOT profile of Mangalam Drugs and Organics Limited provides you an in-depth strategic analysis of the company’
2010 250,00$

China Dasheng Biotechnology Co (CDBT) - Strategic Analysis Review

This comprehensive SWOT profile of China Dasheng Biotechnology Co provides you an in-depth strategic analysis of the company’s bus
2010 250,00$

Manitex Capital Inc. (MNX) - Strategic Analysis Review

Manitex Capital Inc. (Manitex) is a diversified technology investment company which invest in the life science industry. The compa
2010 250,00$

China Health Industries Holdings Inc (CHHE) - Strategic Analysis Review

This comprehensive SWOT profile of China Health Industries Holdings Inc provides you an in-depth strategic analysis of the company
2010 250,00$

Livewave Media Plc (LIVP) - Strategic Analysis Review

This comprehensive SWOT profile of Livewave Media Plc provides you an in-depth strategic analysis of the company’s businesses and
2010 125,00$

Miravant Medical Technologies - Strategic Analysis Review

Miravant Medical Technologies (Miravant Medical) is a US based pharmaceutical company. Miravant Medical is engaged in research and
2010 250,00$

Daehwa Pharm Co., Ltd. - Strategic Analysis Review

This comprehensive SWOT profile of Daehwa Pharm Co., Ltd. provides you an in-depth strategic analysis of the company’s businesses
2010 250,00$

Gliatech Inc. (GLIAQ) - Strategic Analysis Review

Gliatech Inc. (Gliatech) is principally engaged in the discovery and development of biosurgery and pharmaceutical products. The co
2010 250,00$

Compare Generiks, Inc. (COGE) - Strategic Analysis Review

Compare Generiks, Inc. (CGI) is a pharmaceutical company engaged in marketing and distribution of dietary supplements and Over-the
2010 250,00$

Schiff Nutrition International Inc. (WNI) - Strategic Analysis Review

This comprehensive SWOT profile of Schiff Nutrition International Inc. provides you an in-depth strategic analysis of the company’
2010 250,00$

BioTransplant Inc. - Strategic Analysis Review

BioTransplant Inc. (BioTransplant) is a specialty pharmaceutical company engaged in providing intellectual property rights that it
2010 250,00$

Entropin, Inc. (ETOP) - Strategic Analysis Review

This comprehensive SWOT profile of Entropin, Inc. provides you an in-depth strategic analysis of the company’s businesses and oper
2010 250,00$

MitoPharm Corporation - Strategic Analysis Review

Mitopharm Corporation (MTPM) is a pharmaceutical company. The company engages in the research, development, marketing and sales of
2010 250,00$

Select Therapeutics Inc. - Strategic Analysis Review

Select Therapeutics Inc. (Select Therapeutics) is a pharmaceutical company principally engaged in the research and development of
2010 250,00$

Pilot Therapeutics Holdings, Inc. - Strategic Analysis Review

Pilot Therapeutics Holdings, Inc. (Pilot Therapeutics), formerly Interallied Group, Inc. is a pharmaceutical company principally e
2010 250,00$

CHUO BUSSAN CORPORATION (9852) - Strategic Analysis Review

This comprehensive SWOT profile of CHUO BUSSAN CORPORATION provides you an in-depth strategic analysis of the company’s businesses
2010 250,00$

BHK Inc. - Strategic Analysis Review

BHK Inc. (BHK) is engaged in selling electric parts, including MP3 and related business activities. In addition, it is also engage
2010 250,00$

CTD Holdings Inc. - Strategic Analysis Review

CTD Holdings, Inc., (CHI) is a Florida based manufacturing and distribution company. CHI is principally engages in the distributio
2010 250,00$

Avantogen Oncology, Inc. - Strategic Analysis Review

Avantogen Oncology, Inc. (Avantogen) is principally engaged in the development and commercialization of oncology drugs. It is form
2010 250,00$

Inner Mongolia Jinyu Group Co Ltd (600201) - Strategic Analysis Review

This comprehensive SWOT profile of Inner Mongolia Jinyu Group Co Ltd provides you an in-depth strategic analysis of the company’s
2010 250,00$

Stem Cell Sciences Plc. - Strategic Analysis Review

Stem Cell Sciences plc is a provider of stem cells and associated technologies for drug discovery. The company is specialized in d
2010 250,00$

Procognia Israel Ltd - Strategic Analysis Review

This comprehensive SWOT profile of Procognia Israel Ltd provides you an in-depth strategic analysis of the company’s businesses an
2010 125,00$

GlaxoSmithkline Consumer Nig PLC (GLAXOSMITH) - Strategic Analysis Review

GlaxoSmithKline Consumer Nigeria Plc company is engaged in manufacturing, distribution and marketing a range of consumer healthcar
2010 250,00$

Synova Healthcare Group, Inc. (SNVHQ) - Strategic Analysis Review

This comprehensive SWOT profile of Synova Healthcare Group, Inc. provides you an in-depth strategic analysis of the company’s busi
2010 250,00$

Span Diagnostics Ltd - Strategic Analysis Review

Span Diagnostics SARL (Span Diagnostics) is a healthcare company, engaged in the development and manufacturing of novel products f
2010 250,00$

Transderm Laboratories Corporation (TLCC) - Strategic Analysis Review

This comprehensive SWOT profile of Transderm Laboratories Corporation provides you an in-depth strategic analysis of the company’s
2010 250,00$

CuraTech Industries Inc - Strategic Analysis Review

CuraTech Industries, Inc., (CII), is a pharmaceutical company. CII is engaged in development and marketing of a health supplements
2010 250,00$

Response Oncology, Inc. (ROIX) - Strategic Analysis Review

This comprehensive SWOT profile of Response Oncology, Inc. provides you an in-depth strategic analysis of the company’s businesses
2010 250,00$

U.S. Homecare Corporation (USHO) - Strategic Analysis Review

This comprehensive SWOT profile of U.S. Homecare Corporation provides you an in-depth strategic analysis of the company’s business
2010 250,00$

Integra, Inc. (INGA) - Strategic Analysis Review

This comprehensive SWOT profile of Integra, Inc. provides you an in-depth strategic analysis of the company’s businesses and opera
2010 250,00$

Innovative Clinical Sol. - Strategic Analysis Review

Innovative Clinical Solutions, Ltd. (ICSL) is a contract research organization engaged in the management of investigative clinical
2010 250,00$

Infu-tech, Inc. (IFUI) - Strategic Analysis Review

Infu-Tech, Inc. (Infu-tech) is a healthcare company, providing infusion therapies. The company's business is divided into two serv
2010 250,00$

ProMedCo Management Co. - Strategic Analysis Review

ProMedCo Management Co. (ProMedCo) is a pharmaceutical company engaged in providing medical and healthcare services in the non-urb
2010 250,00$

RainTree Healthcare Corp. - Strategic Analysis Review

RainTree Healthcare Corp. (RainTree Healthcare), formerly Unison HealthCare Corp. is a pharmaceutical company that provides compre
2010 250,00$

Diversified Senior Services, Inc. - Strategic Analysis Review

Diversified Senior Services, Inc. (DISS) is engaged in the development, acquisition and management of apartments, independent livi
2010 250,00$

Molecular Imaging Corporation - Strategic Analysis Review

Molecular Imaging Corporation (Molecular Imaging) is a diagnostic imaging company engaged in the provision of molecular imaging se
2010 250,00$

BITComputer (32850) - Strategic Analysis Review

This comprehensive SWOT profile of BITComputer provides you an in-depth strategic analysis of the company’s businesses and operati
2010 125,00$

Instituto de Diagnostico S.A. (INDISA) - Strategic Analysis Review

This comprehensive SWOT profile of Instituto de Diagnostico S.A. provides you an in-depth strategic analysis of the company’s busi
2010 250,00$

Hythiam Inc. - Strategic Analysis Review

This comprehensive SWOT profile of Hythiam Inc. provides you an in-depth strategic analysis of the company’s businesses and operat
2010 250,00$

Northstar Healthcare, Inc. - Strategic Analysis Review

This comprehensive SWOT profile of Northstar Healthcare, Inc. provides you an in-depth strategic analysis of the company’s busines
2010 125,00$

Siemens Medical Solutions Diagnostics (506559) - Strategic Analysis Review

This comprehensive SWOT profile of Siemens Medical Solutions Diagnostics provides you an in-depth strategic analysis of the compan
2010 125,00$

MedTech Global Ltd. - Strategic Analysis Review

This comprehensive SWOT profile of MedTech Global Ltd. provides you an in-depth strategic analysis of the company’s businesses and
2010 125,00$

NewBiotics, Inc. - Strategic Analysis Review

NewBiotics Inc. (NewBiotics) is a privately held pharmaceutical company engaged in the development of breakthrough drugs for the t
2010 250,00$

PT Multi Indocitra Tbk (MICE) - Strategic Analysis Review

This comprehensive SWOT profile of PT Multi Indocitra Tbk provides you an in-depth strategic analysis of the company’s businesses
2010 250,00$

Advanced Technology Company (ATC) - Strategic Analysis Review

This comprehensive SWOT profile of Advanced Technology Company provides you an in-depth strategic analysis of the company’s busine
2010 250,00$

Alta Natural Herbs & Supplements Ltd. (AHS) - Strategic Analysis Review

This comprehensive SWOT profile of Alta Natural Herbs & Supplements Ltd. provides you an in-depth strategic analysis of the compan
2010 250,00$

American Surgical Holdings Inc (ASRG) - Strategic Analysis Review

This comprehensive SWOT profile of American Surgical Holdings Inc provides you an in-depth strategic analysis of the company’s bus
2010 250,00$

American Vietnamese Biotech Inc (AMV) - Strategic Analysis Review

This comprehensive SWOT profile of American Vietnamese Biotech Inc provides you an in-depth strategic analysis of the company’s bu
2010 250,00$

Animalcare Group Plc (ANCR) - Strategic Analysis Review

This comprehensive SWOT profile of Animalcare Group Plc provides you an in-depth strategic analysis of the company’s businesses an
2010 250,00$

Aperture Health, Inc. (APRE) - Strategic Analysis Review

This comprehensive SWOT profile of Aperture Health, Inc. provides you an in-depth strategic analysis of the company’s businesses a
2010 250,00$

Aquamer Medical Corp (AQUM) - Strategic Analysis Review

This comprehensive SWOT profile of Aquamer Medical Corp provides you an in-depth strategic analysis of the company’s businesses an
2010 250,00$

Hamai Industries Ltd. (6497) - Financial and Strategic Analysis Review

Hamai Industries Ltd. (6497) - Financial and Strategic Analysis Review / / Summary / / Hamai Industries Ltd. (Hamai) is a Japan
2010 250,00$

OmniComm Systems, Inc. (OMCM) - Financial and Strategic Analysis Review

OmniComm Systems, Inc. (OMCM) - Financial and Strategic Analysis Review / / Summary / / OmniComm Systems, Inc., (OmniComm) is a
2010 125,00$

Flexpoint Sensor Systems, Inc. (FLXT) - Financial and Strategic Analysis Review

Flexpoint Sensor Systems, Inc. (FLXT) - Financial and Strategic Analysis Review / / Summary / / Flexpoint Sensor Systems, Inc. (
2010 250,00$

AXS-One Inc. (AXSO) - Financial and Strategic Analysis Review

AXS-One Inc. (AXSO) - Financial and Strategic Analysis Review / / Summary / / AXS-One Inc. (AXA-One) is engaged in providing con
2010 125,00$

TZ Limited (TZL) - Financial and Strategic Analysis Review

TZ Limited (TZL) - Financial and Strategic Analysis Review / / Summary / / TZ Limited is engaged in providing fuse environmental
2010 125,00$

Comvita New Zealand Limited (CVT) - Financial and Strategic Analysis Review

Comvita New Zealand Limited (CVT) - Financial and Strategic Analysis Review / / Summary / / Comvita New Zealand Limited (Comvita
2010 125,00$

D. Medical Industries Limited (DMDC) - Financial and Strategic Analysis Review

D. Medical Industries Limited (DMDC) - Financial and Strategic Analysis Review / / Summary / / D. Medical Industries Limited (D.
2010 250,00$

Craneware plc (CRW) - Financial and Strategic Analysis Review

Craneware plc (CRW) - Financial and Strategic Analysis Review / / Summary / / Craneware plc is a supplier of business intelligen
2010 125,00$

Global Med Technologies, Inc. (GLOB) - Financial and Strategic Analysis Review

Global Med Technologies, Inc. (GLOB) - Financial and Strategic Analysis Review / / Summary / / Global Med Technologies, Inc., (G
2010 125,00$

VentriPoint Diagnostics Ltd. (VPT) - Financial and Strategic Analysis Review

VentriPoint Diagnostics Ltd. (VPT) - Financial and Strategic Analysis Review / / Summary / / VentriPoint Diagnostics, Ltd. (Vent
2010 250,00$

GEOMC Co., Ltd. (33030) - Financial and Strategic Analysis Review

GEOMC Co., Ltd. (33030) - Financial and Strategic Analysis Review / / Summary / / GEOMC Co, Ltd. (GEOMC) is engaged in manufactu
2010 250,00$

Pro Medicus Limited (PME) - Financial and Strategic Analysis Review

Pro Medicus Limited (PME) - Financial and Strategic Analysis Review / / Summary / / Pro Medicus Limited (Pro Medicus) is an Aust
2010 125,00$

System C Healthcare plc (SYS) - Financial and Strategic Analysis Review

System C Healthcare plc (SYS) - Financial and Strategic Analysis Review / / Summary / / System C Healthcare plc (SCH) is a UK ba
2010 125,00$

Wound Management Technologies, Inc. (WNDM) - Financial and Strategic Analysis Review

Wound Management Technologies, Inc. (WNDM) - Financial and Strategic Analysis Review / / Summary / / Wound Management Technologi
2010 250,00$

Bioland co., Ltd (52260) - Financial and Strategic Analysis Review

Bioland co., Ltd (52260) - Financial and Strategic Analysis Review / / Summary / / Bioland co., Ltd (Bioland) is a privately hel
2010 250,00$

Angelica Corporation - Strategic Analysis Review

Angelica Corporation (Angelica) is a provider of outsourced linen management services to the US healthcare industry. It provides l
2010 250,00$

Medtronic CryoCath, LP. - Strategic Analysis Review

Medtronic CryoCath, LP. (CryoCath), formerly CryoCath Technologies Inc. is a medical device company engaged in developing and esta
2010 250,00$

IOMED, Inc. - Strategic Analysis Review

IOMED, Inc. (IOMED) is a medical devices company. It is engaged in the development, manufacturing and marketing of active drug del
2010 250,00$

FUJIFILM Medical Systems USA, Inc. - Strategic Analysis Review

FUJIFILM Medical Systems USA, Inc. (Fujifilm Medical) is a medical device company engaged in providing medical imaging products, i
2010 250,00$

3DM Inc. - Strategic Analysis Review

3DM Inc. (3DM) is a privately held specialty biomaterials and medical device company. It develops clinical products for orthopedic
2010 250,00$

Acri Tec Gmbh - Strategic Analysis Review

Acri.Tec AG (Acri.Tec) is engaged in the development, manufacture and production of sterile ophthalmologic medial products used in
2010 250,00$

Alertis Medical AS - Strategic Analysis Review

Alertis Medical AS (Alertis) is a specialty medical devices company, engaged in the development of new technologies for biosensors
2010 250,00$

Blood Cell Storage, Inc. - Strategic Analysis Review

Blood Cell Storage, Inc. (BCS) is a medical device company engaged in the development and manufacturing of products for non invasi
2010 250,00$

MDS Nordion - Strategic Analysis Review

MDS Nordion is a biotechnology company engaged in the production of isotopes, used in the prevention, diagnosis and treatment of d
2010 125,00$

MicroMed Cardiovascular, Inc. - Strategic Analysis Review

MicroMed Cardiovascular ( MicroMed ) is a medical device company engaged in development of medical products for the cardiovascular
2010 250,00$

Miraculins Inc. (MOM) - Strategic Analysis Review

Miraculins Inc (Miraculins) is a research and development company engaged in the discovery and validation of cancer biomarkers, wh
2010 250,00$

Spacelabs Healthcare, Inc. - Strategic Analysis Review

Spacelabs Healthcare, Inc. (Spacelabs Healthcare) is a medical device company engaged in the development, manufacturing and sellin
2010 125,00$

CIBA Vision Corporation - Strategic Analysis Review

CIBA Vision Corporation (CIBA) is an ophthalmic device company engaged in the research, development and manufacturing of optical p
2010 250,00$

US Endoscopy - Strategic Analysis Review

US Endoscopy is a privately held medical devices company engaged in the design and manufacture of accessories pertaining to Gastro
2010 250,00$

Ivoclar Vivadent AG - Strategic Analysis Review

Ivoclar Vivadent AG (Ivoclar) is a medical device company engaged in the manufacturing and marketing of dental products. The compa
2010 125,00$

Planmeca Oy - Strategic Analysis Review

Planmeca Oy (Planmeca) is a medical device company engaged in the design, manufacturing and marketing of high-tech dental equipmen
2010 125,00$

AMG Medical Inc. - Strategic Analysis Review

AMG Medical Inc. (AMG), formerly AMG Sales Agency Inc. is a medical device company engaged in the development, manufacture and dis
2010 250,00$

CooperVision, Inc. - Strategic Analysis Review

CooperVision, Inc. (CVI) is a medical device company principally engaged in the development, manufacturing and marketing of contac
2010 125,00$

Johnson & Johnson Vision Care, Inc. - Strategic Analysis Review

Johnson & Johnson Vision Care, Inc. (J&J Vision Care) is a opthalmic device company principally engaged in the design and manufact
2010 125,00$

GE Sensing & Inspection Technologies - Strategic Analysis Review

GE Sensing & Inspection Technologies (GE Sensing) is a technology instruments company, engaged in the design, manufacture and sale
2010 250,00$

BIOTRONIK SE & Co. KG - Strategic Analysis Review

BIOTRONIK SE & Co. KG (BIOTRONIK) is a privately-held European based company, engaged in the field of biomedical technology. The c
2010 250,00$

Schiller AG - Strategic Analysis Review

Schiller AG (Schiller) is a global medical device company, engaged in the manufacture and marketing of electrocardiographs, spirom
2010 250,00$

Glidewell Dental Laboratories - Strategic Analysis Review

Glidewell Dental Laboratories (Glidewell) is a dental company principally engaged in the development, manufacturing and marketing
2010 250,00$

MAQUET GmbH & Co. KG - Strategic Analysis Review

MAQUET GmbH & Co. KG (MAQUET) is engaged in the design, manufacture and sale of medical devices and equipment for healthcare indus
2010 125,00$

TRACOE medical GmbH - Strategic Analysis Review

TRACOE medical GmbH (Tracoe medical) is a medical device company principally engaged in the development, manufacture, marketing an
2010 250,00$

Molnlycke Health Care AB - Strategic Analysis Review

Molnlycke Health Care AB (Molnlycke) is engaged in the manufacturing and marketing of single use surgical and wound care products
2010 125,00$

Sunrise Medical, Inc. - Strategic Analysis Review

Sunrise Medical, Inc. (Sunrise Medical) is a medical device company, which is principally engaged in the design, manufacture, dist
2010 250,00$

DeRoyal Industries, Inc. - Strategic Analysis Review

DeRoyal Industries, Inc. (DeRoyal) is engaged in the manufacturing and distribution of quality and innovative medical products and
2010 250,00$

TORNIER, Inc. - Strategic Analysis Review

TORNIER, Inc. (TORNIER) is a medical device company, principally engaged in the design, development, manufacture and sale of ortho
2010 250,00$

Ventana Medical Systems, Inc. - Strategic Analysis Review

Ventana Medical Systems, Inc. (Ventana Medical) is engaged in the development, manufacture and marketing of medical diagnostic ins
2010 250,00$

Atritech, Inc. - Strategic Analysis Review

Atritech, Inc. (Atritech) is a privately held and a clinical stage medical device company. The company is principally engaged in t
2010 250,00$

Medikro Oy. - Strategic Analysis Review

Medikro Oy. (Medikro) is a medical equipment manufacturing company. The company is principally engaged in the development, manufac
2010 250,00$

MedSolutions - Strategic Analysis Review

MedSolutions (MedSolutions) is principally engaged in providing medical and diagnostic imaging and radiology management services t
2010 250,00$

KaVo Dental Corporation - Strategic Analysis Review

KaVo Dental Corporation (KaVo Dental) is a dental equipments manufacturing company, which is engaged in the designing and distribu
2010 250,00$

A-dec Inc. - Strategic Analysis Review

A-dec Inc. (A-dec) is a dental equipment manufacturing company, engaged in the design, development, production and sales of dental
2010 250,00$

Ortho-Clinical Diagnostics Inc. - Strategic Analysis Review

Ortho-Clinical Diagnostics, Inc., (Ortho-Clinical) is a subsidiary of Johnson & Johnson company. The company is principally engage
2010 250,00$

Gendex Dental Systems - Strategic Analysis Review

Gendex Dental Systems (Gendex) is a dental X-ray equipment company, which is engaged in the research and development, manufacture
2010 250,00$

Mennen Medical Ltd. - Strategic Analysis Review

Mennen Medical Ltd. (Mennen Medical) is a privately held global medical device company. The company is principally engaged in the
2010 250,00$

Hollister Incorporated - Strategic Analysis Review

Hollister Incorporated (Hollister), a specialty medical products company, which is engaged in the development and manufacturing of
2010 250,00$

AlloSource - Strategic Analysis Review

AlloSource is engaged in the development, processing and distribution of specialized bone and soft tissue allografts that are used
2010 250,00$

Microtek Medical Holdings, Inc. - Strategic Analysis Review

Microtek Medical Holdings, Inc. (Microtek Medical) is engaged in the design, manufacture and marketing of a wide range of surgical
2010 250,00$

Creganna Medical Devices Limited - Strategic Analysis Review

Creganna Medical Devices Limited (Creganna) is a provider of innovative delivery device solutions to the medical industry. It spec
2010 250,00$

Biosound Esaote, Inc. - Strategic Analysis Review

Biosound Esaote, Inc. (Biosound) is engaged in developing advanced ultrasound systems that applies high-resolution technology to v
2010 250,00$

Cozart Bioscience Ltd - Strategic Analysis Review

Cozart plc (Cozart) is a medical diagnostic company engaged in the design, manufacture and marketing of diagnostics products used
2010 250,00$

Excel-Tech Ltd. (NRV) - Strategic Analysis Review

Excel-Tech Ltd. is a medical technology company that designs, develops and sells proprietary medical devices. The company is engag
2010 250,00$

Inovise Medical, Inc. - Strategic Analysis Review

Inovise Medical, Inc. (Inovise Medical) is a cardiac diagnostic medical technology company, engaged in the development of portable
2010 250,00$

SensiVida Medical Technologies, Inc - Strategic Analysis Review

SensiVida Medical Systems, Inc. is a minimally-invasive diagnostic device company. The company's technology addresses a number of
2010 250,00$

Teleflex Medical - Strategic Analysis Review

Teleflex Medical, a business segment of Teleflex Incorporated, is engaged in the manufacturing and distribution of medical devices
2010 125,00$

BARRX Medical, Inc. - Strategic Analysis Review

BARRX Medical, Inc. (BARRX) is a medical device company, engaged in the development of solutions pertaining to the diagnosis of Ba
2010 250,00$

ADInstruments Pty Ltd - Strategic Analysis Review

ADInstruments Pty Ltd (ADI) is a leading provider of computer-based data acquisition and analysis systems for life science researc
2010 250,00$

ALung Technologies, Inc. - Strategic Analysis Review

ALung Technologies, Inc. (ALung) develops medical devices which can supplement or provide mechanical ventilation for patients in I
2010 250,00$

Amedica Corporation - Strategic Analysis Review

Amedica Corporation (Amedica) is engaged in the development of orthopedic and spinal implants company using silicon nitride cerami
2010 250,00$

LifeWatch Corp. - Strategic Analysis Review

LifeWatch Corp. (LWC) is an ambulatory health monitoring solutions company. It is a subsidiary of LifeWatch AG. LWC is principally
2010 250,00$

Integra Spine - Strategic Analysis Review

Integra Spine (Previously known as Theken Spine, LLC) is a medical device company engaged in the design, development, manufacture
2010 250,00$

IMPAC Medical Systems, Inc. - Strategic Analysis Review

IMPAC Medical Systems, Inc. (IMPAC) is engaged in providing oncology charting, practice management, clinical laboratory, anatomic
2010 250,00$

Mercury Medical, Inc. - Strategic Analysis Review

Mercury Medical, Inc. (Mercury Medical) is a privately-held medical device company, engaged in the development, manufacture and ma
2010 250,00$

Cook Medical Incorporated - Strategic Analysis Review

Cook Medical Incorporated (Cook) is a conglomeration of various medical device manufacturing companies. The company is collectivel
2010 250,00$

American Diagnostic Corporation - Strategic Analysis Review

American Diagnostic Corporation (ADC), a medical device company, is engaged in the development, manufacturing and marketing of dia
2010 250,00$

Vygon SA - Strategic Analysis Review

Vygon SA (Vygon) is a medical device company engaged in the design, manufacture and marketing of single use medical and surgical p
2010 250,00$

Specialized Health Products International, Inc. (SHPI) - Strategic Analysis Review

Specialized Health Products International, Inc. (SHPI) is a medical device company engaged in the design, development and marketin
2010 250,00$

Advanced Bionics Corporation - Strategic Analysis Review

Advanced Bionics Corporation (Advanced Bionics) is engaged in the development, manufacture and marketing of bionic technologies an
2010 250,00$

LifeScan, Inc. - Strategic Analysis Review

LifeScan, Inc. (LifeScan) is engaged in the manufacture and marketing of blood glucose monitoring systems for home and hospital us
2010 250,00$

Showa-Best Glove, Inc. - Strategic Analysis Review

Showa-Best Glove, Inc (Showa-Best Glove) is a medical device company engaged in the design, development, manufacture and marketing
2010 250,00$

ZEVEX International, Inc. - Strategic Analysis Review

ZEVEX International, Inc. (ZEVEX) is a medical device company engaged in the design, manufacture, development and distribution of
2010 250,00$

GN ReSound A/S - Strategic Analysis Review

GN ReSound A/S (GN ReSound) is engaged in the manufacture of advanced technology hearing instruments and innovative solutions for
2010 125,00$

ViOptix Inc. - Strategic Analysis Review

ViOptix Inc. (ViOptix) is engaged in the design and development of non-invasive local tissue oxygen measuring devices. Its product
2010 250,00$

Universal Medical Technologies Inc. - Strategic Analysis Review

Universal Medical Technologies Inc. (Universal Medical) is principally engaged in the design, manufacture and development of intra
2010 250,00$

Kibow Biotech Inc. - Strategic Analysis Review

Kibow Biotech Inc. (Kibow) is a medical equipment company engaged in the development and marketing of products that treat Uremic S
2010 250,00$

Alara, Inc. - Strategic Analysis Review

Alara, Inc. (Alara) is engaged in the design, development, manufacture, marketing and servicing of high quality imaging products b
2010 250,00$

ApaTech Limited - Strategic Analysis Review

ApaTech Limited (ApaTech) is an orthobiologics company, which is engaged in the manufacture and development of synthetic bone graf
2010 250,00$

HydroCision, Inc. - Strategic Analysis Review

HydroCision, Inc. (HydroCision), a medical device company, is engaged in the development, manufacturing and marketing of surgical
2010 250,00$

Current Technology Corporation (CRTCF) - Strategic Analysis Review

Current Technology Corporation (CTC) is a medical device company engaged in the development, manufacture and marketing of electrot
2010 250,00$

US Spine, Inc. - Strategic Analysis Review

US Spine, Inc. (US Spine) is a privately-held medical technology company, engaged in the development, manufacturing and marketing
2010 250,00$

Heraeus Holding GmbH - Strategic Analysis Review

Heraeus Holding GmbH (Heraeus) is a precious metals and technology group. It is engaged in the production and trading of high-qual
2010 125,00$

Omnisonics Medical Technologies, Inc. - Strategic Analysis Review

Omnisonics Medical Technologies, Inc. (Omnisonics), a medical device company, is engaged in the development of breakthrough produc
2010 250,00$

Fallbrook Engineering, Inc. - Strategic Analysis Review

Fallbrook Engineering, Inc. (Fallbrook Engineering) is engaged in providing consulting services related to contract product develo
2010 250,00$

InfraReDx, Inc. - Strategic Analysis Review

InfraReDx, Inc. (InfraReDx) is a medical device company engaged in developing novel, photonic-based medical devices that improve t
2010 250,00$

Tyco Healthcare/Kendall - Strategic Analysis Review

Tyco Healthcare/Kendall (Kendall) is a medical device company. It is principally engaged in the manufacture, development, distribu
2010 250,00$

Nexgen Spine Inc. - Strategic Analysis Review

Nexgen Spine Inc. (Nexgen) is a privately held medical device company. It is principally engaged in the design, development and ma
2010 250,00$

Larsen & Toubro Medical Equipment & Systems - Strategic Analysis Review

Larsen & Toubro Medical Equipment and Systems (L&T Medical) is a sub-division of the group’s (Larsen & Toubro Limited) Electrical
2010 250,00$

Aniara Corporation - Strategic Analysis Review

Aniara Corporation (Aniara) is a medical device company engaged in the manufacture and marketing of screening tools, and diagnosti
2010 250,00$

Aperio Technologies, Inc. - Strategic Analysis Review

Aperio Technologies, Inc. (Aperio) is principally engaged in the design, development, manufacture and sale of systems and services
2010 250,00$

Applied Spectral Imaging, Ltd. - Strategic Analysis Review

Applied Spectral Imaging, Ltd. (ASI), is engaged in the design, manufacture and marketing of various healthcare imaging and data m
2010 250,00$

ERBLAN Surgical, Inc. - Strategic Analysis Review

ERBLAN Surgical, Inc. (ERBLAN Surgical) is engaged in the design, development and commercialization of medical devices and surgica
2010 250,00$

Everest Biomedical Instruments Company - Strategic Analysis Review

Everest Biomedical Instruments Company (Everest Biomedical) is principally engaged in the design and development of advanced, stat
2010 250,00$

LifeSync Corporation - Strategic Analysis Review

LifeSync Corporation (LifeSync) is a privately owned medical device company engaged in the development and sale of the LifeSync Sy
2010 250,00$

Cardiva Medical, Inc. - Strategic Analysis Review

Cardiva Medical, Inc. (Cardiva) is a medical device company engaged in the manufacture and marketing of medical devices to meet th
2010 250,00$

SHPS, Inc. - Strategic Analysis Review

SHPS, Inc. (SHPS) is engaged in providing a broad range of health management programs, tools and services to help consumers take w
2010 250,00$

HD Medical Group Limited - Strategic Analysis Review

HD Medical Group Limited (HD Medical) is an Australian company, which is principally engaged in the development of proprietary and
2010 250,00$

Sensors for Medicine and Science, Inc. - Strategic Analysis Review

Sensors for Medicine and Science, Inc. (SMSI), a medical technology company, is engaged in the research, development and commercia
2010 250,00$

ProRhythm Inc. - Strategic Analysis Review

ProRhythm, Inc. (ProRhythm) is a medical device company, engaged in the development, manufacture and marketing of high intensity f
2010 250,00$

NsGene A/S - Strategic Analysis Review

NsGene A/S (NsGene) is a provider of cell and gene based products for the treatment of neurological diseases. The company also dev
2010 250,00$

NovoSci Corporation - Strategic Analysis Review

NovoSci Corporation (NovoSci) is a medical device company engaged in the development and manufacture of products that are used by
2010 250,00$

Access Bio, Inc. - Strategic Analysis Review

Access Bio, Inc. (Access Bio) is a medical technology company. It is engaged in the development, manufacture and marketing of In-V
2010 250,00$

Active Implants Corporation - Strategic Analysis Review

Active Implants Corporation (AIC) is an orthopedic medical device company engaged in the development of advanced polymer orthopedi
2010 250,00$

Medtronic CoreValve, LLC - Strategic Analysis Review

Medtronic CoreValve, LLC (previously known as CoreValve, Inc.) is a medical technology company, engaged in the development, manufa
2010 250,00$

Medtrode Inc. - Strategic Analysis Review

Medtrode Inc. (Medtrode) is a medical device company, which is engaged in the development of neuromodulation therapy for cognitive
2010 250,00$

Valleylab, Inc. - Strategic Analysis Review

Valleylab, Inc. (Valleylab) is engaged in the design, manufacture and marketing of electrosurgery systems for the surgical markets
2010 250,00$

Bone Biologics, Inc. - Strategic Analysis Review

Bone Biologics, Inc. (Bone Biologics) is a biotechnology company, engaged in the development and manufacture of bone regeneration
2010 250,00$

BoneSupport AB - Strategic Analysis Review

BoneSupport AB (BoneSupport) is a medical technology company engaged in the development of bone substitute products for the orthop
2010 250,00$

Boule Diagnostics International AB - Strategic Analysis Review

Boule Diagnostics International AB (Boule Diagnostics International) is a diagnostic company engaged in the development and market
2010 125,00$

Dornier MedTech GmbH - Strategic Analysis Review

Dornier MedTech GmbH (Dornier MedTech) is a privately held medical device company, principally engaged in the development, manufac
2010 250,00$

Lumenis Ltd. - Strategic Analysis Review

Lumenis Ltd. (Lumenis) is one of the leading medical and aesthetic lasers and light-based technology company. The company has inst
2010 125,00$

PENTAX of America, Inc. - Strategic Analysis Review

PENTAX of America, Inc. (PENTAX) operates in two business divisions namely: PENTAX Medical Company and PENTAX Imaging Company. It
2010 250,00$

Ethicon Endo-Surgery, Inc. - Strategic Analysis Review

Ethicon Endo-Surgery, Inc. (EES) is a medical device company engaged in the development and distribution of advanced medical devic
2010 125,00$

Abbott Diagnostics - Strategic Analysis Review

Abbott Diagnostics is a subsidiary of Abbott Laboratories. The company is engaged in developing, manufacturing and supplying of pr
2010 125,00$

TiGenix Limited - Strategic Analysis Review

OrthoMimetics Limited (OrthoMimetics) is a medical technology company engaged in the design, development and manufacturing of biol
2010 250,00$

OrthoHelix Surgical Designs, Inc. - Strategic Analysis Review

OrthoHelix Surgical Designs, Inc. (OrthoHelix) is an orthopedic medical device company, engaged in the development of a comprehens
2010 250,00$

Berlin Heart GmbH - Strategic Analysis Review

Berlin Heart GmbH (Berlin Heart) is engaged in development, manufacture, sale and commercialization of cardiovascular devices. The
2010 250,00$

1-800 Contacts, Inc. - Strategic Analysis Review

1-800 Contacts, Inc (1-800 Contacts) is one of the worlds largest contact lens store. The company is involved in manufacturing, de
2010 250,00$

Kreatech Holding B.V. - Strategic Analysis Review

Kreatech Holding B.V (Kreatech) is a molecular diagnostics company. It is engaged in the development, manufacture and marketing of
2010 250,00$

Kuros Biosurgery AG - Strategic Analysis Review

Kuros Biosurgery AG (Kuros) is a biomedical company engaged in the development of biomaterial products. It develops a broad range
2010 250,00$

Planmed Oy - Strategic Analysis Review

Planmed Oy (Planmed) is a Finnish medical equipment manufacturer. The company is engaged in the research and development of novel
2010 250,00$

Gaymar Industries, Inc. - Strategic Analysis Review

Gaymar Industries, Inc. (Gaymar) is a provider of products for pressure ulcer management, temperature therapy management, muscle a
2010 250,00$

Burkhart Dental, Inc. - Strategic Analysis Review

Burkhart Dental, Inc. (Burkhart), is a dental supplier company principally engaged in the supply, distribution and marketing of de
2010 250,00$

Medison Co., Ltd. - Strategic Analysis Review

Medison Co., Ltd. (Medison) is a medical equipment company engaged in the development and sales of high-tech ultrasound devices. I
2010 250,00$

HeartSine Technologies, Inc. - Strategic Analysis Review

HeartSine Technologies, Inc. (HeartSine) is a medical device company, which is principally engaged in the development of easy-to-u
2010 250,00$

m2m Imaging Corporation - Strategic Analysis Review

m2m Imaging Corporation (m2m Imaging) is engaged in the manufacture and development of magnetic resonance imaging (MRI) coils and
2010 250,00$

Japan Medical Materials Corporation - Strategic Analysis Review

Japan Medical Materials Corporation (JMM) is engaged in the development, manufacture and marketing of medical devices for the heal
2010 250,00$

Ferno-Washington, Inc. - Strategic Analysis Review

Ferno-Washington, Inc. (Ferno) is engaged in the manufacture and distribution of patient handling solutions for emergency, mortuar
2010 250,00$

Oxford Nanopore Technologies Ltd. - Strategic Analysis Review

Oxford Nanopore Technologies Ltd. (Oxford Nanopore), formerly known as Oxford NanoLabs Ltd., is a privately-held biotechnology dia
2010 250,00$

Oxford Immunotec Limited - Strategic Analysis Review

Oxford Immunotec Limited (Oxford Immunotec) is an international T cell measurement company engaged in the development and commerci
2010 250,00$

Oxford Biomedical Research, Inc. - Strategic Analysis Review

Oxford Biomedical Research, Inc. (OBR) is engaged in the development and manufacture of high quality immunoassay products, such as
2010 250,00$

Optovue Corporation - Strategic Analysis Review

Optovue, Inc (Optovue) is an ophthalmic device company engaged in the development, designing, production, marketing and commercial
2010 250,00$

Otto Bock HealthCare GmbH - Strategic Analysis Review

Otto Bock HealthCare GmbH (Otto Bock) is a medical device company engaged in the production and distribution of prosthetic and ort
2010 125,00$

Prodesse, Inc. - Strategic Analysis Review

Gen-Probe Prodesse, Inc. (Prodesse), a biotechnology company engaged in the manufacture, development and distribution of molecular
2010 250,00$

IDS plc - Strategic Analysis Review

IDS plc formally known as IDS Nordic a/s is a biotechnology company, which is principally engaged in the manufacture, development
2010 125,00$

BioMedical Enterprises, Inc. - Strategic Analysis Review

BioMedical Enterprises, Inc. (BME) is a medical device company, engaged in the development, manufacture and marketing of orthopedi
2010 250,00$

FASgen, Inc. - Strategic Analysis Review

FASgen, Inc. (FASgen) is a medical company principally engaged in the manufacturing and development of new drugs and therapeutic p
2010 250,00$

Unipath Limited - Strategic Analysis Review

Unipath Limited (Unipath) is a medical company principally engaged in research, design, production, marketing and sales of diagnos
2010 250,00$

Finsbury Orthopaedics Limited - Strategic Analysis Review

Finsbury Orthopedic Limited (Finsbury) is a medical device company, principally engaged in the design, development, manufacture an
2010 250,00$

TeraRecon, Inc. - Strategic Analysis Review

TeraRecon, Inc. (TeraRecon) is a provider of technological solutions for professional imaging applications with a focus on medical
2010 250,00$

Hai Kang Life Corporation Limited - Strategic Analysis Review

Hai Kang Life Corporation Limited (Hai Kang Life) is a biotechnology company engaged in the research, development and manufacture
2010 250,00$

ARKRAY, Inc. - Strategic Analysis Review

ARKRAY, Inc. (ARKRAY) is engaged in the development and manufacture of medical diagnostic products for diabetes diagnosis, urinaly
2010 250,00$

Globus Medical, Inc. - Strategic Analysis Review

Globus Medical, Inc. (Globus Medical) is a privately-held medical device company, which is principally engaged in the research and
2010 250,00$

Evolved Digital Systems Inc. (EVD) - Strategic Analysis Review

Evolved Digital Systems Inc. (Evolved Digital) is a healthcare technology solutions company, which specializes in delivering manag
2010 250,00$

Fujinon Corporation - Strategic Analysis Review

Fujinon Corporation (Fujinon), formerly Fuji Photo Optical Co., Ltd. is a conglomerate principally engaged in the development, man
2010 250,00$

Coherex Medical, Inc. - Strategic Analysis Review

Coherex Medical, Inc. (Coherex Medical) is a medical device company engaged in the development of innovative medical devices for t
2010 250,00$

Deep Breeze Ltd. - Strategic Analysis Review

Deep Breeze Ltd. (Deep Breeze) is a privately owned medical device company engaged in the development, manufacturing and distribut
2010 250,00$

Hemosystem - Strategic Analysis Review

Hemosystem is a French based biotechnology company, which is principally engaged in the development of solutions that improves saf
2010 250,00$

Kyungwon Medical Co., Ltd. - Strategic Analysis Review

Kyungwon Medical Co., Ltd. (Kyungwon Medical) is a medical device company principally engaged in the manufacture and distribution
2010 250,00$

dbMotion Inc. - Strategic Analysis Review

dbMotion Inc. (dbMotion) is a privately-held healthcare information technology company that provides clinical information integrat
2010 250,00$

iMDsoft Inc. - Strategic Analysis Review

iMDsoft Inc. (iMDsoft) is a privately-held medical software company principally engaged in the development, manufacture and sales
2010 250,00$

Medicalis Corporation - Strategic Analysis Review

Medicalis Corporation (Medicalis) is principally engaged in the development of radiology workflow and decision support solutions.
2010 250,00$

Doxa AB - Strategic Analysis Review

Doxa AB (Doxa) is a dental device company engaged in the manufacture and development of bioceramic dental products. Their products
2010 250,00$

Gene Express, Inc. - Strategic Analysis Review

Gene Express, Inc. (Gene Express) is principally engaged in the development and marketing of molecular diagnostic products and sta
2010 250,00$

Integrated Sensing Systems, Inc. - Strategic Analysis Review

Integrated Sensing Systems, Inc. (ISSYS) is engaged in the design, manufacture, development and distribution of microelectromechan
2010 250,00$

IntelligentMDx - Strategic Analysis Review

IntelligentMDx (IMDx) is a molecular diagnostics company that is engaged in the design, development and marketing of molecular dia
2010 250,00$

ONTEX International N.V. - Strategic Analysis Review

ONTEX International N.V. (ONTEX) is a medical device company. The company is engaged in the design, development, manufacture and m
2010 250,00$

Spectrum Surgical Instruments Corporation - Strategic Analysis Review

Spectrum Surgical Instruments Corporation (Spectrum Surgical) is a medical device supplier, principally involved in providing a br
2010 250,00$

Scanlan International, Inc. - Strategic Analysis Review

Scanlan International (Scanlan) is a medical device company, which is principally engaged in the design, development, manufacture
2010 250,00$

Boss Instruments, Ltd. - Strategic Analysis Review

Boss Instruments, Ltd. (Boss Instruments) is a privately-held medical device company engaged in the development, manufacture and m
2010 250,00$

InterGenetics Incorporated - Strategic Analysis Review

InterGenetics Incorporated (InterGenetics) is engaged in the development and manufacture of genetic medicines with a focus on impr
2010 250,00$

MEDICON eG - Strategic Analysis Review

MEDICON eG (MEDICON) is a medical device company that is principally engaged in the design, manufacture and distribution of surgic
2010 250,00$

ESAOTE S.p.A. - Strategic Analysis Review

ESAOTE S.p.A. (Esaote) is a privately-held company engaged in the manufacturing of the non-invasive diagnostic equipment and syste
2010 125,00$

Bayer MaterialScience AG - Strategic Analysis Review

Bayer MaterialScience AG (BMS), a subsidiary of Bayer AG, is engaged in the development and production of raw materials for coatin
2010 125,00$

Prosonic Co., Ltd. - Strategic Analysis Review

Prosonic Co., Ltd. (Prosonic) is formerly known as Daewon Electronic Co., Ltd. was established in 1990. Prosonic is medical equipm
2010 250,00$

Nypro, Incorporated - Strategic Analysis Review

Nypro, Incorporated (Nypro) is engaged in the designing, manufacturing and development of precision plastics injection molding, de
2010 125,00$

Bracco S.p.A. - Strategic Analysis Review

Bracco S.p.A. (Bracco) is a healthcare company that primarily focuses on diagnostic imaging. Bracco develops optimized contrast ag
2010 125,00$

Jebsen & Jessen (SEA) Pte Ltd - Strategic Analysis Review

The Jebsen & Jessen (SEA) Pte Ltd (Jebsen & Jessen) is a group company and principally operates in seven core businesses namely Ch
2010 250,00$

Shofu Dental Corporation (7979) - Strategic Analysis Review

Shofu Dental Corporation (Shofu) is a dental materials and equipment manufacturer that provides high-quality products and services
2010 250,00$

LipoScience, Inc. - Strategic Analysis Review

LipoSceince, Inc. (LipoScience) is a medical technology company. It is engaged in the research, development and marketing of clini
2010 250,00$

ADVANCE CO., LTD. - Strategic Analysis Review

ADVANCE CO., LTD. (Advance) is principally engaged in the development and manufacture of Medical devices, Information security equ
2010 250,00$

Healthnostics, Inc. (HNSO) - Strategic Analysis Review

Healthnostics, Inc. (Healthnostics) is a medical and biotechnology analytics company, engaged in providing patient clinical monito
2010 250,00$

National Distribution & Contracting, Inc. - Strategic Analysis Review

National Distribution & Contracting, Inc. (NDC) is a distributor company of medical, surgical, dental and laboratory equipments. T
2010 250,00$

Advanced BioHealing, Inc. - Strategic Analysis Review

Advanced BioHealing, Inc. (ABH) is a specialty private biotechnology company. It is engaged in the development and marketing of ce
2010 250,00$

Medical Information Technology, Inc. - Strategic Analysis Review

Medical Information Technology, Inc. (MEDITECH) is a healthcare information technology company. It is engaged in the development,
2010 125,00$

iSOFT Group PLC - Strategic Analysis Review

iSOFT Group plc (iSOFT) is a Healthcare Information Technology company and a part of IBA Health Group. The company is engaged in t
2010 250,00$

CLINICARE Corporation - Strategic Analysis Review

CLINICARE Corporation (CLINICARE) is a healthcare IT company, which is engaged in the development, marketing and providing compute
2010 250,00$

QHR Technologies Inc. (QHR) - Strategic Analysis Review

QHR Technologies Inc. (QHR) is a healthcare IT company, which is specialized in the design of software to improve the efficiency o
2010 125,00$

VEPRO AG - Strategic Analysis Review

VEPRO AG (VEPRO) is a medical technology company that is principally engaged in the development, manufacture, monitoring and distr
2010 250,00$

Healthphone Solutions Limited - Strategic Analysis Review

Healthphone Solutions Limited (Healthphone Solutions) is a Healthcare IT company, which is principally engaged in the development,
2010 250,00$

Profdoc ASA - Strategic Analysis Review

Profdoc ASA (Profdoc) is a healthcare IT company that is engaged in providing healthcare information technology and software to me
2010 250,00$

Spinal Restoration, Inc. - Strategic Analysis Review

Spinal Restoration, Inc. (Spinal Restoration) is a medical device company principally engaged in the development, manufacture and
2010 250,00$

ATMOS MedizinTechnik GmbH & Co. KG - Strategic Analysis Review

ATMOS MedizinTechnik GmbH & Co. KG (ATMOS) is a medical devices company that specializes in the development and manufacture of var
2010 125,00$

Spine Smith, LP - Strategic Analysis Review

Spine Smith, LP (SpineSmith) is a medical device company, which is principally engaged in the design and manufacture of surgical i
2010 250,00$

BioTex, Inc. - Strategic Analysis Review

BioTex, Inc. (BioTex) is principally engaged in the research, development and commercialization of novel optical solutions and tec
2010 250,00$

Focal Corporation - Strategic Analysis Review

Focal Corporation (Focal) is principally engaged in the supply of quality medical products for the healthcare industry to its over
2010 250,00$

Lantis Laser, Inc. (LLSR) - Strategic Analysis Review

Lantis Laser Inc. (Lantis Laser) is a medical device company, engaged in the development, manufacture and distribution of dental t
2010 250,00$

IDMoS plc - Strategic Analysis Review

IDMoS plc (IDMoS) is a medical technology company, which is engaged in the development and providing of innovative technologies an
2010 250,00$

SOLOS Endoscopy, Inc. (SNDY) - Strategic Analysis Review

SOLOS Endoscopy, Inc. (SOLOS) is a medical technology company, engaged in development and marketing of medical devices and technol
2010 250,00$

DMG America LLC - Strategic Analysis Review

DMG America LLC (DMG America), formerly known as Zenith Dental, is a manufacturer and distributor of dental equipment and material
2010 250,00$

Leonhard Lang GmbH - Strategic Analysis Review

Leonhard Lang GmbH (Leonhard) is a privately held medical device company engaged in the design, manufacture and distribution of hi
2010 250,00$

Alltracel Pharmaceuticals plc (AP) - Strategic Analysis Review

Alltracel Pharmaceuticals plc (Alltracel) is a medical technology company, which is principally engaged in the manufacture, distri
2010 250,00$

Symphogen A/S - Strategic Analysis Review

Symphogen A/S is a biopharmaceutical company engaged in developing recombinant polyclonal antibodies (rpAb), a new class of biopha
2010 125,00$

PLC Medical Systems, Inc. (PLCSF) - Strategic Analysis Review

PLC Medical Systems, Inc. (PLC) is engaged in the development and marketing of innovative cardiac and vascular medical device-base
2010 250,00$

Kane Biotech Inc. (KNE) - Strategic Analysis Review

Kane Biotech Inc. (Kane Biotech) is a developmental stage biotechnology company that is principally engaged in the research and de
2010 250,00$

Visicu, Inc. (EICU) - Strategic Analysis Review

VISICU, Inc. (VISICU) is a Healthcare Information Technology company principally engaged in the development, marketing and sale of
2010 250,00$

Biomoda, Inc. (BMOD) - Strategic Analysis Review

Biomoda, Inc. (Biomoda) is a medical device manufacturing company principally engaged in the development of disease specific test
2010 250,00$

XTend Medical Corporation (XMDC) - Strategic Analysis Review

XTend Medical Corporation (XTend Medical) is a healthcare IT company, which is engaged in the development, manufacturing and distr
2010 250,00$

Glide Pharmaceutical Technologies Limited - Strategic Analysis Review

Glide Pharmaceutical Technologies Limited (Glide Pharma) is a specialty pharmaceutical company, which is principally engaged in th
2010 250,00$

Theken - Strategic Analysis Review

Theken family of companies are medical device companies, that are principally engaged in the research, development, manufacture an
2010 125,00$

Alere LLC - Strategic Analysis Review

Alere LLC (Alere) is a healthcare company. It provides the most comprehensive and patient-centric health management services, rang
2010 250,00$

Aquamatrix, Inc. (AQMT) - Strategic Analysis Review

Aquamatrix, Inc. (formerly known as Nesco Industries, Inc.) is a medical device company, which is engaged in developing, manufactu
2010 250,00$

Pan Probe Biotech, Inc. - Strategic Analysis Review

Pan Probe Biotech, Inc. is a medical device manufacturing company in the rapid diagnostic kit industry. It is very useful to detec
2010 250,00$

Sorin Group USA, Inc. - Strategic Analysis Review

Sorin Group USA, Inc. (Sorin USA) is the US division of Sorin Group. The company is engaged in the design, manufacturing and marke
2010 250,00$

PEAK Surgical, Inc. - Strategic Analysis Review

PEAK Surgical, Inc. (PEAK Surgical) is a medical device company, engaged in developing a new category of tissue dissection systems
2010 250,00$

Transasia Bio-Medicals Ltd. - Strategic Analysis Review

Transasia Bio-Medicals Ltd. (Transasia) is an India-based medical device company, engaged in the designing, manufacturing and sel
2010 250,00$

Teijin Pharma Limited - Strategic Analysis Review

Teijin Pharma Limited (Teijin Pharma) is engaged in the manufacturing and marketing of pharmaceuticals and medical devices. It is
2010 250,00$

Shree Pacetronix Ltd. (SPAC) - Strategic Analysis Review

Shree Pacetronix Ltd. (Pacetronix) is a medical equipment company, engaged in development and manufacturing of quality medical equ
2010 250,00$

PulmoBioTech Inc (PLMO) - Strategic Analysis Review

PulmoBioTech Inc (Pulmo) is engaged in designing, development and distributing of medial technology for diagnostic and research ap
2010 250,00$

GANZONI MANAGEMENT AG - Strategic Analysis Review

GANZONI MANAGEMENT AG (Ganzoni) is a medical device manufacturing company, founded in 1864. The company focuses in the research an
2010 125,00$

OrthoPediatrics Corp. - Strategic Analysis Review

OrthoPediatrics Corp. (OrthoPediatrics) is a medical device company, engaged in inventing, designing and distributing anatomically
2010 250,00$

OsteoRad, Co., Ltd. - Strategic Analysis Review

OsteoRad, Co., Ltd. (OsteoRad) is a medical device company. The company mainly focuses on the research and development of novel te
2010 250,00$

HoMedics, Inc. - Strategic Analysis Review

HoMedics, Inc. (HoMedics) is engaged in developing, manufacturing and marketing of self-care, wellness and personal health product
2010 250,00$

BREG Incorporated - Strategic Analysis Review

BREG Incorporated (BREG) is a medical device company engaged in the designing, manufacturing and distribution of orthopedic, recon
2010 125,00$

Aspect Magnet Technologies Ltd. - Strategic Analysis Review

Aspect Magnet Technologies Ltd. (Aspect) is engaged in designing, developing and manufacturing medical- grade, desktop-size, high-
2010 250,00$

Biomagnetics Diagnostics Corporation (BMGP) - Strategic Analysis Review

Biomagnetics Diagnostics Corporation (Biomagnetics Diagnostics) is a medical devices company that is principally engaged in provid
2010 250,00$

Sialo Technology Ltd. (SALO) - Strategic Analysis Review

Sialo Technology Ltd. (Sialo Technology) is a developer of medical devices for the treatment of temporomandibular joint (TMJ) synd
2010 250,00$

Span Diagnostics Ltd. (524727) - Strategic Analysis Review

Span Diagnostics Ltd. (Span Diagnostics) is an Indian based company. It is principally engaged in the manufacture and marketing of
2010 125,00$

Julius Zorn, Inc. - Strategic Analysis Review

Julius Zorn, Inc. (Juzo) is engaged in the manufacture of medical compression and support therapy garments. Their products are dev
2010 250,00$

Bauerfeind USA, Inc. - Strategic Analysis Review

Bauerfeind USA, Inc. (Bauerfeind USA) is engaged in the manufacturing of orthopedic supports and orthoses. The company is involved
2010 250,00$

Sanrad International Pvt Ltd - Strategic Analysis Review

Sanrad International Pvt Ltd (Sanrad) is a medical equipment supplier. Sanrad is engaged in the business of import, export, and sa
2010 250,00$

Kronos Incorporated - Strategic Analysis Review

Kronos Incorporated (Kronos) is a US-based privately-held technology company. The company is engaged in providing human capital ma
2010 250,00$

biospace med - Strategic Analysis Review

The company Biospace Med (formerly BIOSPACE Instruments) is an orthopedic imaging company is primarily engaged in manufacture of e
2010 250,00$

Ascent Healthcare Solutions, Inc. - Strategic Analysis Review

Ascent Healthcare Solutions, Inc. (Ascent) is a privately held medical device company engaged in medical device reprocessing and r
2010 250,00$

Unomedical Inc. - Strategic Analysis Review

Unomedical Inc. (Unomedical), is engaged in the manufacture and distribution of single use respiratory and anesthesiology care pro
2010 250,00$

CBaySystems Holdings Ltd. (CBAY) - Strategic Analysis Review

CBaySystems Holdings Ltd. (CBaySystems) is a privately-held healthcare IT company engaged in providing software solutions for hea
2010 250,00$

Diagnostic Imaging International Corp. (DIIG) - Strategic Analysis Review

Diagnostic Imaging International Corp. (DIIC) is a US based medical device company. The company was formerly known as Galloway Inv
2010 250,00$

Oberg Industries, Inc. - Strategic Analysis Review

Oberg Industries, Inc. (Oberg) is engaged in providing precision manufacturing technologies to various industries. Its product por
2010 250,00$

Marshall Products Limited - Strategic Analysis Review

Marshall Products Limited (Marshall) is a medical equipment supplier company engaged in the importing, marketing and distribution
2010 250,00$

KARL STORZ Endoscopy-America, Inc. - Strategic Analysis Review

KARL STORZ Endoscopy-America, Inc. (KSEA) is a medical device company that is engaged in the marketing and distribution of endosco
2010 250,00$

Xion GmbH - Strategic Analysis Review

Xion GmbH (Xion) is a privately held medical devices company engaged in the manufacturing of bronchoscopes, video endoscopes, naso
2010 250,00$

ChromoCure, Inc. (KKUR) - Strategic Analysis Review

ChromoCure, Inc., formerly known as Cyberhand Technologies International, Inc., is engaged in developing and providing technologie
2010 250,00$

Allocade, Inc. - Strategic Analysis Review

Allocade, Inc. (Allocade) is a privately owned software technology company, which focuses on the development and marketing of capa
2010 250,00$

Medtronic Xomed, Inc. - Strategic Analysis Review

Medtronic Xomed, Inc. (Medtronic Xomed), a subsidiary of Medtronic, Inc., is engaged in the development, manufacturing and marketi
2010 125,00$

InStar Systems International, LLC - Strategic Analysis Review

InStar Systems International, LLC (InStar Systems) is a privately-held company, which is engaged in providing a wide range of radi
2010 250,00$

eClinicalWorks, LLC - Strategic Analysis Review

eClinicalWorks, LLC (eClinicalWorks) is a privately-held healthcare IT company that is engaged in providing the tools needed for h
2010 125,00$

Systagenix Wound Management - Strategic Analysis Review

Systagenix Wound Management (Systagenix) is a medical device company engaged in developing wound care solutions. Its product portf
2010 250,00$

Materialise NV - Strategic Analysis Review

The Materialise Group (Materialise) is a diversified business company, engaged in providing prototyping, software, medical, and de
2010 250,00$

Medixsysteme - Strategic Analysis Review

Medixsysteme is a medical device company, which is principally engaged in the manufacture of medical equipments in France. The com
2010 250,00$

Cardiocom, LLC - Strategic Analysis Review

Cardiocom, LLC (Cardiocom) is a leader in providing patient monitoring and disease management solutions to the healthcare communit
2010 250,00$

Healthpoint, Ltd. - Strategic Analysis Review

Healthpoint, Ltd. (Healthpoint) is a specialty pharmaceutical company, which is engaged in the development and marketing of high-q
2010 250,00$

JN-International Medical Corporation - Strategic Analysis Review

JN-International Medical Corporation (JNI Medical) is a privately-held biopharmaceutical corporation. The company focuses on the d
2010 250,00$

American Scientific Resources, Inc. (ASFX) - Strategic Analysis Review

American Scientific Resources, Inc. (ASR) is a provider of medical products and healthcare supplements through retail drug chains,
2010 250,00$

Barco Medical Imaging - Strategic Analysis Review

Barco Medical Imaging (Barco Medical) is engaged in the design, development, manufacture and supply of visualization products for
2010 125,00$

Dr. Langer Medical GmbH - Strategic Analysis Review

Dr. Langer Medical GmbH (Langer Medical) is engaged in the design and development of devices for intraoperative neurological monit
2010 250,00$

Asyah Haavot Ltd. - Strategic Analysis Review

Asyah Haavot Ltd. (Asyah) is a privately-held wholesale medical supplier company. The company focuses on marketing and distributio
2010 250,00$

Eldan Electronic Instruments Co. Ltd - Strategic Analysis Review

Eldan Electronic Instruments Co. Ltd (Eldan) is a privately-held supplier of equipment and consumables in the areas of Healthcare,
2010 250,00$

ATEK Medical, LLC - Strategic Analysis Review

ATEK Medical, LLC (ATEK Medical) is a privately-owned contract manufacturer of medical devices. The company offers complete produc
2010 250,00$

Nobel Biocare AB (NOBL) - Strategic Analysis Review

Nobel Biocare AB (Nobel Biocare) is a publicly held medical device company engaged in the production of pioneer dental solutions u
2010 250,00$

Bederra Corporation (BDRR) - Strategic Analysis Review

Bederra Corporation is a diversified medical services provider and is engaged in financing of equipment and other assets to doctor
2010 250,00$

Maximus Medical Products, Inc. - Strategic Analysis Review

Maximus Medical Products, Inc. (Maximus Medical) is engaged in the manufacture and distribution of specialty intravenous (I.V.) th
2010 250,00$

Metiscan, Inc. (MTIZ) - Strategic Analysis Review

Metiscan, Inc. (Metiscan) is a public company that is focused on healthcare related businesses. The company is a provider of web-b
2010 250,00$

LifeMasters Supported SelfCare, Inc. - Strategic Analysis Review

LifeMasters Supported SelfCare, Inc. (LifeMasters) is a US based disease management company. The company is engaged in the provisi
2010 250,00$

Goold Health Systems, Inc. - Strategic Analysis Review

Goold Health Systems, Inc. (GHS) is a privately-held healthcare management company that focuses in providing pharmacy benefit serv
2010 250,00$

Capsule Technologie S.A. - Strategic Analysis Review

Capsule Technologie S.A. (Capsule) is one of the leading medical device company that deals in providing Enterprise Medical Device
2010 250,00$

Dimensional Insight, Inc. - Strategic Analysis Review

Dimensional Insight, Inc. (DI) is specialty service providing company that specializes in the development and marketing of multidi
2010 250,00$

Peter-Brehm GMBH - Strategic Analysis Review

Peter-Brehm GMBH (Peter-Brehm) is engaged in the research, development, manufacture, marketing and export of medical devices for t
2010 250,00$

Futuremed Health Care Products L.P.s - Strategic Analysis Review

Futuremed Health Care Products L.P. (Futuremed) is a privately-held medical devices company. It is engaged in the development, man
2010 250,00$

Sonic Innovations, Inc. - Strategic Analysis Review

Sonic Innovations, Inc. (Sonic) is a hearing aid company, which is engaged in the design, development, manufacture and marketing o
2010 250,00$

Arthro Kinetics plcs - Strategic Analysis Review

Arthro Kinetics plc (Arthro Kinetics) is an orthopedic company engaged in the development and commercialization of biological cart
2010 250,00$

ESTECH - Strategic Analysis Review

ESTECH is a medical device company engaged in the manufacture and distribution of least invasive products for cardiac surgery. The
2010 250,00$

Atto Corporation - Strategic Analysis Review

Atto Corporation (Atto) is a medical device manufacturing company principally engaged in developing, manufacturing and marketing o
2010 250,00$

Futuremed Healthcare Income Fund (FMD.UN) - Strategic Analysis Review

Futuremed Healthcare Income Fund (Futuremed) is engaged in the manufacture and distribution of innovative healthcare products. The
2010 250,00$

Health Science Products, Inc. - Strategic Analysis Review

Health Science Products, Inc. (Health Science Products) is a medical device company, engaged in the design and manufacture of dent
2010 250,00$

A&T Corporation (6722) - Strategic Analysis Review

This comprehensive SWOT profile of A&T Corporation provides you an in-depth strategic analysis of the company’s businesses and ope
2010 250,00$

DOBI Medical International, Inc. - Strategic Analysis Review

DOBI Medical International, Inc. (DOBI Medical) is a technology based medical device company engaged in the development of diagnos
2010 250,00$

The Medical House PLC (MLH) - Strategic Analysis Review

The Medical House PLC (TMH) is engaged in the development and supply of innovative delivery systems for injectable drugs. Its prod
2010 250,00$

American Shared Hospital Services - Strategic Analysis Review

This comprehensive SWOT profile of American Shared Hospital Services provides you an in-depth strategic analysis of the company’s
2010 250,00$

Healthcare Integrated Services, Inc. - Strategic Analysis Review

Healthcare Integrated Services, Inc. is engaged in manufacture and sale of medical devices Relating to Diagnostic Imaging and Also
2010 250,00$

Topcon Corporation - Strategic Analysis Review

This comprehensive SWOT profile of Topcon Corporation provides you an in-depth strategic analysis of the company’s businesses and
2010 250,00$

Rockeby Biomed Limiteds - Strategic Analysis Review

Rockeby biomed Limited (Rockeby), is bio-technology service provider company. The company is principally engaged in the research a
2010 125,00$

Baumer S.A.s - Strategic Analysis Review

Baumer S.A. (Baumer) is a medical device manufacturing company principally engaged in the development, manufacturing and marketing
2010 250,00$

Safety Medical Products Limited (SFP) - Strategic Analysis Review

This comprehensive SWOT profile of Safety Medical Products Limited provides you an in-depth strategic analysis of the company’s bu
2010 250,00$

National Quality Care, Inc. (NQCI) - Strategic Analysis Review

This comprehensive SWOT profile of National Quality Care, Inc. provides you an in-depth strategic analysis of the company’s busine
2010 250,00$

Integrated Surgical Systems, Inc. (ISSM) - Strategic Analysis Review

This comprehensive SWOT profile of Integrated Surgical Systems, Inc. provides you an in-depth strategic analysis of the company’s
2010 250,00$

SMC Ventures Inc. - Strategic Analysis Review

This comprehensive SWOT profile of SMC Ventures Inc. provides you an in-depth strategic analysis of the company’s businesses and o
2010 250,00$

HealtheTech, Inc. - Strategic Analysis Review

This comprehensive SWOT profile of HealtheTech, Inc. provides you an in-depth strategic analysis of the company’s businesses and o
2010 250,00$

Glycorex Transplantation AB - Strategic Analysis Review

This comprehensive SWOT profile of Glycorex Transplantation AB provides you an in-depth strategic analysis of the company’s busine
2010 250,00$

Cell Robotics International, Inc. (CRII) - Strategic Analysis Review

Cell Robotics International, Inc. manufactures, markets and sells laser-based medical devices and scientific research instruments.
2010 250,00$

Ichimaru Sangyo Co., Ltd. - Strategic Analysis Review

This comprehensive SWOT profile of Ichimaru Sangyo Co., Ltd. provides you an in-depth strategic analysis of the company’s business
2010 250,00$

SurgiLight, Inc. - Strategic Analysis Review

This comprehensive SWOT profile of SurgiLight, Inc. provides you an in-depth strategic analysis of the company’s businesses and op
2010 250,00$

Morishita Jintan Co., Ltd. - Strategic Analysis Review

Morishita Jintan Co., Ltd. is a Japan based company that engages in offering product and services in the OTC market. The company o
2010 250,00$

Nadex Co., Ltd. - Strategic Analysis Review

Nadex Co., Ltd. is a Japan-based company that engages in offering product and services in the Opthalmic device market. The company
2010 250,00$

OKAMOTO INDUSTRIES, INC. - Strategic Analysis Review

This comprehensive SWOT profile of OKAMOTO INDUSTRIES, INC. provides you an in-depth strategic analysis of the company’s businesse
2010 250,00$

Hartest Holdings plc (HTH) - Strategic Analysis Review

Hartest Holdings plc is a medical device company engaged in the manufacture and sale of specialist scientific instrumentation toge
2010 250,00$

Cardio Vascular Medical Device Corp. - Strategic Analysis Review

This comprehensive SWOT profile of Cardio Vascular Medical Device Corp. provides you an in-depth strategic analysis of the company
2010 250,00$

Sagentia Group AG (SAG) - Strategic Analysis Review

This comprehensive SWOT profile of Sagentia Group AG provides you an in-depth strategic analysis of the company’s businesses and o
2010 250,00$

Medigus Ltd. (MDGS) - Strategic Analysis Review

This comprehensive SWOT profile of Medigus Ltd. provides you an in-depth strategic analysis of the company’s businesses and operat
2010 250,00$

Ingen Technologies, Inc. - Strategic Analysis Review

This comprehensive SWOT profile of Ingen Technologies, Inc. provides you an in-depth strategic analysis of the company’s businesse
2010 250,00$

InforMedix Holdings, Inc. (IFMX) - Strategic Analysis Review

This comprehensive SWOT profile of InforMedix Holdings, Inc. provides you an in-depth strategic analysis of the company’s business
2010 250,00$

Acceleware Corp. (AXE) - Strategic Analysis Review

This comprehensive SWOT profile of Acceleware Corp. provides you an in-depth strategic analysis of the company’s businesses and op
2010 250,00$

Synbiotics Corporation - Strategic Analysis Review

Synbiotics Corporation, based in Kansas City,United States, is a developer, manufacturer and marketer of diagnostic products dedi
2010 250,00$

A&D Company, Limited. - Strategic Analysis Review

This comprehensive SWOT profile of A&D Company, Limited. provides you an in-depth strategic analysis of the company’s businesses a
2010 250,00$

American Science & Engineering Inc (ASEI) - Strategic Analysis Review

American Science & Engineering Inc is engaged in manufacturing of X-ray inspection products that can be used to inspect parcels, b
2010 250,00$

Atos Wellness Ltd - Strategic Analysis Review

This comprehensive SWOT profile of Atos Wellness Ltd provides you an in-depth strategic analysis of the company’s businesses and o
2010 250,00$

Bb Medtech Ag - Strategic Analysis Review

This comprehensive SWOT profile of Bb Medtech Ag provides you an in-depth strategic analysis of the company’s businesses and opera
2010 250,00$

Bio-Gate Ag (BIG) - Strategic Analysis Review

This comprehensive SWOT profile of Bio-Gate Ag provides you an in-depth strategic analysis of the company’s businesses and operati
2010 250,00$

Biomerge Industries Ltd. (BIL.H) - Strategic Analysis Review

This comprehensive SWOT profile of Biomerge Industries Ltd. provides you an in-depth strategic analysis of the company’s businesse
2010 250,00$

Capitol Health Limited - Strategic Analysis Review

This comprehensive SWOT profile of Capitol Health Limited provides you an in-depth strategic analysis of the company’s businesses
2010 125,00$

China Asean Resources Limited - Strategic Analysis Review

This comprehensive SWOT profile of China Asean Resources Limited provides you an in-depth strategic analysis of the company’s busi
2010 250,00$

Corem Property Group Ab - Strategic Analysis Review

Corem Property Group AB (publ) is a real estate company that owns and manages properties in central and southern Sweden and Denmar
2010 250,00$

Cul 2 Inc. - Strategic Analysis Review

This comprehensive SWOT profile of Cul 2 Inc. provides you an in-depth strategic analysis of the company’s businesses and operatio
2010 250,00$

Egm International, Inc. - Strategic Analysis Review

This comprehensive SWOT profile of Egm International, Inc. provides you an in-depth strategic analysis of the company’s businesses
2010 250,00$

Ellen Ab - Strategic Analysis Review

This comprehensive SWOT profile of Ellen Ab provides you an in-depth strategic analysis of the company’s businesses and operations
2010 250,00$

Euromedis Groupe Sa (EMG) - Strategic Analysis Review

Euromedis Groupe Sa is a medical device company which provides products in five different categories. They are parenteral access,
2010 250,00$

Fenwal Controls Of Japan Ltd - Strategic Analysis Review

This comprehensive SWOT profile of Fenwal Controls Of Japan Ltd provides you an in-depth strategic analysis of the company’s busin
2010 250,00$

Gentex Corporation (GNTX) - Strategic Analysis Review

Gentex Corporation designs, develops, manufactures and markets products employing electro-optic technology, automatic-dimming rear
2010 250,00$

Jawon Medical Co.,Ltd. - Strategic Analysis Review

Jawon Medical Co.,Ltd. is a medical device company that is engaged in the design and development of Body composition analysers and
2010 250,00$

Kel Corporation - Strategic Analysis Review

This comprehensive SWOT profile of Kel Corporation provides you an in-depth strategic analysis of the company’s businesses and ope
2010 250,00$

Kmh Co Ltd - Strategic Analysis Review

This comprehensive SWOT profile of Kmh Co Ltd provides you an in-depth strategic analysis of the company’s businesses and operatio
2010 250,00$

Liberating Technologies Inc - Strategic Analysis Review

This comprehensive SWOT profile of Liberating Technologies Inc provides you an in-depth strategic analysis of the company’s busine
2010 250,00$

Lifeport, Inc - Strategic Analysis Review

This comprehensive SWOT profile of Lifeport, Inc provides you an in-depth strategic analysis of the company’s businesses and opera
2010 250,00$

Mani, Inc. (7730) - Strategic Analysis Review

This comprehensive SWOT profile of Mani, Inc. provides you an in-depth strategic analysis of the company’s businesses and operatio
2010 250,00$

Medic Vision Limited - Strategic Analysis Review

Medic Vision Limited is an Australia based provider of healthcare training solutions. The company engages in providing training se
2010 250,00$

Medical Resources Inc - Strategic Analysis Review

Medical Resources, Inc. is a company which owns and manages fixed-site outpatient medical diagnostic imaging centers in the United
2010 250,00$

Monogen, Inc. - Strategic Analysis Review

Monogen, Inc. (Monogen) is a medical devices and diagnostics company that offers cytological screening and diagnostic products for
2010 250,00$

Oculus Innovative Sciences Netherlands B.V. - Strategic Analysis Review

Oculus Innovative Sciences Netherlands B.V. is a wholly owned subsidiary of Oculus Innovative Sciences, Inc. was founded at the en
2010 250,00$

Photon Control Inc - Strategic Analysis Review

This comprehensive SWOT profile of Photon Control Inc provides you an in-depth strategic analysis of the company’s businesses and
2010 250,00$

Polartechnics Limited - Strategic Analysis Review

Polartechnics Limited is a life sciences company involved in the research, development, manufacture and marketing of innovative me
2010 125,00$

Poly Medicure Ltd. - Strategic Analysis Review

This comprehensive SWOT profile of Poly Medicure Ltd. provides you an in-depth strategic analysis of the company’s businesses and
2010 250,00$

Roesch Ag Medizintechnik - Strategic Analysis Review

This comprehensive SWOT profile of Roesch Ag Medizintechnik provides you an in-depth strategic analysis of the company’s businesse
2010 250,00$

Scantek Medical, Inc. - Strategic Analysis Review

Scantek Medical, Inc. (Scantek) is engaged in the design and marketing of BreastCare Differential Temperature Sensor (DTS). The pr
2010 250,00$

Shanghai Pudong Jinhuan Medical Products Co., Ltd. - Strategic Analysis Review

Shanghai Pudong Jinhuan Medical Products Co., Ltd. (Jinhuan) is engaged in manufacturing and marketing of single use medical instr
2010 250,00$

Simtronics Asa - Strategic Analysis Review

This comprehensive SWOT profile of Simtronics Asa provides you an in-depth strategic analysis of the company’s businesses and oper
2010 250,00$

Somnomed Limited - Strategic Analysis Review

This comprehensive SWOT profile of Somnomed Limited provides you an in-depth strategic analysis of the company’s businesses and op
2010 125,00$

Sound Health Solutions Inc. - Strategic Analysis Review

This comprehensive SWOT profile of Sound Health Solutions Inc. provides you an in-depth strategic analysis of the company’s busine
2010 250,00$

Sunray Holdings Limited - Strategic Analysis Review

This comprehensive SWOT profile of Sunray Holdings Limited provides you an in-depth strategic analysis of the company’s businesses
2010 250,00$

Trestle Holdings, Inc. - Strategic Analysis Review

Trestle Holdings, Inc. is engaged in the development and selling of digital tissue imaging products and solutions for improved wor
2010 250,00$

Tso3 Inc (TOS) - Strategic Analysis Review

This comprehensive SWOT profile of Tso3 Inc provides you an in-depth strategic analysis of the company’s businesses and operations
2010 125,00$

Viscom Ag - Strategic Analysis Review

This comprehensive SWOT profile of Viscom Ag provides you an in-depth strategic analysis of the company’s businesses and operation
2010 250,00$

Yagami Inc. - Strategic Analysis Review

This comprehensive SWOT profile of Yagami Inc. provides you an in-depth strategic analysis of the company’s businesses and operati
2010 250,00$

Immersion Corporation - Strategic Analysis Review

Immersion Corporation is engaged in developing touch technology for automotive, consumer electronics, gaming, industrial, commerci
2010 250,00$

Emerging Vision, Inc. - Strategic Analysis Review

This comprehensive SWOT profile of Emerging Vision, Inc. provides you an in-depth strategic analysis of the company’s businesses a
2010 250,00$

Oncologix Tech, Inc. (OCLG) - Strategic Analysis Review

Oncologix Tech, Inc. (OCLG) is engaged in the research and development of medical devices for the treatment of soft tissue cancers
2010 250,00$

In Veritas Medical Diagnostics Inc. (IVME) - Strategic Analysis Review

This comprehensive SWOT profile of In Veritas Medical Diagnostics Inc. provides you an in-depth strategic analysis of the company’
2010 125,00$

DSM Dyneema - Strategic Analysis Review

This comprehensive SWOT profile of DSM Dyneema provides you an in-depth strategic analysis of the company’s businesses and operati
2010 125,00$

co.don AG - Strategic Analysis Review

This comprehensive SWOT profile of co.don AG provides you an in-depth strategic analysis of the company’s businesses and operation
2010 250,00$

HepaLife Technologies Inc. (HPLF) - Strategic Analysis Review

HepaLife Technologies, Inc. (HepaLife) is Bioartificial Liver System Developer in United States. The company was principally engag
2010 250,00$

INDUS Holding AG - Strategic Analysis Review

This comprehensive SWOT profile of INDUS Holding AG provides you an in-depth strategic analysis of the company’s businesses and op
2010 250,00$

CLX Medical, Inc. (CLXM) - Strategic Analysis Review

This comprehensive SWOT profile of CLX Medical, Inc. provides you an in-depth strategic analysis of the company’s businesses and o
2010 250,00$

American HealthChoice, Inc. - Strategic Analysis Review

This comprehensive SWOT profile of American HealthChoice, Inc. provides you an in-depth strategic analysis of the company’s busine
2010 250,00$

Acrongenomics Inc. (AGNM) - Strategic Analysis Review

Acrongenomics, Inc. is engaged in developing and commercializing novel technology platforms concerning the life sciences sector. A
2010 250,00$

addVise inredning skyddsventilation AB (ADDV) - Strategic Analysis Review

This comprehensive SWOT profile of addVise inredning skyddsventilation AB provides you an in-depth strategic analysis of the compa
2010 250,00$

Advanced Optics Electronics Inc. (ADOT) - Strategic Analysis Review

This comprehensive SWOT profile of Advanced Optics Electronics Inc. provides you an in-depth strategic analysis of the company’s b
2010 250,00$

Applisonix Ltd. (APLS) - Strategic Analysis Review

This comprehensive SWOT profile of Applisonix Ltd. provides you an in-depth strategic analysis of the company’s businesses and ope
2010 250,00$

Austofix Group Limited (AYX) - Strategic Analysis Review

This comprehensive SWOT profile of Austofix Group Limited provides you an in-depth strategic analysis of the company’s businesses
2010 125,00$

Bilcare Limited (526853) - Strategic Analysis Review

Bilcare Limited is engaged in pharma packaging research solutions. It is a solutions provider that partners with the global pharma
2010 250,00$

MeVis Medical Solutions AG - Strategic Analysis Review

This comprehensive SWOT profile of MeVis Medical Solutions AG provides you an in-depth strategic analysis of the company’s busines
2010 125,00$

GENESIS BIOMEDICAL LTD - Strategic Analysis Review

This comprehensive SWOT profile of GENESIS BIOMEDICAL LTD provides you an in-depth strategic analysis of the company’s businesses
2010 125,00$

Allied Motion Technologies, Inc. - Strategic Analysis Review

This comprehensive SWOT profile of Allied Motion Technologies, Inc. provides you an in-depth strategic analysis of the company’s b
2010 250,00$

Bio-Cell Ltd. - Strategic Analysis Review

Bio-Cell Ltd. focuses on the development and manufacturing of protein-based medicines, using genetically engineered vegetal cultur
2010 250,00$

Allan International Holdings Ltd. (684) - Strategic Analysis Review

This comprehensive SWOT profile of Allan International Holdings Ltd. provides you an in-depth strategic analysis of the company’s
2010 250,00$

American Biomed, Inc. - Strategic Analysis Review

This comprehensive SWOT profile of American Biomed, Inc. provides you an in-depth strategic analysis of the company’s businesses a
2010 250,00$

Bio-Matrix Scientific Group, Inc. - Strategic Analysis Review

Bio-Matrix Scientific Group, Inc. is a biotechnology research and development company engaged in inventing, developing, acquiring
2010 250,00$

Lifeline Scientific, Inc. (LSI) - Strategic Analysis Review

This comprehensive SWOT profile of Lifeline Scientific, Inc. provides you an in-depth strategic analysis of the company’s business
2010 250,00$

Raysearch Laboratories AB - Strategic Analysis Review

Raysearch Laboratories AB is a medical technology company that develops software for radiation therapy of cancer. The company's pr
2010 250,00$

Polylite Taiwan Co., Ltd. (1813) - Strategic Analysis Review

This comprehensive SWOT profile of Polylite Taiwan Co., Ltd. provides you an in-depth strategic analysis of the company’s business
2010 250,00$

Electronic Sensor Technology (ESNR) - Strategic Analysis Review

This comprehensive SWOT profile of Electronic Sensor Technology provides you an in-depth strategic analysis of the company’s busin
2010 250,00$

MDwerks, Inc. (MDWK) - Strategic Analysis Review

This comprehensive SWOT profile of MDwerks, Inc. provides you an in-depth strategic analysis of the company’s businesses and opera
2010 250,00$

Invivosense ASA - Strategic Analysis Review

This comprehensive SWOT profile of Invivosense ASA provides you an in-depth strategic analysis of the company’s businesses and ope
2010 250,00$

Guidant Corp. - Strategic Analysis Review

This comprehensive SWOT profile of Guidant Corp. provides you an in-depth strategic analysis of the company’s businesses and opera
2010 250,00$

Caprius, Inc. (CAPI) - Strategic Analysis Review

This comprehensive SWOT profile of Caprius, Inc. provides you an in-depth strategic analysis of the company’s businesses and opera
2010 250,00$

PJ Electronics Co., Ltd. (6140) - Strategic Analysis Review

This comprehensive SWOT profile of PJ Electronics Co., Ltd. provides you an in-depth strategic analysis of the company’s businesse
2010 250,00$

CUREXO INC. - Strategic Analysis Review

This comprehensive SWOT profile of CUREXO INC. provides you an in-depth strategic analysis of the company’s businesses and operati
2010 250,00$

Theralase Technologies Inc. - Strategic Analysis Review

This comprehensive SWOT profile of Theralase Technologies Inc. provides you an in-depth strategic analysis of the company’s busine
2010 125,00$

Cryonic Medical SA (MLCRY) - Strategic Analysis Review

This comprehensive SWOT profile of Cryonic Medical SA provides you an in-depth strategic analysis of the company’s businesses and
2010 250,00$

C-Rad AB (CRAD B) - Strategic Analysis Review

This comprehensive SWOT profile of C-Rad AB provides you an in-depth strategic analysis of the company’s businesses and operations
2010 250,00$

Universal Detection Technology - Strategic Analysis Review

Universal Detection Technology is a developer of monitoring technologies, including bio-terrorism detection devices.presently the
2010 250,00$

ANGLE plc (AGL) - Strategic Analysis Review

This comprehensive SWOT profile of ANGLE plc provides you an in-depth strategic analysis of the company’s businesses and operation
2010 250,00$

3M India Limited (523395) - Strategic Analysis Review

This comprehensive SWOT profile of 3M India Limited provides you an in-depth strategic analysis of the company’s businesses and op
2010 250,00$

IntriCon Corporation (IIN) - Strategic Analysis Review

This comprehensive SWOT profile of IntriCon Corporation provides you an in-depth strategic analysis of the company’s businesses an
2010 250,00$

Oclaro, Inc. (OCLR) - Strategic Analysis Review

Oclaro, Inc. is a engaged in providing optical and laser components and solutions for a broad range of diverse markets, including
2010 250,00$

1300 Smiles Limited (ONT) - Strategic Analysis Review

This comprehensive SWOT profile of 1300 Smiles Limited provides you an in-depth strategic analysis of the company’s businesses and
2010 250,00$

athenahealth, Inc. (ATHN) - Strategic Analysis Review

athenahealth, Inc. offers the revenue cycle management solution to the healthcare industry. The company provides services related
2010 250,00$

HealthStream, Inc. (HSTM) - Strategic Analysis Review

This comprehensive SWOT profile of HealthStream, Inc. provides you an in-depth strategic analysis of the company’s businesses and
2010 250,00$

Chemel AB - Strategic Analysis Review

This comprehensive SWOT profile of Chemel AB provides you an in-depth strategic analysis of the company’s businesses and operation
2010 250,00$

ZMAY Holdings Limited (8085) - Strategic Analysis Review

This comprehensive SWOT profile of ZMAY Holdings Limited provides you an in-depth strategic analysis of the company’s businesses a
2010 250,00$

Techtran Polylenses Limited (523455) - Strategic Analysis Review

This comprehensive SWOT profile of Techtran Polylenses Limited provides you an in-depth strategic analysis of the company’s busine
2010 250,00$

Omnisystem Co., Ltd (57540) - Strategic Analysis Review

This comprehensive SWOT profile of Omnisystem Co., Ltd provides you an in-depth strategic analysis of the company’s businesses and
2010 250,00$

Memory & Testing Inc. (65150) - Strategic Analysis Review

This comprehensive SWOT profile of Memory & Testing Inc. provides you an in-depth strategic analysis of the company’s businesses a
2010 250,00$

3S Korea Co., Ltd. (60310) - Strategic Analysis Review

This comprehensive SWOT profile of 3S Korea Co., Ltd. provides you an in-depth strategic analysis of the company’s businesses and
2010 250,00$

Universal Vision Biotechnology Co., Ltd (3218) - Strategic Analysis Review

This comprehensive SWOT profile of Universal Vision Biotechnology Co., Ltd provides you an in-depth strategic analysis of the comp
2010 250,00$

Berli Jucker Public Company Limited (BJC) - Strategic Analysis Review

This comprehensive SWOT profile of Berli Jucker Public Company Limited provides you an in-depth strategic analysis of the company’
2010 125,00$

Pharma Plast Co. S.A.E - Strategic Analysis Review

This comprehensive SWOT profile of Pharma Plast Co. S.A.E provides you an in-depth strategic analysis of the company’s businesses
2010 250,00$

3D Diagnostic Imaging plc (3DDP) - Strategic Analysis Review

This comprehensive SWOT profile of 3D Diagnostic Imaging plc provides you an in-depth strategic analysis of the company’s business
2010 250,00$

CANTRONIC Systems Inc. - Strategic Analysis Review

This comprehensive SWOT profile of CANTRONIC Systems Inc. provides you an in-depth strategic analysis of the company’s businesses
2010 250,00$

Dignitana AB (DIGN) - Strategic Analysis Review

This comprehensive SWOT profile of Dignitana AB provides you an in-depth strategic analysis of the company’s businesses and operat
2010 250,00$

EchoCath, Inc. (ECHTA) - Strategic Analysis Review

This comprehensive SWOT profile of EchoCath, Inc. provides you an in-depth strategic analysis of the company’s businesses and oper
2010 250,00$

Photoelectron Corporation (PECN) - Strategic Analysis Review

This comprehensive SWOT profile of Photoelectron Corporation provides you an in-depth strategic analysis of the company’s business
2010 250,00$

American Cryostem Corp - Strategic Analysis Review

This comprehensive SWOT profile of American Cryostem Corp provides you an in-depth strategic analysis of the company’s businesses
2010 250,00$

Resonance Health Limited (RHT) - Strategic Analysis Review

This comprehensive SWOT profile of Resonance Health Limited provides you an in-depth strategic analysis of the company’s businesse
2010 125,00$

Toumaz Holdings Limited - Strategic Analysis Review

This comprehensive SWOT profile of Toumaz Holdings Limited provides you an in-depth strategic analysis of the company’s businesses
2010 250,00$

HeartWare International, Inc. - Strategic Analysis Review

This comprehensive SWOT profile of HeartWare International, Inc. provides you an in-depth strategic analysis of the company’s busi
2010 125,00$

ACTHERM INC. - Strategic Analysis Review

This comprehensive SWOT profile of ACTHERM INC. provides you an in-depth strategic analysis of the company’s businesses and operat
2010 250,00$

Advanced BioMedical Technologies, Inc. (ABMT) - Strategic Analysis Review

This comprehensive SWOT profile of Advanced BioMedical Technologies, Inc. provides you an in-depth strategic analysis of the compa
2010 250,00$

Avisio, Inc. - Strategic Analysis Review

This comprehensive SWOT profile of Avisio, Inc. provides you an in-depth strategic analysis of the company’s businesses and operat
2010 250,00$

B2 Health Inc. (BTWO) - Strategic Analysis Review

This comprehensive SWOT profile of B2 Health Inc. provides you an in-depth strategic analysis of the company’s businesses and oper
2010 250,00$

D.Western Therapeutics Institute, Inc. (4576) - Strategic Analysis Review

This comprehensive SWOT profile of D.Western Therapeutics Institute, Inc. provides you an in-depth strategic analysis of the compa
2010 250,00$

HANS BIOMED CORPORATION (42520) - Strategic Analysis Review

This comprehensive SWOT profile of HANS BIOMED CORPORATION provides you an in-depth strategic analysis of the company’s businesses
2010 250,00$

Healthcare Enterprise Group PLC (HCEG) - Strategic Analysis Review

This comprehensive SWOT profile of Healthcare Enterprise Group PLC provides you an in-depth strategic analysis of the company’s bu
2010 250,00$

Microvision, Inc. (MVIS) - Strategic Analysis Review

This comprehensive SWOT profile of Microvision, Inc. provides you an in-depth strategic analysis of the company’s businesses and o
2010 250,00$

MZT Holdings, Inc. (MZT) - Strategic Analysis Review

MZT Holdings, Inc. (formerly Matritech, Inc.), is engaged in development of proteomics-based diagnostic products for the early det
2010 250,00$

Alexandria Medical Services Company (AMES) - Strategic Analysis Review

Alexandria Medical Services Company is a company engaged in providing medical diagnostic and treatment services. Its facilities in
2010 250,00$

biOasis Technologies Inc. (BTI.V) - Strategic Analysis Review

biOasis Technologies Inc. (formerly W.R. Partners Ltd.) is a biotechnology company engaged in the development of biomarkers for di
2010 125,00$

Sun Life Corporation - Strategic Analysis Review

This comprehensive SWOT profile of Sun Life Corporation provides you an in-depth strategic analysis of the company’s businesses an
2010 250,00$

Eldav Investments Ltd. (ELDAV) - Strategic Analysis Review

Eldav Investments Ltd. is a public investment company. It is seeking to invest in high potential industrial, service and commercia
2010 250,00$

The Lanka Hospitals Corporation PLC (LHCL) - Financial and Strategic Analysis Review

The Lanka Hospitals Corporation PLC (LHCL) - Financial and Strategic Analysis Review / / Summary / / The Lanka Hospitals Corpora
2010 250,00$

EIS Eczacibasi Ilac Sinai ve Finansal Yatirmlar Sanayi Ve Ticaret A.S. (ECILC.E) - Financial and Strategic Analysis Review

EIS Eczacibasi Ilac Sinai ve Finansal Yatirmlar Sanayi Ve Ticaret A.S. (ECILC.E) - Financial and Strategic Analysis Review / / Su
2010 125,00$

StemCells, Inc. (STEM) - Financial and Strategic Analysis Review

StemCells, Inc. (STEM) - Financial and Strategic Analysis Review / / Summary / / StemCells, Inc. (StemCells) is a biopharmaceuti
2010 250,00$

Egyptian International Pharmaceutical Industries Company (PHAR) - Financial and Strategic Analysis Review

Egyptian International Pharmaceutical Industries Company (PHAR) - Financial and Strategic Analysis Review / / Summary / / Egypti
2010 125,00$

Cardica, Inc. (CRDC) - Financial and Strategic Analysis Review

Cardica, Inc. (CRDC) - Financial and Strategic Analysis Review / / Summary / / Cardica, Inc. (Cardica) is a manufacturing compan
2010 250,00$

Zorka Pharma A.D. Sabac (ZOPH) - Financial and Strategic Analysis Review

Zorka Pharma A.D. Sabac (ZOPH) - Financial and Strategic Analysis Review / / Summary / / Zorka Pharma A.D. Sabac (Zorka Pharma),
2010 250,00$

Deepak Nitrite Ltd. (506401) - Financial and Strategic Analysis Review

Deepak Nitrite Ltd. (506401) - Financial and Strategic Analysis Review / / Summary / / Deepak Nitrite Ltd. (DNL) is engaged in m
2010 250,00$

Halcygen Pharmaceuticals Limited (HGN) - Financial and Strategic Analysis Review

Halcygen Pharmaceuticals Limited (HGN) - Financial and Strategic Analysis Review / / Summary / / Halcygen Pharmaceuticals Limite
2010 250,00$

Hadasit Bio-Holdings Ltd. (HDST) - Financial and Strategic Analysis Review

Hadasit Bio-Holdings Ltd. (HDST) - Financial and Strategic Analysis Review / / Summary / / Hadasit Bio-Holdings Ltd. (HBL) is su
2010 250,00$

Abbott Laboratories (Pakistan) Limited (ABOT) - Financial and Strategic Analysis Review

Abbott Laboratories (Pakistan) Limited (ABOT) - Financial and Strategic Analysis Review / / Summary / / Abbott Laboratories (Pak
2010 250,00$

ZhuZhou QianJin Pharmaceutical Co., Ltd (600479) - Financial and Strategic Analysis Review

ZhuZhou QianJin Pharmaceutical Co., Ltd (600479) - Financial and Strategic Analysis Review / / Summary / / ZhuZhou QianJin Pharm
2010 250,00$

Maywufa Company Limited (1731) - Financial and Strategic Analysis Review

Maywufa Company Limited (1731) - Financial and Strategic Analysis Review / / Summary / / Maywufa Company Limited (Maywufa) is en
2010 250,00$

Ham-Let (Israel-Canada) Ltd. (HAML) - Financial and Strategic Analysis Review

Ham-Let (Israel-Canada) Ltd. (HAML) - Financial and Strategic Analysis Review / / Summary / / Ham-Let (Israel-Canada) Ltd. (Ham-
2010 250,00$

Znomics, Inc. (ZNOM) - Financial and Strategic Analysis Review

Znomics, Inc. (ZNOM) - Financial and Strategic Analysis Review / / Summary / / Znomics, Inc. is a biotechnology company engaged
2010 250,00$

Abl Biotechnologies Limited (526955) - Financial and Strategic Analysis Review

Abl Biotechnologies Limited (526955) - Financial and Strategic Analysis Review / / Summary / / Abl biotechnologies Limited (ABL)
2010 250,00$

Mavens Biotech Ltd (590083) - Financial and Strategic Analysis Review

Mavens Biotech Ltd (590083) - Financial and Strategic Analysis Review / / Summary / / Mavens Biotech Ltd. (Mavens) is a biotechn
2010 250,00$

Aphton Corporation (APHTQ) - Financial and Strategic Analysis Review

Aphton Corporation (APHTQ) - Financial and Strategic Analysis Review / / Summary / / Aphton Corporation (Aphton) is a pennsylvan
2010 125,00$

Ads Media Group Inc (AMGU) - Financial and Strategic Analysis Review

Ads Media Group Inc (AMGU) - Financial and Strategic Analysis Review / / Summary / / ADS Media Group (ADSMG) is principally enga
2010 125,00$

BioSyent Inc. (RX) - Financial and Strategic Analysis Review

BioSyent Inc. (RX) - Financial and Strategic Analysis Review / / Summary / / BioSyent Inc. (BioSyent) is a specialty pharmaceuti
2010 250,00$

CellMetrix, Inc. (CLMI) - Financial and Strategic Analysis Review

CellMetrix, Inc. (CLMI) - Financial and Strategic Analysis Review / / Summary / / CellMetrix, Inc. (CellMetrix) is a medical tec
2010 125,00$

Hi-Tech Pharmacal Co., Inc. (HITK) - Financial and Strategic Analysis Review

Hi-Tech Pharmacal Co., Inc. (HITK) - Financial and Strategic Analysis Review / / Summary / / Hi-Tech Pharmacal Co., Inc. (Hi-Tec
2010 250,00$

Phosphagenics Limited (POH) - Financial and Strategic Analysis Review

Phosphagenics Limited (POH) - Financial and Strategic Analysis Review / / Summary / / Phosphagenics Limited (Phosphagenics), for
2010 250,00$

Solagran Ltd. (SLA) - Financial and Strategic Analysis Review

Solagran Ltd. (SLA) - Financial and Strategic Analysis Review / / Summary / / Solagran Ltd. (Solagran) is a biotechnology compan
2010 250,00$

Ironwood Pharmaceuticals, Inc. (IRWD) - Financial and Strategic Analysis Review

Ironwood Pharmaceuticals, Inc. (IRWD) - Financial and Strategic Analysis Review / / Summary / / Ironwood Pharmaceuticals, Inc. (
2010 250,00$

OptimumCare Corporation (OPMC) - Financial and Strategic Analysis Review

OptimumCare Corporation (OPMC) - Financial and Strategic Analysis Review / / Summary / / OptimumCare Corporation (OptimumCare) i
2010 125,00$

Mammatech Corporation (MAMM) - Financial and Strategic Analysis Review

Mammatech Corporation (MAMM) - Financial and Strategic Analysis Review / / Summary / / Mammatech Corporation (MammaCare) is prin
2010 250,00$

Simulations Plus, Inc. (SLP) - Financial and Strategic Analysis Review

Simulations Plus, Inc. (SLP) - Financial and Strategic Analysis Review / / Summary / / Simulations Plus, Inc. (Simulations Plus)
2010 125,00$

IVI Communications, Inc. (IVII) - Financial and Strategic Analysis Review

IVI Communications, Inc. (IVII) - Financial and Strategic Analysis Review / / Summary / / IVI Communications, Inc., (IVI) is an
2010 125,00$

Sitestar Corporation (SYTE) - Financial and Strategic Analysis Review

Sitestar Corporation (SYTE) - Financial and Strategic Analysis Review / / Summary / / Sitestar Corporation operates is an Intern
2010 125,00$

HMS Holdings Corp. (HMSY) - Financial and Strategic Analysis Review

HMS Holdings Corp. (HMSY) - Financial and Strategic Analysis Review / / Summary / / HMS Holdings Corp. (HMS) is a healthcare ser
2010 125,00$

Toxin Alert Inc. (TOX) - Financial and Strategic Analysis Review

Toxin Alert Inc. (TOX) - Financial and Strategic Analysis Review / / Summary / / Toxin Alert Inc. (Toxin Alert) is a development
2010 250,00$

Viropro Inc. (VPRO) - Financial and Strategic Analysis Review

Viropro Inc. (VPRO) - Financial and Strategic Analysis Review / / Summary / / ViroNovative BV (ViroNovative) is a pharmaceutical
2010 250,00$

Vivalis SA (VLS) - Financial and Strategic Analysis Review

Vivalis SA (VLS) - Financial and Strategic Analysis Review / / Summary / / Vivalis is a public bio-pharmaceutical company, engag
2010 250,00$

MOCON Inc. (MOCO) - Financial and Strategic Analysis Review

MOCON Inc. (MOCO) - Financial and Strategic Analysis Review / / Summary / / Mocon Inc (Mocon) is a publicly traded company engag
2010 250,00$

Natural Capsules Limited (524654) - Financial and Strategic Analysis Review

Natural Capsules Limited (524654) - Financial and Strategic Analysis Review / / Summary / / Natural Capsules Limited (Natural Ca
2010 250,00$

CordLife Pte. Ltd. (CBB) - Financial and Strategic Analysis Review

CordLife Pte. Ltd. (CBB) - Financial and Strategic Analysis Review / / Summary / / CordLife Pte. Ltd. (Cordlife) is a publicly h
2010 250,00$

Orchid Cellmark (ORCH) - Financial and Strategic Analysis Review

Orchid Cellmark (ORCH) - Financial and Strategic Analysis Review / / Summary / / Orchid Cellmark is a forensic and human identit
2010 125,00$

Orion HealthCorp, Inc. (ORNH) - Financial and Strategic Analysis Review

Orion HealthCorp, Inc. (ORNH) - Financial and Strategic Analysis Review / / Summary / / Orion HealthCorp, Inc. (Orion HealthCorp
2010 125,00$

Global Health Ventures Inc. (GHLV) - Financial and Strategic Analysis Review

Global Health Ventures Inc. (GHLV) - Financial and Strategic Analysis Review / / Summary / / Global Health Ventures Inc. (Global
2010 250,00$

Cellectis S.A. (ALCLS) - Financial and Strategic Analysis Review

Cellectis S.A. (ALCLS) - Financial and Strategic Analysis Review / / Summary / / Cellectis S.A. (Cellectis) is a biotechnology c
2010 250,00$

Protide Pharmaceuticals, Inc. (PPMD) - Financial and Strategic Analysis Review

Protide Pharmaceuticals, Inc. (PPMD) - Financial and Strategic Analysis Review / / Summary / / Protide Pharmaceuticals, Inc. (Pr
2010 125,00$

Protokinetix Inc. (PKTX) - Financial and Strategic Analysis Review

Protokinetix Inc. (PKTX) - Financial and Strategic Analysis Review / / Summary / / ProtoKinetix, Inc. (ProtoKinetix) is a biotec
2010 250,00$

Applied DNA Sciences, Inc. (APDN) - Financial and Strategic Analysis Review

Applied DNA Sciences, Inc. (APDN) - Financial and Strategic Analysis Review / / Summary / / Applied DNA Sciences, Inc. (APDN) is
2010 250,00$

Tremont Fair, Inc. (TMTF) - Financial and Strategic Analysis Review

Tremont Fair, Inc. (TMTF) - Financial and Strategic Analysis Review / / Summary / / Tremont Fair, Inc. (Tremont) is the US based
2010 250,00$

Mondobiotech Holding AG (RARE) - Financial and Strategic Analysis Review

Mondobiotech Holding AG (RARE) - Financial and Strategic Analysis Review / / Summary / / Mondobiotech Holding AG (Mondobiotech)
2010 125,00$

XenaCare Holdings, Inc. (XCHO) - Financial and Strategic Analysis Review

XenaCare Holdings, Inc. (XCHO) - Financial and Strategic Analysis Review / / Summary / / XenaCare Holdings, Inc. (XenaCare) is e
2010 250,00$

Kalahari Greentech, Inc. (KHGT) - Financial and Strategic Analysis Review

Kalahari Greentech, Inc. (KHGT) - Financial and Strategic Analysis Review / / Summary / / Kalahari Greentech, Inc.(KGI) is a res
2010 125,00$

Nkbio Co., Ltd. (19260) - Financial and Strategic Analysis Review

Nkbio Co., Ltd. (19260) - Financial and Strategic Analysis Review / / Summary / / Nkbio Co., Ltd. (Nkbio) is a research focused
2010 250,00$

ARCA biopharma, Inc. (ABIO) - Financial and Strategic Analysis Review

ARCA biopharma, Inc. (ABIO) - Financial and Strategic Analysis Review / / Summary / / ARCA biopharma, Inc. (ARCA biopharma) is a
2010 250,00$

Smruthi Organics Limited (590046) - Financial and Strategic Analysis Review

Smruthi Organics Limited (590046) - Financial and Strategic Analysis Review / / Summary / / Smruthi Organics Limited (Smruthi) i
2010 250,00$

MolMed S.p.A. (MLM) - Financial and Strategic Analysis Review

MolMed S.p.A. (MLM) - Financial and Strategic Analysis Review / / Summary / / MolMed S.p.A. (Molmed) is a biotechnology company,
2010 250,00$

Sinovac Biotech Ltd. (SVA) - Financial and Strategic Analysis Review

Sinovac Biotech Ltd. (SVA) - Financial and Strategic Analysis Review / / Summary / / Sinovac Biotech Ltd. engages in the researc
2010 250,00$

Velcera, Inc. (VLCR) - Financial and Strategic Analysis Review

Velcera, Inc. (VLCR) - Financial and Strategic Analysis Review / / Summary / / Velcera, Inc. (Velcera) is a is a development sta
2010 125,00$

Viral Genetics, Inc. (VRAL) - Financial and Strategic Analysis Review

Viral Genetics, Inc. (VRAL) - Financial and Strategic Analysis Review / / Summary / / Viral Genetics, Inc. (Viral Genetics) is a
2010 125,00$

Cordex Pharma, Inc. (CDXP) - Financial and Strategic Analysis Review

Cordex Pharma, Inc. (CDXP) - Financial and Strategic Analysis Review / / Summary / / Cordex Pharma, Inc. (Cordex Pharma) is a ph
2010 250,00$

Myriad Pharmaceuticals, Inc. (MYRX) - Financial and Strategic Analysis Review

Myriad Pharmaceuticals, Inc. (MYRX) - Financial and Strategic Analysis Review / / Summary / / Myriad Pharmaceuticals, Inc. (Myri
2010 250,00$

Genexine Co., Ltd. (95700) - Financial and Strategic Analysis Review

Genexine Co., Ltd. (95700) - Financial and Strategic Analysis Review / / Summary / / Genexine Co., Ltd. (Genexine) is involved i
2010 250,00$

Giaconda Limited (GIA) - Financial and Strategic Analysis Review

Giaconda Limited (GIA) - Financial and Strategic Analysis Review / / Summary / / Giaconda Limited (Giaconda) is a research focus
2010 250,00$

CytoDyn, Inc. (CYDY) - Financial and Strategic Analysis Review

CytoDyn, Inc. (CYDY) - Financial and Strategic Analysis Review / / Summary / / CytoDyn, Inc. (CytoDyn) is a biotechnology resear
2010 250,00$

Intellect Neurosciences, Inc. (ILNS) - Financial and Strategic Analysis Review

Intellect Neurosciences, Inc. (ILNS) - Financial and Strategic Analysis Review / / Summary / / Intellect Neurosciences, Inc. (In
2010 250,00$

QRxPharma Limited (QRX) - Financial and Strategic Analysis Review

QRxPharma Limited (QRX) - Financial and Strategic Analysis Review / / Summary / / QRxPharma Limited (QRxPharma) is clinical-stag
2010 250,00$

Omeros Corporation (OMER) - Financial and Strategic Analysis Review

Omeros Corporation (OMER) - Financial and Strategic Analysis Review / / Summary / / Omeros Corporation (Omeros) is the US based
2010 250,00$

Sosei Co. Ltd. (4565) - Financial and Strategic Analysis Review

Sosei Co. Ltd. (4565) - Financial and Strategic Analysis Review / / Summary / / Sosei Co. Ltd., (Sosei)is a privately held compa
2010 250,00$

China Medical System Holdings Limited (CMSH) - Financial and Strategic Analysis Review

China Medical System Holdings Limited (CMSH) - Financial and Strategic Analysis Review / / Summary / / China Medical System Hold
2010 250,00$

Laboratorios Farmaceuticos ROVI, S.A. (ROVI) - Financial and Strategic Analysis Review

Laboratorios Farmaceuticos ROVI, S.A. (ROVI) - Financial and Strategic Analysis Review / / Summary / / Laboratorios Farmaceutico
2010 125,00$

BioStar Pharmaceuticals, Inc. (BSPM) - Financial and Strategic Analysis Review

BioStar Pharmaceuticals, Inc. (BSPM) - Financial and Strategic Analysis Review / / Summary / / BioStar Pharmaceuticals, Inc. (Bi
2010 250,00$

China Medicine Corporation (CHME) - Financial and Strategic Analysis Review

China Medicine Corporation (CHME) - Financial and Strategic Analysis Review / / Summary / / China Medicine Corporation (CMC) is
2010 250,00$

Lijun International Pharmaceutical (Holding) Co., Ltd. (2005) - Financial and Strategic Analysis Review

Lijun International Pharmaceutical (Holding) Co., Ltd. (2005) - Financial and Strategic Analysis Review / / Summary / / Lijun In
2010 125,00$

China Shineway Pharmaceutical Group Limited (2877) - Financial and Strategic Analysis Review

China Shineway Pharmaceutical Group Limited (2877) - Financial and Strategic Analysis Review / / Summary / / China Shineway Phar
2010 125,00$

Cornerstone Therapeutics Inc. (CRTX) - Financial and Strategic Analysis Review

Cornerstone Therapeutics Inc. (CRTX) - Financial and Strategic Analysis Review / / Summary / / Cornerstone Therapeutics Inc. (Co
2010 250,00$

Zhejiang CONBA Pharmaceutical Co.,Ltd. (600572) - Financial and Strategic Analysis Review

Zhejiang CONBA Pharmaceutical Co.,Ltd. (600572) - Financial and Strategic Analysis Review / / Summary / / Zhejiang CONBA Pharmac
2010 125,00$

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196) - Financial and Strategic Analysis Review

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196) - Financial and Strategic Analysis Review / / Summary / / Shanghai Fosu
2010 125,00$

Tongjitang Chinese Medicines Company (TCM) - Financial and Strategic Analysis Review

Tongjitang Chinese Medicines Company (TCM) - Financial and Strategic Analysis Review / / Summary / / Tongjitang Chinese Medicine
2010 250,00$

Shanghai Industrial Pharmaceutical Investment Co. Ltd. (600607) - Financial and Strategic Analysis Review

Shanghai Industrial Pharmaceutical Investment Co. Ltd. (600607) - Financial and Strategic Analysis Review / / Summary / / Shangh
2010 125,00$

Guilin Sanjin Pharmaceutical Co., Ltd. (2275) - Financial and Strategic Analysis Review

Guilin Sanjin Pharmaceutical Co., Ltd. (2275) - Financial and Strategic Analysis Review / / Summary / / Guilin Sanjin Pharmaceut
2010 125,00$

Zdravlje A.D. Leskovac (ZDRV) - Financial and Strategic Analysis Review

Zdravlje A.D. Leskovac (ZDRV) - Financial and Strategic Analysis Review / / Summary / / Zdravlje A.D. Leskovac (Actavis Serbia)
2010 250,00$

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. (600436) - Financial and Strategic Analysis Review

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. (600436) - Financial and Strategic Analysis Review / / Summary / / Zhangzhou Pie
2010 250,00$

Sanofi-aventis Pakistan limited (SAPL) - Financial and Strategic Analysis Review

Sanofi-aventis Pakistan limited (SAPL) - Financial and Strategic Analysis Review / / Summary / / Sanofi-aventis Pakistan limited
2010 250,00$

Vetoquinol S A (VETO) - Financial and Strategic Analysis Review

Vetoquinol S A (VETO) - Financial and Strategic Analysis Review / / Summary / / Vetoquinol S A (Vetoquinol) is an independent co
2010 125,00$

Shandong Lukang International Trading Co., Ltd (600789) - Financial and Strategic Analysis Review

Shandong Lukang International Trading Co., Ltd (600789) - Financial and Strategic Analysis Review / / Summary / / Shandong Lukan
2010 125,00$

Vital Pharmaceutical Holdings Limited (1164) - Financial and Strategic Analysis Review

Vital Pharmaceutical Holdings Limited (1164) - Financial and Strategic Analysis Review / / Summary / / Vital Pharmaceutical Hold
2010 250,00$

Shandong Luoxin Pharmacy Stock Co., Ltd. (8058) - Financial and Strategic Analysis Review

Shandong Luoxin Pharmacy Stock Co., Ltd. (8058) - Financial and Strategic Analysis Review / / Summary / / Shandong Luoxin Pharma
2010 250,00$

Shin Nippon Biomedical Laboratories, Ltd. (2395) - Financial and Strategic Analysis Review

Shin Nippon Biomedical Laboratories, Ltd. (2395) - Financial and Strategic Analysis Review / / Summary / / Shin Nippon Biomedica
2010 125,00$

Wai Yuen Tong Medicine Holdings Limited (897) - Financial and Strategic Analysis Review

Wai Yuen Tong Medicine Holdings Limited (897) - Financial and Strategic Analysis Review / / Summary / / Wai Yuen Tong Medicine H
2010 250,00$

Shanghai Jiao Da Onlly Co., Ltd. (600530) - Financial and Strategic Analysis Review

Shanghai Jiao Da Onlly Co., Ltd. (600530) - Financial and Strategic Analysis Review / / Summary / / Shanghai Jiao Da Onlly Co.,
2010 250,00$

Jiangsu Sihuan Bioengineering Co., Ltd (518) - Financial and Strategic Analysis Review

Jiangsu Sihuan Bioengineering Co., Ltd (518) - Financial and Strategic Analysis Review / / Summary / / Jiangsu Sihuan Bioenginee
2010 250,00$

Beijing Tiantan Biological Products Co., Ltd. (600161) - Financial and Strategic Analysis Review

Beijing Tiantan Biological Products Co., Ltd. (600161) - Financial and Strategic Analysis Review / / Summary / / Beijing Tiantan
2010 250,00$

Caplin Point Laboratories Ltd (524742) - Financial and Strategic Analysis Review

Caplin Point Laboratories Ltd (524742) - Financial and Strategic Analysis Review / / Summary / / Caplin Point Laboratories Ltd (
2010 250,00$

ImmunoVaccine Technologies Inc. (IMV) - Financial and Strategic Analysis Review

ImmunoVaccine Technologies Inc. (IMV) - Financial and Strategic Analysis Review / / Summary / / ImmunoVaccine Technologies Inc.
2010 250,00$

Mediscience Planning Inc. (2182) - Financial and Strategic Analysis Review

Mediscience Planning Inc. (2182) - Financial and Strategic Analysis Review / / Summary / / Mediscience Planning Inc. (Mediscienc
2010 250,00$

Winteam Pharmaceutical Group Limited (570) - Financial and Strategic Analysis Review

Winteam Pharmaceutical Group Limited (570) - Financial and Strategic Analysis Review / / Summary / / Winteam Pharmaceutical Grou
2010 250,00$

Southwest Synthetic Pharmaceutical Corporation Ltd. (788) - Financial and Strategic Analysis Review

Southwest Synthetic Pharmaceutical Corporation Ltd. (788) - Financial and Strategic Analysis Review / / Summary / / Southwest Sy
2010 250,00$

Zhejiang Hangzhou Xinfu Pharma Co., Ltd. (2019) - Financial and Strategic Analysis Review

Zhejiang Hangzhou Xinfu Pharma Co., Ltd. (2019) - Financial and Strategic Analysis Review / / Summary / / Zhejiang Hangzhou Xinf
2010 250,00$

Zhejiang Hisoar Pharmaceutical Co.,LTD. (2099) - Financial and Strategic Analysis Review

Zhejiang Hisoar Pharmaceutical Co.,LTD. (2099) - Financial and Strategic Analysis Review / / Summary / / Zhejiang Hisoar Pharmac
2010 250,00$

Zhejiang Hisun Pharmaceutical Co. Ltd. (600267) - Financial and Strategic Analysis Review

Zhejiang Hisun Pharmaceutical Co. Ltd. (600267) - Financial and Strategic Analysis Review / / Summary / / Zhejiang Hisun Pharmac
2010 125,00$

Zhejiang Jingxin Pharmaceutical Co., Ltd (2020) - Financial and Strategic Analysis Review

Zhejiang Jingxin Pharmaceutical Co., Ltd (2020) - Financial and Strategic Analysis Review / / Summary / / Zhejiang Jingxin Pharm
2010 250,00$

Tianjin Tasly Pharmaceutical Co., Ltd. (600535) - Financial and Strategic Analysis Review

Tianjin Tasly Pharmaceutical Co., Ltd. (600535) - Financial and Strategic Analysis Review / / Summary / / Tianjin Tasly Pharmace
2010 125,00$

Welichem Biotech Inc. (WBI) - Financial and Strategic Analysis Review

Welichem Biotech Inc. (WBI) - Financial and Strategic Analysis Review / / Summary / / Welichem Biotech Inc. (Welichem, formerly
2010 250,00$

Adeona Pharmaceuticals, Inc. (AEN) - Financial and Strategic Analysis Review

Adeona Pharmaceuticals, Inc. (AEN) - Financial and Strategic Analysis Review / / Summary / / Adeona Pharmaceuticals, Inc. (Adeon
2010 250,00$

Tianjin Zhongxin Pharmaceutical Group Corporation Limited (T14) - Financial and Strategic Analysis Review

Tianjin Zhongxin Pharmaceutical Group Corporation Limited (T14) - Financial and Strategic Analysis Review / / Summary / / Tianji
2010 125,00$

Pharmstandard (PHST) - Financial and Strategic Analysis Review

Pharmstandard (PHST) - Financial and Strategic Analysis Review / / Summary / / Pharmstandard is engaged in the manufacture and m
2010 250,00$

Vital Living, Inc. (VTLV) - Financial and Strategic Analysis Review

Vital Living, Inc. (VTLV) - Financial and Strategic Analysis Review / / Summary / / Vital Living, Inc. (Vital Living) is a publi
2010 125,00$

The United Laboratories International Holdings Limited (3933) - Financial and Strategic Analysis Review

The United Laboratories International Holdings Limited (3933) - Financial and Strategic Analysis Review / / Summary / / The Unit
2010 125,00$

Wuhan Humanwell Hi-Tech Industry Co., LTD. (600079) - Financial and Strategic Analysis Review

Wuhan Humanwell Hi-Tech Industry Co., LTD. (600079) - Financial and Strategic Analysis Review / / Summary / / Wuhan Humanwell Hi
2010 125,00$

Wuyi International Pharmaceutical Company Limited (1889) - Financial and Strategic Analysis Review

Wuyi International Pharmaceutical Company Limited (1889) - Financial and Strategic Analysis Review / / Summary / / Wuyi Internat
2010 250,00$

GeneLink BioSciences, Inc. (GNLK) - Financial and Strategic Analysis Review

GeneLink BioSciences, Inc. (GNLK) - Financial and Strategic Analysis Review / / Summary / / GeneLink BioSciences, Inc. (Genelink
2010 250,00$

GENova Biotherapeutics, Inc. (GVBP) - Financial and Strategic Analysis Review

GENova Biotherapeutics, Inc. (GVBP) - Financial and Strategic Analysis Review / / Summary / / GENova Biotherapeutics, Inc. (GENo
2010 250,00$

Millenia Hope Inc. (MLF) - Financial and Strategic Analysis Review

Millenia Hope Inc. (MLF) - Financial and Strategic Analysis Review / / Summary / / Millenia Hope, Inc. (Millenia) is a research
2010 125,00$

BioChem Solutions Inc. (BCHS) - Financial and Strategic Analysis Review

BioChem Solutions Inc. (BCHS) - Financial and Strategic Analysis Review / / Summary / / BioChem Solutions Inc. (BioChem Solution
2010 125,00$

Shandong Jintai Group Co.,Ltd. (600385) - Financial and Strategic Analysis Review

Shandong Jintai Group Co.,Ltd. (600385) - Financial and Strategic Analysis Review / / Summary / / Shandong Jintai Group Co.,Ltd.
2010 250,00$

iBio, Inc. (IBPM) - Financial and Strategic Analysis Review

iBio, Inc. (IBPM) - Financial and Strategic Analysis Review / / Summary / / iBio, Inc. (iBio, formerly iBioPharma, Inc.) is a bi
2010 250,00$

Stem Cell Innovations, Inc. (SCLL) - Financial and Strategic Analysis Review

Stem Cell Innovations, Inc. (SCLL) - Financial and Strategic Analysis Review / / Summary / / Stem Cell Innovations, Inc. (SCI) i
2010 125,00$

Cellceutix Corporation (CTIX) - Financial and Strategic Analysis Review

Cellceutix Corporation (CTIX) - Financial and Strategic Analysis Review / / Summary / / Cellceutix Corporation (Cellceutix) is a
2010 250,00$

VIA Pharmaceuticals, Inc. (VIAP) - Financial and Strategic Analysis Review

VIA Pharmaceuticals, Inc. (VIAP) - Financial and Strategic Analysis Review / / Summary / / VIA Pharmaceuticals, Inc. (VIA) is a
2010 250,00$

Vanda Pharmaceuticals Inc. (VNDA) - Financial and Strategic Analysis Review

Vanda Pharmaceuticals Inc. (VNDA) - Financial and Strategic Analysis Review / / Summary / / Vanda Pharmaceuticals Inc. (Vanda),
2010 250,00$

Virax Holdings Limited (VHL) - Financial and Strategic Analysis Review

Virax Holdings Limited (VHL) - Financial and Strategic Analysis Review / / Summary / / Virax Holdings Limited (Virax) is a bioph
2010 250,00$

Intellipharmaceutics International Inc. (IPCI) - Financial and Strategic Analysis Review

Intellipharmaceutics International Inc. (IPCI) - Financial and Strategic Analysis Review / / Summary / / Intellipharmaceutics In
2010 250,00$

AB Science (AB) - Financial and Strategic Analysis Review

AB Science (AB) - Financial and Strategic Analysis Review / / Summary / / AB Science (ABS) is a biopharmaceutical company that i
2010 250,00$

Tetragenex Pharmaceuticals, Inc. (TTRX) - Financial and Strategic Analysis Review

Tetragenex Pharmaceuticals, Inc. (TTRX) - Financial and Strategic Analysis Review / / Summary / / Tetragenex Pharmaceuticals, In
2010 250,00$

Anthera Pharmaceuticals‚ Inc. (ANTH) - Financial and Strategic Analysis Review

Anthera Pharmaceuticals‚ Inc. (ANTH) - Financial and Strategic Analysis Review / / Summary / / Anthera Pharmaceuticals, Inc. (An
2010 250,00$

GNI, LTD. (2160) - Financial and Strategic Analysis Review

GNI, LTD. (2160) - Financial and Strategic Analysis Review / / Summary / / GNI, LTD. (GNI) is a publicly traded bio-pharmaceutic
2010 250,00$

Adamis Pharmaceuticals Corporation (ADMP) - Financial and Strategic Analysis Review

Adamis Pharmaceuticals Corporation (ADMP) - Financial and Strategic Analysis Review / / Summary / / Adamis Pharmaceuticals Corpo
2010 250,00$

Tianyin Pharmaceutical Co., Inc. (TPI) - Financial and Strategic Analysis Review

Tianyin Pharmaceutical Co., Inc. (TPI) - Financial and Strategic Analysis Review / / Summary / / Tianyin Pharmaceutical Co., Inc
2010 250,00$

Cannabis Science, Inc. (CBIS) - Financial and Strategic Analysis Review

Cannabis Science, Inc. (CBIS) - Financial and Strategic Analysis Review / / Summary / / Cannabis Science, Inc. (formerly, Gulf O
2010 250,00$

Synergy Pharmaceuticals, Inc. (SGYP) - Financial and Strategic Analysis Review

Synergy Pharmaceuticals, Inc. (SGYP) - Financial and Strategic Analysis Review / / Summary / / Synergy Pharmaceuticals, Inc. (Sy
2010 250,00$

SinoFresh HealthCare, Inc. (SFSH) - Financial and Strategic Analysis Review

SinoFresh HealthCare, Inc. (SFSH) - Financial and Strategic Analysis Review / / Summary / / SinoFresh HealthCare, Inc. (SinoFres
2010 125,00$

AVEO Pharmaceuticals, Inc. (AVEO) - Financial and Strategic Analysis Review

AVEO Pharmaceuticals, Inc. (AVEO) - Financial and Strategic Analysis Review / / Summary / / AVEO Pharmaceuticals, Inc. (Aveo) is
2010 250,00$

Winston Pharmaceuticals, Inc. (WPHM) - Financial and Strategic Analysis Review

Winston Pharmaceuticals, Inc. (WPHM) - Financial and Strategic Analysis Review / / Summary / / Winston Pharmaceuticals, Inc. (Wi
2010 250,00$

Vitro Diagnostics, Inc. (VODG) - Financial and Strategic Analysis Review

Vitro Diagnostics, Inc. (VODG) - Financial and Strategic Analysis Review / / Summary / / Vitro Diagnostics, Inc. (Vitro Biopharm
2010 250,00$

Medistem, Inc. (MEDS) - Financial and Strategic Analysis Review

Medistem, Inc. (MEDS) - Financial and Strategic Analysis Review / / Summary / / Medistem, Inc. (Medistem) is a research focused
2010 125,00$

BioNeutral Group, Inc. (BONU) - Financial and Strategic Analysis Review

BioNeutral Group, Inc. (BONU) - Financial and Strategic Analysis Review / / Summary / / BioNeutral Group, Inc. (BioNeutral) is a
2010 250,00$

Polydex Pharmaceuticals Limited (POLXF) - Financial and Strategic Analysis Review

Polydex Pharmaceuticals Limited (POLXF) - Financial and Strategic Analysis Review / / Summary / / Polydex Pharmaceuticals Limite
2010 250,00$

Swiss Medica, Inc. (SWME) - Financial and Strategic Analysis Review

Swiss Medica, Inc. (SWME) - Financial and Strategic Analysis Review / / Summary / / Swiss Medica, Inc. (Swiss Medica) is a speci
2010 125,00$

ViroMed Co., Ltd. (84990) - Financial and Strategic Analysis Review

ViroMed Co., Ltd. (84990) - Financial and Strategic Analysis Review / / Summary / / Viromed Co. Ltd. (Viromed) is a Korea based
2010 250,00$

NasVax Ltd. (NSVX) - Financial and Strategic Analysis Review

NasVax Ltd. (NSVX) - Financial and Strategic Analysis Review / / Summary / / NasVax Ltd. (NasVax) is bio-pharmaceutical company,
2010 250,00$

Afexa Life Sciences Inc. (FXA) - Financial and Strategic Analysis Review

Afexa Life Sciences Inc. (FXA) - Financial and Strategic Analysis Review / / Summary / / Afexa Life Sciences Inc. (ALSI, formerl
2010 250,00$

Ind-Swift Limited. (524652) - Financial and Strategic Analysis Review

Ind-Swift Limited. (524652) - Financial and Strategic Analysis Review / / Summary / / Ind-Swift Limited. (Ind-Swift) is a public
2010 250,00$

VasoActive Pharmaceuticals, Inc. (VAPHQ) - Financial and Strategic Analysis Review

VasoActive Pharmaceuticals, Inc. (VAPHQ) - Financial and Strategic Analysis Review / / Summary / / VasoActive Pharmaceuticals, I
2010 125,00$

AngioGenex, Inc. (AGGX) - Financial and Strategic Analysis Review

AngioGenex, Inc. (AGGX) - Financial and Strategic Analysis Review / / Summary / / AngioGenex, Inc. (AngioGenex) is a development
2010 250,00$

Anu's Laboratories Limited (532981) - Financial and Strategic Analysis Review

Anu's Laboratories Limited (532981) - Financial and Strategic Analysis Review / / Summary / / Anu's Laboratories Limited (Anu's
2010 250,00$

BPH Corporate Limited (BPH) - Financial and Strategic Analysis Review

BPH Corporate Limited (BPH) - Financial and Strategic Analysis Review / / Summary / / BPH Corporate Limited (BPH, previously Bio
2010 250,00$

Kawamura Cycle Co., Ltd. (7311) - Financial and Strategic Analysis Review

Kawamura Cycle Co., Ltd. (7311) - Financial and Strategic Analysis Review / / Summary / / Kawamura Cycle Co., Ltd.(Kawamura Cycl
2010 250,00$

AURELIUS AG (AR4) - Financial and Strategic Analysis Review

AURELIUS AG (AR4) - Financial and Strategic Analysis Review / / Summary / / Aurelius AG (Aurelius) is a private equity firm that
2010 125,00$

IADELPA SAECA (IAD) - Financial and Strategic Analysis Review

IADELPA SAECA (IAD) - Financial and Strategic Analysis Review / / Summary / / IADELPA SAECA (IADELPA) also known as Andromaco In
2010 250,00$

Hangzhou Tian-Mu-Shan Pharm. Enterp. Co (600671) - Financial and Strategic Analysis Review

Hangzhou Tian-Mu-Shan Pharm. Enterp. Co (600671) - Financial and Strategic Analysis Review / / Summary / / Hangzhou Tian-Mu-Shan
2010 250,00$

B.O.S. Better OnLine Solutions Ltd. (BOSC) - Financial and Strategic Analysis Review

B.O.S. Better OnLine Solutions Ltd. (BOSC) - Financial and Strategic Analysis Review / / Summary / / B.O.S. Better OnLine Soluti
2010 125,00$

BackWeb Technologies Ltd. (BWEBF) - Financial and Strategic Analysis Review

BackWeb Technologies Ltd. (BWEBF) - Financial and Strategic Analysis Review / / Summary / / BackWeb Technologies Ltd. (BackWeb)
2010 125,00$

Bal Pharma Limited (524824) - Financial and Strategic Analysis Review

Bal Pharma Limited (524824) - Financial and Strategic Analysis Review / / Summary / / Bal Pharma Limited (Bal Pharma) is a pharm
2010 250,00$

Fabryka Kosmetykow POLLENA-EWA SA (PLE) - Financial and Strategic Analysis Review

Fabryka Kosmetykow POLLENA-EWA SA (PLE) - Financial and Strategic Analysis Review / / Summary / / Fabryka Kosmetykow POLLENA-EWA
2010 250,00$

Harbin Pharm Group Sanjing Pharm Co Ltd (600829) - Financial and Strategic Analysis Review

Harbin Pharm Group Sanjing Pharm Co Ltd (600829) - Financial and Strategic Analysis Review / / Summary / / Harbin Pharm Group Sa
2010 125,00$

Al Borg Laboratory (ALAB) - Financial and Strategic Analysis Review

Al Borg Laboratory (ALAB) - Financial and Strategic Analysis Review / / Summary / / Al Borg Laboratory (Al Borg) formerly known
2010 250,00$

Cairo Radiology Center Co. (RADI) - Financial and Strategic Analysis Review

Cairo Radiology Center Co. (RADI) - Financial and Strategic Analysis Review / / Summary / / Cairo Radiology Center Co. (Cairo Sc
2010 250,00$

Ahlcon Parenterals (India) Limited (524448) - Financial and Strategic Analysis Review

Ahlcon Parenterals (India) Limited (524448) - Financial and Strategic Analysis Review / / Summary / / Ahlcon Parenterals (India)
2010 250,00$

Daewoong Bio, Inc. (16890) - Financial and Strategic Analysis Review

Daewoong Bio, Inc. (16890) - Financial and Strategic Analysis Review / / Summary / / Daewoong Bio, Inc. (DBI), is a leading phar
2010 125,00$

Hatay Pharmaceutical JSC (DHT) - Financial and Strategic Analysis Review

Hatay Pharmaceutical JSC (DHT) - Financial and Strategic Analysis Review / / Summary / / Hatay Pharmaceutical JSC (Hatay Pharmac
2010 250,00$

HC Innovations, Inc. (HCNV) - Financial and Strategic Analysis Review

HC Innovations, Inc. (HCNV) - Financial and Strategic Analysis Review / / Summary / / HC Innovations, Inc.(HC Innovations) is a
2010 250,00$

Health Grades, Inc. (HGRD) - Financial and Strategic Analysis Review

Health Grades, Inc. (HGRD) - Financial and Strategic Analysis Review / / Summary / / Health Grades, Inc. (HGRD) is a publicly he
2010 250,00$

Healthcare Providers Direct, Inc. (HPRD) - Financial and Strategic Analysis Review

Healthcare Providers Direct, Inc. (HPRD) - Financial and Strategic Analysis Review / / Summary / / Healthcare Providers Direct,
2010 125,00$

HealthSport, Inc. (HSPO) - Financial and Strategic Analysis Review

HealthSport, Inc. (HSPO) - Financial and Strategic Analysis Review / / Summary / / HealthSport, Inc. (HealthSport) is a drug del
2010 250,00$

Surya Pharmaceutical Limited (532516) - Financial and Strategic Analysis Review

Surya Pharmaceutical Limited (532516) - Financial and Strategic Analysis Review / / Summary / / Surya Pharmaceutical Limited (Su
2010 250,00$

ImmunoBiotics, Inc. (IMBI) - Financial and Strategic Analysis Review

ImmunoBiotics, Inc. (IMBI) - Financial and Strategic Analysis Review / / Summary / / ImmunoBiotics, Inc. (ImmunoBiotics) is a bi
2010 250,00$

Immunotech Laboratories, Inc. (IMMB) - Financial and Strategic Analysis Review

Immunotech Laboratories, Inc. (IMMB) - Financial and Strategic Analysis Review / / Summary / / Immunotech Laboratories, Inc. (Im
2010 125,00$

SSI Surgical Services, Inc. (SGSI) - Financial and Strategic Analysis Review

SSI Surgical Services, Inc. (SGSI) - Financial and Strategic Analysis Review / / Summary / / SSI Surgical Services, Inc. (SSI) i
2010 125,00$

OdontoPrev S.A. (ODPV3) - Financial and Strategic Analysis Review

OdontoPrev S.A. (ODPV3) - Financial and Strategic Analysis Review / / Summary / / Odontoprev SA (Odontoprev) is a health service
2010 125,00$

RX for Africa, Inc. (RXAF) - Financial and Strategic Analysis Review

RX for Africa, Inc. (RXAF) - Financial and Strategic Analysis Review / / Summary / / RX for Africa, Inc. (RXoA) is an investment
2010 125,00$

Procognia Limited (PRCG) - Financial and Strategic Analysis Review

Procognia Limited (PRCG) - Financial and Strategic Analysis Review / / Summary / / Procognia Limited (Procognia) is a public lis
2010 250,00$

Alpa Laboratories Limited (ALPA) - Financial and Strategic Analysis Review

Alpa Laboratories Limited (ALPA) - Financial and Strategic Analysis Review / / Summary / / Alpa Laboratories Limited (Alpa) is p
2010 250,00$

Merriman Curhan Ford Group, Inc. (MERR) - Financial and Strategic Analysis Review

Merriman Curhan Ford Group, Inc. (MERR) - Financial and Strategic Analysis Review / / Summary / / Merriman Curhan Ford Group, In
2010 250,00$

Access Plans, Inc. (APNC) - Financial and Strategic Analysis Review

Access Plans, Inc. (APNC) - Financial and Strategic Analysis Review / / Summary / / Access Plans, Inc. (Access Plans) formerly k
2010 250,00$

Pacific Healthcare Holdings Ltd. (P47) - Financial and Strategic Analysis Review

Pacific Healthcare Holdings Ltd. (P47) - Financial and Strategic Analysis Review / / Summary / / Pacific Healthcare Holdings Ltd
2010 250,00$

CardioGenics Holdings Inc. (CGNH) - Financial and Strategic Analysis Review

CardioGenics Holdings Inc. (CGNH) - Financial and Strategic Analysis Review / / Summary / / CardioGenics Holdings Inc. (CardioGe
2010 250,00$

SMS Pharmaceuticals Ltd (532815) - Financial and Strategic Analysis Review

SMS Pharmaceuticals Ltd (532815) - Financial and Strategic Analysis Review / / Summary / / SMS Pharmaceuticals Ltd. (SMS) is a p
2010 250,00$

Transax International Limited (TNSX) - Financial and Strategic Analysis Review

Transax International Limited (TNSX) - Financial and Strategic Analysis Review / / Summary / / Transax International Limited (Tr
2010 125,00$

Bliss GVS Pharma Limited (506197) - Financial and Strategic Analysis Review

Bliss GVS Pharma Limited (506197) - Financial and Strategic Analysis Review / / Summary / / Bliss GVS Pharma Limited (Bliss) is
2010 250,00$

Advanced Plant Pharmaceuticals, Inc. (APPI) - Financial and Strategic Analysis Review

Advanced Plant Pharmaceuticals, Inc. (APPI) - Financial and Strategic Analysis Review / / Summary / / Advanced Plant Pharmaceuti
2010 125,00$

The Advisory Board Company (ABCO) - Financial and Strategic Analysis Review

The Advisory Board Company (ABCO) - Financial and Strategic Analysis Review / / Summary / / The Advisory Board Company (The Advi
2010 125,00$

Landela Pharmaceutical (RXEI) - Financial and Strategic Analysis Review

Landela Pharmaceutical (RXEI) - Financial and Strategic Analysis Review / / Summary / / Landela Pharmaceutical (Landela) is a ph
2010 125,00$

Spectral Diagnostics Inc. (SDI) - Financial and Strategic Analysis Review

Spectral Diagnostics Inc. (SDI) - Financial and Strategic Analysis Review / / Summary / / Spectral Diagnostics Inc. (Spectral) i
2010 250,00$

Omni Medical Holdings, Inc. (OMHI) - Financial and Strategic Analysis Review

Omni Medical Holdings, Inc. (OMHI) - Financial and Strategic Analysis Review / / Summary / / Omni Medical Holdings Inc. (Omni) i
2010 125,00$

Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. (8329) - Financial and Strategic Analysis Review

Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. (8329) - Financial and Strategic Analysis Review / / Summary / / Shenzhen Nep
2010 250,00$

Venturepharm Laboratories Limited (8225) - Financial and Strategic Analysis Review

Venturepharm Laboratories Limited (8225) - Financial and Strategic Analysis Review / / Summary / / Venturepharm Laboratories Lim
2010 250,00$

The Arab Pharmaceutical Manufacturing Co. Ltd. (APMC) - Financial and Strategic Analysis Review

The Arab Pharmaceutical Manufacturing Co. Ltd. (APMC) - Financial and Strategic Analysis Review / / Summary / / The Arab Pharmac
2010 125,00$

Medika d.d. (MDKA-R-A) - Financial and Strategic Analysis Review

Medika d.d. (MDKA-R-A) - Financial and Strategic Analysis Review / / Summary / / Medika d.d. (Medika) is a publicly held wholesa
2010 125,00$

WuXi PharmaTech (Cayman), Inc. (WX) - Financial and Strategic Analysis Review

WuXi PharmaTech (Cayman), Inc. (WX) - Financial and Strategic Analysis Review / / Summary / / WuXi PharmaTech (Cayman), Inc. (Wu
2010 125,00$

VaxGen, Inc. (VXGN) - Financial and Strategic Analysis Review

VaxGen, Inc. (VXGN) - Financial and Strategic Analysis Review / / Summary / / VaxGen, Inc., (VaxGen) is a biopharmaceutical comp
2010 250,00$

Cancer Therapeutics, Inc. (CTHP) - Financial and Strategic Analysis Review

Cancer Therapeutics, Inc. (CTHP) - Financial and Strategic Analysis Review / / Summary / / Cancer Therapeutics, Inc. (CTI) is a
2010 250,00$

Lee's Pharmaceutical Holdings Limited (8221) - Financial and Strategic Analysis Review

Lee's Pharmaceutical Holdings Limited (8221) - Financial and Strategic Analysis Review / / Summary / / Lee's Pharmaceutical Hold
2010 250,00$

Shrink Nanotechnologies, Inc. (INKN) - Financial and Strategic Analysis Review

Shrink Nanotechnologies, Inc. (INKN) - Financial and Strategic Analysis Review / / Summary / / Shrink Nanotechnologies, Inc. (Sh
2010 250,00$

China Biologic Products, Inc. (CBPO) - Financial and Strategic Analysis Review

China Biologic Products, Inc. (CBPO) - Financial and Strategic Analysis Review / / Summary / / China Biologic Products, Inc. (Ch
2010 250,00$

Burcon NutraScience Corporation (BU) - Financial and Strategic Analysis Review

Burcon NutraScience Corporation (BU) - Financial and Strategic Analysis Review / / Summary / / Burcon NutraScience Corporation (
2010 250,00$

Total Nutraceutical Solutions, Inc. (TNUS.OB) - Financial and Strategic Analysis Review

Total Nutraceutical Solutions, Inc. (TNUS.OB) - Financial and Strategic Analysis Review / / Summary / / Total Nutraceutical Solu
2010 250,00$

Select Medical Holdings Corporation (SEM) - Financial and Strategic Analysis Review

Select Medical Holdings Corporation (SEM) - Financial and Strategic Analysis Review / / Summary / / Select Medical Holdings Corp
2010 125,00$

EPS Co., Ltd. (4282) - Financial and Strategic Analysis Review

EPS Co., Ltd. (4282) - Financial and Strategic Analysis Review / / Summary / / EPS Co., Ltd. (EPS) is a contract research organi
2010 125,00$

Microfluidics International Corporation (MFLU) - Financial and Strategic Analysis Review

Microfluidics International Corporation (MFLU) - Financial and Strategic Analysis Review / / Summary / / Microfluidics Internati
2010 250,00$

Yomeishu Seizo Co. Ltd. (2540) - Financial and Strategic Analysis Review

Yomeishu Seizo Co. Ltd. (2540) - Financial and Strategic Analysis Review / / Summary / / Yomeishu Seizo Co. Ltd. (Yomeishu Seizo
2010 250,00$

Addus HomeCare Corporation (ADUS) - Financial and Strategic Analysis Review

Addus HomeCare Corporation (ADUS) - Financial and Strategic Analysis Review / / Summary / / Addus HomeCare Corporation (Addus Ho
2010 125,00$

NuRx Pharmaceuticals, Inc. (NUXP) - Financial and Strategic Analysis Review

NuRx Pharmaceuticals, Inc. (NUXP) - Financial and Strategic Analysis Review / / Summary / / NuRx Pharmaceuticals, Inc. (NuRx Pha
2010 250,00$

First Physicians Capital Group, Inc. (FPCG) - Financial and Strategic Analysis Review

First Physicians Capital Group, Inc. (FPCG) - Financial and Strategic Analysis Review / / Summary / / First Physicians Capital G
2010 250,00$

Dil Ltd. (506414) - Financial and Strategic Analysis Review

Dil Ltd. (506414) - Financial and Strategic Analysis Review / / Summary / / Dil Ltd. (DIL, formerly known as Duphar Interfran Lt
2010 250,00$

Entest BioMedical Inc. (ENTB) - Financial and Strategic Analysis Review

Entest BioMedical Inc. (ENTB) - Financial and Strategic Analysis Review / / Summary / / Entest BioMedical Inc. (Entest), a major
2010 250,00$

Sihuan Pharmaceutical Holdings Group Ltd. (BL5) - Financial and Strategic Analysis Review

Sihuan Pharmaceutical Holdings Group Ltd. (BL5) - Financial and Strategic Analysis Review / / Summary / / Sihuan Pharmaceutical
2010 250,00$

Chuounyu Co., Ltd. (9053) - Financial and Strategic Analysis Review

Chuounyu Co., Ltd. (9053) - Financial and Strategic Analysis Review / / Summary / / Chuounyu Co., Ltd. (Chuounyu) is a Japan-bas
2010 250,00$

Freedom Eye Resources Limited (FYI) - Financial and Strategic Analysis Review

Freedom Eye Resources Limited (FYI) - Financial and Strategic Analysis Review / / Summary / / Freedom Eye Limited (Freedom Eye)
2010 250,00$

China Baoan Group Co., Ltd. (9) - Financial and Strategic Analysis Review

China Baoan Group Co., Ltd. (9) - Financial and Strategic Analysis Review / / Summary / / China Baoan Group Co., Ltd. (CBGC) is
2010 125,00$

Vivakor, Inc. (VIVK) - Financial and Strategic Analysis Review

Vivakor, Inc. (VIVK) - Financial and Strategic Analysis Review / / Summary / / Vivakor, Inc. (Vivakor) is engaged in the researc
2010 250,00$

Reliv International, Inc. (RELV) - Financial and Strategic Analysis Review

Reliv International, Inc. (RELV) - Financial and Strategic Analysis Review / / Summary / / Reliv International, Inc. (Reliv) is
2010 125,00$

Adventa Berhad (ADVENTA) - Financial and Strategic Analysis Review

Adventa Berhad (ADVENTA) - Financial and Strategic Analysis Review / / Summary / / Adventa Berhad (Adventa) is an investment hol
2010 250,00$

Fountain Healthy Aging Inc. (FHAI) - Financial and Strategic Analysis Review

Fountain Healthy Aging Inc. (FHAI) - Financial and Strategic Analysis Review / / Summary / / Fountain Healthy Aging, Inc. (FHAI)
2010 250,00$

Acuvax Ltd (ACU) - Financial and Strategic Analysis Review

Acuvax Ltd (ACU) - Financial and Strategic Analysis Review / / Summary / / Acuvax Ltd (Acuvax) is a publicly held holding compan
2010 250,00$

J-COM Holdings Co., Ltd. (2462) - Financial and Strategic Analysis Review

J-COM Holdings Co., Ltd. (2462) - Financial and Strategic Analysis Review / / Summary / / J-COM Holdings Co., Ltd. (J-COM Holdin
2010 250,00$

Ohr Pharmaceutical Inc. (OHRP) - Financial and Strategic Analysis Review

Ohr Pharmaceutical Inc. (OHRP) - Financial and Strategic Analysis Review / / Summary / / Ohr Pharmaceutical Inc. (Ohr) is a publ
2010 250,00$

Shanghai Dingli Technology Development (Group) Co., Ltd. (900907) - Financial and Strategic Analysis Review

Shanghai Dingli Technology Development (Group) Co., Ltd. (900907) - Financial and Strategic Analysis Review / / Summary / / Shan
2010 250,00$

Centric Health Corporation (CHH) - Financial and Strategic Analysis Review

Centric Health Corporation (CHH) - Financial and Strategic Analysis Review / / Summary / / Centric Health Corporation (Centric H
2010 250,00$

Sinopharm Group Co. Ltd. (1099) - Financial and Strategic Analysis Review

Sinopharm Group Co. Ltd. (1099) - Financial and Strategic Analysis Review / / Summary / / Sinopharm Group Co. Ltd. (Sinopharm Gr
2010 125,00$

Synmosa Biopharma Corporation (4114) - Financial and Strategic Analysis Review

Synmosa Biopharma Corporation (4114) - Financial and Strategic Analysis Review / / Summary / / Synmosa Biopharma Corporation (Sy
2010 250,00$

Sunshine Biopharma, Inc. (SBFM) - Financial and Strategic Analysis Review

Sunshine Biopharma, Inc. (SBFM) - Financial and Strategic Analysis Review / / Summary / / Sunshine Biopharma, Inc. (Sunshine Bio
2010 250,00$

Optigenex Inc. (OPGX) - Financial and Strategic Analysis Review

Optigenex Inc. (OPGX) - Financial and Strategic Analysis Review / / Summary / / Optigenex Inc. (Optigenex) is an applied life sc
2010 125,00$

ECI, Inc. (4567) - Financial and Strategic Analysis Review

ECI, Inc. (4567) - Financial and Strategic Analysis Review / / Summary / / ECI, Inc. (ECI) is a publicly traded bio-pharmaceutic
2010 250,00$

The Westaim Corporation (WED) - Financial and Strategic Analysis Review

The Westaim Corporation (WED) - Financial and Strategic Analysis Review / / Summary / / The Westaim Corporation (Westaim) is a h
2010 250,00$

ISU ABXIS Co.,Ltd. (86890) - Financial and Strategic Analysis Review

ISU ABXIS Co.,Ltd. (86890) - Financial and Strategic Analysis Review / / Summary / / ISU ABXIS Co., Ltd. (ISU ABXIS) is a biotec
2010 250,00$

Biosynergy, Inc. (BSYN) - Financial and Strategic Analysis Review

Biosynergy, Inc. (BSYN) - Financial and Strategic Analysis Review / / Summary / / Biosynergy, Inc.(Biosynergy) is publicly held
2010 125,00$

Impreglon AG (I3M) - Financial and Strategic Analysis Review

Impreglon AG (I3M) - Financial and Strategic Analysis Review / / Summary / / Impreglon AG (Impreglon) is a technology based comp
2010 250,00$

Fem Care Pharma Ltd. (524608) - Financial and Strategic Analysis Review

Fem Care Pharma Ltd. (524608) - Financial and Strategic Analysis Review / / Summary / / Fem Care Pharma Ltd. (Fem Care Pharma) i
2010 250,00$

Baolingbao Biology Co., Ltd. (2286) - Financial and Strategic Analysis Review

Baolingbao Biology Co., Ltd. (2286) - Financial and Strategic Analysis Review / / Summary / / Baolingbao Biology Co., Ltd. (Baol
2010 250,00$

Cardia Bioplastics Limited (CNN) - Financial and Strategic Analysis Review

Cardia Bioplastics Limited (CNN) - Financial and Strategic Analysis Review / / Summary / / Cardia Bioplastics Limited (Cardia Bi
2010 250,00$

Care Advantage, Inc. (CADV) - Financial and Strategic Analysis Review

Care Advantage, Inc. (CADV) - Financial and Strategic Analysis Review / / Summary / / Care Advantage, Inc. (Care Advantage) is a
2010 250,00$

La Positiva Seguros y Reaseguros S.A. (POSITIC1) - Financial and Strategic Analysis Review

La Positiva Seguros y Reaseguros S.A. (POSITIC1) - Financial and Strategic Analysis Review / / Summary / / La Positiva Seguros y
2010 250,00$

Kangmei Pharmaceutical Co., Ltd. (600518) - Financial and Strategic Analysis Review

Kangmei Pharmaceutical Co., Ltd. (600518) - Financial and Strategic Analysis Review / / Summary / / Kangmei Pharmaceutical Co.,
2010 125,00$

Henley Healthcare, Inc. (HENL) - Financial and Strategic Analysis Review

Henley Healthcare, Inc. (HENL) - Financial and Strategic Analysis Review / / Summary / / Henley Healthcare, Inc. (Henley), forme
2010 125,00$

BDH Industries Ltd. (524828) - Financial and Strategic Analysis Review

BDH Industries Ltd. (524828) - Financial and Strategic Analysis Review / / Summary / / BDH Industries Ltd. (BDH) is a pharmaceut
2010 250,00$

Auriga International SA (AURI) - Financial and Strategic Analysis Review

Auriga International SA (AURI) - Financial and Strategic Analysis Review / / Summary / / Auriga International S.A. (Auriga) is a
2010 125,00$

JCL Bioassay Corporation (2190) - Financial and Strategic Analysis Review

JCL Bioassay Corporation (2190) - Financial and Strategic Analysis Review / / Summary / / JCL Bioassay Corporation (JCL Bioassay
2010 250,00$

Equispharm Co., Ltd (58530) - Financial and Strategic Analysis Review

Equispharm Co., Ltd (58530) - Financial and Strategic Analysis Review / / Summary / / EquisPharm Co., Ltd.,(EquisPharm) is a pub
2010 250,00$

Modern Medical Modalities Corporation (MODM) - Financial and Strategic Analysis Review

Modern Medical Modalities Corporation (MODM) - Financial and Strategic Analysis Review / / Summary / / Modern Medical Modalities
2010 250,00$

General Biologicals Corporation (4117) - Financial and Strategic Analysis Review

General Biologicals Corporation (4117) - Financial and Strategic Analysis Review / / Summary / / General Biologicals Corporation
2010 250,00$

General Medical Clinics PLC (GMCP) - Financial and Strategic Analysis Review

General Medical Clinics PLC (GMCP) - Financial and Strategic Analysis Review / / Summary / / General Medical Clinics PLC (Genera
2010 250,00$

Synthetech, Inc. (NZYM) - Financial and Strategic Analysis Review

Synthetech, Inc. (NZYM) - Financial and Strategic Analysis Review / / Summary / / Synthetech, Inc. (Synthetech) is a publicly he
2010 250,00$

Easton Pharmaceuticals Inc. (LAIC) - Financial and Strategic Analysis Review

Easton Pharmaceuticals Inc. (LAIC) - Financial and Strategic Analysis Review / / Summary / / Easton Pharmaceuticals Inc. (Easton
2010 125,00$

Concord Medical Services Holdings Limited (CCM) - Financial and Strategic Analysis Review

Concord Medical Services Holdings Limited (CCM) - Financial and Strategic Analysis Review / / Summary / / Concord Medical Servic
2010 250,00$

Cell Biotech Co., Ltd. (49960) - Financial and Strategic Analysis Review

Cell Biotech Co., Ltd. (49960) - Financial and Strategic Analysis Review / / Summary / / Cell Biotech Co., Ltd. (Cell Biotech) i
2010 250,00$

Cell Kinetics Ltd. (CKNTF) - Financial and Strategic Analysis Review

Cell Kinetics Ltd. (CKNTF) - Financial and Strategic Analysis Review / / Summary / / Cell Kinetics Ltd. (Cell Kinetics) is engag
2010 250,00$

Jiangbo Pharmaceuticals, Inc. (JGBO) - Financial and Strategic Analysis Review

Jiangbo Pharmaceuticals, Inc. (JGBO) - Financial and Strategic Analysis Review / / Summary / / Jiangbo Pharmaceuticals, Inc. (Ji
2010 250,00$

KDL Biotech Ltd (532291) - Financial and Strategic Analysis Review

KDL Biotech Ltd (532291) - Financial and Strategic Analysis Review / / Summary / / KDL Biotech Ltd (KDL) is a publicly held heal
2010 250,00$

Jiangsu Kanion Pharmaceutical Co., Ltd. (600557) - Financial and Strategic Analysis Review

Jiangsu Kanion Pharmaceutical Co., Ltd. (600557) - Financial and Strategic Analysis Review / / Summary / / Jiangsu Kanion Pharma
2010 250,00$

Jiangsu Lianhuan Pharmaceutical Co. Ltd (600513) - Financial and Strategic Analysis Review

Jiangsu Lianhuan Pharmaceutical Co. Ltd (600513) - Financial and Strategic Analysis Review / / Summary / / Jiangsu Lianhuan Phar
2010 250,00$

Genmed Holding Corp. (GENM) - Financial and Strategic Analysis Review

Genmed Holding Corp. (GENM) - Financial and Strategic Analysis Review / / Summary / / Genmed Holding Corp. (GHC) is an integrate
2010 250,00$

Kerala Ayurveda Limited (530163) - Financial and Strategic Analysis Review

Kerala Ayurveda Limited (530163) - Financial and Strategic Analysis Review / / Summary / / Kerala Ayurveda Limited (KAL) is a he
2010 250,00$

GFR Pharmaceuticals, Inc. (GFRP) - Financial and Strategic Analysis Review

GFR Pharmaceuticals, Inc. (GFRP) - Financial and Strategic Analysis Review / / Summary / / GFR Pharmaceuticals, Inc.(GFR Pharmac
2010 250,00$

Beijing Tong Ren Tang Group Co., Ltd. (600085) - Financial and Strategic Analysis Review

Beijing Tong Ren Tang Group Co., Ltd. (600085) - Financial and Strategic Analysis Review / / Summary / / Beijing Tong Ren Tang G
2010 125,00$

Larrea Biosciences Corp (LRRA) - Financial and Strategic Analysis Review

Larrea Biosciences Corp (LRRA) - Financial and Strategic Analysis Review / / Summary / / Larrea Biosciences Corp (Larrea Bioscie
2010 125,00$

Center for Wound Healing, Inc. (CFWH) - Financial and Strategic Analysis Review

Center for Wound Healing, Inc. (CFWH) - Financial and Strategic Analysis Review / / Summary / / Center for Wound Healing, Inc. (
2010 250,00$

Central Securities Corporation (CET) - Financial and Strategic Analysis Review

Central Securities Corporation (CET) - Financial and Strategic Analysis Review / / Summary / / Central Securities Corporation (C
2010 250,00$

Amil Participacoes S.A. (AMIL3) - Financial and Strategic Analysis Review

Amil Participacoes S.A. (AMIL3) - Financial and Strategic Analysis Review / / Summary / / Amil Participacoes S.A. (Amil Par) is
2010 125,00$

Ayrton Drugs Manufacturing Company Ltd. (AYRTN) - Financial and Strategic Analysis Review

Ayrton Drugs Manufacturing Company Ltd. (AYRTN) - Financial and Strategic Analysis Review / / Summary / / Ayrton Drug Manufactur
2010 250,00$

C-Pharma, Inc. (CPBM) - Financial and Strategic Analysis Review

C-Pharma, Inc. (CPBM) - Financial and Strategic Analysis Review / / Summary / / C-Pharma, Inc. (C-Pharma), is a publicly held bi
2010 250,00$

Jordan Emirates Insurance Co Psc (OASI) - Financial and Strategic Analysis Review

Jordan Emirates Insurance Co Psc (OASI) - Financial and Strategic Analysis Review / / Summary / / Jordan Emirates Insurance Co P
2010 250,00$

Ceylon Hospitals PLC (CHL) - Financial and Strategic Analysis Review

Ceylon Hospitals PLC (CHL) - Financial and Strategic Analysis Review / / Summary / / Ceylon Hospitals PLC (Ceylon Hospitals), a
2010 250,00$

CHA Bio & Diostech Co., Ltd. (85660) - Financial and Strategic Analysis Review

CHA Bio & Diostech Co., Ltd. (85660) - Financial and Strategic Analysis Review / / Summary / / CHA Bio & Diostech Co., Ltd. (CHA
2010 125,00$

Changchun High & New Tech Industry Inc (661) - Financial and Strategic Analysis Review

Changchun High & New Tech Industry Inc (661) - Financial and Strategic Analysis Review / / Summary / / Changchun High & New Tech
2010 250,00$

LecTec Corporation (LECT) - Financial and Strategic Analysis Review

LecTec Corporation (LECT) - Financial and Strategic Analysis Review / / Summary / / LecTec Corporation (LecTec) is an intellectu
2010 250,00$

Activar Technical Products Group (MGSR) - Financial and Strategic Analysis Review

Activar Technical Products Group (MGSR) - Financial and Strategic Analysis Review / / Summary / / Activar Technical Products Gro
2010 125,00$

LensWista AG (LZVB) - Financial and Strategic Analysis Review

LensWista AG (LZVB) - Financial and Strategic Analysis Review / / Summary / / LensWista AG (LensWista) is engaged in the product
2010 250,00$

ChemoMetec A/S (CHEMM) - Financial and Strategic Analysis Review

ChemoMetec A/S (CHEMM) - Financial and Strategic Analysis Review / / Summary / / ChemoMetec A/S (ChemoMetec) is engaged in worki
2010 250,00$

Chennai Meenakshi Multispeciality Hospit (523489) - Financial and Strategic Analysis Review

Chennai Meenakshi Multispeciality Hospit (523489) - Financial and Strategic Analysis Review / / Summary / / Chennai Meenakshi Mu
2010 250,00$

Cherwell Capital PLC (CHEP) - Financial and Strategic Analysis Review

Cherwell Capital PLC (CHEP) - Financial and Strategic Analysis Review / / Summary / / Cherwell Capital Plc (Cherwell Capital) is
2010 250,00$

Lotus Pharmaceutical Co., Ltd. (1795) - Financial and Strategic Analysis Review

Lotus Pharmaceutical Co., Ltd. (1795) - Financial and Strategic Analysis Review / / Summary / / Lotus Pharmaceutical Co., Ltd. (
2010 250,00$

China Animal Husbandry Industry Co., Ltd (600195) - Financial and Strategic Analysis Review

China Animal Husbandry Industry Co., Ltd (600195) - Financial and Strategic Analysis Review / / Summary / / China Animal Husband
2010 125,00$

China Bio-Immunity Corporation (CHHB) - Financial and Strategic Analysis Review

China Bio-Immunity Corporation (CHHB) - Financial and Strategic Analysis Review / / Summary / / China Bio-Immunity Corporation (
2010 125,00$

Life Nutrition Products, Inc. (LIPN) - Financial and Strategic Analysis Review

Life Nutrition Products, Inc. (LIPN) - Financial and Strategic Analysis Review / / Summary / / Life Nutrition Products, Inc., is
2010 250,00$

Hong Kong Health Check and Medical Diagnostic Centre (397) - Financial and Strategic Analysis Review

Hong Kong Health Check and Medical Diagnostic Centre (397) - Financial and Strategic Analysis Review / / Summary / / Hong Kong H
2010 250,00$

Linical Co., Ltd. (2183) - Financial and Strategic Analysis Review

Linical Co., Ltd. (2183) - Financial and Strategic Analysis Review / / Summary / / Linical Co., Ltd., (Lincal) is a contract res
2010 250,00$

China Longyi Group International Holdings Limited (CGYG) - Financial and Strategic Analysis Review

China Longyi Group International Holdings Limited (CGYG) - Financial and Strategic Analysis Review / / Summary / / China Longyi
2010 250,00$

Syncom Formulations (India) Ltd (524470) - Financial and Strategic Analysis Review

Syncom Formulations (India) Ltd (524470) - Financial and Strategic Analysis Review / / Summary / / Syncom Formulations (India) L
2010 250,00$

China Shenghuo Pharmaceutical Holdings, Inc. (KUN) - Financial and Strategic Analysis Review

China Shenghuo Pharmaceutical Holdings, Inc. (KUN) - Financial and Strategic Analysis Review / / Summary / / China Shenghuo Phar
2010 250,00$

Hubei Biocause Pharmaceutical Co. , Ltd. (627) - Financial and Strategic Analysis Review

Hubei Biocause Pharmaceutical Co. , Ltd. (627) - Financial and Strategic Analysis Review / / Summary / / Hubei Biocause Pharmace
2010 250,00$

O.I. Corporation (OICO) - Financial and Strategic Analysis Review

O.I. Corporation (OICO) - Financial and Strategic Analysis Review / / Summary / / O.I. Corporation is a specialty medical device
2010 250,00$

Bharat Immunologicals and Biologicals Corporation Limited (524663) - Financial and Strategic Analysis Review

Bharat Immunologicals and Biologicals Corporation Limited (524663) - Financial and Strategic Analysis Review / / Summary / / Bha
2010 250,00$

Longrun Tea Group Company Limited (2898) - Financial and Strategic Analysis Review

Longrun Tea Group Company Limited (2898) - Financial and Strategic Analysis Review / / Summary / / Longrun Tea Group Company Lim
2010 250,00$

China SXAN Biotech, Inc. (CSXB) - Financial and Strategic Analysis Review

China SXAN Biotech, Inc. (CSXB) - Financial and Strategic Analysis Review / / Summary / / China SXAN Biotech, Inc. (China SXAN),
2010 250,00$

Wakefield Health Limited (WFD) - Financial and Strategic Analysis Review

Wakefield Health Limited (WFD) - Financial and Strategic Analysis Review / / Summary / / Wakefield Health Limited (Wakefield Hea
2010 250,00$

T-Ray Science, Inc. (THZ) - Financial and Strategic Analysis Review

T-Ray Science, Inc. (THZ) - Financial and Strategic Analysis Review / / Summary / / T-Ray Science, Inc. (T-Ray) is a provider of
2010 250,00$

Scientific Industries, Inc. (SCND) - Financial and Strategic Analysis Review

Scientific Industries, Inc. (SCND) - Financial and Strategic Analysis Review / / Summary / / Scientific Industries, Inc. (Scient
2010 125,00$

Choong Ang Biotech Co., Ltd. (15170) - Financial and Strategic Analysis Review

Choong Ang Biotech Co., Ltd. (15170) - Financial and Strategic Analysis Review / / Summary / / Choong Ang Biotech Co., Ltd. (Cho
2010 250,00$

Cybrdi, Inc. (CYDI) - Financial and Strategic Analysis Review

Cybrdi, Inc. (CYDI) - Financial and Strategic Analysis Review / / Summary / / Cybrdi, Inc., (Cybrdi) is a tissue micro-array pro
2010 250,00$

Orchestra Therapeutics, Inc. (OCHT) - Financial and Strategic Analysis Review

Orchestra Therapeutics, Inc. (OCHT) - Financial and Strategic Analysis Review / / Summary / / Orchestra Therapeutics, Inc. (OCHT
2010 125,00$

VitalCare Diabetes Treatment Centers, Inc. (VDTI) - Financial and Strategic Analysis Review

VitalCare Diabetes Treatment Centers, Inc. (VDTI) - Financial and Strategic Analysis Review / / Summary / / VitalCare Diabetes T
2010 250,00$

Xechem International, Inc (XKEMQ) - Financial and Strategic Analysis Review

Xechem International, Inc (XKEMQ) - Financial and Strategic Analysis Review / / Summary / / Xechem International, Inc. (Xechem)
2010 125,00$

China YCT International Group, Inc. (CYIG) - Financial and Strategic Analysis Review

China YCT International Group, Inc. (CYIG) - Financial and Strategic Analysis Review / / Summary / / China YCT International Gro
2010 125,00$

GlycoGenesys, Inc. (GLGSQ) - Financial and Strategic Analysis Review

GlycoGenesys, Inc. (GLGSQ) - Financial and Strategic Analysis Review / / Summary / / GlycoGenesys, Inc. (formerly known as SafeS
2010 125,00$

Micro Laboratories, Inc. (MLAR) - Financial and Strategic Analysis Review

Micro Laboratories, Inc. (MLAR) - Financial and Strategic Analysis Review / / Summary / / Micro Laboratories, Inc. (Micro Lab) i
2010 125,00$

CNS Response, Inc. (CNSO) - Financial and Strategic Analysis Review

CNS Response, Inc. (CNSO) - Financial and Strategic Analysis Review / / Summary / / CNS Response, Inc. (CNS) is a life sciences
2010 250,00$

Millennium Biotechnologies Group, Inc. (MBTG) - Financial and Strategic Analysis Review

Millennium Biotechnologies Group, Inc. (MBTG) - Financial and Strategic Analysis Review / / Summary / / Millennium Biotechnologi
2010 250,00$

Argonaut Technologies, Inc. (AGNT) - Financial and Strategic Analysis Review

Argonaut Technologies, Inc. (AGNT) - Financial and Strategic Analysis Review / / Summary / / Argonaut Technologies, Inc. (Argona
2010 125,00$

Medical Marketing International Group plc (MMG) - Financial and Strategic Analysis Review

Medical Marketing International Group plc (MMG) - Financial and Strategic Analysis Review / / Summary / / Medical Marketing Inte
2010 250,00$

Yung Shin Pharma Ind. Co. Ltd (1716) - Financial and Strategic Analysis Review

Yung Shin Pharma Ind. Co. Ltd (1716) - Financial and Strategic Analysis Review / / Summary / / Yung Shin Pharma Ind. Co. Ltd (Yu
2010 125,00$

Shandong Xinhua Pharmaceutical Company Limited (719) - Financial and Strategic Analysis Review

Shandong Xinhua Pharmaceutical Company Limited (719) - Financial and Strategic Analysis Review / / Summary / / Shandong Xinhua P
2010 125,00$

Vita Life Sciences Limited (VSC) - Financial and Strategic Analysis Review

Vita Life Sciences Limited (VSC) - Financial and Strategic Analysis Review / / Summary / / Vita Life Sciences Limited (Vita Life
2010 250,00$

May & Baker Nigeria PLC. (MAYBAKER) - Financial and Strategic Analysis Review

May & Baker Nigeria PLC. (MAYBAKER) - Financial and Strategic Analysis Review / / Summary / / May & Baker Nigeria PLC. (May & Ba
2010 250,00$

Kaken Pharmaceutical Co., Ltd. (4521) - Financial and Strategic Analysis Review

Kaken Pharmaceutical Co., Ltd. (4521) - Financial and Strategic Analysis Review / / Summary / / Kaken Pharmaceutical Co., Ltd. (
2010 125,00$

Egis Gyogyszergyar Nyrt. (EGIS) - Financial and Strategic Analysis Review

Egis Gyogyszergyar Nyrt. (EGIS) - Financial and Strategic Analysis Review / / Summary / / Egis Gyogyszergyar Nyrt (Egis) is enga
2010 125,00$

Paradise Entertainment Limited (1180) - Financial and Strategic Analysis Review

Paradise Entertainment Limited (1180) - Financial and Strategic Analysis Review / / Summary / / Paradise Entertainment Limited (
2010 250,00$

RNL BIO Co., Ltd. (3190) - Financial and Strategic Analysis Review

RNL BIO Co., Ltd. (3190) - Financial and Strategic Analysis Review / / Summary / / RNL BIO Co., Ltd. (RNL BIO) is a biotechnolog
2010 250,00$

Savoy Equities Limited (SVY) - Financial and Strategic Analysis Review

Savoy Equities Limited (SVY) - Financial and Strategic Analysis Review / / Summary / / Savoy Equities Limited (Savoy Equities) o
2010 250,00$

Enerland Corporation Co., Ltd. (45260) - Financial and Strategic Analysis Review

Enerland Corporation Co., Ltd. (45260) - Financial and Strategic Analysis Review / / Summary / / Enerland Corporation Co., Ltd.
2010 250,00$

North China Pharmaceutical Co., Ltd. (600812) - Financial and Strategic Analysis Review

North China Pharmaceutical Co., Ltd. (600812) - Financial and Strategic Analysis Review / / Summary / / North China Pharmaceutic
2010 125,00$

J Communications Co., Ltd. (60750) - Financial and Strategic Analysis Review

J Communications Co., Ltd. (60750) - Financial and Strategic Analysis Review / / Summary / / J Communications Co., Ltd. (J Commu
2010 250,00$

Chongqing Taiji Industry (Group)Co., Ltd. (600129) - Financial and Strategic Analysis Review

Chongqing Taiji Industry(Group)Co., Ltd. (600129) - Financial and Strategic Analysis Review / / Summary / / Chongqing Taiji Indu
2010 125,00$

Hillestad Pharmaceuticals Inc. (HPH) - Financial and Strategic Analysis Review

Hillestad Pharmaceuticals Inc. (HPH) - Financial and Strategic Analysis Review / / Summary / / Hillestad Pharmaceuticals Inc. (H
2010 125,00$

Shanghai Wingsung Investment Management Co., Ltd. (900904) - Financial and Strategic Analysis Review

Shanghai Wingsung Investment Management Co., Ltd. (900904) - Financial and Strategic Analysis Review / / Summary / / Shanghai Wi
2010 250,00$

Shenzhen Neptunus Bioengineering Co. Ltd (78) - Financial and Strategic Analysis Review

Shenzhen Neptunus Bioengineering Co. Ltd (78) - Financial and Strategic Analysis Review / / Summary / / Shenzhen Neptunus Bioeng
2010 125,00$

Ams Life Science Co., Ltd. (2927) - Financial and Strategic Analysis Review

Ams Life Science Co., Ltd. (2927) - Financial and Strategic Analysis Review / / Summary / / AMS Life Science Co.,Ltd. (AMS Life
2010 250,00$

Dottikon ES Holding AG (DESN) - Financial and Strategic Analysis Review

Dottikon ES Holding AG (DESN) - Financial and Strategic Analysis Review / / Summary / / Dottikon ES Holding AG (Dottikon ES) is
2010 250,00$

Phylaxia 1912 Holding Nyrt (PHYLAXIA) - Financial and Strategic Analysis Review

Phylaxia 1912 Holding Nyrt (PHYLAXIA) - Financial and Strategic Analysis Review / / Summary / / Phylaxia 1912 Holding Nyrt (Phyl
2010 250,00$

Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co.,Ltd. (8231) - Financial and Strategic Analysis Review

Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co.,Ltd. (8231) - Financial and Strategic Analysis Review / / Summary / / Shanghai
2010 250,00$

Shanghai Modern Pharmaceutical Co., Ltd. (600420) - Financial and Strategic Analysis Review

Shanghai Modern Pharmaceutical Co., Ltd. (600420) - Financial and Strategic Analysis Review / / Summary / / Shanghai Modern Phar
2010 125,00$

Shandong Shanda Wit Science & Tech Co (915) - Financial and Strategic Analysis Review

Shandong Shanda Wit Science & Tech Co (915) - Financial and Strategic Analysis Review / / Summary / / Shandong Shanda Wit Scienc
2010 250,00$

Southwest Pharmaceutical Co., Ltd. (600666) - Financial and Strategic Analysis Review

Southwest Pharmaceutical Co., Ltd. (600666) - Financial and Strategic Analysis Review / / Summary / / Southwest Pharmaceutical C
2010 250,00$

Shanghai Furen Industrial (Group) Co., Ltd. (600781) - Financial and Strategic Analysis Review

Shanghai Furen Industrial (Group) Co., Ltd. (600781) - Financial and Strategic Analysis Review / / Summary / / Shanghai Furen In
2010 250,00$

Yabao Pharmaceutical Group Co., Ltd (600351) - Financial and Strategic Analysis Review

Yabao Pharmaceutical Group Co., Ltd (600351) - Financial and Strategic Analysis Review / / Summary / / Yabao Pharmaceutical Grou
2010 250,00$

Shenzhen Cau Technology Co., Ltd. (4) - Financial and Strategic Analysis Review

Shenzhen Cau Technology Co., Ltd. (4) - Financial and Strategic Analysis Review / / Summary / / Shenzhen Cau Technology Co., Ltd
2010 250,00$

Shanghai Zhongxi Pharmaceutical Co., Ltd. (600842) - Financial and Strategic Analysis Review

Shanghai Zhongxi Pharmaceutical Co., Ltd. (600842) - Financial and Strategic Analysis Review / / Summary / / Shanghai Zhongxi Ph
2010 250,00$

Institute of Applied Medicine, Inc. (2123) - Financial and Strategic Analysis Review

Institute of Applied Medicine, Inc. (2123) - Financial and Strategic Analysis Review / / Summary / / Institute of Applied Medici
2010 250,00$

Middle East Pharmaceutical and Chemical Industries & Medical Appliances Co. (MPHA) - Financial and Strategic Analysis Review

Middle East Pharmaceutical and Chemical Industries & Medical Appliances Co. (MPHA) - Financial and Strategic Analysis Review / /
2010 250,00$

Omega Diagnostics Group PLC (ODX) - Financial and Strategic Analysis Review

Omega Diagnostics Group PLC (ODX) - Financial and Strategic Analysis Review / / Summary / / Omega Diagnostics Group PLC (ODG) is
2010 250,00$

Wyeth Pakistan Limited (WYETH) - Financial and Strategic Analysis Review

Wyeth Pakistan Limited (WYETH) - Financial and Strategic Analysis Review / / Summary / / Wyeth Pakistan Limited (Wyeth Pakistan)
2010 250,00$

Shandong Wohua Pharmaceutical Co., Ltd. (2107) - Financial and Strategic Analysis Review

Shandong Wohua Pharmaceutical Co., Ltd. (2107) - Financial and Strategic Analysis Review / / Summary / / Shandong Wohua Pharmace
2010 250,00$

Nuvilex, Inc. (NVLX) - Financial and Strategic Analysis Review

Nuvilex, Inc. (NVLX) - Financial and Strategic Analysis Review / / Summary / / Nuvilex, Inc. (Nuvilex) is a US based holding com
2010 250,00$

Worldwide Biotech & Pharmaceutical Co. (WWBP) - Financial and Strategic Analysis Review

Worldwide Biotech & Pharmaceutical Co. (WWBP) - Financial and Strategic Analysis Review / / Summary / / Worldwide Biotech & Phar
2010 250,00$

Xeno Transplants Corporation (XENO) - Financial and Strategic Analysis Review

Xeno Transplants Corporation (XENO) - Financial and Strategic Analysis Review / / Summary / / Xeno Transplants Corporation, (Xen
2010 125,00$

Tissera, Inc. (TSSR) - Financial and Strategic Analysis Review

Tissera, Inc. (TSSR) - Financial and Strategic Analysis Review / / Summary / / Tissera, Inc. (Tissera) is a developmental stage
2010 250,00$

VYTA Corp. (VYTC) - Financial and Strategic Analysis Review

VYTA Corp. (VYTC) - Financial and Strategic Analysis Review / / Summary / / Vyta Corp. (Vyta), formerly NanoPierce Technologies,
2010 250,00$

Woogene B&G Co, Ltd. (18620) - Financial and Strategic Analysis Review

Woogene B&G Co, Ltd. (18620) - Financial and Strategic Analysis Review / / Summary / / Woogene B&G Co, Ltd. (Woogene B&G) is a K
2010 250,00$

Ivy Medical Chemicals PLC (IVMP) - Financial and Strategic Analysis Review

Ivy Medical Chemicals PLC (IVMP) - Financial and Strategic Analysis Review / / Summary / / Ivy Medical Chemicals PLC (Ivy Medica
2010 250,00$

AquaSource Algae Group PLC (AAGP) - Financial and Strategic Analysis Review

AquaSource Algae Group PLC (AAGP) - Financial and Strategic Analysis Review / / Summary / / AquaSource Algae Group PLC (AquaSour
2010 250,00$

Medical Developments International Limited (MVP) - Financial and Strategic Analysis Review

Medical Developments International Limited (MVP) - Financial and Strategic Analysis Review / / Summary / / Medical Developments
2010 250,00$

AlumiFuel Power Corporation (AFPW) - Financial and Strategic Analysis Review

AlumiFuel Power Corporation (AFPW) - Financial and Strategic Analysis Review / / Summary / / AlumiFuel Power Corporation (AlumiF
2010 250,00$

Intra Infotech Ltd (531959) - Financial and Strategic Analysis Review

Intra Infotech Ltd (531959) - Financial and Strategic Analysis Review / / Summary / / Intra Infotech Ltd (Intra Infotech) is an
2010 250,00$

Super Luck, Inc. (SULU) - Financial and Strategic Analysis Review

Super Luck, Inc. (SULU) - Financial and Strategic Analysis Review / / Summary / / Super Luck, Inc. (Super Luck) is a development
2010 250,00$

Integrated Pharmaceuticals, Inc. (INTP) - Financial and Strategic Analysis Review

Integrated Pharmaceuticals, Inc. (INTP) - Financial and Strategic Analysis Review / / Summary / / Integrated Pharmaceuticals, In
2010 125,00$

Thomas Pharmaceuticals, Ltd. (TPHM) - Financial and Strategic Analysis Review

Thomas Pharmaceuticals, Ltd. (TPHM) - Financial and Strategic Analysis Review / / Summary / / Thomas Pharmaceuticals, Ltd. focus
2010 250,00$

RegenoCELL Therapeutics, Inc. (RCLL) - Financial and Strategic Analysis Review

RegenoCELL Therapeutics, Inc. (RCLL) - Financial and Strategic Analysis Review / / Summary / / RegenoCELL Therapeutics, Inc. (RC
2010 250,00$

Omnimmune Holdings, Inc. (OMMH) - Financial and Strategic Analysis Review

Omnimmune Holdings, Inc. (OMMH) - Financial and Strategic Analysis Review / / Summary / / Omnimmune Holdings, Inc. (Omnimmune) i
2010 250,00$

Kun Run Biotechnology, Inc. (KURU) - Financial and Strategic Analysis Review

Kun Run Biotechnology, Inc. (KURU) - Financial and Strategic Analysis Review / / Summary / / Kun Run Biotechnology, Inc. (Kun Ru
2010 250,00$

Metabolic Research, Inc. (MTBR) - Financial and Strategic Analysis Review

Metabolic Research, Inc. (MTBR) - Financial and Strategic Analysis Review / / Summary / / Metabolic Research, Inc. (Metabolic Re
2010 250,00$

Procyon Corporation (PCYN) - Financial and Strategic Analysis Review

Procyon Corporation (PCYN) - Financial and Strategic Analysis Review / / Summary / / Procyon Corporation (Procyon) is a publicly
2010 250,00$

Naturade, Inc. (NRDCQ) - Financial and Strategic Analysis Review

Naturade, Inc. (NRDCQ) - Financial and Strategic Analysis Review / / Summary / / Naturade, Inc. (Naturade) markets scientificall
2010 125,00$

Stem Cell Therapy International, Inc. (SCII) - Financial and Strategic Analysis Review

Stem Cell Therapy International, Inc. (SCII) - Financial and Strategic Analysis Review / / Summary / / Stem Cell Therapy Interna
2010 250,00$

NanoRepro AG (NN6) - Financial and Strategic Analysis Review

NanoRepro AG (NN6) - Financial and Strategic Analysis Review / / Summary / / NanoRepro AG (NanoRepro), a pan-European company fo
2010 125,00$

Mycenax Biotech Inc. (4726) - Financial and Strategic Analysis Review

Mycenax Biotech Inc. (4726) - Financial and Strategic Analysis Review / / Summary / / Mycenax Biotech Inc. (Mycenax Biotech) is
2010 250,00$

Tensall Bio-Tech Co., LTD. (4135) - Financial and Strategic Analysis Review

Tensall Bio-Tech Co., LTD. (4135) - Financial and Strategic Analysis Review / / Summary / / Tensall Bio-Tech Co.,Ltd (Tensall) i
2010 250,00$

Comprehensive Healthcare Solutions, Inc. (HYBE) - Financial and Strategic Analysis Review

Comprehensive Healthcare Solutions, Inc. (HYBE) - Financial and Strategic Analysis Review / / Summary / / Comprehensive Healthca
2010 125,00$

Maxicare Health Plans, Inc. (MAXI) - Financial and Strategic Analysis Review

Maxicare Health Plans, Inc. (MAXI) - Financial and Strategic Analysis Review / / Summary / / Maxicare Health Plans, Inc. (MHP) i
2010 125,00$

Mednax, Inc. (MD) - Financial and Strategic Analysis Review

Mednax, Inc. (MD) - Financial and Strategic Analysis Review / / Summary / / Mednax, Inc. (Mednax) is a publicly held healthcare
2010 125,00$

The Sagemark Companies Ltd. (SKCO) - Financial and Strategic Analysis Review

The Sagemark Companies Ltd. (SKCO) - Financial and Strategic Analysis Review / / Summary / / The Sagemark Companies Ltd. (Sagema
2010 250,00$

China Healthcare Limited (592) - Financial and Strategic Analysis Review

China Healthcare Limited (592) - Financial and Strategic Analysis Review / / Summary / / China Healthcare Limited (CHL) is healt
2010 250,00$

Supporta Plc (SOR) - Financial and Strategic Analysis Review

Supporta Plc (SOR) - Financial and Strategic Analysis Review / / Summary / / Supporta Plc (Supporta) is a publicly held holding
2010 250,00$

Asiri Hospital PLC (ASIR) - Financial and Strategic Analysis Review

Asiri Hospital PLC (ASIR) - Financial and Strategic Analysis Review / / Summary / / Asiri Hospital PLC (Asiri) is principally en
2010 250,00$

Corporacion Dermoestetica SA (DERM) - Financial and Strategic Analysis Review

Corporacion Dermoestetica SA (DERM) - Financial and Strategic Analysis Review / / Summary / / Corporacion Dermoestetica SA (Corp
2010 250,00$

Nafais Holding Company (K.S.C.C.) (NAFAIS) - Financial and Strategic Analysis Review

Nafais Holding Company (K.S.C.C.) (NAFAIS) - Financial and Strategic Analysis Review / / Summary / / Nafais Holding Company KSCC
2010 250,00$

Topchoice Medical Invesment Co., Inc (600763) - Financial and Strategic Analysis Review

Topchoice Medical Invesment Co., Inc (600763) - Financial and Strategic Analysis Review / / Summary / / Topchoice Medical Invest
2010 250,00$

Thai Nakarin Hospital Public Company Limited (TNH) - Financial and Strategic Analysis Review

Thai Nakarin Hospital Public Company Limited (TNH) - Financial and Strategic Analysis Review / / Summary / / Thai Nakarin Hospit
2010 250,00$

MedTech Holdings Limited (MEDTECH) - Financial and Strategic Analysis Review

MedTech Holdings Limited (MEDTECH) - Financial and Strategic Analysis Review / / Summary / / MedTech Holdings Limited (MedTech)
2010 125,00$

Union Dental Holdings, Inc. (UDHI) - Financial and Strategic Analysis Review

Union Dental Holdings, Inc. (UDHI) - Financial and Strategic Analysis Review / / Summary / / Union Dental Holdings, Inc. (Union
2010 125,00$

Sirona Biochem Corp (SBM) - Financial and Strategic Analysis Review

Sirona Biochem Corp (SBM) - Financial and Strategic Analysis Review / / Summary / / Sirona Biochem Corp (Sirona Biochem), is a b
2010 250,00$

Biomm S.A. (BIOM4) - Financial and Strategic Analysis Review

Biomm S.A.(BIOM4) - Financial and Strategic Analysis Review / / Summary / / Biomm S.A. (Biomm) is a publicly held Brazil-based b
2010 250,00$

Fibrocell Sciences, Inc. (ILEIQ) - Financial and Strategic Analysis Review

Fibrocell Sciences, Inc.(ILEIQ) - Financial and Strategic Analysis Review / / Summary / / Fibrocell Sciences, Inc. (Fibrocell Sc
2010 250,00$

VivoMedica plc - Financial and Strategic Analysis Review

VivoMedica plc - Financial and Strategic Analysis Review / / Summary / / VivoMedica plc (VivoMedica) is engaged in research, dev
2010 250,00$

Spine Pain Management, Inc. - Financial and Strategic Analysis Review

Spine Pain Management, Inc. - Financial and Strategic Analysis Review / / Summary / / Spine Pain Management, Inc. (Spine Pain Ma
2010 250,00$

Patient Portal Technologies, Inc. - Financial and Strategic Analysis Review

Patient Portal Technologies, Inc. - Financial and Strategic Analysis Review / / Summary / / Patient Portal Technologies, Inc. (P
2010 250,00$

ONE Bio, Corp. (ONBI) - Financial and Strategic Analysis Review

ONE Bio, Corp.(ONBI) - Financial and Strategic Analysis Review / / Summary / / ONE Bio, Corp. (ONE Bio), formerly known as One H
2010 250,00$

Jordanian Pharmaceutical Manufacturing Co. PLC (JPHM) - Financial and Strategic Analysis Review

Jordanian Pharmaceutical Manufacturing Co. PLC(JPHM) - Financial and Strategic Analysis Review / / Summary / / Jordanian Pharmac
2010 250,00$

Twilight Litaka Pharma Ltd. (506985) - Financial and Strategic Analysis Review

Twilight Litaka Pharma Ltd.(506985) - Financial and Strategic Analysis Review / / Summary / / Twilight Litaka Pharma Ltd. (TL Ph
2010 250,00$

PHARMENA SA (PHR) - Financial and Strategic Analysis Review

PHARMENA SA(PHR) - Financial and Strategic Analysis Review / / Summary / / PHARMENA SA (PHARMENA) is a pharmaceutical company en
2010 250,00$

Agennix AG (AGX) - Financial and Strategic Analysis Review

Agennix AG(AGX) - Financial and Strategic Analysis Review / / Summary / / Agennix AG is a biopharmaceutical company resulting fr
2010 250,00$

Traphaco Joint Stock Company (TRA) - Financial and Strategic Analysis Review

Traphaco Joint Stock Company(TRA) - Financial and Strategic Analysis Review / / Summary / / Traphaco Joint Stock Company (Trapha
2010 250,00$

Molecular Pharmacology (USA) Limited (MLPH) - Financial and Strategic Analysis Review

Molecular Pharmacology (USA) Limited(MLPH) - Financial and Strategic Analysis Review / / Summary / / Molecular Pharmacology (USA
2010 250,00$

Rekah Pharmaceutical Industry Ltd. (REKA) - Financial and Strategic Analysis Review

Rekah Pharmaceutical Industry Ltd.(REKA) - Financial and Strategic Analysis Review / / Summary / / Rekah Pharmaceutical Industry
2010 250,00$

Wintac Limited (524758) - Financial and Strategic Analysis Review

Wintac Limited(524758) - Financial and Strategic Analysis Review / / Summary / / Wintac Limited (Wintac), formerly known as Reco
2010 250,00$

Luye Pharma Group Co., Ltd. (A61) - Financial and Strategic Analysis Review

Luye Pharma Group Co., Ltd.(A61) - Financial and Strategic Analysis Review / / Summary / / Luye Pharma Group Ltd. (Luye Pharma),
2010 250,00$

Shenzhen Salubris Pharmaceuticals Co., Ltd. - Financial and Strategic Analysis Review

Shenzhen Salubris Pharmaceuticals Co., Ltd. - Financial and Strategic Analysis Review / / Summary / / Shenzhen Salubris Pharmace
2010 250,00$

InMedica Development Corporation (IMDD) - Financial and Strategic Analysis Review

InMedica Development Corporation(IMDD) - Financial and Strategic Analysis Review / / Summary / / InMedica Development Corporatio
2010 250,00$

QSound Labs, Inc. (QSND) - Financial and Strategic Analysis Review

QSound Labs, Inc.(QSND) - Financial and Strategic Analysis Review / / Summary / / QSound Labs, Inc. (QSound Labs) is an audio te
2010 250,00$

Kunming Pharmaceutical Group Co., Ltd. - Financial and Strategic Analysis Review

Kunming Pharmaceutical Group Co., Ltd. - Financial and Strategic Analysis Review / / Summary / / Kunming Pharmaceutical Group Co
2010 250,00$

Sierra Health Services - Strategic Analysis Review

Sierra Health Services, Inc. is a diversified healthcare services company that operates health maintenance organizations, indemnit
2010 250,00$

Lady Drug Store Co., Ltd. (3027) - Strategic Analysis Review

This comprehensive SWOT profile of Lady Drug Store Co., Ltd. provides you an in-depth strategic analysis of the company’s business
2010 250,00$

Familymeds Group Inc. - Strategic Analysis Review

This comprehensive SWOT profile of Familymeds Group Inc. provides you an in-depth strategic analysis of the company’s businesses a
2010 250,00$

Targanta Therapeutics Corporation - Strategic Analysis Review

Targanta Therapeutics Corporation (TTC) is an operational part of The Medicines Company, critical care hospital products provider.
2010 250,00$

Regent Assisted Living Inc. (RGNT) - Strategic Analysis Review

This comprehensive SWOT profile of Regent Assisted Living Inc. provides you an in-depth strategic analysis of the company’s busine
2010 250,00$

Skinwell Holdings Limited (SKW) - Strategic Analysis Review

This comprehensive SWOT profile of Skinwell Holdings Limited provides you an in-depth strategic analysis of the company’s business
2010 250,00$

BND Co., Ltd. (47940) - Strategic Analysis Review

This comprehensive SWOT profile of BND Co., Ltd. provides you an in-depth strategic analysis of the company’s businesses and opera
2010 250,00$

Polymer Research Corp. of America (PROAQ) - Strategic Analysis Review

This comprehensive SWOT profile of Polymer Research Corp. of America provides you an in-depth strategic analysis of the company’s
2010 250,00$

Actinogen LIMITED - Strategic Analysis Review

Actinogen Limited is a broad based biotechnology company engaged in the detection and isolation of soil actinomycetes found in Wes
2010 250,00$

Aevum Limited (AVE) - Strategic Analysis Review

Aevum Limited (Aveum) is principally engaged in the development, operation and management of retirement villages and aged care fac
2010 250,00$

EUGENE SCIENCE, INC. (EUSI) - Strategic Analysis Review

Eugene Science, Inc. is a biotechnology company that develops, manufactures and markets nutraceuticals, or functional foods and ta
2010 250,00$

Eyecare Partners Limited (EPL) - Strategic Analysis Review

Eyecare Partners Limited is healthcare company principally engaged in the operations of optometry practices providing optometric h
2010 250,00$

Golden Pond Healthcare, Inc. - Strategic Analysis Review

This comprehensive SWOT profile of Golden Pond Healthcare, Inc. provides you an in-depth strategic analysis of the company’s busin
2010 250,00$

Helicon Group Limited - Strategic Analysis Review

Helicon Group Limited is a pharma company engaged in finding and providing oppopportunities for advanced western Biomedical produc
2010 250,00$

HEXIMA LIMITED - Strategic Analysis Review

Hexima Limited is an Australia-based agribusiness company. The Company is engaged in the research, development and commercializati
2010 250,00$

Integrated Health Service - Strategic Analysis Review

Integrated Health Services (Integrated Health) is engaged in providing post-acute healthcare services. Post-acute care is the prov
2010 250,00$

Alert B&C Corporation - Strategic Analysis Review

This comprehensive SWOT profile of Alert B&C Corporation provides you an in-depth strategic analysis of the company’s businesses a
2010 125,00$

Assura Group Limited - Strategic Analysis Review

Assura Group Limited runs it business through 4 segments: Medical, Pharmacy, Property and Property Development. The medical depart
2010 125,00$

American Biogenetic Sciences, Inc. (MABAA) - Strategic Analysis Review

American Biogenetic Sciences, Inc. (ABS) is a biopharmaceutical company focused in researching, developing and marketing cardiovas
2010 250,00$

Anhui Fengyuan Pharmaceutical Co., Ltd. - Strategic Analysis Review

This comprehensive SWOT profile of Anhui Fengyuan Pharmaceutical Co., Ltd. provides you an in-depth strategic analysis of the comp
2010 125,00$

Apeloa Company Limited (739) - Strategic Analysis Review

This comprehensive SWOT profile of Apeloa Company Limited provides you an in-depth strategic analysis of the company’s businesses
2010 125,00$

IDT Australia Limited (IDT) - Strategic Analysis Review

IDT Australia Limited (IDT), formerly Institute of Drug Technology Australia Limited, is an Australia-based pharmaceutical manufac
2010 250,00$

IRI SEPARATION TECHNOLOGIES INC. (IRI) - Strategic Analysis Review

IRI Separation Technologies Inc is a biotechnology company specialized in the extraction, development and commercialization antibo
2010 250,00$

Kiotech International plc (KIO) - Strategic Analysis Review

Kiotech International Plc is principally engaged in the development and marketing of biochemical stimulants. The company's mainly
2010 250,00$

Life Therapeutics Limited (LFE) - Strategic Analysis Review

Life Therapeutics Limited (Life Therapeutics) is a biotechnology company engaged in providing therapeutics products and diagnostic
2010 250,00$

Lifebank Corp. (LBK) - Strategic Analysis Review

Lifebank Corp.(Lifebank) is a healthcare services company principally engaged in the business of processing and cryo-preservation
2010 250,00$

Astralis, Ltd. - Strategic Analysis Review

Astralis, Ltd. is a early stage biotechnology company engaged in research and development of treatments for immune system disorder
2010 250,00$

MEMORY PHARMACEUTICALS CORP. - Strategic Analysis Review

Memory Pharmaceuticals Corp. (Memory Pharmaceutical) is a biopharmaceutical company, engaged in the discovery and development of d
2010 250,00$

BioProspect Limited (BPO) - Strategic Analysis Review

BioProspect Limited, a brisbane based natural compound and product development company, engages in research and commercialization
2010 250,00$

National Research Corporation (NRCI) - Strategic Analysis Review

National Research Corporation is a healthcare company principally engaged in providing ongoing survey-based performance measuremen
2010 250,00$

China Healthcare Acquisition Corp. - Strategic Analysis Review

China Healthcare Acquisition Corporation (CHAC) is engaged in acquiring one or more operating businesses in the healthcare sector.
2010 250,00$

OBJ LIMITED - Strategic Analysis Review

OBJ LIMITED is formed with the compabination of medical, scientific and commercial specialists to deliver medical technology solut
2010 125,00$

Clover Corporation Limited (CLV) - Strategic Analysis Review

This comprehensive SWOT profile of Clover Corporation Limited provides you an in-depth strategic analysis of the company’s busines
2010 125,00$

PEARL HEALTHCARE LIMITED (PHL) - Strategic Analysis Review

Pearl Healthcare Limited is an Australia-based company which is principally engaged in the management, acquisition, consolidation
2010 250,00$

Advanced Medical Institute Inc. (AVMD) - Strategic Analysis Review

This comprehensive SWOT profile of Advanced Medical Institute Inc. provides you an in-depth strategic analysis of the company’s bu
2010 250,00$

NightHawk Radiology Holdings, Inc. (NHWK) - Strategic Analysis Review

This comprehensive SWOT profile of NightHawk Radiology Holdings, Inc. provides you an in-depth strategic analysis of the company’s
2010 250,00$

Setiba Participacoes SA (SETI3B) - Strategic Analysis Review

This comprehensive SWOT profile of Setiba Participacoes SA provides you an in-depth strategic analysis of the company’s businesses
2010 250,00$

Krebs Biochemicals & Industries Ltd - Strategic Analysis Review

Krebs Biochemicals & Industries Limited is a pharmaceutical company engaged in the manufacture and sale of API. The company manufa
2010 250,00$

Insas Berhad (INSAS) - Strategic Analysis Review

This comprehensive SWOT profile of Insas Berhad provides you an in-depth strategic analysis of the company’s businesses and operat
2010 250,00$

NuRx Pharmaceuticals Inc - Strategic Analysis Review

This comprehensive SWOT profile of NuRx Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesse
2010 125,00$

NL Industries, Inc. (NL) - Strategic Analysis Review

NL Industries, Inc. (NL Industries) is primarily a holding company that operates through its subsidiaries namely, CompX Internatio
2010 250,00$

Dimed S.A Distribuidora de Medicamentos (PNVL3) - Strategic Analysis Review

This comprehensive SWOT profile of Dimed S.A Distribuidora de Medicamentos provides you an in-depth strategic analysis of the comp
2010 250,00$

Soprocal, Calerias e Industrias S.A. (SOPROCAL) - Strategic Analysis Review

This comprehensive SWOT profile of Soprocal, Calerias e Industrias S.A. provides you an in-depth strategic analysis of the company
2010 250,00$

South Egypt Drug Industries Company - Strategic Analysis Review

This comprehensive SWOT profile of South Egypt Drug Industries Company provides you an in-depth strategic analysis of the company’
2010 250,00$

Minapharm Pharmaceuticals & Chemical Industries - Strategic Analysis Review

Minapharm Pharmaceuticals & Chemical Industries (Minapharm) is a privately held specialty pharmaceutical company engaged in the ma
2010 250,00$

Global Napi Pharmaceuticals - Strategic Analysis Review

Global Napi Pharmaceuticals (Global Napi) is an Egypt based pharmaceutical company. Global Napi is engaged in developing and manuf
2010 250,00$

Egyptian International Medical Center - Strategic Analysis Review

Egyptian International Medical Center (EIMC) is a distributor and supplier of cytotoxics, plasma derivatives and intensive care pr
2010 250,00$

Arab Pharmaceuticals (ADCI) - Strategic Analysis Review

This comprehensive SWOT profile of Arab Pharmaceuticals provides you an in-depth strategic analysis of the company’s businesses an
2010 250,00$

APEX Pharma S.A.E. - Strategic Analysis Review

APEX Pharma S.A.E. (APEX) is an Egyptian based Joint Stock company, engaged in the production, marketing and sale and importation
2010 250,00$

Divis Laboratories Limited - Strategic Analysis Review

Divis Laboratories Limited (Divis), formerly known as Divi’s Research Center is a biotechnology company. It is engaged in the prod
2010 125,00$

Anand Electric Supply Company Limited (501630) - Strategic Analysis Review

This comprehensive SWOT profile of Anand Electric Supply Company Limited provides you an in-depth strategic analysis of the compan
2010 250,00$

Immune Network Research Ltd. - Strategic Analysis Review

Immune Network Research Ltd. (INR) is a biotechnology company. It is engaged in the development of immunological products for the
2010 250,00$

Keunwha Pharmaceutical Co.,Ltd. - Strategic Analysis Review

This comprehensive SWOT profile of Keunwha Pharmaceutical Co.,Ltd. provides you an in-depth strategic analysis of the company’s bu
2010 250,00$

Beijing SL Pharmaceutical Co., Ltd (2038) - Strategic Analysis Review

Beijing SL Pharmaceutical Co., Ltd (SL Pharm) is a biotechnology-pharmaceutical company, engaged in developing and marketing of ge
2010 250,00$

Caribbean American Health Resorts, Inc. (CAHR) - Strategic Analysis Review

Caribbean American Health Resorts, Inc, (CAHR) is formerly known as Vital Health Technologies, Inc. The company is a development-s
2010 250,00$

Lexington Healthcare Group, Inc. (LEXI) - Strategic Analysis Review

Lexington Healthcare Group, Inc. (Lexington Healthcare) in engaged in providing a wide range of healthcare services, including nur
2010 250,00$

Adinath Bio-Labs Limited (590088) - Strategic Analysis Review

This comprehensive SWOT profile of Adinath Bio-Labs Limited provides you an in-depth strategic analysis of the company’s businesse
2010 250,00$

Sinovac Biotech Co., Ltd. - Strategic Analysis Review

Sinovac Biotech Co., Ltd. (also known as Beijing Kexing Bioproducts) is a biotechnology company engaged in the research, developme
2010 250,00$

Origio AS - Strategic Analysis Review

Origio A/S (Origio) operates through three companies, namely, MediCult, Humagen Fertility Diagnostics and MidAtlantic Diagnostics.
2010 250,00$

Huadong Medicine Co., Ltd. (963) - Strategic Analysis Review

Huadong Medicine Co., Ltd. is engaged in manufacture and sale of medical products. It provides provides Chinese medicine products,
2010 125,00$

GreaterChina Technology Group Limited (8032) - Strategic Analysis Review

This comprehensive SWOT profile of GreaterChina Technology Group Limited provides you an in-depth strategic analysis of the compan
2010 250,00$

Select Vaccines Ltd. - Strategic Analysis Review

This comprehensive SWOT profile of Select Vaccines Ltd. provides you an in-depth strategic analysis of the company’s businesses an
2010 125,00$

Dr. Reddy's Laboratories Ltd. - Strategic Analysis Review

This comprehensive SWOT profile of Dr. Reddy's Laboratories Ltd. provides you an in-depth strategic analysis of the company’s busi
2010 125,00$

D I L Limited - Strategic Analysis Review

This comprehensive SWOT profile of D I L Limited provides you an in-depth strategic analysis of the company’s businesses and opera
2010 250,00$

I''rom Holdings Co. Ltd. (2372) - Strategic Analysis Review

This comprehensive SWOT profile of I''rom Holdings Co. Ltd. provides you an in-depth strategic analysis of the company’s businesse
2010 250,00$

Bafna Pharmaceuticals Limited - Strategic Analysis Review

This comprehensive SWOT profile of Bafna Pharmaceuticals Limited provides you an in-depth strategic analysis of the company’s busi
2010 250,00$

Daebong LS Co., Ltd. (78140) - Strategic Analysis Review

This comprehensive SWOT profile of Daebong LS Co., Ltd. provides you an in-depth strategic analysis of the company’s businesses an
2010 250,00$

Harvard Scientific Corp. - Strategic Analysis Review

Harvard Scientific Corp. (Harvard Scientific) is a bio pharmaceutical company engaged in the development, manufacturing and distri
2010 250,00$

Health Sciences Group, Inc. (HESG) - Strategic Analysis Review

Health Sciences Group, Inc. (Health Sciences Group) is focused on the development and commercialization of products and functional
2010 250,00$

Cancer Therapeutics Inc - Strategic Analysis Review

This comprehensive SWOT profile of Cancer Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses
2010 250,00$

Flagship Global Health, Inc. (FGHH) - Strategic Analysis Review

Flagship Global Health, Inc. (formerly Patients & Physicians, Inc., ) is a health assurance organization providing prority access
2010 250,00$

Bridgetech Holdings International, Inc. (BGTH) - Strategic Analysis Review

Bridgetech Holdings International, Inc. is an early-stage company focused primarily on the business of facilitating the transfer o
2010 250,00$

Comvita Limited - Strategic Analysis Review

This comprehensive SWOT profile of Comvita Limited provides you an in-depth strategic analysis of the company’s businesses and ope
2010 125,00$

Terveystalo Healthcare Oyj - Strategic Analysis Review

Terveystalo Healthcare Oyj (Terveystalo) is engaged in providing healthcare, occupational healthcare and hospital services. The se
2010 250,00$

Blue Cross and Blue Shield Association - Strategic Analysis Review

Blue Cross and Blue Shield Association (BCBSA) is a provider of health care coverage services. Operating through 39 independent, c
2010 250,00$

Stiefel Laboratories, Inc. - Strategic Analysis Review

Stiefel Laboratories, Inc. (Stiefel Laboratories) is a US based pharmaceutical company which specializes in dermatology. Stiefel L
2010 250,00$

Vivimed Labs Ltd (532660) - Strategic Analysis Review

Vivimed Labs (Vivimed) is an publicly held India based pharma company. It is engaged in the manufacture of ingredients used in the
2010 125,00$

Shanghai Fosun Medical Technology Development Co., Ltd. - Strategic Analysis Review

Shanghai Fosun Med-Tech Development Co.,Ltd. (Shanghai Fosun) is a China based private company engaged in producuing in vitro diag
2010 250,00$

The University of Texas M. D. Anderson Cancer Center - Strategic Analysis Review

The University of Texas M. D. Anderson Cancer Center (M. D. Anderson) is a cancer research organization providing services in canc
2010 250,00$

Henry Ford Health System - Strategic Analysis Review

Henry Ford Health System is a one of the leading health care services providers in the US, engaged in offering a seamless array of
2010 125,00$

Millennium Pharmaceuticals, Inc. - Strategic Analysis Review

Millennium Pharmaceuticals, Inc. (Millennium) is a biopharmaceutical company engaged in the research, development, and commerciali
2010 250,00$

Epic Systems Corporation - Strategic Analysis Review

Epic Systems Corporation (Epic) is a privately held healthcare IT company, engaged in developing and installing software services
2010 250,00$

Arkopharma SA - Strategic Analysis Review

Arkopharma SA (Arkopharma) is one of the leading providers of phytotherapy and nutritional supplements in Europe. The company is e
2010 125,00$

Austin Health - Strategic Analysis Review

Austin Health (Austin) is one of the leading providers of tertiary health services, health professional education and research in
2010 125,00$

Bay of Plenty District Health Board - Strategic Analysis Review

Bay of Plenty District Health Board (BOPDHB) operates as one of the 21 district health boards in New Zealand. It provides a range
2010 125,00$

Crucell Switzerland AG (CRX) - Strategic Analysis Review

Crucell Switzerland AG (Crucell) is a private biopharmaceutical company engaged in producing vaccines and antibodies. The company
2010 125,00$

Capital & Coast District Health Board - Strategic Analysis Review

Capital & Coast District Health Board (C&C DHB) is a one of the leading specialist health services providers in the central region
2010 125,00$

Chiesi Farmaceutici SpA - Strategic Analysis Review

Chiesi Farmaceutici SpA is a Europe based pharmaceutical company, engaged in research, development and commercialization of ethica
2010 125,00$

Chong Kun Dang Pharmaceutical - Strategic Analysis Review

Chong Kun Dang Pharmaceutical (CKD) is a Korean company, engaged in the manufacturing, distribution, import and export of pharmace
2010 125,00$

Danbury Hospital - Strategic Analysis Review

Danbury Hospital is a US based health care centre. The company is principally engaged in the providing various treatments relating
2010 125,00$

DCH Health System - Strategic Analysis Review

DCH Health System (DCH Health) is a medical and healthcare services provider. The company is a US government subdivision, operatin
2010 250,00$

Esteve Group - Strategic Analysis Review

Esteve Group (EG) is a family owned chemical and pharmaceutical group. It largely engages in the research and development activiti
2010 125,00$

Ferrosan A/S - Strategic Analysis Review

Ferrosan A/S (Ferrosan) is an international consumer and healthcare company. The company offers various supplements and healthcare
2010 125,00$

Fisher Scientific International Inc. (FSH) - Strategic Analysis Review

Fisher Scientific International, Inc. (Fisher) is an US based public company that provides analytical instruments and services to
2010 250,00$

Five Star Quality Care, Inc - Strategic Analysis Review

FIVE STAR QUALITY CARE, INC. (FSQC) is basically a health care services company. It offers communities where it provides its guest
2010 250,00$

Galderma S.A. - Strategic Analysis Review

Galderma S.A. (GSA) is one of the leading dermatology companies. The company provides therapeutic and aesthetic solutions for the
2010 250,00$

General Nutrition Centers, Inc - Strategic Analysis Review

General Nutrition Centers, Inc. (GNC) is a specialty retailer of nutritional supplements in the US and around the world. It offers
2010 125,00$

Health Care Service Corporation - Strategic Analysis Review

Health Care Service Corporation is one of the largest customer-owned health insurers in the US. It operates through its Blue Cros
2010 250,00$

Health Protection Agency - Strategic Analysis Review

The Health Protection Agency (HPA) is a government organization that focuses on defending the public against health dangers in the
2010 250,00$

Jose de Mello, SGPS - Strategic Analysis Review

Jose de Mello, SGPS (Jose de Mello) is one of the Portugal’s biggest corporate groups. It is an economic group which concentrates
2010 250,00$

Laboratoires Urgo - Strategic Analysis Review

Laboratoires Urgo (URGO) is one of the first aid and family medication specialists company specialized in wound dressings, tapes,
2010 125,00$

LEO Pharma A/S - Strategic Analysis Review

LEO Pharma A/S (LEO Pharma) is one of the leading pharmaceutical companies within Dermatology and Critical Care. The company maint
2010 250,00$

MDS Analytical Technologies - Strategic Analysis Review

MDS Analytical Technologies (MDS Analytical) is one of the leading global suppliers of analytical instruments and technology solut
2010 250,00$

Melbourne Health - Strategic Analysis Review

Melbourne Health is an Australia based health service provider. The company is principally engaged in providing acute, sub-acute a
2010 250,00$

Merz GmbH & Co. KGaA - Strategic Analysis Review

Merz GmbH & Co. KGaA is a Germany based healthcare company. The company is principally engaged in providing pharmaceuticals, consu
2010 250,00$

Metropolitan Ambulance Services - Strategic Analysis Review

Metropolitan Ambulance Service (MAS) is an Australia based emergency medical service provider. The company principally engaged in
2010 250,00$

MidCentral District Health Board - Strategic Analysis Review

MidCentral District Health Board (MDHB) is a New Zealand based health and disability support service provider. The company princip
2010 250,00$

Norgine Limited - Strategic Analysis Review

Norgine Limited (Norgine) is the UK based pharmaceutical company. The company is principally engaged in the development, manufactu
2010 250,00$

Nuffield Hospitals - Strategic Analysis Review

Nuffield Hospitals is the UK based healthcare provider. The company is principally engaged in the hospital, fitness and wellbeing,
2010 250,00$

Sandoz GmbH - Strategic Analysis Review

Sandoz GmbH (Sandoz) is a pharmaceutical company engaged in developing, producing and distributing generic pharmaceuticals and bio
2010 125,00$

Select Medical Corporation - Strategic Analysis Review

Select Medical Corporation (Select Medical) is a US based company which provides specialty health care services in the US. Select
2010 250,00$

Taiho Pharmaceutical Co., Ltd. - Strategic Analysis Review

Taiho Pharmaceutical Co., Ltd. (Taiho Pharmaceutical) is a Japan based pharmaceutical company engaged in the development, producti
2010 250,00$

Tamro Group - Strategic Analysis Review

Tamro Corporation is involved in the wholesale supply and distribution of pharmaceuticals principally in Northern Europe. It princ
2010 250,00$

Toyama Chemical Co. Ltd - Strategic Analysis Review

Toyama Chemical Co. Ltd. was acquired by Fujifilm Holdings Corporation and became a consolidated subsidiary during 2008. Toyama Ch
2010 250,00$

United Surgical Partners International - Strategic Analysis Review

United Surgical Partners International (United Surgical Partners) is one of the leaders in the ambulatory surgery center and short
2010 125,00$

Western Health - Strategic Analysis Review

Western Health (WH) is an Australian based health related service provider. The company is principally engaged in the field of off
2010 125,00$

Zambon Group S.p.A. - Strategic Analysis Review

Zambon Group S.p.A (Zambon) is a leading multinational pharmaceutical and chemicals company with a reputation of inventive and inn
2010 250,00$

Carl-Zeiss-Stiftung - Strategic Analysis Review

Carl-Zeiss-Stiftung (Carl-Zeiss) is Germany based company, engaged in glass business. The company is engaged in the production of
2010 250,00$

Nelson Marlborough District Health Board - Strategic Analysis Review

Nelson Marlborough District Health Board (Nelson Marlborough) is a New Zealand based health board. The company principally engages
2010 250,00$

APS Healthcare Inc - Strategic Analysis Review

APS Healthcare Inc. (APS) is a private health care company, which offers customized, integrated healthcare solutions. These health
2010 250,00$

Groupe ORPEA - Strategic Analysis Review

Groupe ORPEA (Orpea) is a France based company, engaged in offering long-term care and post-acute care. The company principally pr
2010 125,00$

PHOENIX Group - Strategic Analysis Review

PHOENIX group is a leading pharmaceutical distribution company in Europe. It provides a range of pharmaceutical and healthcare pro
2010 250,00$

Universal Hospital Services Inc (UHS) - Strategic Analysis Review

Universal Hospital Services, Inc. (UHS) is a leading provider of medical equipment outsourcing and lifecycle solutions in the US.
2010 125,00$

Nova BioGenetics, Inc. (NVBG) - Strategic Analysis Review

Nova BioGenetics, Inc. (Nova) is a publicly held research focused biotechnology company, engaged in discovery, development, commer
2010 250,00$

ALIGN Pharmaceuticals, LLC. - Strategic Analysis Review

ALIGN Pharmaceuticals is a specialty pharmaceutical company principally engaged in providing supportive care solutions for symptom
2010 250,00$

Scandinavian Clinical Nutrition i Sverige AB (SCN) - Strategic Analysis Review

Scandinavian Clinical Nutrition i Sverige AB (SCN) is a Sweden based company is nutritional products developer and supplier. The
2010 250,00$

Kaken Pharmaceutical Co.,Ltd. (4521) - Strategic Analysis Review

Kaken Pharmaceutical Co., Ltd. (Kaken Pharmaceutical) is a Japan based pharmaceutical company, which is engaged in the development
2010 125,00$

KARMELSONIX LIMITED (KSX) - Strategic Analysis Review

Karmel Sonix Limited (Karmel Sonix) is an Australian based company engaged in research, development and commercialization of medic
2010 125,00$

Medicago Inc. (MDG) - Strategic Analysis Review

Medicago Inc. (Medicago) is a publicly held Canada based biotechnology company. It is engaged in the development of vaccines based
2010 250,00$

Mesoblast Ltd (MSB) - Strategic Analysis Review

Mesoblast Limited is an Australian biotechnology company which is committed to the development of novel treatments for orthopaedic
2010 250,00$

ReGenX Biosciences, LLC - Strategic Analysis Review

ReGenX Biosciences, LLC (ReGenX) is a bio pharmaceutical company that is engaged in research and development of therapeutics based
2010 250,00$

NeuroGenesis, Inc. (NEUN) - Strategic Analysis Review

NeuroGenesis, Inc. (Neurogenesis) is publicly held US based company. It is principally engaged in development of nutritional suppl
2010 250,00$

Medical & Biological Laboratories Co., Ltd. (4557) - Strategic Analysis Review

Medical & Biological Laboratories Co., Ltd.(MBL) is engaged in the research, development and manufacture of clinical reagents and
2010 250,00$

RegeneRx Biopharmaceuticals, Inc. (RGN) - Strategic Analysis Review

RegeneRx Biopharmaceuticals, Inc. (RegeneRx Biopharmaceuticals) is publicly held US based biopharmaceutical company. The company i
2010 250,00$

Unigene Laboratories, Inc. (UGNE) - Strategic Analysis Review

Unigene Laboratories, Inc. (Unigene) is publicly held US based biopharmaceutical company provides peptide related products. It is
2010 250,00$

Binex Co., Ltd. (53030) - Strategic Analysis Review

Binex Co., Ltd. (Binex) is a pharmaceutical company engaged in manufacturing over-the-counter (OTC) drugs and bulk pharmaceuticals
2010 250,00$

PCI Biotech AS (PCIB) - Strategic Analysis Review

PCI Biotech AS (PCI Biotech) is a drug delivery company, engaged in commercialization of photochemical drug delivery technology fo
2010 250,00$

Mednax, Inc - Strategic Analysis Review

Mednax, Inc (Mednax) is an US based health service provider. The company principally engages in providing of physician services wh
2010 250,00$

InterSystems Corporation - Strategic Analysis Review

InterSystems Corporation (InterSystems) is a privately-held software company engaged in providing premier platform for connected h
2010 125,00$

Carolinas Hospital System - Strategic Analysis Review

Carolinas Hospital System (CHS) is a hospital providing acute health care services in Florence, South Carolina. The hospital has a
2010 250,00$

TMC HealthCare - Strategic Analysis Review

TMC HealthCare (TMC) is a community, not-for-profit hospital. TMC owns and operates Tucson Medical Center hospital and offers mate
2010 250,00$

University Medical Center Corporation - Strategic Analysis Review

University Medical Center Corporation (UMC) is a US based private, non-profit hospital located in Tucson, Arizona. The organizatio
2010 125,00$

Ingenix - Strategic Analysis Review

Ingenix is a global healthcare information and technology company and a subsidiary of UnitedHealth Group. Its information services
2010 250,00$

SCIOinspire Corp. - Strategic Analysis Review

SCIOinspire Corp. (SCIOinspire) is a healthcare IT services company that is engaged in providing healthcare cost management servic
2010 250,00$

D-Pharm Ltd. (DPRM) - Strategic Analysis Review

D-Pharm LTD.(D-Pharm) is a specialty bio-pharmaceutical company. It is engaged in the design and development of innovative drugs f
2010 250,00$

Ecron Acunova - Strategic Analysis Review

Ecron Acunova is a privately-held company engaged in providing clinical development services to the pharmaceutical, biotechnology,
2010 250,00$

CepTor Corporation (CEPO) - Strategic Analysis Review

CepTor Corporation (CepTor) is a development-stage biopharmaceutical company engaged in the discovery, development, and commercial
2010 250,00$

Axiogenesis AG (AI8) - Strategic Analysis Review

Axiogenesis is an innovative biotechnology company that specializes in applied stem cell technology and molecular and cellular bio
2010 250,00$

The State University of New York - Strategic Analysis Review

The State University of New York (SUNY) is one of the the largest and most comprehensive state university system in the US. It pro
2010 125,00$

Biovet JSC (53B) - Strategic Analysis Review

BIOVET JSC (BIOVET) is a privately held biotechnology company that is engaged in the manufacture and marketing of medicated and n
2010 250,00$

Artec, Inc. (ATKJ) - Strategic Analysis Review

Artec, Inc. (Artec) is a publicly held pharmaceutical company which is engaged in the manufacture and distributor of a polysaccha
2010 250,00$

AccentCare, Inc. - Strategic Analysis Review

AccentCare, Inc. (AccentCare) is a healthcare services company that engages in offering home healthcare services to seniors across
2010 250,00$

Italfarmaco S.p.A. - Strategic Analysis Review

Italfarmaco S.p.A. (Italfarmaco) is an independently held private company based in Italy. The company, along with its subsidiaries
2010 125,00$

Movetis NV (MOVE ) - Strategic Analysis Review

Movetis NV (Movetis) is a public traded pharmaceutical company engaged in the discovery, development and marketing of innovative d
2010 250,00$

LONGPORT, INC (LPTI) - Strategic Analysis Review

LONGPORT, INC (Longport) is a publicly-held Delaware corporation, which develops, manufactures, markets, and sells high resolution
2010 250,00$

Advik Laboratories Ltd. (ADVIKLA) - Strategic Analysis Review

Advik Laboratories Ltd. (Advik) is an India based pharmaceuticals company engaged in the manufacture and sale of ethical and gener
2010 250,00$

Julphar (JULPHUR) - Strategic Analysis Review

Julphar (Gulf Pharmaceutical Industries) is a publicly held company, engaged in the manufacture of medicines, drugs and various ot
2010 250,00$

Oncolin Therapeutics, Inc. (OCOL) - Strategic Analysis Review

Oncolin Therapeutics, Inc. (Oncolin Therapeutics), formerly Edgeline Holdings, Inc. operates in the healthcare division through it
2010 250,00$

Migami, Inc. (MIGA) - Strategic Analysis Review

Migami, Inc. (Migami) is a privately held development stage company, engaged in the distribution of pharmaceutical products. The c
2010 250,00$

Cavit Sciences, Inc. (CVIT) - Strategic Analysis Review

Cavit Sciences, Inc. (Cavit Sciences) is a biotechnology company that is engaged in the development of therapeutic treatment for
2010 250,00$

Renato Corporation (4OZ) - Strategic Analysis Review

Renato Corporation (Renato) is the US based company which is engaged in providing health diagnostic services. The company offers d
2010 250,00$

GenoMed, Inc. (GMED) - Strategic Analysis Review

GenoMed, Inc.(GenoMed) is a medical genomics and a disease management (DM) company that uses medical genomics to improve patient o
2010 250,00$

Laboratorios Liomont S.A. de C.V. - Strategic Analysis Review

Laboratorios Liomont S.A. de C.V. (Liomont) is a Mexico-based pharmaceutical company, engaged in offering a wide range of pharmace
2010 250,00$

Armstrong Laboratorios de Mexico S.A. de C.V. - Strategic Analysis Review

Armstrong Laboratorios de Mexico SA de C.V. (Armstrong Laboratorios) is a company based in Mexico that supplies quality medicines
2010 250,00$

TranXenoGen, Inc. (TXN.L) - Strategic Analysis Review

TranXenoGen, Inc. (TranXenoGen) is the US based biotechnology company which is engaged in the development of new therapeutic manuf
2010 250,00$

Canopus BioPharma Incorporated (CBIA) - Strategic Analysis Review

Canopus BioPharma Incorporated (Canopus BioPharma) is a pharmaceutical company engaged in the research and development of pharmace
2010 250,00$

Stemgent, Inc. - Strategic Analysis Review

Stemgent, Inc. (Stemgent) is a biotechnology company engaged in advancing stem cell research by providing proprietary reagents and
2010 250,00$

BIOQUAL, Inc. (BIOQ) - Strategic Analysis Review

BIOQUAL, Inc. (Bioqual) is a public traded, research, development and consulting company engaged in providing quality research, de
2010 250,00$

Caleco Pharma Corp. (CAEH) - Strategic Analysis Review

Caleco Pharma Corp. (Caleco) is a publicly listed company engaged in the development of products to treat moderate to severe liver
2010 250,00$

Kiwa Bio-Tech Products Group Corporation (KWBT) - Strategic Analysis Review

Kiwa Bio-Tech Products Group Corporation (Kiwa Bio-Tech) develops, manufactures, distributes and markets environmentally safe bio-
2010 250,00$

Sinobiopharma Inc. (SNBP) - Strategic Analysis Review

Sinobiopharma Inc. (Sinobiopharma) is an integrated and innovative biotechnology company. It is focused on the research and develo
2010 250,00$

Multiple Myeloma Research Foundation (MMRF) - Strategic Analysis Review

Multiple Myeloma Research Foundation (MMRF) is a publicly traded bio-pharmaceutical company, engaged in the development of advance
2010 250,00$

Amazon BioTech (AMZB) - Strategic Analysis Review

Amazon BioTech (Amazon) is a pharmaceutical company that is involved in researching and developing natural drugs for the treatment
2010 250,00$

China Health Management Corp. (CNHC) - Strategic Analysis Review

China Health Management Corp. (CHMC) engages in providing operations and management of hospitals in China. Its services include, h
2010 250,00$

Immune-tree International, Inc. (IMUT) - Strategic Analysis Review

Immune-tree International, Inc. (Immune tree)specializes in the development and manufacture of colostrum-based health food product
2010 250,00$

Cannasat Therapeutics, Inc. (CTH) - Strategic Analysis Review

Cannasat Therapeutics, Inc. (Cannasat) engages in the discovery and development of therapeutics for the treatment of neuropathic p
2010 250,00$

DelSite Biotechnologies, Inc. (DSII) - Strategic Analysis Review

DelSite Biotechnologies, Inc. is an early stage drug-delivery and biotechnology company established to provide the pharmaceutical
2010 250,00$

Mach One Corporation (MNCN) - Strategic Analysis Review

Mach One Corporation (Mach One) is a veterinary services company that offers a variety of services ranging from improving the immu
2010 250,00$

Milestone Biosciences, LLC (ACCP) - Strategic Analysis Review

Milestone Biosciences, LLC (Milestone) is a development-stage biotechnology company. It is principally focuses on in-licensing and
2010 250,00$

iDiS Limited (ICNET) - Strategic Analysis Review

iDiS Limited (IDIS), has created a tool of Mobile Asset Management which helps to take giant strides within the space. Mobile Asse
2010 250,00$

Shin Poong Pharm Co., Ltd. (19170) - Strategic Analysis Review

Shin Poong Pharm Co., Ltd.(Shin Poong) is a pharmaceutical company engaged in the development, marketing, and distribution of phar
2010 250,00$

Tularik, Inc. (TLRK) - Strategic Analysis Review

Tularik, Inc. (Tularik) is a pharmaceutical company that is engaged in the discovery and development of oral medicines. The produc
2010 250,00$

SOHM Inc. (SOHM) - Strategic Analysis Review

SOHM Inc. (SOHM) is a pharmaceutical company engaged in the manufacturing and marketing of generic pharmaceuticals. The company ma
2010 250,00$

Vanguard Pharmaceutical Corporation (VGPH) - Strategic Analysis Review

Vanguard Pharmaceutical Corporation (Vanguard) is engaged in research, development, manufacture, and sale of generic and oncology
2010 250,00$

First Health Services Corporation - Strategic Analysis Review

First Health Services Corporation (First Health Services) is a leading provider of integrated clinical management services for pub
2010 250,00$

Islet Holdings, Inc. (ISHI) - Strategic Analysis Review

Islet Holdings, Inc. (formerly known as Biozhem Cosmeceuticals, Inc.) is a marketer of personal care products through a worldwide
2010 250,00$

Chemaphor Inc. (CFR) - Strategic Analysis Review

Chemaphor Inc. (Chemaphor) is a publicly held biotechnology company that is engaged in the development and commercialization of sm
2010 250,00$

Perrigo Israel Pharmaceuticals Ltd. (PRGO) - Strategic Analysis Review

Perrigo Israel Pharmaceuticals Ltd. (Perrigo Israel) is a pharmaceutical company that develops, manufactures and markets generic p
2010 250,00$

Ventana Biotech Inc. (VNTA) - Strategic Analysis Review

Ventana Biotech Inc. (Ventana Biotech) is a bioscience company that is engaged in the development and marketing of products for th
2010 250,00$

Chemizon, Inc. (10170) - Strategic Analysis Review

Chemizon, Inc. (Chemizon) is a biotechnology company, engaged in the discovery and development of innovative therapeutics. The com
2010 250,00$

Aurora Health Care, Inc. - Strategic Analysis Review

Aurora Health Care, Inc. (AHC) is a not-for-profit healthcare organization, providing integrated healthcare services in Wisconsin.
2010 250,00$

Cellceutix Pharmaceuticals, Inc. (CTIX) - Strategic Analysis Review

Cellceutix Pharmaceuticals, Inc. (Cellceutix) is a publicly traded start-up biopharmaceutical company. It is principally engaged i
2010 250,00$

AIM Health Group Inc. (AHG) - Strategic Analysis Review

AIM Health Group Inc. (AIM Health Group) is a health care service provider that mainly focuses on offering health care solutions a
2010 250,00$

Sinil Pharma Ltd. (12790) - Strategic Analysis Review

Sinil Pharma Co Ltd. (Sinil Pharma) is a pharmaceutical company. Sinil Pharma is engaged in the manufacture and distribution of ph
2010 250,00$

Ranaz Corporation (RNZ) - Strategic Analysis Review

Ranaz Corporation (Ranaz) is engaged in designing, producing, and marketing of nutritional, protein, and dietary supplements all a
2010 250,00$

China Pediatric Pharmaceuticals, Inc. (CPDU) - Strategic Analysis Review

China Pediatric Pharmaceuticals, Inc.(China Pediatric Pharmaceuticals) is a pharmaceutical company principally engaged in the deve
2010 250,00$

Help at Home, Inc. (HAHI) - Strategic Analysis Review

Help at Home, Inc. (Help at Home) is a healthcare service provider that offers homemaker, custodial, and personal home care servic
2010 250,00$

NGL Fine-chem Ltd. (524774) - Strategic Analysis Review

NGL Fine-chem Ltd. (NGL) is a pharmaceutical company that is principally engaged in the manufacture of pharmaceutical ingredients
2010 250,00$

Beluga Composites Corp. (BGCC) - Strategic Analysis Review

Beluga Composites Corp. (Beluga) is engaged in the development of immunodiagnostic testing systems. The company performs immunodia
2010 250,00$

Piedmont Behavioral Healthcare - Strategic Analysis Review

Piedmont Behavioral Healthcare (PBH) is engaged in managing a system of care for children and adults with mental health, developme
2010 250,00$

Auro Laboratories Limited (530233) - Strategic Analysis Review

Auro Laboratories Limited (Auro Laboratories) is pharmaceutical company, engaged in the manufacturer of active pharmaceutical ingr
2010 250,00$

U.S NeuroSurgical, Inc. (USN) - Strategic Analysis Review

U.S NeuroSurgical, Inc. (U.S. Neurosurgical) is a publicly traded specialty service company that offers expertise in the field of
2010 250,00$

UCB S.A. (UCB) - Strategic Analysis Review

UCB S.A (UCB) is a publicly held bio-pharmaceutical company engaged in developing treatments for severe diseases. It focuses on bo
2010 250,00$

CellSeed Inc. (7776) - Strategic Analysis Review

CellSeed Inc. (CellSeed) is a publicly held company that is engaged in developing, supplying and commercialization of cell culture
2010 250,00$

Ortin Laboratories Limited (590074) - Strategic Analysis Review

Ortin Laboratories Limited (Ortin Labs) is a privately held company focused on the manufacture and supply of drugs and medicines i
2010 250,00$

BioLife Remedies, Inc. (BLRS) - Strategic Analysis Review

BioLife Remedies, Inc. (BioLife) is a pharmaceutical company that combines traditional chinese medicine and western academic resea
2010 250,00$

Antex Biologics, Inc. (ANXB) - Strategic Analysis Review

Antex Biologics, Inc. (Antex) is a US based biopharmaceutical company. The company is principally engaged in the development and c
2010 250,00$

DocPlanet.com Inc. (DOCP) - Strategic Analysis Review

DocPlanet.com Inc. (DPI) is a business-to-business e-commerce company that provides pharmaceuticals to office-based physicians. Th
2010 250,00$

Trinity Medical Group USA, Inc. (TMGU) - Strategic Analysis Review

Trinity Medical Group USA, Inc. (TMG USA), is a development stage company operating in the healthcare sector. The group is engaged
2010 250,00$

PharmChem, Inc. (PCHM) - Strategic Analysis Review

PharmChem, Inc. (PharmChem) is a laboratory that offers integrated drug testing services to government and corporate customers. Th
2010 250,00$

Complete Wellness Centers (CMWLQ) - Strategic Analysis Review

Complete Wellness Centers (Complete Wellness) is an organization that offers healthcare practices to its members. The company prov
2010 250,00$

Physicians Adult Daycare Inc. (PHYA) - Strategic Analysis Review

Physicians Adult Daycare Inc. (Adult Daycare) is a managed healthcare organization engaged in providing senior living services. Th
2010 250,00$

Venkat Pharma Limited (VKTP) - Strategic Analysis Review

Venkat Pharma Limited (Venkat Pharma) is a publicly held Indian based pharmaceutic company. The company is principally engaged in
2010 250,00$

Cellmid Ltd (CDY) - Strategic Analysis Review

Cellmid Ltd (Cellmid) is a privately held biotechnology company. It is principally engaged in the development of therapeutic and d
2010 250,00$

Promethean Corporation. (PRMN) - Strategic Analysis Review

Promethean Corp. ("Promethean") is a New York City based Health Care related products and services company that develops, manufact
2010 250,00$

London Pacific & Partners, Inc. (LDPP) - Strategic Analysis Review

London Pacific & Partners, Inc. (London Pacific) is engaged in providing various services in the health care, hospitality, and fin
2010 250,00$

ResCare, Inc (RSCR) - Strategic Analysis Review

ResCare, Inc (ResCare) is a healthcare services company involved in providing job training and educational supports to people disa
2010 250,00$

Searle Pakistan Limited (SEARL) - Strategic Analysis Review

Searle Pakistan Limited (SPL) is a Pakistan-based pharmaceutical company engaged in the manufacture, sale, and distribution of pha
2010 250,00$

Nigerian-German Chemicals Plc (NIG-GERMAN) - Strategic Analysis Review

Nigerian-German Chemicals Plc (NGC) is a biotechnology company engaged in manufacturing and distributing pharmaceutical, consumer
2010 250,00$

Brawn Pharmaceuticals Limited (530207) - Strategic Analysis Review

Brawn Pharmaceuticals Limited (BRAWN) engages in the marketing, trading and distribution of pharmaceutical products. The company's
2010 250,00$

Vivimed Labs Limited (532660) - Strategic Analysis Review

Vivimed Labs Limited (Vivimed) is engaged in the manufacture of specialty chemicals. It manufactures home care, personal care and
2010 250,00$

Renata Limited (RENATA) - Strategic Analysis Review

Renata Limited (Renata) is specialized in the manufacture and marketing of pharmaceutical and nutritional products for both human
2010 250,00$

Scandimed International A.S - Strategic Analysis Review

Scandimed International A.S (Scandimed) specializes in the production of surgical, endo-urological and gastro-endoscopy devices. T
2010 250,00$

Pine Rest Christian Mental Health Services - Strategic Analysis Review

Pine Rest Christian Mental Health Services (Pine Rest) is a non-profit health center engaged in providing comprehensive behavioral
2010 250,00$

Health Dialog Services Corporation - Strategic Analysis Review

Health Dialog Services Corporation (Health Dialog) is a US based health support services provider. The company is engaged in provi
2010 250,00$

Harvard Vanguard Medical Associates - Strategic Analysis Review

Harvard Vanguard Medical Associates (Harvard Vanguard) is a non-profit organization that provides healthcare services. It offers a
2010 250,00$

National Medical Development, Inc. - Strategic Analysis Review

National Medical Development, Inc. (NMDI) is a healthcare organization that provides physician care services, treatment services,
2010 250,00$

Summit plc (SUMM) - Strategic Analysis Review

Summit plc (Summit) is engaged in the discovery and development of novel drugs. It develops new medicines using its proprietary im
2010 250,00$

Biolight AB (BIOL) - Strategic Analysis Review

Biolight AB (Biolight) is a Sweden-based medical technology company. It is principally engaged in the development and sale of mach
2010 250,00$

NaviNet, Inc. - Strategic Analysis Review

NaviNet, Inc. (NaviNet) is a real-time network provider of healthcare communications solutions. It is engaged in developing new an
2010 250,00$

PD-Rx Pharmaceuticals, Inc (PDRX) - Strategic Analysis Review

PD-Rx Pharmaceuticals, Inc (PD-Rx) is a provider of pharmaceutical services. It is engaged in distribution of pharmaceutical produ
2010 250,00$

OptumHealth, Inc. - Strategic Analysis Review

OptumHealth, Inc. (OptumHealth) is a health, wealth and financial solutions provider for the healthcare markets. It is the health
2010 250,00$

TCP Reliable (TCPN) - Strategic Analysis Review

TCP Reliable is engaged in providing packaging solution in the field of temperature controlled packaging right from needs assessme
2010 250,00$

Cardio Incorporated - Strategic Analysis Review

Cardio Incorporated (Cardio) is a privately held health care company. It is involved in maintaining and improving the life of pati
2010 250,00$

Nventa Biopharmaceuticals Corp. (NVN) - Strategic Analysis Review

This comprehensive SWOT profile of Nventa Biopharmaceuticals Corp. provides you an in-depth strategic analysis of the company’s bu
2010 250,00$

Miracor Diagnostics, Inc. (MRDG) - Strategic Analysis Review

This comprehensive SWOT profile of Miracor Diagnostics, Inc. provides you an in-depth strategic analysis of the company’s business
2010 250,00$

The Medipattern Corporation (MKI) - Strategic Analysis Review

The Medipattern Corporation (Medipattern) is a medical technology company specializing in computer-aided detection (CAD) solutions
2010 250,00$

Brain Resources Company Limited (The) - Strategic Analysis Review

This comprehensive SWOT profile of Brain Resources Company Limited (The) provides you an in-depth strategic analysis of the compan
2010 250,00$

Egyptian Saudi Co. For Medical Manufacturing MASCO (The) - Strategic Analysis Review

This comprehensive SWOT profile of Egyptian Saudi Co. For Medical Manufacturing MASCO (The) provides you an in-depth strategic ana
2010 125,00$

Summer Infant, Inc. - Strategic Analysis Review

Summer Infant, Inc. is a consumer goods and baby care products manufacturing company. The company products includes nursery audio/
2010 250,00$

Allied Hearts Holdings Co., Ltd. - Strategic Analysis Review

Allied Hearts Holdings Co., Ltd. is a pharmaceutical products, cosmetics and miscellaneous daily goods retailer. It is also engage
2010 250,00$

BioScrip, Inc - Strategic Analysis Review

BioScrip, Inc. is a provider of specialty pharmaceutical and pharmacy benefit management (PBM) services in the United States. It o
2010 250,00$

China National Medicines Corp Ltd. - Strategic Analysis Review

This comprehensive SWOT profile of China National Medicines Corp Ltd. provides you an in-depth strategic analysis of the company’s
2010 250,00$

Chongqing Tongjunge Co., Ltd. - Strategic Analysis Review

This comprehensive SWOT profile of Chongqing Tongjunge Co., Ltd. provides you an in-depth strategic analysis of the company’s busi
2010 250,00$

CNTIC Trading Co. Ltd. - Strategic Analysis Review

This comprehensive SWOT profile of CNTIC Trading Co. Ltd. provides you an in-depth strategic analysis of the company’s businesses
2010 250,00$

Kirindo Co Ltd - Strategic Analysis Review

Kirindo Co., Ltd. a drug store chains and dispensing pharmacies company. It offers medical products, healthcare products, cosmetic
2010 250,00$

Medca Japan Co. Ltd. - Strategic Analysis Review

This comprehensive SWOT profile of Medca Japan Co. Ltd. provides you an in-depth strategic analysis of the company’s businesses an
2010 250,00$

Nanjing Medical Co., Ltd. - Strategic Analysis Review

This comprehensive SWOT profile of Nanjing Medical Co., Ltd. provides you an in-depth strategic analysis of the company’s business
2010 250,00$

Orpea SA - Strategic Analysis Review

This comprehensive SWOT profile of Orpea SA provides you an in-depth strategic analysis of the company’s businesses and operations
2010 250,00$

American Medical Technologies, Inc. (ADLI) - Financial and Strategic Analysis Review

American Medical Technologies, Inc. (ADLI) - Financial and Strategic Analysis Review / / Summary / / American Medical Technologi
2010 125,00$

BioClinica (BIOC) - Financial and Strategic Analysis Review

BioClinica (BIOC) - Financial and Strategic Analysis Review / / Summary / / BioClinica is a health information technology compan
2010 125,00$

Kawasumi Laboratories, Inc. (7703) - Financial and Strategic Analysis Review

Kawasumi Laboratories, Inc. (7703) - Financial and Strategic Analysis Review / / Summary / / Kawasumi Laboratories, Inc. (Kawasu
2010 125,00$

Calypte Biomedical Corporation (CBMC) - Financial and Strategic Analysis Review

Calypte Biomedical Corporation (CBMC) - Financial and Strategic Analysis Review / / Summary / / Calypte Biomedical Corporation (
2010 125,00$

LifeWatch AG (LIFE) - Financial and Strategic Analysis Review

LifeWatch AG (LIFE) - Financial and Strategic Analysis Review / / Summary / / LifeWatch AG (LifeWatch), formerly known as Card G
2010 125,00$

CAS Medical Systems, Inc. (CASM) - Financial and Strategic Analysis Review

CAS Medical Systems, Inc. (CASM) - Financial and Strategic Analysis Review / / Summary / / CAS Medical Systems, Inc. (CASMED) is
2010 125,00$

Dermisonics, Inc. (DMSI) - Financial and Strategic Analysis Review

Dermisonics, Inc. (DMSI) - Financial and Strategic Analysis Review / / Summary / / Dermisonics, Inc. (Dermisonics) is a drug del
2010 125,00$

Imaging Diagnostic Systems, Inc. (IMDS) - Financial and Strategic Analysis Review

Imaging Diagnostic Systems, Inc. (IMDS) - Financial and Strategic Analysis Review / / Summary / / Imaging Diagnostic Systems, In
2010 125,00$

International Isotopes Inc. (INIS) - Financial and Strategic Analysis Review

International Isotopes Inc. (INIS) - Financial and Strategic Analysis Review / / Summary / / International Isotopes Inc. (INIS)
2010 125,00$

PC Group, Inc. (PCGR) - Financial and Strategic Analysis Review

PC Group, Inc. (PCGR) - Financial and Strategic Analysis Review / / Summary / / Langer, Inc. (Langer) is engaged in the design,
2010 125,00$

1st Dental Laboratories plc (FDT) - Financial and Strategic Analysis Review

1st Dental Laboratories plc (FDT) - Financial and Strategic Analysis Review / / Summary / / 1st Dental Laboratories PLC (1st Den
2010 125,00$

AFP Imaging Corporation (AFPC) - Financial and Strategic Analysis Review

AFP Imaging Corporation (AFPC) - Financial and Strategic Analysis Review / / Summary / / AFP Imaging Corporation (AFP Imaging) i
2010 250,00$

Arrhythmia Research Technology, Inc. (ART) - Financial and Strategic Analysis Review

Arrhythmia Research Technology, Inc. (ART) - Financial and Strategic Analysis Review / / Summary / / Arrhythmia Research Technol
2010 250,00$

Biohit Oyj (BIOBV) - Financial and Strategic Analysis Review

Biohit Oyj (BIOBV) - Financial and Strategic Analysis Review / / Summary / / Biohit Oyj (Biohit), is engaged in the manufacturin
2010 250,00$

CHAD Therapeutics, Inc. (CHADQ) - Financial and Strategic Analysis Review

CHAD Therapeutics, Inc. (CHADQ) - Financial and Strategic Analysis Review / / Summary / / CHAD Therapeutics (CHAD ) is engaged i
2010 250,00$

Corin Group PLC (CRG) - Financial and Strategic Analysis Review

Corin Group PLC (CRG) - Financial and Strategic Analysis Review / / Summary / / Corin Group plc (Corin Group) is a medical devic
2010 125,00$

Del Global Technologies Corp. (DGTC) - Financial and Strategic Analysis Review

Del Global Technologies Corp. (DGTC) - Financial and Strategic Analysis Review / / Summary / / Del Global Technologies Corp. (De
2010 125,00$

DiaSys Corporation (DYXC) - Financial and Strategic Analysis Review

DiaSys Corporation (DYXC) - Financial and Strategic Analysis Review / / Summary / / DiaSys Corporation ( DiaSys ) is a medical d
2010 125,00$

Digirad Corporation (DRAD) - Financial and Strategic Analysis Review

Digirad Corporation (DRAD) - Financial and Strategic Analysis Review / / Summary / / Digirad Corporation (Digirad) is a medical
2010 125,00$

Fonar Corporation (FONR) - Financial and Strategic Analysis Review

Fonar Corporation (FONR) - Financial and Strategic Analysis Review / / Summary / / Fonar Corporation (Fonar) is a medical device
2010 125,00$

Hemagen Diagnostics, Inc. (HMGN) - Financial and Strategic Analysis Review

Hemagen Diagnostics, Inc. (HMGN) - Financial and Strategic Analysis Review / / Summary / / Hemagen Diagnostics, Inc. (Hemagen) i
2010 250,00$

Kensey Nash Corporation (KNSY) - Financial and Strategic Analysis Review

Kensey Nash Corporation (KNSY) - Financial and Strategic Analysis Review / / Summary / / Kensey Nash Corp (Kensey Nash) a medica
2010 250,00$

MTS Systems Corporation (MTSC) - Financial and Strategic Analysis Review

MTS Systems Corporation (MTSC) - Financial and Strategic Analysis Review / / Summary / / MTS Systems Corporation (MTS) is a supp
2010 250,00$

NeuroMetrix, Inc. (NURO) - Financial and Strategic Analysis Review

NeuroMetrix, Inc. (NURO) - Financial and Strategic Analysis Review / / Summary / / NeuroMetrix, Inc. (NeuroMetrix) is a science-
2010 250,00$

Ophthalmic Imaging Systems Inc. (OISI) - Financial and Strategic Analysis Review

Ophthalmic Imaging Systems Inc. (OISI) - Financial and Strategic Analysis Review / / Summary / / Ophthalmic Imaging Systems Inc.
2010 250,00$

Retractable Technologies, Inc. (RVP) - Financial and Strategic Analysis Review

Retractable Technologies, Inc. (RVP) - Financial and Strategic Analysis Review / / Summary / / Retractable Technologies ( Retrac
2010 250,00$

The Spectranetics Corporation (SPNC) - Financial and Strategic Analysis Review

The Spectranetics Corporation (SPNC) - Financial and Strategic Analysis Review / / Summary / / Spectranetics is engaged in the d
2010 250,00$

AtCor Medical Holdings Limited (ACG) - Financial and Strategic Analysis Review

AtCor Medical Holdings Limited (ACG) - Financial and Strategic Analysis Review / / Summary / / AtCor Medical Holdings Limited (A
2010 125,00$

Biocompatibles International plc (BII) - Financial and Strategic Analysis Review

Biocompatibles International plc (BII) - Financial and Strategic Analysis Review / / Summary / / Biocompatibles International pl
2010 125,00$

MacKay Life Sciences, Inc. (BZEC) - Financial and Strategic Analysis Review

MacKay Life Sciences, Inc. (BZEC) - Financial and Strategic Analysis Review / / Summary / / Biofield Corporation (Biofield) is e
2010 250,00$

Biophan Technologies, Inc. (BIPH) - Financial and Strategic Analysis Review

Biophan Technologies, Inc. (BIPH) - Financial and Strategic Analysis Review / / Summary / / Biophan Technologies, Inc. (Biophan
2010 125,00$

Conceptus, Inc. (CPTS) - Financial and Strategic Analysis Review

Conceptus, Inc. (CPTS) - Financial and Strategic Analysis Review / / Summary / / Conceptus, Inc. (Conceptus) is a medical device
2010 125,00$

Black Ridge Mining Limited (BRD) - Financial and Strategic Analysis Review

Black Ridge Mining Limited (BRD) - Financial and Strategic Analysis Review / / Summary / / Black Ridge Mining Limited (formerly
2010 125,00$

Lombard Medical Technologies PLC (LMT) - Financial and Strategic Analysis Review

Lombard Medical Technologies PLC (LMT) - Financial and Strategic Analysis Review / / Summary / / Lombard Medical Technologies PL
2010 125,00$

Magna-Lab Inc. (MAGAA) - Financial and Strategic Analysis Review

Magna-Lab Inc. (MAGAA) - Financial and Strategic Analysis Review / / Summary / / Magna-Lab is a medical device company which is
2010 125,00$

MedTox Scientific, Inc. (MTOX) - Financial and Strategic Analysis Review

MedTox Scientific, Inc. (MTOX) - Financial and Strategic Analysis Review / / Summary / / MEDTOX Scientific, Inc. (MedTox) is med
2010 125,00$

Akers Biosciences, Inc. (AKR) - Financial and Strategic Analysis Review

Akers Biosciences, Inc. (AKR) - Financial and Strategic Analysis Review / / Summary / / Akers Biosciences, Inc. (ABI) is engaged
2010 125,00$

Ametek, Inc. (AME) - Financial and Strategic Analysis Review

Ametek, Inc. (AME) - Financial and Strategic Analysis Review / / Summary / / Ametek, Inc. (Ametek) is a global manufacturer of e
2010 250,00$

AMICAS, Inc. (AMCS) - Financial and Strategic Analysis Review

AMICAS, Inc. (AMCS) - Financial and Strategic Analysis Review / / Summary / / Amicas, Inc. (Amicas) is engaged in providing radi
2010 125,00$

Angeion Corporation (ANGN) - Financial and Strategic Analysis Review

Angeion Corporation (ANGN) - Financial and Strategic Analysis Review / / Summary / / Angeion Corporation (Angeion) is engaged in
2010 250,00$

Atrion Corporation (ATRI) - Financial and Strategic Analysis Review

Atrion Corporation (ATRI) - Financial and Strategic Analysis Review / / Summary / / Atrion Corporation (Atrion), is engaged in t
2010 250,00$

Biotel Incorporated (BTEL) - Financial and Strategic Analysis Review

Biotel Incorporated (BTEL) - Financial and Strategic Analysis Review / / Summary / / Biotel Incorporated (Biotel) is engaged in
2010 250,00$

BSML, Inc. (BSML) - Financial and Strategic Analysis Review

BSML, Inc. (BSML) - Financial and Strategic Analysis Review / / Summary / / BSML, Inc ( BSML ). is a medical devices company . I
2010 250,00$

Cardima, Inc. (CADM) - Financial and Strategic Analysis Review

Cardima, Inc. (CADM) - Financial and Strategic Analysis Review / / Summary / / Cardima, Inc. (Cardima) designs, develops, manufa
2010 250,00$

AdvanSource Biomaterials Corporation (ASB) - Financial and Strategic Analysis Review

AdvanSource Biomaterials Corporation (ASB) - Financial and Strategic Analysis Review / / Summary / / AdvanSource Biomaterials Co
2010 125,00$

China Medical Technologies, Inc. (CMED) - Financial and Strategic Analysis Review

China Medical Technologies, Inc. (CMED) - Financial and Strategic Analysis Review / / Summary / / China Medical Technologies, (C
2010 250,00$

Chindex International, Inc. (CHDX) - Financial and Strategic Analysis Review

Chindex International, Inc. (CHDX) - Financial and Strategic Analysis Review / / Summary / / Chindex International, Inc. (Chinde
2010 250,00$

Diomed Holdings, Inc. (DIOMQ) - Financial and Strategic Analysis Review

Diomed Holdings, Inc. (DIOMQ) - Financial and Strategic Analysis Review / / Summary / / Diomed Holdings, Inc. (Diomed) is engage
2010 125,00$

Elron Electronic Industries, Ltd. (ELRN) - Financial and Strategic Analysis Review

Elron Electronic Industries, Ltd. (ELRN) - Financial and Strategic Analysis Review / / Summary / / Elron Electronic Industries,
2010 250,00$

Given Imaging Ltd. (GIVN) - Financial and Strategic Analysis Review

Given Imaging Ltd. (GIVN) - Financial and Strategic Analysis Review / / Summary / / Given Imaging Ltd. (Given Imaging) is engage
2010 125,00$

Hamamatsu Photonics K.K. (6965) - Financial and Strategic Analysis Review

Hamamatsu Photonics K.K. (6965) - Financial and Strategic Analysis Review / / Summary / / Hamamatsu Photonics K.K. (Hamamatsu) i
2010 125,00$

HEI, Inc. (HEII) - Financial and Strategic Analysis Review

HEI, Inc. (HEII) - Financial and Strategic Analysis Review / / Summary / / HEI Inc., an electronic device and medical equipment
2010 250,00$

Hydromer, Inc. (HYDI) - Financial and Strategic Analysis Review

Hydromer, Inc. (HYDI) - Financial and Strategic Analysis Review / / Summary / / Hydromer, Inc. (Hydromer) is a biotechnology com
2010 250,00$

I-Flow Corporation (IFLO) - Financial and Strategic Analysis Review

I-Flow Corporation (IFLO) - Financial and Strategic Analysis Review / / Summary / / I-Flow Corporation (I-Flow) is engaged in th
2010 250,00$

Immunicon Corporation (IMMCQ) - Financial and Strategic Analysis Review

Immunicon Corporation (IMMCQ) - Financial and Strategic Analysis Review / / Summary / / Immunicon Corporation (Immunicon) is eng
2010 125,00$

IntegraMed America, Inc. (INMD) - Financial and Strategic Analysis Review

IntegraMed America, Inc. (INMD) - Financial and Strategic Analysis Review / / Summary / / IntegraMed America, Inc. (IntegraMed)
2010 250,00$

International Brachytherapy S.A. (IBT) - Financial and Strategic Analysis Review

International Brachytherapy S.A. (IBT) - Financial and Strategic Analysis Review / / Summary / / International Brachytherapy S.A
2010 250,00$

IRIDEX Corporation (IRIX) - Financial and Strategic Analysis Review

IRIDEX Corporation (IRIX) - Financial and Strategic Analysis Review / / Summary / / IRIDEX Corporation (IRIDEX) is a medical dev
2010 250,00$

Landauer, Inc. (LDR) - Financial and Strategic Analysis Review

Landauer, Inc. (LDR) - Financial and Strategic Analysis Review / / Summary / / Landauer, Inc. (Landauer) is a medical device com
2010 250,00$

MedMira Inc. (MIR) - Financial and Strategic Analysis Review

MedMira Inc. (MIR) - Financial and Strategic Analysis Review / / Summary / / MedMira, Inc (MedMira) is a diagnostic company prin
2010 250,00$

Medwave, Inc. (MDWV) - Financial and Strategic Analysis Review

Medwave, Inc. (MDWV) - Financial and Strategic Analysis Review / / Summary / / Medwave, Inc . ( Medwave ) is a medical devices c
2010 125,00$

Forticell Bioscience, Inc. (FORBQ) - Financial and Strategic Analysis Review

Forticell Bioscience, Inc. (FORBQ) - Financial and Strategic Analysis Review / / Summary / / Forticell Bioscience, Inc. ( Fortic
2010 125,00$

Capstone Therapeutics (CAPS) - Financial and Strategic Analysis Review

Capstone Therapeutics (CAPS) - Financial and Strategic Analysis Review / / Summary / / Capstone Therapeutics (Capstone ) formerl
2010 250,00$

PhotoMedex, Inc. (PHMD) - Financial and Strategic Analysis Review

PhotoMedex, Inc. (PHMD) - Financial and Strategic Analysis Review / / Summary / / PhotoMedex, Inc. (PhotoMedex) is engaged in th
2010 250,00$

Somanetics Corporation (SMTS) - Financial and Strategic Analysis Review

Somanetics Corporation (SMTS) - Financial and Strategic Analysis Review / / Summary / / Somanetics Corporation, a medical device
2010 250,00$

ALR Technologies Inc. (ALRT) - Financial and Strategic Analysis Review

ALR Technologies Inc. (ALRT) - Financial and Strategic Analysis Review / / Summary / / ALR Technologies Inc. (ALRT), formerly Mo
2010 125,00$

CompuMed, Inc. (CMPD) - Financial and Strategic Analysis Review

CompuMed, Inc. (CMPD) - Financial and Strategic Analysis Review / / Summary / / CompuMed, Inc. (CompuMed) is a medical diagnosti
2010 125,00$

Cyberkinetics Neurotechnology Systems, Inc. (CYKN) - Financial and Strategic Analysis Review

Cyberkinetics Neurotechnology Systems, Inc. (CYKN) - Financial and Strategic Analysis Review / / Summary / / Cyberkinetics Neuro
2010 125,00$

MediVision Medical Imaging Ltd. (MEDV) - Financial and Strategic Analysis Review

MediVision Medical Imaging Ltd. (MEDV) - Financial and Strategic Analysis Review / / Summary / / MediVision Medical Imaging (Med
2010 125,00$

Micrus Endovascular Corporation (MEND) - Financial and Strategic Analysis Review

Micrus Endovascular Corporation (MEND) - Financial and Strategic Analysis Review / / Summary / / Micrus Endovascular Corporation
2010 250,00$

Nakanishi Inc. (7716) - Financial and Strategic Analysis Review

Nakanishi Inc. (7716) - Financial and Strategic Analysis Review / / Summary / / Nakanishi Inc. (Nakanishi) is engaged in the des
2010 250,00$

NMT Medical, Inc. (NMTI) - Financial and Strategic Analysis Review

NMT Medical, Inc. (NMTI) - Financial and Strategic Analysis Review / / Summary / / NMT Medical, Inc. (NMT Medical) designs, deve
2010 250,00$

NxStage Medical, Inc. (NXTM) - Financial and Strategic Analysis Review

NxStage Medical, Inc. (NXTM) - Financial and Strategic Analysis Review / / Summary / / NxStage Medical, Inc. (NxStage) is a medi
2010 250,00$

STAAR Surgical Company (STAA) - Financial and Strategic Analysis Review

STAAR Surgical Company (STAA) - Financial and Strategic Analysis Review / / Summary / / STAAR Surgical Company (STAAR Surgical)
2010 250,00$

Synovis Life Technologies, Inc. (SYNO) - Financial and Strategic Analysis Review

Synovis Life Technologies, Inc. (SYNO) - Financial and Strategic Analysis Review / / Summary / / Synovis Life Technologies, Inc.
2010 125,00$

SyntheMed, Inc. (SYMD) - Financial and Strategic Analysis Review

SyntheMed, Inc. (SYMD) - Financial and Strategic Analysis Review / / Summary / / SyntheMed, Inc. (SyntheMed) is a biomaterial co
2010 250,00$

TranS1 Inc. (TSON) - Financial and Strategic Analysis Review

TranS1 Inc. (TSON) - Financial and Strategic Analysis Review / / Summary / / Trans1, Inc. (Trans1) is engaged in the design, dev
2010 250,00$

Utah Medical Products, Inc. (UTMD) - Financial and Strategic Analysis Review

Utah Medical Products, Inc. (UTMD) - Financial and Strategic Analysis Review / / Summary / / Utah Medical Products, Inc. (Utah M
2010 250,00$

VNUS Medical Technologies, Inc. (VNUS) - Financial and Strategic Analysis Review

VNUS Medical Technologies, Inc. (VNUS) - Financial and Strategic Analysis Review / / Summary / / VNUS Medical Technologies, Inc.
2010 250,00$

Positron Corporation (POSC) - Financial and Strategic Analysis Review

Positron Corporation (POSC) - Financial and Strategic Analysis Review / / Summary / / Positron Corporation (POSC) is a is a med
2010 250,00$

biolitec AG (BIB) - Financial and Strategic Analysis Review

biolitec AG (BIB) - Financial and Strategic Analysis Review / / Summary / / Biolitec AG (Biolitec) is engaged in the research, d
2010 125,00$

CareCentric, Inc. (CREC) - Financial and Strategic Analysis Review

CareCentric, Inc. (CREC) - Financial and Strategic Analysis Review / / Summary / / CareCentric, Inc. (CareCentric) is engaged in
2010 125,00$

Celsis International plc (CEL) - Financial and Strategic Analysis Review

Celsis International plc (CEL) - Financial and Strategic Analysis Review / / Summary / / Celsis International plc (Celsis) is en
2010 125,00$

Medisana AG (MHH) - Financial and Strategic Analysis Review

Medisana AG (MHH) - Financial and Strategic Analysis Review / / Summary / / Medisana AG (Medisana) is engaged in the development
2010 250,00$

Ortivus AB (ORTI B) - Financial and Strategic Analysis Review

Ortivus AB (ORTI B) - Financial and Strategic Analysis Review / / Summary / / Ortivus AB (Ortivus) is a medical technology compa
2010 125,00$

Oridion Systems Ltd. (ORIDN) - Financial and Strategic Analysis Review

Oridion Systems Ltd. (ORIDN) - Financial and Strategic Analysis Review / / Summary / / Oridion Systems Ltd. (Oridion) is a medic
2010 125,00$

Apex Medical Corporation (4106) - Financial and Strategic Analysis Review

Apex Medical Corporation (4106) - Financial and Strategic Analysis Review / / Summary / / Apex Medical Corporation (Apex Medical
2010 250,00$

American Bio Medica Corporation (ABMC) - Financial and Strategic Analysis Review

American Bio Medica Corporation (ABMC) - Financial and Strategic Analysis Review / / Summary / / American Bio Medica Corporation
2010 125,00$

SHOFU INC. (7979) - Financial and Strategic Analysis Review

SHOFU INC. (7979) - Financial and Strategic Analysis Review / / Summary / / SHOFU INC. (SHOFU) is a medical device company which
2010 125,00$

RTI Biologics, Inc. (RTIX) - Financial and Strategic Analysis Review

RTI Biologics, Inc. (RTIX) - Financial and Strategic Analysis Review / / Summary / / RTI Biologics, Inc. (RTI) provides tissue-b
2010 125,00$

United-Guardian, Inc. (UG) - Financial and Strategic Analysis Review

United-Guardian, Inc. (UG) - Financial and Strategic Analysis Review / / Summary / / United-Guardian, Inc. (United-Guardian) is
2010 250,00$

OccuLogix, Inc. (TEAR) - Financial and Strategic Analysis Review

OccuLogix, Inc. (TEAR) - Financial and Strategic Analysis Review / / Summary / / OccuLogix, Inc. (OccuLogix) is a is an ophthalm
2010 250,00$

Prism Medical Ltd. (PM) - Financial and Strategic Analysis Review

Prism Medical Ltd. (PM) - Financial and Strategic Analysis Review / / Summary / / Prism Medical Ltd. (Prism) is engaged in provi
2010 125,00$

Pro-Dex, Inc. (PDEX) - Financial and Strategic Analysis Review

Pro-Dex, Inc. (PDEX) - Financial and Strategic Analysis Review / / Summary / / Pro-Dex, Inc. (Pro-Dex) is engaged in the design,
2010 125,00$

Synergy Health plc (SYR) - Financial and Strategic Analysis Review

Synergy Health plc (SYR) - Financial and Strategic Analysis Review / / Summary / / Synergy Health plc (Synergy Health) is engage
2010 125,00$

American Medical Alert Corp. (AMAC) - Financial and Strategic Analysis Review

American Medical Alert Corp. (AMAC) - Financial and Strategic Analysis Review / / Summary / / American Medical Alert Corp. (AMAC
2010 125,00$

Cyberonics, Inc. (CYBX) - Financial and Strategic Analysis Review

Cyberonics, Inc. (CYBX) - Financial and Strategic Analysis Review / / Summary / / Cyberonics, Inc. (Cyberonics) is a neuromodula
2010 125,00$

LiDCO Group Plc (LID) - Financial and Strategic Analysis Review

LiDCO Group Plc (LID) - Financial and Strategic Analysis Review / / Summary / / LiDCO Group Plc (LiDCO) is engaged in research,
2010 125,00$

Planar Systems, Inc. (PLNR) - Financial and Strategic Analysis Review

Planar Systems, Inc. (PLNR) - Financial and Strategic Analysis Review / / Summary / / Planar Systems, Inc. (Planar Systems) is e
2010 125,00$

Lincare Holdings Inc. (LNCR) - Financial and Strategic Analysis Review

Lincare Holdings Inc. (LNCR) - Financial and Strategic Analysis Review / / Summary / / Lincare Holdings Inc. (Lincare) is engage
2010 125,00$

Mesa Laboratories, Inc. (MLAB) - Financial and Strategic Analysis Review

Mesa Laboratories, Inc. (MLAB) - Financial and Strategic Analysis Review / / Summary / / Mesa Laboratories, Inc. (Mesa) is engag
2010 125,00$

Signature Eyewear, Inc. (SEYE) - Financial and Strategic Analysis Review

Signature Eyewear, Inc. (SEYE) - Financial and Strategic Analysis Review / / Summary / / Signature Eyewear, Inc. (Signature) is
2010 125,00$

CTS Corporation (CTS) - Financial and Strategic Analysis Review

CTS Corporation (CTS) - Financial and Strategic Analysis Review / / Summary / / CTS Corporation (CTS) is engaged in the design,
2010 125,00$

Cynosure, Inc. (CYNO) - Financial and Strategic Analysis Review

Cynosure, Inc. (CYNO) - Financial and Strategic Analysis Review / / Summary / / Cynosure, Inc. (Cynosure) is a medical device co
2010 125,00$

Encision Inc. (ECIA) - Financial and Strategic Analysis Review

Encision Inc. (ECIA) - Financial and Strategic Analysis Review / / Summary / / Encision Inc. (Encision) is a medical device comp
2010 125,00$

Hypertension Diagnostics, Inc. (HDII) - Financial and Strategic Analysis Review

Hypertension Diagnostics, Inc. (HDII) - Financial and Strategic Analysis Review / / Summary / / Hypertension Diagnostics, Inc. (
2010 125,00$

IS Pharma plc (ISPH) - Financial and Strategic Analysis Review

IS Pharma plc (ISPH) - Financial and Strategic Analysis Review / / Summary / / IS Pharma plc (Previously known as Maelor plc) (I
2010 125,00$

Neovasc Inc. (NVC) - Financial and Strategic Analysis Review

Neovasc Inc. (NVC) - Financial and Strategic Analysis Review / / Summary / / Neovasc Inc. (Neovasc), formerly known as Medical V
2010 125,00$

Arbios Systems, Inc. (ABOQE) - Financial and Strategic Analysis Review

Arbios Systems, Inc. (ABOQE) - Financial and Strategic Analysis Review / / Summary / / Arbios Systems, Inc. (Arbios) is a develo
2010 250,00$

Apogee Technology, Inc. (ATA) - Financial and Strategic Analysis Review

Apogee Technology, Inc. (ATA) - Financial and Strategic Analysis Review / / Summary / / Apogee Technology, Inc. (Apogee) is invo
2010 125,00$

BSD Medical Corporation (BSDM) - Financial and Strategic Analysis Review

BSD Medical Corporation (BSDM) - Financial and Strategic Analysis Review / / Summary / / BSD Medical Corporation (BSD) is engage
2010 125,00$

ASAHI INTECC CO., LTD. (7747) - Financial and Strategic Analysis Review

ASAHI INTECC CO., LTD. (7747) - Financial and Strategic Analysis Review / / Summary / / ASAHI INTECC CO., LTD. (ASAHI) is engage
2010 125,00$

Astro-Med, Inc. (ALOT) - Financial and Strategic Analysis Review

Astro-Med, Inc. (ALOT) - Financial and Strategic Analysis Review / / Summary / / Astro-Med, Inc. (Astro-Med) is engaged in the d
2010 125,00$

Cambridge Heart, Inc. (CAMH) - Financial and Strategic Analysis Review

Cambridge Heart, Inc. (CAMH) - Financial and Strategic Analysis Review / / Summary / / Cambridge Heart, Inc. (Cambridge Heart) i
2010 125,00$

Artimplant AB (ARTI B) - Financial and Strategic Analysis Review

Artimplant AB (ARTI B) - Financial and Strategic Analysis Review / / Summary / / Artimplant AB (Artimplant) is a biomaterials co
2010 125,00$

GRANT Life Sciences, Inc. (GLIF) - Financial and Strategic Analysis Review

GRANT Life Sciences, Inc. (GLIF) - Financial and Strategic Analysis Review / / Summary / / Grant Life Sciences, Inc. (GLS) is a
2010 125,00$

Home Diagnostics, Inc. (HDIX) - Financial and Strategic Analysis Review

Home Diagnostics, Inc. (HDIX) - Financial and Strategic Analysis Review / / Summary / / Home Diagnostics, Inc. (Home Diagnostics
2010 250,00$

Medical Action Industries, Inc. (MDCI) - Financial and Strategic Analysis Review

Medical Action Industries, Inc. (MDCI) - Financial and Strategic Analysis Review / / Summary / / Medical Action Industries, Inc.
2010 125,00$

AGA Medical Holdings, Inc. (AGAM) - Financial and Strategic Analysis Review

AGA Medical Holdings, Inc. (AGAM) - Financial and Strategic Analysis Review / / Summary / / AGA Medical Holdings, Inc. (AGA Medi
2010 125,00$

Cardiogenesis Corporation (CGCP) - Financial and Strategic Analysis Review

Cardiogenesis Corporation (CGCP) - Financial and Strategic Analysis Review / / Summary / / Cardiogenesis Corporation (Cardiogene
2010 250,00$

BIONIME Corporation (4737) - Financial and Strategic Analysis Review

BIONIME Corporation (4737) - Financial and Strategic Analysis Review / / Summary / / BIONIME Corporation (BIONIME), a privately-
2010 250,00$

Dynatronics Corporation (DYNT) - Financial and Strategic Analysis Review

Dynatronics Corporation (DYNT) - Financial and Strategic Analysis Review / / Summary / / Dynatronics Corporation (Dynatronics) i
2010 250,00$

Exactech, Inc. (EXAC) - Financial and Strategic Analysis Review

Exactech, Inc. (EXAC) - Financial and Strategic Analysis Review / / Summary / / Exactech, Inc. (Exactech) is engaged in the deve
2010 125,00$

Japan Medical Dynamic Marketing, INC. (7600) - Financial and Strategic Analysis Review

Japan Medical Dynamic Marketing, INC. (7600) - Financial and Strategic Analysis Review / / Summary / / Japan Medical Dynamic Mar
2010 125,00$

DiaSorin S.p.A (DIA) - Financial and Strategic Analysis Review

DiaSorin S.p.A (DIA) - Financial and Strategic Analysis Review / / Summary / / DiaSorin S.p.A. (DiaSorin) is a medical device co
2010 125,00$

AcuNetx, Inc. (ANTX) - Financial and Strategic Analysis Review

AcuNetx, Inc. (ANTX) - Financial and Strategic Analysis Review / / Summary / / AcuNetx, Inc. (AcuNetx) is a medical device compa
2010 250,00$

aap Implantate AG (AAQ) - Financial and Strategic Analysis Review

aap Implantate AG (AAQ) - Financial and Strategic Analysis Review / / Summary / / aap Implantate AG (aap) is a medical technolog
2010 125,00$

Anteo Diagnostics Limited (ADO) - Financial and Strategic Analysis Review

Anteo Diagnostics Limited (ADO) - Financial and Strategic Analysis Review / / Summary / / Anteo Diagnostics Limited (Anteo) form
2010 125,00$

CMT Medical Technologies Ltd (CMD) - Financial and Strategic Analysis Review

CMT Medical Technologies Ltd (CMD) - Financial and Strategic Analysis Review / / Summary / / CMT Medical Technologies Ltd (CMT)
2010 250,00$

Hansen Medical, Inc. (HNSN) - Financial and Strategic Analysis Review

Hansen Medical, Inc. (HNSN) - Financial and Strategic Analysis Review / / Summary / / Hansen Medical, Inc. (Hansen Medical), for
2010 125,00$

HORIBA, Ltd. (6856) - Financial and Strategic Analysis Review

HORIBA, Ltd. (6856) - Financial and Strategic Analysis Review / / Summary / / HORIBA, Ltd. (HORIBA) is a medical device manufact
2010 250,00$

Imaging Dynamics Company, Ltd. (IDL) - Financial and Strategic Analysis Review

Imaging Dynamics Company, Ltd. (IDL) - Financial and Strategic Analysis Review / / Summary / / Imaging Dynamics Company, Ltd. (I
2010 250,00$

Cellestis Limited (CST) - Financial and Strategic Analysis Review

Cellestis Limited (CST) - Financial and Strategic Analysis Review / / Summary / / Cellestis Limited (Cellestis) is engaged in th
2010 250,00$

DiagnoCure Inc. (CUR) - Financial and Strategic Analysis Review

DiagnoCure Inc. (CUR) - Financial and Strategic Analysis Review / / Summary / / DiagnoCure Inc. (DiagnoCure) is engaged in the d
2010 250,00$

Montvale Technologies, Inc. (IVVI) - Financial and Strategic Analysis Review

Montvale Technologies, Inc. (IVVI) - Financial and Strategic Analysis Review / / Summary / / Montvale Technologies, Inc. (Montva
2010 250,00$

LMS Medical Systems Inc. (LMZ) - Financial and Strategic Analysis Review

LMS Medical Systems Inc. (LMZ) - Financial and Strategic Analysis Review / / Summary / / LMS Medical Systems Inc. (LMS), a healt
2010 250,00$

MAKO Surgical Corp. (MAKO) - Financial and Strategic Analysis Review

MAKO Surgical Corp. (MAKO) - Financial and Strategic Analysis Review / / Summary / / MAKO Surgical Corp. (MAKO Surgical) is a me
2010 250,00$

Pyng Medical Corporation (PYT) - Financial and Strategic Analysis Review

Pyng Medical Corporation (PYT) - Financial and Strategic Analysis Review / / Summary / / Pyng Medical Corp. (Pyng), is engaged i
2010 250,00$

SQI Diagnostics Inc. (SQD) - Financial and Strategic Analysis Review

SQI Diagnostics Inc. (SQD) - Financial and Strategic Analysis Review / / Summary / / SQI Diagnostics Inc. (SQI) is a privately-h
2010 250,00$

Cardiovascular Systems, Inc. (CSII) - Financial and Strategic Analysis Review

Cardiovascular Systems, Inc. (CSII) - Financial and Strategic Analysis Review / / Summary / / Cardiovascular Systems, Inc. (CSI)
2010 250,00$

Medgenics Inc. (MEDG) - Financial and Strategic Analysis Review

Medgenics Inc. (MEDG) - Financial and Strategic Analysis Review / / Summary / / Medgenics Inc. (Medgenics) is a clinical-stage b
2010 250,00$

Medicsight PLC (MDST) - Financial and Strategic Analysis Review

Medicsight PLC (MDST) - Financial and Strategic Analysis Review / / Summary / / Medicsight PLC (Medicsight) is engaged in the de
2010 250,00$

NuSep Ltd (NSP) - Financial and Strategic Analysis Review

NuSep Ltd (NSP) - Financial and Strategic Analysis Review / / Summary / / NuSep Ltd (NuSep) is a Life Science Separations compan
2010 250,00$

StatSure Diagnostic Systems, Inc. (SSUR) - Financial and Strategic Analysis Review

StatSure Diagnostic Systems, Inc. (SSUR) - Financial and Strategic Analysis Review / / Summary / / StatSure Diagnostic Systems,
2010 125,00$

American Homepatient, Inc. (AHOM) - Financial and Strategic Analysis Review

American Homepatient, Inc. (AHOM) - Financial and Strategic Analysis Review / / Summary / / American HomePatient, Inc. (American
2010 125,00$

Uroplasty, Inc. (UPI) - Financial and Strategic Analysis Review

Uroplasty, Inc. (UPI) - Financial and Strategic Analysis Review / / Summary / / Uroplasty, Inc. (Uroplasty), a medical device co
2010 250,00$

Vision-Sciences, Inc. (VSCI) - Financial and Strategic Analysis Review

Vision-Sciences, Inc. (VSCI) - Financial and Strategic Analysis Review / / Summary / / Vision-Sciences, Inc. (Vision-Sciences) i
2010 250,00$

CardioNet, Inc. (BEAT) - Financial and Strategic Analysis Review

CardioNet, Inc. (BEAT) - Financial and Strategic Analysis Review / / Summary / / CardioNet, Inc, (CardioNet) is a medical device
2010 125,00$

DelSite, Inc. (CARN) - Financial and Strategic Analysis Review

DelSite, Inc. (CARN) - Financial and Strategic Analysis Review / / Summary / / DelSite, Inc. (DelSite) is a global provider of m
2010 125,00$

GSI Group Inc. (GSIG) - Financial and Strategic Analysis Review

GSI Group Inc. (GSIG) - Financial and Strategic Analysis Review / / Summary / / GSI Group Inc. (GSI) is a provider of precision
2010 125,00$

HeartWare International Inc. (HTWR) - Financial and Strategic Analysis Review

HeartWare International Inc. (HTWR) - Financial and Strategic Analysis Review / / Summary / / HeartWare Limited (HeartWare) is a
2010 125,00$

Non-Invasive Monitoring Systems, Inc. (NIMU) - Financial and Strategic Analysis Review

Non-Invasive Monitoring Systems, Inc. (NIMU) - Financial and Strategic Analysis Review / / Summary / / Non-Invasive Monitoring S
2010 125,00$

Merge Healthcare Incorporated (MRGE) - Financial and Strategic Analysis Review

Merge Healthcare Incorporated (MRGE) - Financial and Strategic Analysis Review / / Summary / / Merge Healthcare Incorporated (Me
2010 250,00$

SSL International plc (SSL) - Financial and Strategic Analysis Review

SSL International plc (SSL) - Financial and Strategic Analysis Review / / Summary / / SSL International plc (SSL) is engaged in
2010 125,00$

XTENT, Inc. (XTNT) - Financial and Strategic Analysis Review

XTENT, Inc. (XTNT) - Financial and Strategic Analysis Review / / Summary / / XTENT, Inc. (XTENT), a development stage medical de
2010 250,00$

ALUS Liquidation Corp. (ALUS) - Financial and Strategic Analysis Review

ALUS Liquidation Corp. (ALUS) - Financial and Strategic Analysis Review / / Summary / / ALUS Liquidation Corp. (previously known
2010 250,00$

Heart Tronics, Inc. (HRTT) - Financial and Strategic Analysis Review

Heart Tronics, Inc. (HRTT) - Financial and Strategic Analysis Review / / Summary / / Heart Tronics, Inc. (Heart Tronics), former
2010 125,00$

pSivida Corp. (PSDV) - Financial and Strategic Analysis Review

pSivida Corp. (PSDV) - Financial and Strategic Analysis Review / / Summary / / pSivida Limited (pSivida) is engaged in the manuf
2010 125,00$

Inion Oy (IIN) - Financial and Strategic Analysis Review

Inion Oy (IIN) - Financial and Strategic Analysis Review / / Summary / / Inion Oy, (Inion) is engaged in the development of biod
2010 125,00$

Seikagaku Corporation (4548) - Financial and Strategic Analysis Review

Seikagaku Corporation (4548) - Financial and Strategic Analysis Review / / Summary / / Seikagaku Corporation (Seikagaku), is pri
2010 125,00$

MAZOR Surgical Technologies Ltd. (MZOR) - Financial and Strategic Analysis Review

MAZOR Surgical Technologies Ltd. (MZOR) - Financial and Strategic Analysis Review / / Summary / / MAZOR Surgical Technologies Lt
2010 250,00$

MedicalCV, Inc. (MCVI) - Financial and Strategic Analysis Review

MedicalCV, Inc. (MCVI) - Financial and Strategic Analysis Review / / Summary / / MedicalCV, Inc. (MedicalCV) is engaged in the d
2010 125,00$

Greatbatch, Inc. (GB) - Financial and Strategic Analysis Review

Greatbatch, Inc. (GB) - Financial and Strategic Analysis Review / / Summary / / Greatbatch, Inc.(GB) is engaged in the design, d
2010 125,00$

Beijing Wandong Medical Equipment Co., Ltd. (600055) - Financial and Strategic Analysis Review

Beijing Wandong Medical Equipment Co., Ltd. (600055) - Financial and Strategic Analysis Review / / Summary / / Beijing Wandong M
2010 125,00$

Compumedics Limited (CMP) - Financial and Strategic Analysis Review

Compumedics Limited (CMP) - Financial and Strategic Analysis Review / / Summary / / Compumedics Limited (Compumedics) is a medic
2010 125,00$

Paradigm Medical Industries, Inc. (PDMI) - Financial and Strategic Analysis Review

Paradigm Medical Industries, Inc. (PDMI) - Financial and Strategic Analysis Review / / Summary / / Paradigm Medical Industries,
2010 125,00$

Acme United Corporation (ACU) - Financial and Strategic Analysis Review

Acme United Corporation (ACU) - Financial and Strategic Analysis Review / / Summary / / Acme United Corporation (AUC) is a suppl
2010 250,00$

Tepnel Life Sciences PLC (TED) - Financial and Strategic Analysis Review

Tepnel Life Sciences PLC (TED) - Financial and Strategic Analysis Review / / Summary / / Tepnel Life Sciences PLC is engaged in
2010 250,00$

Sunshine Heart Company, Pty. Ltd. (SHC) - Financial and Strategic Analysis Review

Sunshine Heart Company, Pty. Ltd. (SHC) - Financial and Strategic Analysis Review / / Summary / / Sunshine Heart, Inc. (Sunshine
2010 250,00$

Dmatek Ltd. (DTK) - Financial and Strategic Analysis Review

Dmatek Ltd. (DTK) - Financial and Strategic Analysis Review / / Summary / / Dmatek Ltd. (Dmatek) is principally engaged in the m
2010 125,00$

BioCurex, Inc. (BOCX) - Financial and Strategic Analysis Review

BioCurex, Inc. (BOCX) - Financial and Strategic Analysis Review / / Summary / / BioCurex, Inc. (BioCurex) is a biotechnology com
2010 250,00$

Urologix Inc. (ULGX) - Financial and Strategic Analysis Review

Urologix Inc. (ULGX) - Financial and Strategic Analysis Review / / Summary / / Urologix, Inc. (Urologix) is engaged in the resea
2010 125,00$

Milestone Scientific Inc. (MLSS) - Financial and Strategic Analysis Review

Milestone Scientific Inc. (MLSS) - Financial and Strategic Analysis Review / / Summary / / Milestone Scientific Inc. (Milestone
2010 250,00$

Deltex Medical Group plc (DEMG) - Financial and Strategic Analysis Review

Deltex Medical Group plc (DEMG) - Financial and Strategic Analysis Review / / Summary / / Deltex Medical Group plc (Deltex) is e
2010 125,00$

Electro-Optical Sciences, Inc. (MELA) - Financial and Strategic Analysis Review

Electro-Optical Sciences, Inc. (MELA) - Financial and Strategic Analysis Review / / Summary / / Electro-Optical Sciences, Inc. (
2010 250,00$

Goodman Co., Ltd. (7535) - Financial and Strategic Analysis Review

Goodman Co., Ltd. (7535) - Financial and Strategic Analysis Review / / Summary / / Goodman Co., Ltd. (Goodman) is a medical devi
2010 250,00$

JMS CO., LTD. (7702) - Financial and Strategic Analysis Review

JMS CO., LTD. (7702) - Financial and Strategic Analysis Review / / Summary / / JMS CO., LTD. (JMS) is engaged in the research, d
2010 125,00$

Medikit Co., Ltd. (7749) - Financial and Strategic Analysis Review

Medikit Co., Ltd. (7749) - Financial and Strategic Analysis Review / / Summary / / Medikit Co., Ltd. (Medikit) is a global techn
2010 250,00$

Itamar Medical Ltd. (ITMR) - Financial and Strategic Analysis Review

Itamar Medical Ltd. (ITMR) - Financial and Strategic Analysis Review / / Summary / / Itamar Medical Ltd. (Itamar Medical) is a m
2010 250,00$

bioMD Limited (BOD) - Financial and Strategic Analysis Review

bioMD Limited (BOD) - Financial and Strategic Analysis Review / / Summary / / bioMD Limited is a Western Australia- based medica
2010 250,00$

Advanced Refractive Technologies, Inc. (ARFR) - Financial and Strategic Analysis Review

Advanced Refractive Technologies, Inc. (ARFR) - Financial and Strategic Analysis Review / / Summary / / Advanced Refractive Tech
2010 125,00$

Bovie Medical Corporation (BVX) - Financial and Strategic Analysis Review

Bovie Medical Corporation (BVX) - Financial and Strategic Analysis Review / / Summary / / Bovie Medical Corporation (Bovie Medic
2010 125,00$

Medical Australia Limited (MLA) - Financial and Strategic Analysis Review

Medical Australia Limited (MLA) - Financial and Strategic Analysis Review / / Summary / / Medical Australia Limited (Medical Aus
2010 125,00$

Genetix Group plc (GTX) - Financial and Strategic Analysis Review

Genetix Group plc (GTX) - Financial and Strategic Analysis Review / / Summary / / Genetix Group plc (Genetix) is a Medical Diagn
2010 125,00$

Mediwatch Plc (MDW) - Financial and Strategic Analysis Review

Mediwatch Plc (MDW) - Financial and Strategic Analysis Review / / Summary / / Mediwatch Plc (Mediwatch) is a medical device comp
2010 125,00$

BIOQUELL (BQE) - Financial and Strategic Analysis Review

BIOQUELL (BQE) - Financial and Strategic Analysis Review / / Summary / / BIOQUELL is a privately-held medical device company, en
2010 250,00$

BioForm Medical, Inc. (BFRM) - Financial and Strategic Analysis Review

BioForm Medical, Inc. (BFRM) - Financial and Strategic Analysis Review / / Summary / / BioForm Medical, Inc. (BioForm Medical),
2010 125,00$

Obagi Medical Products, Inc. (OMPI) - Financial and Strategic Analysis Review

Obagi Medical Products, Inc. (OMPI) - Financial and Strategic Analysis Review / / Summary / / Obagi Medical Products, Inc. (Obag
2010 250,00$

Lancer Orthodontics, Inc. (LANZ) - Financial and Strategic Analysis Review

Lancer Orthodontics, Inc. (LANZ) - Financial and Strategic Analysis Review / / Summary / / Lancer Orthodontics, Inc. (Lancer Ort
2010 125,00$

Carpenter Technology Corporation (CRS) - Financial and Strategic Analysis Review

Carpenter Technology Corporation (CRS) - Financial and Strategic Analysis Review / / Summary / / Carpenter Technology Corporatio
2010 125,00$

Neogen Corporation (NEOG) - Financial and Strategic Analysis Review

Neogen Corporation (NEOG) - Financial and Strategic Analysis Review / / Summary / / Neogen Corporation (Neogen) is a medical dev
2010 125,00$

BIOTEQUE CORPORATION (4107) - Financial and Strategic Analysis Review

BIOTEQUE CORPORATION (4107) - Financial and Strategic Analysis Review / / Summary / / BIOTEQUE CORPORATION (BIOTEQUE) is a priva
2010 250,00$

Cutera, Inc. (CUTR) - Financial and Strategic Analysis Review

Cutera, Inc. (CUTR) - Financial and Strategic Analysis Review / / Summary / / Cutera, Inc. (Cutera) is engaged in the design, de
2010 125,00$

QuadraMed Corporation (QDHC) - Financial and Strategic Analysis Review

QuadraMed Corporation (QDHC) - Financial and Strategic Analysis Review / / Summary / / Quadramed Corporation (Quadramed) is a pu
2010 125,00$

OSSTEM IMPLANT Co., Ltd. (48260) - Financial and Strategic Analysis Review

OSSTEM IMPLANT Co., Ltd. (48260) - Financial and Strategic Analysis Review / / Summary / / OSSTEM IMPLANT Co., Ltd. (Osstem) is
2010 250,00$

RION Co., Ltd. (6823) - Financial and Strategic Analysis Review

RION Co., Ltd. (6823) - Financial and Strategic Analysis Review / / Summary / / RION Co., Ltd. (Rion) is engaged in the developm
2010 250,00$

DexCom, Inc. (DXCM) - Financial and Strategic Analysis Review

DexCom, Inc. (DXCM) - Financial and Strategic Analysis Review / / Summary / / DexCom, Inc. (DexCom) is a medical device company.
2010 125,00$

Biological Signal Processing Ltd. (BSP) - Financial and Strategic Analysis Review

Biological Signal Processing Ltd. (BSP) - Financial and Strategic Analysis Review / / Summary / / Biological Signal Processing L
2010 250,00$

VirtualScopics, Inc. (VSCP) - Financial and Strategic Analysis Review

VirtualScopics, Inc. (VSCP) - Financial and Strategic Analysis Review / / Summary / / VirtualScopics, Inc. (VirtualScopics) is a
2010 125,00$

Zygo Corporation (ZIGO) - Financial and Strategic Analysis Review

Zygo Corporation (ZIGO) - Financial and Strategic Analysis Review / / Summary / / ZYGO Corporation (ZYGO) is engaged in the desi
2010 250,00$

Holista CollTech Limited (HCT) - Financial and Strategic Analysis Review

Holista CollTech Limited (HCT) - Financial and Strategic Analysis Review / / Summary / / Holista CollTech Limited (Holista CollT
2010 125,00$

ContextVision AB (COV) - Financial and Strategic Analysis Review

ContextVision AB (COV) - Financial and Strategic Analysis Review / / Summary / / ContextVision AB (ContextVision) is a medical t
2010 125,00$

Oncoprobe Biotech Inc. (4113) - Financial and Strategic Analysis Review

Oncoprobe Biotech Inc. (4113) - Financial and Strategic Analysis Review / / Summary / / Oncoprobe Biotech Inc. (Oncoprobe) is a
2010 250,00$

CardioComm Solutions, Inc. (EKG) - Financial and Strategic Analysis Review

CardioComm Solutions, Inc. (EKG) - Financial and Strategic Analysis Review / / Summary / / CardioComm Solutions, Inc. (CardioCom
2010 125,00$

National Dentex Corporation (NADX) - Financial and Strategic Analysis Review

National Dentex Corporation (NADX) - Financial and Strategic Analysis Review / / Summary / / National Dentex Corporation (Nation
2010 125,00$

Tyrian Diagnostics Limited (TDX) - Financial and Strategic Analysis Review

Tyrian Diagnostics Limited (TDX) - Financial and Strategic Analysis Review / / Summary / / Tyrian Diagnostics Limited (Tyrian) i
2010 125,00$

Microhelix, Inc. (CPYT) - Financial and Strategic Analysis Review

Microhelix, Inc. (CPYT) - Financial and Strategic Analysis Review / / Summary / / Microhelix, Inc. (Microhelix) is a public comp
2010 250,00$

Helicos BioSciences Corporation (HLCS) - Financial and Strategic Analysis Review

Helicos BioSciences Corporation (HLCS) - Financial and Strategic Analysis Review / / Summary / / Helicos BioSciences Corporation
2010 125,00$

NISSAN MEDICAL INDUSTRIES LTD. (NISA) - Financial and Strategic Analysis Review

NISSAN MEDICAL INDUSTRIES LTD. (NISA) - Financial and Strategic Analysis Review / / Summary / / NISSAN MEDICAL INDUSTRIES LTD. (
2010 250,00$

United Orthopedic Corporation (4129) - Financial and Strategic Analysis Review

United Orthopedic Corporation (4129) - Financial and Strategic Analysis Review / / Summary / / United Orthopedic Corporation (UO
2010 125,00$

Telzuit Medical Technologies, Inc. (TZMT) - Financial and Strategic Analysis Review

Telzuit Medical Technologies, Inc. (TZMT) - Financial and Strategic Analysis Review / / Summary / / Telzuit Medical Technologies
2010 125,00$

MEDICREA INTERNATIONAL (ALMED) - Financial and Strategic Analysis Review

MEDICREA INTERNATIONAL (ALMED) - Financial and Strategic Analysis Review / / Summary / / MEDICREA INTERNATIONAL (Medicrea) is a
2010 250,00$

Solco Biomedical Co., Ltd. (43100) - Financial and Strategic Analysis Review

Solco Biomedical Co., Ltd. (43100) - Financial and Strategic Analysis Review / / Summary / / Solco Biomedical Co., Ltd. (Solco)
2010 125,00$

Northstar Neuroscience, Inc. (NSTR) - Financial and Strategic Analysis Review

Northstar Neuroscience, Inc. (NSTR) - Financial and Strategic Analysis Review / / Summary / / Northstar Neuroscience, Inc. (Nort
2010 125,00$

Biocoral, Inc. (BCRA) - Financial and Strategic Analysis Review

Biocoral, Inc. (BCRA) - Financial and Strategic Analysis Review / / Summary / / Biocoral, Inc. (Biocoral) is a medical device co
2010 250,00$

Applied NeuroSolutions, Inc. (APSN) - Financial and Strategic Analysis Review

Applied NeuroSolutions, Inc. (APSN) - Financial and Strategic Analysis Review / / Summary / / Applied NeuroSolutions, Inc. (APNS
2010 125,00$

ZoomMed Inc. (ZMD) - Financial and Strategic Analysis Review

ZoomMed Inc. (ZMD) - Financial and Strategic Analysis Review / / Summary / / ZoomMed Inc. (ZoomMed) is engaged in the developmen
2010 250,00$

MCS Medical Compression Systems (DBN) Ltd. (MDCL) - Financial and Strategic Analysis Review

MCS Medical Compression Systems (DBN) Ltd. (MDCL) - Financial and Strategic Analysis Review / / Summary / / MCS Medical Compress
2010 250,00$

Andover Medical, Inc. (ADOV) - Financial and Strategic Analysis Review

Andover Medical, Inc. (ADOV) - Financial and Strategic Analysis Review / / Summary / / Andover Medical, Inc. (AMI) is engaged in
2010 125,00$

NorDiag ASA (NORD) - Financial and Strategic Analysis Review

NorDiag ASA (NORD) - Financial and Strategic Analysis Review / / Summary / / NorDiag ASA (NorDiag) is a gene based clinical diag
2010 125,00$

Noveko International Inc. (EKO) - Financial and Strategic Analysis Review

Noveko International Inc. (EKO) - Financial and Strategic Analysis Review / / Summary / / Noveko International Inc. (Noveko) is
2010 250,00$

Osmetech plc (OMH) - Financial and Strategic Analysis Review

Osmetech plc (OMH) - Financial and Strategic Analysis Review / / Summary / / Osmetech plc (Osmetech) is engaged in the manufactu
2010 125,00$

Power Medical Interventions, Inc. (PMII) - Financial and Strategic Analysis Review

Power Medical Interventions, Inc. (PMII) - Financial and Strategic Analysis Review / / Summary / / Power Medical Interventions,
2010 250,00$

Fermiscan Holdings Limited (FER) - Financial and Strategic Analysis Review

Fermiscan Holdings Limited (FER) - Financial and Strategic Analysis Review / / Summary / / Fermiscan Holdings Limited (Fermiscan
2010 125,00$

Amplifon S.p.A. (AMP) - Financial and Strategic Analysis Review

Amplifon S.p.A. (AMP) - Financial and Strategic Analysis Review / / Summary / / Amplifon S.p.A. (Amplifon) is a multinational co
2010 125,00$

Bioheart, Inc. (BHRT) - Financial and Strategic Analysis Review

Bioheart, Inc. (BHRT) - Financial and Strategic Analysis Review / / Summary / / Bioheart, Inc. (Bioheart) is a biotechnology com
2010 250,00$

Computerized Thermal Imaging, Inc. (COIB) - Financial and Strategic Analysis Review

Computerized Thermal Imaging, Inc. (COIB) - Financial and Strategic Analysis Review / / Summary / / Computerized Thermal Imaging
2010 125,00$

Topspin Medical Inc. (TOPMD) - Financial and Strategic Analysis Review

Topspin Medical Inc. (TOPMD) - Financial and Strategic Analysis Review / / Summary / / Topspin Medical Inc. (TopSpin) is medical
2010 250,00$

Bioneer Corporation (64550) - Financial and Strategic Analysis Review

Bioneer Corporation (64550) - Financial and Strategic Analysis Review / / Summary / / Bioneer Corporation (Bioneer) is a biotech
2010 250,00$

BodyTel Scientific Inc. (BDYT) - Financial and Strategic Analysis Review

BodyTel Scientific Inc. (BDYT) - Financial and Strategic Analysis Review / / Summary / / BodyTel Scientific Inc. (BodyTel) is a
2010 125,00$

Guardian Technologies International, Inc. (GDTI) - Financial and Strategic Analysis Review

Guardian Technologies International, Inc. (GDTI) - Financial and Strategic Analysis Review / / Summary / / Guardian Technologies
2010 125,00$

Cosmo Bio Co., Ltd. (3386) - Financial and Strategic Analysis Review

Cosmo Bio Co., Ltd. (3386) - Financial and Strategic Analysis Review / / Summary / / Cosmo Bio Co., Ltd. (Cosmo Bio) is engaged
2010 250,00$

Insulet Corporation (PODD) - Financial and Strategic Analysis Review

Insulet Corporation (PODD) - Financial and Strategic Analysis Review / / Summary / / Insulet Corporation (Insulet) is engaged in
2010 250,00$

Exploit Technologies Pte Ltd (3544) - Financial and Strategic Analysis Review

Exploit Technologies Pte Ltd (3544) - Financial and Strategic Analysis Review / / Summary / / Exploit Technologies Pte Ltd (Expl
2010 125,00$

ExonHit Therapeutics SA (ALEHT) - Financial and Strategic Analysis Review

ExonHit Therapeutics SA (ALEHT) - Financial and Strategic Analysis Review / / Summary / / ExonHit Therapeutics SA (ExonHit) is a
2010 250,00$

European Institute of Science AB (EURI B) - Financial and Strategic Analysis Review

European Institute of Science AB (EURI B) - Financial and Strategic Analysis Review / / Summary / / European Institute of Scienc
2010 250,00$

LifeAssays AB (LIFE B) - Financial and Strategic Analysis Review

LifeAssays AB (LIFE B) - Financial and Strategic Analysis Review / / Summary / / LifeAssays AB (LifeAssays) is a diagnostic comp
2010 250,00$

MagForce Nanotechnologies AG (MF6) - Financial and Strategic Analysis Review

MagForce Nanotechnologies AG (MF6) - Financial and Strategic Analysis Review / / Summary / / MagForce Nanotechnologies AG (MagFo
2010 250,00$

MedaSorb Technologies Corporation (MSBT) - Financial and Strategic Analysis Review

MedaSorb Technologies Corporation (MSBT) - Financial and Strategic Analysis Review / / Summary / / MedaSorb Technologies Corpora
2010 250,00$

CRH Medical Corporation (CRM) - Financial and Strategic Analysis Review

CRH Medical Corporation (CRM) - Financial and Strategic Analysis Review / / Summary / / CRH Medical Corporation (CRH Medical) is
2010 250,00$

Precision Optics Corporation, Inc. (PEYE) - Financial and Strategic Analysis Review

Precision Optics Corporation, Inc. (PEYE) - Financial and Strategic Analysis Review / / Summary / / Precision Optics Corporation
2010 250,00$

Rossmax International Ltd. (4121) - Financial and Strategic Analysis Review

Rossmax International Ltd. (4121) - Financial and Strategic Analysis Review / / Summary / / Rossmax International Ltd. (Rossmax
2010 250,00$

Nano Mask, Inc. (NANM) - Financial and Strategic Analysis Review

Nano Mask, Inc. (NANM) - Financial and Strategic Analysis Review / / Summary / / Nano Mask, Inc. (formerly known as Emergency Fi
2010 125,00$

E Med Future, Inc. (EMDF) - Financial and Strategic Analysis Review

E Med Future, Inc. (EMDF) - Financial and Strategic Analysis Review / / Summary / / E Med Future, Inc. (E Med Future) is engaged
2010 125,00$

Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) - Financial and Strategic Analysis Review

Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) - Financial and Strategic Analysis Review / / Summary / / Eckert & Ziegle
2010 125,00$

Concateno plc (COT) - Financial and Strategic Analysis Review

Concateno plc (COT) - Financial and Strategic Analysis Review / / Summary / / Concateno PLC (Concateno) is a provider of drug an
2010 125,00$

OPTOPOL Technology S.A. (OPL) - Financial and Strategic Analysis Review

OPTOPOL Technology S.A. (OPL) - Financial and Strategic Analysis Review / / Summary / / OPTOPOL Technology S.A (OPTOPOL) is a me
2010 250,00$

Medtechnica Ltd. (MEDI) - Financial and Strategic Analysis Review

Medtechnica Ltd. (MEDI) - Financial and Strategic Analysis Review / / Summary / / Medtechnica Ltd. (Medtechnica) is a medical de
2010 250,00$

Elbit Imaging Ltd. (EMITF) - Financial and Strategic Analysis Review

Elbit Imaging Ltd. (EMITF) - Financial and Strategic Analysis Review / / Summary / / Elbit Imaging Ltd. (Elbit) is a diversified
2010 125,00$

Global Health Pty Ltd (GLH) - Financial and Strategic Analysis Review

Global Health Pty Ltd (GLH) - Financial and Strategic Analysis Review / / Summary / / Global Health Pty Ltd (Global Health) is a
2010 125,00$

Nightingale Informatix Corporation (NGH) - Financial and Strategic Analysis Review

Nightingale Informatix Corporation (NGH) - Financial and Strategic Analysis Review / / Summary / / Nightingale Informatix Corpor
2010 125,00$

CompuGROUP Holding AG (COP) - Financial and Strategic Analysis Review

CompuGROUP Holding AG (COP) - Financial and Strategic Analysis Review / / Summary / / CompuGROUP Holding AG (CompuGROUP) is a me
2010 250,00$

CathRx Ltd (CXD) - Financial and Strategic Analysis Review

CathRx Ltd (CXD) - Financial and Strategic Analysis Review / / Summary / / CathRx Ltd (CathRx) is a medical device company engag
2010 125,00$

Xcorporeal, Inc. (XCR) - Financial and Strategic Analysis Review

Xcorporeal, Inc. (XCR) - Financial and Strategic Analysis Review / / Summary / / Xcorporeal, Inc. (Xcorporeal) is the US based m
2010 250,00$

Nanosphere, Inc. (NSPH) - Financial and Strategic Analysis Review

Nanosphere, Inc. (NSPH) - Financial and Strategic Analysis Review / / Summary / / Nanosphere, Inc. (Nanosphere) is a nanotechnol
2010 250,00$

AuthentiDate Holding Corporation (ADAT) - Financial and Strategic Analysis Review

AuthentiDate Holding Corporation (ADAT) - Financial and Strategic Analysis Review / / Summary / / Authentidate Holding Corp. is
2010 125,00$

Matrix I.T. Ltd. (MTRX) - Financial and Strategic Analysis Review

Matrix I.T. Ltd. (MTRX) - Financial and Strategic Analysis Review / / Summary / / Matrix I.T. Ltd. (Matrix I.T) is a medical dev
2010 125,00$

Advanced Micronic Devices Limited (517552) - Financial and Strategic Analysis Review

Advanced Micronic Devices Limited (517552) - Financial and Strategic Analysis Review / / Summary / / Advanced Micronic Devices L
2010 250,00$

Elk Corporation (9833) - Financial and Strategic Analysis Review

Elk Corporation (9833) - Financial and Strategic Analysis Review / / Summary / / Elk Corporation (Elk) is a medical device compa
2010 250,00$

Hogy Medical Co., Ltd. (3593) - Financial and Strategic Analysis Review

Hogy Medical Co., Ltd. (3593) - Financial and Strategic Analysis Review / / Summary / / Hogy Medical Co., Ltd. (Hogy) is a medic
2010 125,00$

Refocus Group, Inc. (RFCS) - Financial and Strategic Analysis Review

Refocus Group, Inc. (RFCS) - Financial and Strategic Analysis Review / / Summary / / Refocus Group, Inc. is a medical device com
2010 125,00$

CustomVis Plc (CUS) - Financial and Strategic Analysis Review

CustomVis Plc (CUS) - Financial and Strategic Analysis Review / / Summary / / CustomVis Plc (CustomVis) is a medical technology
2010 125,00$

Banyan International Corp. (BNYN) - Financial and Strategic Analysis Review

Banyan International Corp. (BNYN) - Financial and Strategic Analysis Review / / Summary / / Banyan International Corp. (Banyan I
2010 125,00$

HTL-STREFA S.A. (HTL) - Financial and Strategic Analysis Review

HTL-STREFA S.A. (HTL) - Financial and Strategic Analysis Review / / Summary / / HTL-STREFA S.A (HTL) is engaged in the developme
2010 250,00$

ReGen Biologics, Inc. (RGBI) - Financial and Strategic Analysis Review

ReGen Biologics, Inc. (RGBI) - Financial and Strategic Analysis Review / / Summary / / ReGen Biologics, Inc. (ReGen) is a public
2010 250,00$

Japan Lifeline Co., Ltd. (7575) - Financial and Strategic Analysis Review

Japan Lifeline Co., Ltd. (7575) - Financial and Strategic Analysis Review / / Summary / / Japan Lifeline Co., Ltd. (Japan Lifeli
2010 125,00$

Kawamoto Corporation (3604) - Financial and Strategic Analysis Review

Kawamoto Corporation (3604) - Financial and Strategic Analysis Review / / Summary / / Kawamoto Corporation (Kawamoto) is a Japan
2010 125,00$

KOKEN CO., LTD (7963) - Financial and Strategic Analysis Review

KOKEN CO., LTD (7963) - Financial and Strategic Analysis Review / / Summary / / KOKEN CO., LTD. (KOKEN) is engaged in the develo
2010 250,00$

Mochida Pharmaceutical Co., Ltd. (4534) - Financial and Strategic Analysis Review

Mochida Pharmaceutical Co., Ltd. (4534) - Financial and Strategic Analysis Review / / Summary / / Mochida Pharmaceutical Co., Lt
2010 125,00$

Noritake Co., Limited (5331) - Financial and Strategic Analysis Review

Noritake Co., Limited (5331) - Financial and Strategic Analysis Review / / Summary / / Noritake Co., Limited (Noritake) is a med
2010 250,00$

Response Biomedical Corporation (RBM) - Financial and Strategic Analysis Review

Response Biomedical Corporation (RBM) - Financial and Strategic Analysis Review / / Summary / / Response Biomedical Corporation
2010 125,00$

IVAX Diagnostics, Inc. (IVD) - Financial and Strategic Analysis Review

IVAX Diagnostics, Inc. (IVD) - Financial and Strategic Analysis Review / / Summary / / IVAX Diagnostics, Inc. (IVAX), through it
2010 250,00$

Vitrolife AB (VITR) - Financial and Strategic Analysis Review

Vitrolife AB (VITR) - Financial and Strategic Analysis Review / / Summary / / Vitrolife AB (Vitrolife) is a public limited liabi
2010 125,00$

MedQuist Inc. (MEDQ) - Financial and Strategic Analysis Review

MedQuist Inc. (MEDQ) - Financial and Strategic Analysis Review / / Summary / / MedQuist Inc. (MedQuist) is engaged in providing
2010 125,00$

AOI Medical, Inc. (AOI) - Financial and Strategic Analysis Review

AOI Medical, Inc. (AOI) - Financial and Strategic Analysis Review / / Summary / / AOI Medical, Inc. (AOI Medical) is a growth-st
2010 250,00$

EnteroMedics Inc. (ETRM) - Financial and Strategic Analysis Review

EnteroMedics Inc. (ETRM) - Financial and Strategic Analysis Review / / Summary / / EnteroMedics Inc. (Enteromedics) is a medical
2010 250,00$

Shandong Weigao Group Medical Polymer Company Limited (8199) - Financial and Strategic Analysis Review

Shandong Weigao Group Medical Polymer Company Limited (8199) - Financial and Strategic Analysis Review / / Summary / / Shandong
2010 125,00$

Emdeon Inc. (EM) - Financial and Strategic Analysis Review

Emdeon Inc. (EM) - Financial and Strategic Analysis Review / / Summary / / Emdeon Inc. (Emdeon) is healthcare information techno
2010 250,00$

Ahlstrom Corporation (AHL1V) - Financial and Strategic Analysis Review

Ahlstrom Corporation (AHL1V) - Financial and Strategic Analysis Review / / Summary / / Ahlstrom Corporation (Ahlstrom) is one of
2010 125,00$

Medi-Stim ASA (MEDI) - Financial and Strategic Analysis Review

Medi-Stim ASA (MEDI) - Financial and Strategic Analysis Review / / Summary / / Medi-Stim ASA (Medi-Stim) is a medical device com
2010 125,00$

Intercytex Group plc (ICX) - Financial and Strategic Analysis Review

Intercytex Group plc (ICX) - Financial and Strategic Analysis Review / / Summary / / Intercytex Group plc (Intercytex) is engage
2010 250,00$

Protein Polymer Technologies, Inc. (PPTI) - Financial and Strategic Analysis Review

Protein Polymer Technologies, Inc. (PPTI) - Financial and Strategic Analysis Review / / Summary / / Protein Polymer Technologies
2010 125,00$

Pacific Hospital Supply Co., Ltd. (4126) - Financial and Strategic Analysis Review

Pacific Hospital Supply Co., Ltd. (4126) - Financial and Strategic Analysis Review / / Summary / / Pacific Hospital Supply Co.,
2010 125,00$

Quick-Med Technologies, Inc. (QMDT) - Financial and Strategic Analysis Review

Quick-Med Technologies, Inc. (QMDT) - Financial and Strategic Analysis Review / / Summary / / Quick-Med Technologies, Inc. (Quic
2010 125,00$

curasan AG (CUR) - Financial and Strategic Analysis Review

curasan AG (CUR) - Financial and Strategic Analysis Review / / Summary / / curasan AG (curasan) is a medical device company that
2010 250,00$

ATS Automation Tooling Systems Inc. (ATA) - Financial and Strategic Analysis Review

ATS Automation Tooling Systems Inc. (ATA) - Financial and Strategic Analysis Review / / Summary / / ATS Automation Tooling Syste
2010 250,00$

CSMG Technologies, Inc. (CTGI) - Financial and Strategic Analysis Review

CSMG Technologies, Inc. (CTGI) - Financial and Strategic Analysis Review / / Summary / / CSMG Technologies, Inc. (CSMG Technolog
2010 125,00$

PuriCore plc (PURI) - Financial and Strategic Analysis Review

PuriCore plc (PURI) - Financial and Strategic Analysis Review / / Summary / / PuriCore plc (PuriCore) is a medical device compan
2010 125,00$

Imaging3, Inc. (IMGG) - Financial and Strategic Analysis Review

Imaging3, Inc. (IMGG) - Financial and Strategic Analysis Review / / Summary / / Imaging3, Inc. (Imaging3) is a medical device co
2010 250,00$

Pacific Edge Biotechnology Limited (PEB) - Financial and Strategic Analysis Review

Pacific Edge Biotechnology Limited (PEB) - Financial and Strategic Analysis Review / / Summary / / Pacific Edge Biotechnology Li
2010 125,00$

Celera Corporation (CRA) - Financial and Strategic Analysis Review

Celera Corporation (CRA) - Financial and Strategic Analysis Review / / Summary / / Celera Corporation (Celera) is a publicly hel
2010 125,00$

BioPorto Diagnostics A/S (BIOPOR) - Financial and Strategic Analysis Review

BioPorto Diagnostics A/S (BIOPOR) - Financial and Strategic Analysis Review / / Summary / / BioPorto Diagnostics A/S (BioPorto D
2010 250,00$

DiaGenic ASA (DIAG) - Financial and Strategic Analysis Review

DiaGenic ASA (DIAG) - Financial and Strategic Analysis Review / / Summary / / DiaGenic ASA (DiaGenic) is a life sciences company
2010 125,00$

Nyer Medical Group, Inc. (NYER) - Financial and Strategic Analysis Review

Nyer Medical Group, Inc. (NYER) - Financial and Strategic Analysis Review / / Summary / / Nyer Medical Group, Inc. (Nyer Medical
2010 250,00$

SPO Medical Inc. (SPOM) - Financial and Strategic Analysis Review

SPO Medical Inc. (SPOM) - Financial and Strategic Analysis Review / / Summary / / SPO Medical Inc. (SPO Medical) is a medical de
2010 250,00$

Abviva, Inc. (ABVV) - Financial and Strategic Analysis Review

Abviva, Inc. (ABVV) - Financial and Strategic Analysis Review / / Summary / / Abviva, Inc. (Abviva) is a biomedical company enga
2010 125,00$

Power3 Medical Products, Inc. (PWRM) - Financial and Strategic Analysis Review

Power3 Medical Products, Inc. (PWRM) - Financial and Strategic Analysis Review / / Summary / / Power3 Medical Products, Inc. (Po
2010 125,00$

Optiscan Imaging Limited (OIL) - Financial and Strategic Analysis Review

Optiscan Imaging Limited (OIL) - Financial and Strategic Analysis Review / / Summary / / Optiscan Imaging Limited (Optiscan Imag
2010 250,00$

Zecotek Photonics Inc. (ZMS) - Financial and Strategic Analysis Review

Zecotek Photonics Inc. (ZMS) - Financial and Strategic Analysis Review / / Summary / / Zecotek Photonics Inc. (Zecotek Photonics
2010 125,00$

InfoLogix, Inc. (IFLG) - Financial and Strategic Analysis Review

InfoLogix, Inc. (IFLG) - Financial and Strategic Analysis Review / / Summary / / InfoLogix, Inc. (InfoLogix) is a technology com
2010 125,00$

Ceragenix Pharmaceuticals, Inc. (CGXP) - Financial and Strategic Analysis Review

Ceragenix Pharmaceuticals, Inc. (CGXP) - Financial and Strategic Analysis Review / / Summary / / Ceragenix Pharmaceuticals, Inc.
2010 250,00$

Exiqon A/S (EXQ) - Financial and Strategic Analysis Review

Exiqon A/S (EXQ) - Financial and Strategic Analysis Review / / Summary / / Exiqon A/S (Exiqon) is a biotechnology company princi
2010 125,00$

Rosetta Genomics, Ltd. (ROSG) - Financial and Strategic Analysis Review

Rosetta Genomics, Ltd. (ROSG) - Financial and Strategic Analysis Review / / Summary / / Rosetta Genomics, Ltd. (RGL), engages in
2010 250,00$

PreMD Inc. (PMD) - Financial and Strategic Analysis Review

PreMD Inc. (PMD) - Financial and Strategic Analysis Review / / Summary / / PreMD Inc. (PreMD) a medical device company that is p
2010 125,00$

Eizo Nanao Corporation (6737) - Financial and Strategic Analysis Review

Eizo Nanao Corporation (6737) - Financial and Strategic Analysis Review / / Summary / / Eizo Nanao Corporation (Eizo) is engaged
2010 250,00$

QuantRx Biomedical Corporation (QTXB) - Financial and Strategic Analysis Review

QuantRx Biomedical Corporation (QTXB) - Financial and Strategic Analysis Review / / Summary / / QuantRx Biomedical Corporation (
2010 250,00$

ImpediMed Limited (IPD) - Financial and Strategic Analysis Review

ImpediMed Limited (IPD) - Financial and Strategic Analysis Review / / Summary / / ImpediMed Limited is an Australia-based compan
2010 250,00$

BioView Ltd. (BIOV) - Financial and Strategic Analysis Review

BioView Ltd. (BIOV) - Financial and Strategic Analysis Review / / Summary / / BioView Ltd. (BioView) is a medical diagnostics co
2010 250,00$

Response Genetics, Inc. (RGDX) - Financial and Strategic Analysis Review

Response Genetics, Inc. (RGDX) - Financial and Strategic Analysis Review / / Summary / / Response Genetics, Inc. (RGI) is focuse
2010 250,00$

DNAPrint Genomics, Inc. (DNAG) - Financial and Strategic Analysis Review

DNAPrint Genomics, Inc. (DNAG) - Financial and Strategic Analysis Review / / Summary / / DNAPrint Genomics, Inc. (DNAPrint Genom
2010 125,00$

HealthLinx Limited (HTX) - Financial and Strategic Analysis Review

HealthLinx Limited (HTX) - Financial and Strategic Analysis Review / / Summary / / HealthLinx Limited (HealthLinx) is a developi
2010 125,00$

Avacta Group PLC (AVCT) - Financial and Strategic Analysis Review

Avacta Group PLC (AVCT) - Financial and Strategic Analysis Review / / Summary / / Avacta Group PLC (Avacta) is a biophysics comp
2010 250,00$

Medical International Technology, Inc. (MDLH) - Financial and Strategic Analysis Review

Medical International Technology, Inc. (MDLH) - Financial and Strategic Analysis Review / / Summary / / Medical International Te
2010 250,00$

ClearStream Technologies Group plc (CTN) - Financial and Strategic Analysis Review

ClearStream Technologies Group plc (CTN) - Financial and Strategic Analysis Review / / Summary / / ClearStream Technologies Grou
2010 125,00$

DVx, Inc. (3079) - Financial and Strategic Analysis Review

DVx, Inc. (3079) - Financial and Strategic Analysis Review / / Summary / / DVx Inc. (DVx) is a medical device company, which is
2010 250,00$

Immunodiagnostic Systems Holdings PLC (IDH) - Financial and Strategic Analysis Review

Immunodiagnostic Systems Holdings PLC (IDH) - Financial and Strategic Analysis Review / / Summary / / Immunodiagnostic Systems H
2010 125,00$

Exalenz Bioscience Ltd. (EXEN) - Financial and Strategic Analysis Review

Exalenz Bioscience Ltd. (EXEN) - Financial and Strategic Analysis Review / / Summary / / Exalenz Bioscience Ltd (Exalenz), forme
2010 125,00$

Nephros, Inc. (NEPH) - Financial and Strategic Analysis Review

Nephros, Inc. (NEPH) - Financial and Strategic Analysis Review / / Summary / / Nephros, Inc. (Nephros) is a medical device compa
2010 250,00$

Scivanta Medical Corporation (SCVM) - Financial and Strategic Analysis Review

Scivanta Medical Corporation (SCVM) - Financial and Strategic Analysis Review / / Summary / / Scivanta Medical Corporation (Sciv
2010 125,00$

WaferGen Biosystems, Inc. (WGBS) - Financial and Strategic Analysis Review

WaferGen Biosystems, Inc. (WGBS) - Financial and Strategic Analysis Review / / Summary / / WaferGen Biosystems, Inc. (previously
2010 250,00$

MORIA (MLMOR) - Financial and Strategic Analysis Review

MORIA (MLMOR) - Financial and Strategic Analysis Review / / Summary / / MORIA (Moria) is a medical device company engaged in des
2010 250,00$

Eiken Chemical Co.,Ltd. (4549) - Financial and Strategic Analysis Review

Eiken Chemical Co.,Ltd. (4549) - Financial and Strategic Analysis Review / / Summary / / Eiken Chemical Co., Ltd (Eiken Chemical
2010 250,00$

Accelerator Nordic AB (ACCE B) - Financial and Strategic Analysis Review

Accelerator Nordic AB (ACCE B) - Financial and Strategic Analysis Review / / Summary / / Accelerator Nordic AB (Accelerator) is
2010 125,00$

Advanced Integrated Manufacturing Corp. Ltd (A54) - Financial and Strategic Analysis Review

Advanced Integrated Manufacturing Corp. Ltd (A54) - Financial and Strategic Analysis Review / / Summary / / Advanced Integrated
2010 125,00$

Apex Biotechnology Corp. (1733) - Financial and Strategic Analysis Review

Apex Biotechnology Corp. (1733) - Financial and Strategic Analysis Review / / Summary / / Apex Biotechnology Corp. (ApexBio) is
2010 250,00$

Arkimedica S.P.A (AKM) - Financial and Strategic Analysis Review

Arkimedica S.P.A (AKM) - Financial and Strategic Analysis Review / / Summary / / Arkimedica S.P.A (Arkimedica) is a medical devi
2010 125,00$

Beijing Aerospace Changfeng Co., Ltd (600855) - Financial and Strategic Analysis Review

Beijing Aerospace Changfeng Co., Ltd (600855) - Financial and Strategic Analysis Review / / Summary / / Beijing Aerospace Changf
2010 250,00$

Biospace Co.,Ltd. (41830) - Financial and Strategic Analysis Review

Biospace Co.,Ltd. (41830) - Financial and Strategic Analysis Review / / Summary / / Biospace Co., Ltd. is a medical device compa
2010 250,00$

Central Uni Co Ltd (7706) - Financial and Strategic Analysis Review

Central Uni Co Ltd (7706) - Financial and Strategic Analysis Review / / Summary / / Central Uni Co., Ltd. (C&U) is engaged in de
2010 250,00$

Cogstate Limited (CGS) - Financial and Strategic Analysis Review

Cogstate Limited (CGS) - Financial and Strategic Analysis Review / / Summary / / CogState Limited (CogState) is engaged in provi
2010 250,00$

Create Medic Co., Ltd. (5187) - Financial and Strategic Analysis Review

Create Medic Co., Ltd. (5187) - Financial and Strategic Analysis Review / / Summary / / Create Medic Co., Ltd. (CMCL) is a medic
2010 250,00$

Diagnostic Medical Systems (DGM) - Financial and Strategic Analysis Review

Diagnostic Medical Systems (DGM) - Financial and Strategic Analysis Review / / Summary / / The company Diagnostic Medical System
2010 250,00$

Eastland Medical Systems Limited (EMS) - Financial and Strategic Analysis Review

Eastland Medical Systems Limited (EMS) - Financial and Strategic Analysis Review / / Summary / / Eastland Medical Systems Ltd (E
2010 125,00$

Elexxion AG (E8X) - Financial and Strategic Analysis Review

Elexxion AG (E8X) - Financial and Strategic Analysis Review / / Summary / / Elexxion AG (Elexxion) is engaged in the design, ma
2010 250,00$

Enfield Medical Co., Ltd. (4104) - Financial and Strategic Analysis Review

Enfield Medical Co., Ltd. (4104) - Financial and Strategic Analysis Review / / Summary / / Enfield Medical Co., Ltd. (Enfield Me
2010 250,00$

Etropal Ad (5EO) - Financial and Strategic Analysis Review

Etropal Ad (5EO) - Financial and Strategic Analysis Review / / Summary / / Etropal Ad (Etropal) is a medical device company base
2010 250,00$

Genexel-Sein Inc. (34660) - Financial and Strategic Analysis Review

Genexel-Sein Inc. (34660) - Financial and Strategic Analysis Review / / Summary / / Genexel-Sein Inc. (Genexel-Sein) is the worl
2010 250,00$

Geratherm Medical AG (GME) - Financial and Strategic Analysis Review

Geratherm Medical AG (GME) - Financial and Strategic Analysis Review / / Summary / / Geratherm Medical AG (Geratherm) is an inte
2010 250,00$

Golden Meditech Holdings Limited (801) - Financial and Strategic Analysis Review

Golden Meditech Holdings Limited (801) - Financial and Strategic Analysis Review / / Summary / / Golden Meditech Holdings Limite
2010 250,00$

Hamilton Thorne Ltd. (HTL) - Financial and Strategic Analysis Review

Hamilton Thorne Ltd. (HTL) - Financial and Strategic Analysis Review / / Summary / / Hamilton Thorne Ltd. (Hamilton Thorne) is a
2010 250,00$

Health & Life Co., Ltd. (1781) - Financial and Strategic Analysis Review

Health & Life Co., Ltd. (1781) - Financial and Strategic Analysis Review / / Summary / / Health & Life Co., Ltd. (H&L) is a medi
2010 125,00$

Hi-Clearance Inc. (1788) - Financial and Strategic Analysis Review

Hi-Clearance Inc. (1788) - Financial and Strategic Analysis Review / / Summary / / Hi-Clearance Inc. (HCI) is engaged in providi
2010 250,00$

Infopia Co., Ltd. (36220) - Financial and Strategic Analysis Review

Infopia Co., Ltd. (36220) - Financial and Strategic Analysis Review / / Summary / / Infopia Co., Ltd. (Infopia) is engaged in th
2010 250,00$

Medigard Limited (MGZ) - Financial and Strategic Analysis Review

Medigard Limited (MGZ) - Financial and Strategic Analysis Review / / Summary / / Medigard Limited (Medigard) is engaged in the d
2010 250,00$

Medivac Limited (MDV) - Financial and Strategic Analysis Review

Medivac Limited (MDV) - Financial and Strategic Analysis Review / / Summary / / MediVac Limited (MediVac) is a biomedical waste
2010 250,00$

Microlife Corporation (4103) - Financial and Strategic Analysis Review

Microlife Corporation (4103) - Financial and Strategic Analysis Review / / Summary / / Microlife Corporation (Microlife) is prin
2010 125,00$

Pace Medical, Inc. (PMDL) - Financial and Strategic Analysis Review

Pace Medical, Inc. (PMDL) - Financial and Strategic Analysis Review / / Summary / / Pace Medical, Inc. is a medical device compa
2010 125,00$

Pacific Safety Products Inc (PSP) - Financial and Strategic Analysis Review

Pacific Safety Products Inc (PSP) - Financial and Strategic Analysis Review / / Summary / / Pacific Safety Products Inc. (Pacifi
2010 250,00$

Palomar Medical Technologies, Inc. (PMTI) - Financial and Strategic Analysis Review

Palomar Medical Technologies, Inc. (PMTI) - Financial and Strategic Analysis Review / / Summary / / Palomar Medical Technologies
2010 250,00$

Point Blank Solutions, Inc. (PBSO) - Financial and Strategic Analysis Review

Point Blank Solutions, Inc. (PBSO) - Financial and Strategic Analysis Review / / Summary / / Point Blank Solutions, Inc. (Point
2010 125,00$

Precision System Science Co., Ltd. (7707) - Financial and Strategic Analysis Review

Precision System Science Co., Ltd. (7707) - Financial and Strategic Analysis Review / / Summary / / Precision System Science Co.
2010 250,00$

Radiant Innovation Inc. (3373) - Financial and Strategic Analysis Review

Radiant Innovation Inc. (3373) - Financial and Strategic Analysis Review / / Summary / / Radiant Innovation Inc. (Radiant) is a
2010 250,00$

Simrad Optronics Asa (SIT) - Financial and Strategic Analysis Review

Simrad Optronics Asa (SIT) - Financial and Strategic Analysis Review / / Summary / / Simrad Optronics ASA is one of the leading
2010 250,00$

Sonomax Hearing Healthcare Inc. (SHH) - Financial and Strategic Analysis Review

Sonomax Hearing Healthcare Inc. (SHH) - Financial and Strategic Analysis Review / / Summary / / Sonomax Hearing Healthcare Inc.
2010 250,00$

STRATEC Biomedical Systems AG (SBS) - Financial and Strategic Analysis Review

STRATEC Biomedical Systems AG (SBS) - Financial and Strategic Analysis Review / / Summary / / STRATEC Biomedical Systems AG (STR
2010 250,00$

Universal Technology Systems Inc (5206) - Financial and Strategic Analysis Review

Universal Technology Systems Inc (5206) - Financial and Strategic Analysis Review / / Summary / / Universal Technology Systems I
2010 125,00$

Morepen Laboratories Limited (500288) - Financial and Strategic Analysis Review

Morepen Laboratories Limited (500288) - Financial and Strategic Analysis Review / / Summary / / Morepen Laboratories Limited (Mo
2010 250,00$

Luna Innovations Incorporated (LUNA) - Financial and Strategic Analysis Review

Luna Innovations Incorporated (LUNA) - Financial and Strategic Analysis Review / / Summary / / Luna Innovations Incorporated (Lu
2010 250,00$

NewCardio, Inc. (NWCI) - Financial and Strategic Analysis Review

NewCardio, Inc. (NWCI) - Financial and Strategic Analysis Review / / Summary / / NewCardio, Inc. (NewCardio) is a medical techno
2010 250,00$

Remedent, Inc. (REMI) - Financial and Strategic Analysis Review

Remedent, Inc. (REMI) - Financial and Strategic Analysis Review / / Summary / / Remedent, Inc.(Remedent) is a publicly held comp
2010 250,00$

HARBIN PHARMACEUTICAL GROUP CO., LTD. (600664) - Financial and Strategic Analysis Review

HARBIN PHARMACEUTICAL GROUP CO., LTD. (600664) - Financial and Strategic Analysis Review / / Summary / / HARBIN PHARMACEUTICAL G
2010 250,00$

ProUroCare Medical Inc. (PUMD) - Financial and Strategic Analysis Review

ProUroCare Medical Inc. (PUMD) - Financial and Strategic Analysis Review / / Summary / / ProUroCare Medical, Inc. (ProUroCare) i
2010 250,00$

Opto Circuits India Limited (532391) - Financial and Strategic Analysis Review

Opto Circuits India Limited (532391) - Financial and Strategic Analysis Review / / Summary / / Opto Circuits India Limited (OCI)
2010 125,00$

TaiDoc Technology Corporation (4736) - Financial and Strategic Analysis Review

TaiDoc Technology Corporation (4736) - Financial and Strategic Analysis Review / / Summary / / TaiDoc Technology Corporation (Ta
2010 250,00$

Tyson Bioresearch, Inc. (4134) - Financial and Strategic Analysis Review

Tyson Bioresearch, Inc. (4134) - Financial and Strategic Analysis Review / / Summary / / Tyson Bioresearch, Inc., (Tyson) is an
2010 250,00$

Vatech Co., Ltd. (43150) - Financial and Strategic Analysis Review

Vatech Co., Ltd. (43150) - Financial and Strategic Analysis Review / / Summary / / Vatech Co., Ltd. (Vatech) is a medical equipm
2010 250,00$

Bio-Light - Israeli Life Sciences Investments Ltd. (BOLT) - Financial and Strategic Analysis Review

Bio-Light - Israeli Life Sciences Investments Ltd. (BOLT) - Financial and Strategic Analysis Review / / Summary / / Bio-Light -
2010 250,00$

IPSOGEN SA (ALIPS) - Financial and Strategic Analysis Review

IPSOGEN SA (ALIPS) - Financial and Strategic Analysis Review / / Summary / / IPSOGEN SA (Ipsogen) was established in the year 19
2010 250,00$

Samyang Corporation (70) - Financial and Strategic Analysis Review

Samyang Corporation (70) - Financial and Strategic Analysis Review / / Summary / / Samyang Corporation (Samyang), through its su
2010 125,00$

Patni Computer Systems Ltd. (532517) - Financial and Strategic Analysis Review

Patni Computer Systems Ltd. (532517) - Financial and Strategic Analysis Review / / Summary / / Patni Computer Systems Ltd. (Patn
2010 125,00$

IDEX Corporation (IEX) - Financial and Strategic Analysis Review

IDEX Corporation (IEX) - Financial and Strategic Analysis Review / / Summary / / IDEX Corporation (IDEX) is engaged in design an
2010 250,00$

MedX Health Corp. (MDX) - Financial and Strategic Analysis Review

MedX Health Corp. (MDX) - Financial and Strategic Analysis Review / / Summary / / MedX Health Corp. (MedX) is a medical device c
2010 250,00$

GeneNews Limited (GEN) - Financial and Strategic Analysis Review

GeneNews Limited (GEN) - Financial and Strategic Analysis Review / / Summary / / GeneNews Limited (GeneNews) is a Canada based m
2010 250,00$

Competitive Technologies, Inc. (CTT) - Financial and Strategic Analysis Review

Competitive Technologies, Inc. (CTT) - Financial and Strategic Analysis Review / / Summary / / Competitive Technologies, Inc., (
2010 250,00$

Telanetix Inc. (TNXI) - Financial and Strategic Analysis Review

Telanetix Inc. (TNXI) - Financial and Strategic Analysis Review / / Summary / / Telanetix Inc. is a communications solutions pro
2010 250,00$

Occupational & Medical Innovations Limited (OMI) - Financial and Strategic Analysis Review

Occupational & Medical Innovations Limited (OMI) - Financial and Strategic Analysis Review / / Summary / / Occupational & Medica
2010 250,00$

Nuance Communications, Inc. (NUAN) - Financial and Strategic Analysis Review

Nuance Communications, Inc. (NUAN) - Financial and Strategic Analysis Review / / Summary / / Nuance Communications, Inc. (Nuance
2010 125,00$

TTK Healthcare Limited (507747) - Financial and Strategic Analysis Review

TTK Healthcare Limited (507747) - Financial and Strategic Analysis Review / / Summary / / TTK Healthcare Limited (TTK Healthcare
2010 250,00$

ALAPIS S.A. (ALAPIS) - Financial and Strategic Analysis Review

ALAPIS S.A. (ALAPIS) - Financial and Strategic Analysis Review / / Summary / / ALAPIS S.A. (ALAPIS) is a US based pharmaceutical
2010 250,00$

AMERIGROUP Corporation (AGP) - Financial and Strategic Analysis Review

AMERIGROUP Corporation (AGP) - Financial and Strategic Analysis Review / / Summary / / AMERIGROUP Corporation (AMERIGROUP) is a
2010 125,00$

SafeStitch Medical, Inc. (SFES) - Financial and Strategic Analysis Review

SafeStitch Medical, Inc. (SFES) - Financial and Strategic Analysis Review / / Summary / / SafeStitch Medical, Inc. (formerly kno
2010 250,00$

Vision Group Holdings Limited (VGH) - Financial and Strategic Analysis Review

Vision Group Holdings Limited (VGH) - Financial and Strategic Analysis Review / / Summary / / Vision Group Holdings Limited (Vis
2010 250,00$

Cardo Medical, Inc. (CDOM) - Financial and Strategic Analysis Review

Cardo Medical, Inc. (CDOM) - Financial and Strategic Analysis Review / / Summary / / Cardo Medical, Inc. (Cardo) is an early-sta
2010 250,00$

Daiken Medical Co., Ltd. (7775) - Financial and Strategic Analysis Review

Daiken Medical Co., Ltd. (7775) - Financial and Strategic Analysis Review / / Summary / / Daiken Medical Co., Ltd. (Daiken Medic
2010 250,00$

Kelyniam Global, Inc. (KLYG) - Financial and Strategic Analysis Review

Kelyniam Global, Inc. (KLYG) - Financial and Strategic Analysis Review / / Summary / / Kelyniam Global, Inc (Kelyniam) is an eng
2010 250,00$

Human Care HC AB (HUMA) - Financial and Strategic Analysis Review

Human Care HC AB (HUMA) - Financial and Strategic Analysis Review / / Summary / / Human Care HC AB (Human Care) is a medical dev
2010 250,00$

INVO Bioscience, Inc. (IVOB) - Financial and Strategic Analysis Review

INVO Bioscience, Inc. (IVOB) - Financial and Strategic Analysis Review / / Summary / / INVO Bioscience, Inc. (INVO) is a US base
2010 250,00$

MabCure Inc. (MBCI) - Financial and Strategic Analysis Review

MabCure Inc. (MBCI) - Financial and Strategic Analysis Review / / Summary / / MabCure Inc. (MabCure), formerly Smartec Holdings
2010 250,00$

Qatari German Company for Medical Devices (QGMD) - Financial and Strategic Analysis Review

Qatari German Company for Medical Devices (QGMD) - Financial and Strategic Analysis Review / / Summary / / Qatari German Company
2010 250,00$

Gerresheimer AG (GXI) - Financial and Strategic Analysis Review

Gerresheimer AG (GXI) - Financial and Strategic Analysis Review / / Summary / / Gerresheimer AG (Gerresheimer) is a publicly hel
2010 250,00$

Shanghai Kehua Bio-engineering Co., Ltd. (2022) - Financial and Strategic Analysis Review

Shanghai Kehua Bio-engineering Co., Ltd. (2022) - Financial and Strategic Analysis Review / / Summary / / Shanghai Kehua Bio-eng
2010 125,00$

BioMedical Technology Solutions Holdings, Inc. (BMTL) - Financial and Strategic Analysis Review

BioMedical Technology Solutions Holdings, Inc. (BMTL) - Financial and Strategic Analysis Review / / Summary / / BioMedical Techn
2010 250,00$

Arcam AB (ARCM) - Financial and Strategic Analysis Review

Arcam AB (ARCM) - Financial and Strategic Analysis Review / / Summary / / Arcam AB (Arcam) is engaged in providing a free form f
2010 250,00$

Dialysis Corporation of America (DCAI) - Financial and Strategic Analysis Review

Dialysis Corporation of America (DCAI) - Financial and Strategic Analysis Review / / Summary / / Dialysis Corporation of America
2010 250,00$

Elder Pharmaceuticals Ltd. (532322) - Financial and Strategic Analysis Review

Elder Pharmaceuticals Ltd. (532322) - Financial and Strategic Analysis Review / / Summary / / Elder Pharmaceuticals Ltd. (Elder)
2010 250,00$

Harvard Bioscience, Inc. (HBIO) - Financial and Strategic Analysis Review

Harvard Bioscience, Inc. (HBIO) - Financial and Strategic Analysis Review / / Summary / / Harvard Bioscience, Inc. (HBIO) is eng
2010 250,00$

SXC Health Solutions Corp. (SXC) - Financial and Strategic Analysis Review

SXC Health Solutions Corp. (SXC) - Financial and Strategic Analysis Review / / Summary / / SXC Health Solutions Corp. (SXC) is o
2010 125,00$

Ceradyne, Inc. (CRDN) - Financial and Strategic Analysis Review

Ceradyne, Inc. (CRDN) - Financial and Strategic Analysis Review / / Summary / / Ceradyne, Inc. (Ceradyne) is an integrated devel
2010 125,00$

PAION AG (PA8) - Financial and Strategic Analysis Review

PAION AG (PA8) - Financial and Strategic Analysis Review / / Summary / / Paion AG is a biopharmaceutical holding company. It dev
2010 250,00$

RCM Technologies, Inc. (RCMT) - Financial and Strategic Analysis Review

RCM Technologies, Inc. (RCMT) - Financial and Strategic Analysis Review / / Summary / / RCM Technologies, Inc. (RCM) is a US bas
2010 125,00$

Medy-Tox Inc. (86900) - Financial and Strategic Analysis Review

Medy-Tox Inc. (86900) - Financial and Strategic Analysis Review / / Summary / / Medy-tox Inc. (Medy-tox) is a privately-held bio
2010 250,00$

Versus Technology, Inc. (VSTI) - Financial and Strategic Analysis Review

Versus Technology, Inc. (VSTI) - Financial and Strategic Analysis Review / / Summary / / Versus Technology, Inc. (Versus Technol
2010 250,00$

Transcu Group Limited (E15) - Financial and Strategic Analysis Review

Transcu Group Limited (E15) - Financial and Strategic Analysis Review / / Summary / / Transcu Group Limited (TGL) is a life scie
2010 250,00$

Visiodent SA (SDT) - Financial and Strategic Analysis Review

Visiodent SA (SDT) - Financial and Strategic Analysis Review / / Summary / / Visiodent SA (Visiodent) is a medical technology co
2010 125,00$

Ascribe plc (ASP) - Financial and Strategic Analysis Review

Ascribe plc (ASP) - Financial and Strategic Analysis Review / / Summary / / Ascribe plc (Ascribe) is a healthcare company that i
2010 125,00$

CDEX, Inc. (CEXI) - Financial and Strategic Analysis Review

CDEX, Inc. (CEXI) - Financial and Strategic Analysis Review / / Summary / / CDEX, Inc. (CDEX) is a technology development compan
2010 250,00$

Da An Gene Co., Ltd. (2030) - Financial and Strategic Analysis Review

Da An Gene Co., Ltd. (2030) - Financial and Strategic Analysis Review / / Summary / / Da An Gene Co., Ltd. (Da An Gene) is a med
2010 250,00$

Jiangsu Yuyue Medical Equipment Inc. (2223) - Financial and Strategic Analysis Review

Jiangsu Yuyue Medical Equipment Inc. (2223) - Financial and Strategic Analysis Review / / Summary / / Jiangsu Yuyue Medical Equi
2010 250,00$

Shinva Medical Instrument Co., Ltd. (600587) - Financial and Strategic Analysis Review

Shinva Medical Instrument Co., Ltd. (600587) - Financial and Strategic Analysis Review / / Summary / / Shinva Medical Instrument
2010 250,00$

Huiheng Medical, Inc. (HHGM) - Financial and Strategic Analysis Review

Huiheng Medical, Inc. (HHGM) - Financial and Strategic Analysis Review / / Summary / / Huiheng Medical, Inc. (Huiheng Medical) i
2010 250,00$

Elegance International Holdings Ltd (907) - Financial and Strategic Analysis Review

Elegance International Holdings Ltd (907) - Financial and Strategic Analysis Review / / Summary / / Elegance International Holdi
2010 250,00$

Medidata Solutions, Inc. (MDSO) - Financial and Strategic Analysis Review

Medidata Solutions, Inc. (MDSO) - Financial and Strategic Analysis Review / / Summary / / Medidata Solutions, Inc. (Medidata Sol
2010 250,00$

Cimatron Ltd. (CIMT) - Financial and Strategic Analysis Review

Cimatron Ltd. (CIMT) - Financial and Strategic Analysis Review / / Summary / / Cimatron Ltd. (Cimatron) is a software tools prov
2010 125,00$

The Quantum Group, Inc. (QNGPE) - Financial and Strategic Analysis Review

The Quantum Group, Inc. (QNGPE) - Financial and Strategic Analysis Review / / Summary / / The Quantum Group, Inc. (Quantum) is a
2010 250,00$

Sirtex Medical Limited (SRX) - Financial and Strategic Analysis Review

Sirtex Medical Limited (SRX) - Financial and Strategic Analysis Review / / Summary / / Sirtex Medical Limited (Sirtex), a biotec
2010 250,00$

KM Corporation (83550) - Financial and Strategic Analysis Review

KM Corporation (83550) - Financial and Strategic Analysis Review / / Summary / / KM Corporation (KM) is a health care company, o
2010 250,00$

Ergoresearch Ltd. (ERG) - Financial and Strategic Analysis Review

Ergoresearch Ltd. (ERG) - Financial and Strategic Analysis Review / / Summary / / Ergoresearch Ltd. (Ergoresearch) is a Canada-b
2010 250,00$

Streamline Health Solutions, Inc. (STRM) - Financial and Strategic Analysis Review

Streamline Health Solutions, Inc. (STRM) - Financial and Strategic Analysis Review / / Summary / / Streamline Health Solutions,
2010 250,00$

Nolato AB (NOLAB) - Financial and Strategic Analysis Review

Nolato AB (NOLAB) - Financial and Strategic Analysis Review / / Summary / / Nolato AB (Nolato) is a pharmaceutical company engag
2010 250,00$

DATATRAK International, Inc. (DATA) - Financial and Strategic Analysis Review

DATATRAK International, Inc. (DATA) - Financial and Strategic Analysis Review / / Summary / / DATATRAK International, Inc. (DATA
2010 250,00$

CPC of America, Inc. (CPCF) - Financial and Strategic Analysis Review

CPC of America, Inc. (CPCF) - Financial and Strategic Analysis Review / / Summary / / CPC of America, Inc. (CPC) is a publicly h
2010 250,00$

Vyteris, Inc. (VYTR) - Financial and Strategic Analysis Review

Vyteris, Inc. (VYTR) - Financial and Strategic Analysis Review / / Summary / / Vyteris, Inc. (Vyteris) is a publicly held resear
2010 250,00$

Norwood Abbey Limited (NAL) - Financial and Strategic Analysis Review

Norwood Abbey Limited (NAL) - Financial and Strategic Analysis Review / / Summary / / Norwood Abbey Limited (Norwood Abbey) is a
2010 250,00$

Viralytics Ltd. (VLA) - Financial and Strategic Analysis Review

Viralytics Ltd. (VLA) - Financial and Strategic Analysis Review / / Summary / / Viralytics Ltd. (Viralytics) is a publicly held
2010 250,00$

Questcor Pharmaceuticals, Inc. (QCOR) - Financial and Strategic Analysis Review

Questcor Pharmaceuticals, Inc. (QCOR) - Financial and Strategic Analysis Review / / Summary / / Questcor Pharmaceuticals, Inc. (
2010 250,00$

Cambrex Corporation (CBM) - Financial and Strategic Analysis Review

Cambrex Corporation (CBM) - Financial and Strategic Analysis Review / / Summary / / Cambrex Corporation (Cambrex) is a US based
2010 125,00$

Biotec Pharmacon ASA (BIOTEC) - Financial and Strategic Analysis Review

Biotec Pharmacon ASA (BIOTEC) - Financial and Strategic Analysis Review / / Summary / / Biotec Pharmacon ASA (Biotec Pharmacon)
2010 250,00$

Herbalife Ltd. (HLF) - Financial and Strategic Analysis Review

Herbalife Ltd. (HLF) - Financial and Strategic Analysis Review / / Summary / / Herbalife Ltd. (Herbalife) is a health care relat
2010 125,00$

Bavarian Nordic A/S (BAVA) - Financial and Strategic Analysis Review

Bavarian Nordic A/S (BAVA) - Financial and Strategic Analysis Review / / Summary / / Bavarian Nordic A/S (Bavarian Nordic) is a
2010 250,00$

GUIDED THERAPEUTICS, INC. (GTHP) - Financial and Strategic Analysis Review

GUIDED THERAPEUTICS, INC. (GTHP) - Financial and Strategic Analysis Review / / Summary / / Guided Therapeutics, Inc. (GTI) is a
2010 250,00$

IMPATH Bankruptcy Liquidating Trust (IBLTZ) - Financial and Strategic Analysis Review

IMPATH Bankruptcy Liquidating Trust (IBLTZ) - Financial and Strategic Analysis Review / / Summary / / IMPATH Bankruptcy Liquidat
2010 125,00$

Urodynamix Technologies Ltd. (URO) - Financial and Strategic Analysis Review

Urodynamix Technologies Ltd. (URO) - Financial and Strategic Analysis Review / / Summary / / Urodynamix Technologies Ltd. (Urody
2010 250,00$

Hiran Orgochem Ltd. (506170) - Financial and Strategic Analysis Review

Hiran Orgochem Ltd. (506170) - Financial and Strategic Analysis Review / / Summary / / Hiran Orgochem Ltd. (Hiran), is a publicl
2010 250,00$

PLC Systems Integrators Inc (PLCSF) - Financial and Strategic Analysis Review

PLC Systems Integrators Inc (PLCSF) - Financial and Strategic Analysis Review / / Summary / / Plc Systems Integrators Inc ( Plc
2010 250,00$

PULSION Medical Systems AG (PUS) - Financial and Strategic Analysis Review

PULSION Medical Systems AG (PUS) - Financial and Strategic Analysis Review / / Summary / / PULSION Medical Systems AG (Pulsion)
2010 250,00$

NovaMed, Inc. (NOVA) - Financial and Strategic Analysis Review

NovaMed, Inc. (NOVA) - Financial and Strategic Analysis Review / / Summary / / NovaMed, Inc. (NovaMed) is a publicly held US-bas
2010 250,00$

Univec, Inc. (UNVC) - Financial and Strategic Analysis Review

Univec, Inc. (UNVC) - Financial and Strategic Analysis Review / / Summary / / Univec, Inc. (Univec) is a publicly held pharmaceu
2010 125,00$

HealthSouth Corporation (HLS) - Financial and Strategic Analysis Review

HealthSouth Corporation (HLS) - Financial and Strategic Analysis Review / / Summary / / HealthSouth Corporation (HealthSouth) is
2010 125,00$

Clean Diesel Technologies, Inc. (CDTI) - Financial and Strategic Analysis Review

Clean Diesel Technologies, Inc. (CDTI) - Financial and Strategic Analysis Review / / Summary / / Clean Diesel Technologies, Inc.
2010 250,00$

MDS Inc. (MDS) - Financial and Strategic Analysis Review

MDS Inc. (MDS) - Financial and Strategic Analysis Review / / Summary / / MDS Inc. (MDS) is a publicly held Canada-based global l
2010 125,00$

Curon Medical, Inc. (CRNM) - Financial and Strategic Analysis Review

Curon Medical, Inc. (CRNM) - Financial and Strategic Analysis Review / / Summary / / Curon Medical, Inc. (Curon) is a publicly h
2010 125,00$

Santen Pharmaceutical Co., Ltd. (4536) - Financial and Strategic Analysis Review

Santen Pharmaceutical Co., Ltd. (4536) - Financial and Strategic Analysis Review / / Summary / / Santen Pharmaceutical Co., Ltd.
2010 125,00$

Aksys, Ltd. (AKSY) - Financial and Strategic Analysis Review

Aksys, Ltd. (AKSY) - Financial and Strategic Analysis Review / / Summary / / Aksys, Ltd., (Aksys) is a publicly held pharmaceuti
2010 125,00$

Taisho Pharmaceutical Co., Ltd. (4535) - Financial and Strategic Analysis Review

Taisho Pharmaceutical Co., Ltd. (4535) - Financial and Strategic Analysis Review / / Summary / / Taisho Pharmaceutical Co., Ltd.
2010 125,00$

Tsumura & co. (4540) - Financial and Strategic Analysis Review

Tsumura & co. (4540) - Financial and Strategic Analysis Review / / Summary / / Tsumura & Co (Tsumura) is a Japan based pharmaceu
2010 125,00$

Dechra Pharmaceuticals plc (DPH) - Financial and Strategic Analysis Review

Dechra Pharmaceuticals plc (DPH) - Financial and Strategic Analysis Review / / Summary / / Dechra Pharmaceuticals PLC (Dechra) i
2010 125,00$

Cangene Corporation (CNJ) - Financial and Strategic Analysis Review

Cangene Corporation (CNJ) - Financial and Strategic Analysis Review / / Summary / / Cangene Corporation (Cangene) is a publicly
2010 125,00$

NeoGenomics, Inc. (NGNM) - Financial and Strategic Analysis Review

NeoGenomics, Inc. (NGNM) - Financial and Strategic Analysis Review / / Summary / / NeoGenomics, Inc., (NeoGenomics) is a publicl
2010 250,00$

Covalon Technologies Ltd. (COV) - Financial and Strategic Analysis Review

Covalon Technologies Ltd. (COV) - Financial and Strategic Analysis Review / / Summary / / Covalon Technologies, Ltd. (Covalon) i
2010 250,00$

Span-America Medical Systems, Inc. (SPAN) - Financial and Strategic Analysis Review

Span-America Medical Systems, Inc. (SPAN) - Financial and Strategic Analysis Review / / Summary / / Span-America Medical Systems
2010 250,00$

Jilin Leading Technology Development Co (669) - Financial and Strategic Analysis Review

Jilin Leading Technology Development Co (669) - Financial and Strategic Analysis Review / / Summary / / Jilin Leading Technology
2010 250,00$

ICON plc (ICON) - Financial and Strategic Analysis Review

ICON plc (ICON) - Financial and Strategic Analysis Review / / Summary / / ICON plc (ICON) is a contract research organization th
2010 125,00$

YM BioSciences Inc. (YM) - Financial and Strategic Analysis Review

YM BioSciences Inc. (YM) - Financial and Strategic Analysis Review / / Summary / / YM BioSciences Inc. (YM BioSciences) is a pub
2010 250,00$

Kaigen Co., Ltd. (8000) - Financial and Strategic Analysis Review

Kaigen Co., Ltd. (8000) - Financial and Strategic Analysis Review / / Summary / / Kaigen Co., Ltd. (Kaigen) is a pharmaceutical
2010 250,00$

EBOS Group Limited (EBO) - Financial and Strategic Analysis Review

EBOS Group Limited (EBO) - Financial and Strategic Analysis Review / / Summary / / EBOS Group Limited (EBOS) is basically a supp
2010 125,00$

Quality Systems, Inc. (QSII) - Financial and Strategic Analysis Review

Quality Systems, Inc. (QSII) - Financial and Strategic Analysis Review / / Summary / / Quality Systems, Inc. (QSI) is a publicly
2010 125,00$

ULURU Inc. (ULU) - Financial and Strategic Analysis Review

ULURU Inc. (ULU) - Financial and Strategic Analysis Review / / Summary / / Uluru Inc. (Uluru) is a publicly held specialty pharm
2010 250,00$

Delcath Systems, Inc. (DCTH) - Financial and Strategic Analysis Review

Delcath Systems, Inc. (DCTH) - Financial and Strategic Analysis Review / / Summary / / Delcath Systems, Inc. (Delcath Systems)
2010 250,00$

Oculus Innovative Sciences, Inc. (OCLS) - Financial and Strategic Analysis Review

Oculus Innovative Sciences, Inc. (OCLS) - Financial and Strategic Analysis Review / / Summary / / Oculus Innovative Sciences, In
2010 250,00$

Tissue Therapies Limited (TIS) - Financial and Strategic Analysis Review

Tissue Therapies Limited (TIS) - Financial and Strategic Analysis Review / / Summary / / Tissue Therapies Limited (TTL) is a pub
2010 250,00$

Vermillion, Inc. (VRML) - Financial and Strategic Analysis Review

Vermillion, Inc. (VRML) - Financial and Strategic Analysis Review / / Summary / / Vermillion, Inc. (VRML) is a pharmaceutical co
2010 125,00$

Fuso Pharmaceutical Industries, Ltd. (4538) - Financial and Strategic Analysis Review

Fuso Pharmaceutical Industries, Ltd. (4538) - Financial and Strategic Analysis Review / / Summary / / Fuso Pharmaceutical Indust
2010 250,00$

Piramal Healthcare Limited (500302) - Financial and Strategic Analysis Review

Piramal Healthcare Limited (500302) - Financial and Strategic Analysis Review / / Summary / / Nicholas Piramal India Limited (Pi
2010 125,00$

Celltrion, Inc. (68270) - Financial and Strategic Analysis Review

Celltrion, Inc. (68270) - Financial and Strategic Analysis Review / / Summary / / Celltrion, Inc. (Celltrion) is a publicly held
2010 250,00$

Ardana Plc (ARA) - Financial and Strategic Analysis Review

Ardana Plc (ARA) - Financial and Strategic Analysis Review / / Summary / / Ardana Plc (Ardana) is a publicly held UK based pharm
2010 125,00$

Bio-Path Holdings, Inc. (BPTH) - Financial and Strategic Analysis Review

Bio-Path Holdings, Inc. (BPTH) - Financial and Strategic Analysis Review / / Summary / / Bio-Path Holdings, Inc. (Bio-Path) is a
2010 250,00$

Arterium Corporation (KMED) - Financial and Strategic Analysis Review

Arterium Corporation (KMED) - Financial and Strategic Analysis Review / / Summary / / Arterium Corporation (Arterium) is a publi
2010 125,00$

Ilex Medical Ltd. (ILX) - Financial and Strategic Analysis Review

Ilex Medical Ltd. (ILX) - Financial and Strategic Analysis Review / / Summary / / Ilex Medical Ltd. (Ilex Medical) is a publicly
2010 250,00$

Panacos Pharmaceuticals, Inc. (PANC) - Financial and Strategic Analysis Review

Panacos Pharmaceuticals, Inc. (PANC) - Financial and Strategic Analysis Review / / Summary / / Panacos Pharmaceuticals, Inc. (Pa
2010 125,00$

Biolife Solutions, Inc. (BLFS) - Financial and Strategic Analysis Review

Biolife Solutions, Inc. (BLFS) - Financial and Strategic Analysis Review / / Summary / / BioLife Solutions, Inc. (BioLife) is a
2010 250,00$

Eau Technologies, Inc. (EAUI) - Financial and Strategic Analysis Review

Eau Technologies, Inc. (EAUI) - Financial and Strategic Analysis Review / / Summary / / Eau Technologies, Inc. (EAU) is a public
2010 125,00$

Lutronic Corporation (85370) - Financial and Strategic Analysis Review

Lutronic Corporation (85370) - Financial and Strategic Analysis Review / / Summary / / Lutronic Corporation (Lutronic) is a publ
2010 250,00$

Mts Medication Technologies, Inc. (MTSI) - Financial and Strategic Analysis Review

Mts Medication Technologies, Inc. (MTSI) - Financial and Strategic Analysis Review / / Summary / / MTS Medication Technologies,
2010 250,00$

PTS, Inc. (PTSH) - Financial and Strategic Analysis Review

PTS, Inc. (PTSH) - Financial and Strategic Analysis Review / / Summary / / PTS, Inc. (PTS) is a publicly held consulting company
2010 250,00$

Rad Source Technologies, Inc (IRAD) - Financial and Strategic Analysis Review

Rad Source Technologies, Inc (IRAD) - Financial and Strategic Analysis Review / / Summary / / Rad Source Technologies, Inc (Rad
2010 125,00$

Repro-Med Systems, Inc. (REPR) - Financial and Strategic Analysis Review

Repro-Med Systems, Inc. (REPR) - Financial and Strategic Analysis Review / / Summary / / Repro-Med Systems, Inc. (RMS) is a publ
2010 250,00$

STEN Corporation (STEN) - Financial and Strategic Analysis Review

STEN Corporation (STEN) - Financial and Strategic Analysis Review / / Summary / / STEN Corporation (STEN) is a diversified compa
2010 250,00$

WeiDa Medical Applied Technology Co., Ltd (603) - Financial and Strategic Analysis Review

WeiDa Medical Applied Technology Co., Ltd (603) - Financial and Strategic Analysis Review / / Summary / / WeiDa Medical Applied
2010 250,00$

Biofrontera AG (B8F) - Financial and Strategic Analysis Review

Biofrontera AG (B8F) - Financial and Strategic Analysis Review / / Summary / / Biofrontera AG (Biofrontera) is a publicly held p
2010 250,00$

Jubilant Organosys Limited (530019) - Financial and Strategic Analysis Review

Jubilant Organosys Limited (530019) - Financial and Strategic Analysis Review / / Summary / / Jubilant Organosys Limited (Jubila
2010 125,00$

TiGenix NV (TIG) - Financial and Strategic Analysis Review

TiGenix NV (TIG) - Financial and Strategic Analysis Review / / Summary / / TiGenix NV (TiGenix) is a publicly held Belgium-based
2010 125,00$

Medial Saude S.A. (MEDI3) - Financial and Strategic Analysis Review

Medial Saude S.A. (MEDI3) - Financial and Strategic Analysis Review / / Summary / / Medial Saude S.A. is a health insurance comp
2010 125,00$

ZIOPHARM Oncology, Inc. (ZIOP) - Financial and Strategic Analysis Review

ZIOPHARM Oncology, Inc. (ZIOP) - Financial and Strategic Analysis Review / / Summary / / ZIOPHARM Oncology, Inc. (ZIOPHARM Oncol
2010 250,00$

Sun Healthcare Group, Inc. (SUNH) - Financial and Strategic Analysis Review

Sun Healthcare Group, Inc. (SUNH) - Financial and Strategic Analysis Review / / Summary / / Sun Healthcare Group, Inc. (Sun Heal
2010 125,00$

Cipher Pharmaceuticals Inc. (DND) - Financial and Strategic Analysis Review

Cipher Pharmaceuticals Inc. (DND) - Financial and Strategic Analysis Review / / Summary / / Cipher Pharmaceuticals Inc. (Cipher)
2010 250,00$

Neptune Technologies & Bioressources Inc. (NTB) - Financial and Strategic Analysis Review

Neptune Technologies & Bioressources Inc. (NTB) - Financial and Strategic Analysis Review / / Summary / / Neptune Technologies &
2010 250,00$

Universal Health Services, Inc. (UHS) - Financial and Strategic Analysis Review

Universal Health Services, Inc. (UHS) - Financial and Strategic Analysis Review / / Summary / / Universal Health Services, Inc.
2010 125,00$

Southern Petrochemical Industries Corporation Ltd. (590030) - Financial and Strategic Analysis Review

Southern Petrochemical Industries Corporation Ltd. (590030) - Financial and Strategic Analysis Review / / Summary / / Southern P
2010 125,00$

Health Discovery Corporation (HDVY) - Financial and Strategic Analysis Review

Health Discovery Corporation (HDVY) - Financial and Strategic Analysis Review / / Summary / / Health Discovery Corporation (HDC)
2010 250,00$

American Oriental Bioengineering, Inc. (AOB) - Financial and Strategic Analysis Review

American Oriental Bioengineering, Inc. (AOB) - Financial and Strategic Analysis Review / / Summary / / American Oriental Bioengi
2010 125,00$

Standard Diagnostics, Inc. (66930) - Financial and Strategic Analysis Review

Standard Diagnostics, Inc. (66930) - Financial and Strategic Analysis Review / / Summary / / Standard Diagnostics Incorporation
2010 250,00$

Synvista Therapeutics, Inc. (SYNI) - Financial and Strategic Analysis Review

Synvista Therapeutics, Inc. (SYNI) - Financial and Strategic Analysis Review / / Summary / / Synvista Therapeutics, Inc. (Synvis
2010 125,00$

A&D Pharma Holdings N.V. (ADPH) - Financial and Strategic Analysis Review

A&D Pharma Holdings N.V. (ADPH) - Financial and Strategic Analysis Review / / Summary / / A&D Pharma Holdings N.V. (A&D Pharma H
2010 125,00$

AIN Pharmaciez Inc (9627) - Financial and Strategic Analysis Review

AIN Pharmaciez Inc (9627) - Financial and Strategic Analysis Review / / Summary / / AIN Pharmaciez Inc. (AIN Pharmaciez) is a Ja
2010 125,00$

Air Methods Corporation (AIRM) - Financial and Strategic Analysis Review

Air Methods Corporation (AIRM) - Financial and Strategic Analysis Review / / Summary / / Air Methods Corporation (Air Methods) i
2010 125,00$

Alfresa Holdings Corp. (2784) - Financial and Strategic Analysis Review

Alfresa Holdings Corp. (2784) - Financial and Strategic Analysis Review / / Summary / / Alfresa Holdings Corporation (Alfresa) i
2010 125,00$

Allied Healthcare International, Inc. (AHCI) - Financial and Strategic Analysis Review

Allied Healthcare International, Inc. (AHCI) - Financial and Strategic Analysis Review / / Summary / / Allied Healthcare Interna
2010 125,00$

Amedisys, Inc. (AMED) - Financial and Strategic Analysis Review

Amedisys, Inc. (AMED) - Financial and Strategic Analysis Review / / Summary / / Amedisys Inc. (Amedisys) is one of the leading p
2010 125,00$

AMN Healthcare Services, Inc (AHS) - Financial and Strategic Analysis Review

AMN Healthcare Services, Inc (AHS) - Financial and Strategic Analysis Review / / Summary / / AMN Healthcare Services, Inc. (AMN
2010 125,00$

AmSurg Corp. (AMSG) - Financial and Strategic Analysis Review

AmSurg Corp. (AMSG) - Financial and Strategic Analysis Review / / Summary / / Amsurg Corp. (AmSurg) is one of the leading operat
2010 125,00$

Andreae-Noris Zahn AG (ANZ) - Financial and Strategic Analysis Review

Andreae-Noris Zahn AG (ANZ) - Financial and Strategic Analysis Review / / Summary / / Andreae-Noris Zahn AG (Anzag) is a German
2010 125,00$

Arseus NV (RCUS) - Financial and Strategic Analysis Review

Arseus NV (RCUS) - Financial and Strategic Analysis Review / / Summary / / Arseus NV (Arseus) offers a range of health care prod
2010 125,00$

ASKA Pharmaceutical Co., Ltd (4514) - Financial and Strategic Analysis Review

ASKA Pharmaceutical Co., Ltd (4514) - Financial and Strategic Analysis Review / / Summary / / ASKA Pharmaceutical Co., Ltd. (ASK
2010 125,00$

Assisted Living Concepts, Inc. (ALC) - Financial and Strategic Analysis Review

Assisted Living Concepts, Inc. (ALC) - Financial and Strategic Analysis Review / / Summary / / Assisted Living Concepts, Inc. (A
2010 125,00$

Aurobindo Pharma Ltd (524804) - Financial and Strategic Analysis Review

Aurobindo Pharma Ltd (524804) - Financial and Strategic Analysis Review / / Summary / / Aurobindo Pharma Limited (Aurobindo Phar
2010 125,00$

BB BIOTECH AG (BION) - Financial and Strategic Analysis Review

BB BIOTECH AG (BION) - Financial and Strategic Analysis Review / / Summary / / BB BIOTECH AG (BB BIOTECH) is a Switzerland based
2010 125,00$

Biocon Limited (532523) - Financial and Strategic Analysis Review

Biocon Limited (532523) - Financial and Strategic Analysis Review / / Summary / / Biocon Limited (Biocon) is a fully integrated
2010 125,00$

BML Inc. (4694) - Financial and Strategic Analysis Review

BML Inc. (4694) - Financial and Strategic Analysis Review / / Summary / / BML, INC. is a Japan-based company engaged in the biot
2010 125,00$

Brookdale Senior Living Inc. (BKD) - Financial and Strategic Analysis Review

Brookdale Senior Living Inc. (BKD) - Financial and Strategic Analysis Review / / Summary / / Brookdale Senior Living Inc (Brookd
2010 125,00$

Bruker Corporation (BRKR) - Financial and Strategic Analysis Review

Bruker Corporation (BRKR) - Financial and Strategic Analysis Review / / Summary / / Bruker Corporation (Bruker) is one of the le
2010 125,00$

Campbell Brothers Limited (CPB) - Financial and Strategic Analysis Review

Campbell Brothers Limited (CPB) - Financial and Strategic Analysis Review / / Summary / / Campbell Brothers Limited (Campbell) i
2010 125,00$

Caraco Pharmaceutical Laboratories, Ltd. (CPD) - Financial and Strategic Analysis Review

Caraco Pharmaceutical Laboratories, Ltd. (CPD) - Financial and Strategic Analysis Review / / Summary / / Caraco Pharmaceutical L
2010 125,00$

Care UK plc (CUK) - Financial and Strategic Analysis Review

Care UK plc (CUK) - Financial and Strategic Analysis Review / / Summary / / Care UK Plc is a one of the global leading pharmaceu
2010 125,00$

Centene Corporation (CNC) - Financial and Strategic Analysis Review

Centene Corporation (CNC) - Financial and Strategic Analysis Review / / Summary / / Centene Corporation (Centene) is one of the
2010 125,00$

Charles River Laboratories International, Inc. (CRL) - Financial and Strategic Analysis Review

Charles River Laboratories International, Inc. (CRL) - Financial and Strategic Analysis Review / / Summary / / Charles River Lab
2010 125,00$

Chemed Corporation (CHE) - Financial and Strategic Analysis Review

Chemed Corporation (CHE) - Financial and Strategic Analysis Review / / Summary / / Chemed Corporation (formerly known as Roto-Ro
2010 125,00$

China HealthCare Holdings Limited (673) - Financial and Strategic Analysis Review

China HealthCare Holdings Limited (673) - Financial and Strategic Analysis Review / / Summary / / China HealthCare Holdings Limi
2010 125,00$

China Pharmaceutical Group Limited (1093) - Financial and Strategic Analysis Review

China Pharmaceutical Group Limited (1093) - Financial and Strategic Analysis Review / / Summary / / China Pharmaceutical Group L
2010 125,00$

Cipla Ltd. (500087) - Financial and Strategic Analysis Review

Cipla Ltd. (500087) - Financial and Strategic Analysis Review / / Summary / / Cipla Ltd. (Cipla) is a pharmaceutical company. It
2010 125,00$

Corporativo Fragua, SA de CV (FRAGUAB) - Financial and Strategic Analysis Review

Corporativo Fragua, SA de CV (FRAGUAB) - Financial and Strategic Analysis Review / / Summary / / Corporativo Fragua, SA de CV (C
2010 125,00$

Cross Country Healthcare, Inc. (CCRN) - Financial and Strategic Analysis Review

Cross Country Healthcare, Inc. (CCRN) - Financial and Strategic Analysis Review / / Summary / / Cross Country Healthcare, Inc. (
2010 125,00$

Curanum AG (BHS) - Financial and Strategic Analysis Review

Curanum AG (BHS) - Financial and Strategic Analysis Review / / Summary / / Curanum AG (Curanum) is Germany‘s third largest priva
2010 125,00$

Diagnosticos da America S.A. (DASA3) - Financial and Strategic Analysis Review

Diagnosticos da America S.A. (DASA3) - Financial and Strategic Analysis Review / / Summary / / Diagnosticos da America S.A. (DAS
2010 125,00$

Dksh Holdings (Malaysia) Berhad (DITHELM) - Financial and Strategic Analysis Review

Dksh Holdings (Malaysia) Berhad (DITHELM) - Financial and Strategic Analysis Review / / Summary / / DKSH Holdings (Malaysia) Ber
2010 125,00$

Dr. Reddy's Laboratories Limited (500124) - Financial and Strategic Analysis Review

Dr. Reddy's Laboratories Limited (500124) - Financial and Strategic Analysis Review / / Summary / / Dr. Reddy’s Laboratories Lim
2010 125,00$

Drogasil S.A. (DROG3) - Financial and Strategic Analysis Review

Drogasil S.A. (DROG3) - Financial and Strategic Analysis Review / / Summary / / Drogasil S.A (Drogasil) is a Brazil based retail
2010 125,00$

Emergency Medical Services Corporation (EMS) - Financial and Strategic Analysis Review

Emergency Medical Services Corporation (EMS) - Financial and Strategic Analysis Review / / Summary / / Emergency Medical Service
2010 125,00$

Emeritus Corp. (ESC) - Financial and Strategic Analysis Review

Emeritus Corp. (ESC) - Financial and Strategic Analysis Review / / Summary / / Emeritus Corporation (Emeritus) is one of the lar
2010 125,00$

PT Enseval Putera Megatrading Tbk - Financial and Strategic Analysis Review

PT Enseval Putera Megatrading Tbk - Financial and Strategic Analysis Review / / Summary / / PT Enseval Putera Megatrading Tbk (E
2010 125,00$

Euromedica SA (EUROM) - Financial and Strategic Analysis Review

Euromedica SA (EUROM) - Financial and Strategic Analysis Review / / Summary / / Euromedica SA (Euromedica) is one of the largest
2010 125,00$

Extendicare Real Estate Investment Trust (EXE.UN) - Financial and Strategic Analysis Review

Extendicare Real Estate Investment Trust (EXE.UN) - Financial and Strategic Analysis Review / / Summary / / Extendicare Real Est
2010 125,00$

Falco Biosystems Ltd. (4671) - Financial and Strategic Analysis Review

Falco Biosystems Ltd. (4671) - Financial and Strategic Analysis Review / / Summary / / FALCO SD HOLDINGS Co., Ltd., formerly FAL
2010 250,00$

Fosun International Limited (656) - Financial and Strategic Analysis Review

Fosun International Limited (656) - Financial and Strategic Analysis Review / / Summary / / Fosun International Limited (Fosun)
2010 125,00$

Galenica Ltd. (GALN) - Financial and Strategic Analysis Review

Galenica Ltd. (GALN) - Financial and Strategic Analysis Review / / Summary / / Galenica Ltd (Galenica) is a diversified healthca
2010 125,00$

Generale de Sante (GDS) - Financial and Strategic Analysis Review

Generale de Sante (GDS) - Financial and Strategic Analysis Review / / Summary / / Generale de Sante is one of the leading privat
2010 125,00$

Gentiva Health Services, Inc. (GTIV) - Financial and Strategic Analysis Review

Gentiva Health Services, Inc. (GTIV) - Financial and Strategic Analysis Review / / Summary / / Gentiva Health Services, Inc. (Ge
2010 125,00$

Genus plc (GNS) - Financial and Strategic Analysis Review

Genus plc (GNS) - Financial and Strategic Analysis Review / / Summary / / Genus plc (Genus) is a global company engaged in the a
2010 125,00$

Glenmark Pharmaceuticals Ltd. (532296) - Financial and Strategic Analysis Review

Glenmark Pharmaceuticals Ltd. (532296) - Financial and Strategic Analysis Review / / Summary / / Glenmark Pharmaceuticals Limite
2010 125,00$

Ship Healthcare Holdings,Inc. (3360) - Financial and Strategic Analysis Review

Ship Healthcare Holdings,Inc. (3360) - Financial and Strategic Analysis Review / / Summary / / Ship Healthcare Holdings, Inc. (S
2010 125,00$

Guerbet Group (GBT) - Financial and Strategic Analysis Review

Guerbet Group (GBT) - Financial and Strategic Analysis Review / / Summary / / Guerbet SA (Guerbet) is a France-based pharmaceuti
2010 125,00$

Hanmi Pharmaceutical Co Ltd (8930) - Financial and Strategic Analysis Review

Hanmi Pharmaceutical Co Ltd (8930) - Financial and Strategic Analysis Review / / Summary / / Hanmi Pharmaceutical Co., Ltd. (Han
2010 125,00$

Healthcare Services Group, Inc. (HCSG) - Financial and Strategic Analysis Review

Healthcare Services Group, Inc. (HCSG) - Financial and Strategic Analysis Review / / Summary / / Healthcare Services Group, Inc.
2010 125,00$

Catalyst Health Solutions, Inc. (CHSI) - Financial and Strategic Analysis Review

Catalyst Health Solutions, Inc. (CHSI) - Financial and Strategic Analysis Review / / Summary / / Catalyst Health Solutions, Inc
2010 125,00$

HealthSpring, Inc. (HS) - Financial and Strategic Analysis Review

HealthSpring, Inc. (HS) - Financial and Strategic Analysis Review / / Summary / / HealthSpring, Inc. (HealthSpring) through its
2010 125,00$

HLTH Corporation (HLTH) - Financial and Strategic Analysis Review

HLTH Corporation (HLTH) - Financial and Strategic Analysis Review / / Summary / / HLTH Corporation, through its principal subsid
2010 125,00$

Hooper Holmes, Inc. (HH) - Financial and Strategic Analysis Review

Hooper Holmes, Inc. (HH) - Financial and Strategic Analysis Review / / Summary / / Hooper Holmes, Inc. (Hooper Holmes) is one of
2010 125,00$

Ildong Pharmaceutical Co., Ltd. (230) - Financial and Strategic Analysis Review

Ildong Pharmaceutical Co., Ltd. (230) - Financial and Strategic Analysis Review / / Summary / / Ildong Pharmaceutical Co., Ltd (
2010 125,00$

Integrated Healthcare Holdings Inc. (IHCH) - Financial and Strategic Analysis Review

Integrated Healthcare Holdings Inc. (IHCH) - Financial and Strategic Analysis Review / / Summary / / Integrated Healthcare Holdi
2010 125,00$

Inter Parfums, Inc. (IPAR) - Financial and Strategic Analysis Review

Inter Parfums, Inc. (IPAR) - Financial and Strategic Analysis Review / / Summary / / Inter Parfums, Inc (Inter Parfums), togethe
2010 125,00$

inVentiv Health, Inc (VTIV) - Financial and Strategic Analysis Review

inVentiv Health, Inc (VTIV) - Financial and Strategic Analysis Review / / Summary / / inVentiv Health, Inc (inVentiv Health) is
2010 125,00$

Iwaki & Co. Ltd. (8095) - Financial and Strategic Analysis Review

Iwaki & Co. Ltd. (8095) - Financial and Strategic Analysis Review / / Summary / / IWAKI & CO., LTD. (Iwaki & Co) is a Japan-base
2010 125,00$

Jeil Pharmaceutical Co., Ltd. (2620) - Financial and Strategic Analysis Review

Jeil Pharmaceutical Co., Ltd. (2620) - Financial and Strategic Analysis Review / / Summary / / Jeil Pharmaceutical Co., Ltd (Jei
2010 125,00$

Jenburkt Pharmaceuticals Limited (524731) - Financial and Strategic Analysis Review

Jenburkt Pharmaceuticals Limited (524731) - Financial and Strategic Analysis Review / / Summary / / Jenburkt Pharmaceuticals Lim
2010 125,00$

Kawanishi Holdings, Inc. (2689) - Financial and Strategic Analysis Review

Kawanishi Holdings, Inc. (2689) - Financial and Strategic Analysis Review / / Summary / / Kawanishi Holdings, Inc. (Kawanishi Ho
2010 125,00$

KPJ Healthcare Berhad (KPJ) - Financial and Strategic Analysis Review

KPJ Healthcare Berhad (KPJ) - Financial and Strategic Analysis Review / / Summary / / KPJ Healthcare Berhad (KPJ Healthcare) is
2010 125,00$

LHC Group, Inc. (LHCG) - Financial and Strategic Analysis Review

LHC Group, Inc. (LHCG) - Financial and Strategic Analysis Review / / Summary / / LHC Group, Inc. (LHC Group) provides post-acute
2010 125,00$

Life Sciences Research, Inc. (LSR) - Financial and Strategic Analysis Review

Life Sciences Research, Inc. (LSR) - Financial and Strategic Analysis Review / / Summary / / Life Sciences Research, Inc. (Life
2010 125,00$

Mannatech, Incorporated (MTEX) - Financial and Strategic Analysis Review

Mannatech, Incorporated (MTEX) - Financial and Strategic Analysis Review / / Summary / / Mannatech, Incorporated (Mannatech) is
2010 125,00$

Marseille-Kliniken AG (MKA) - Financial and Strategic Analysis Review

Marseille-Kliniken AG (MKA) - Financial and Strategic Analysis Review / / Summary / / Marseille-Kliniken AG (Marseille-Kliniken)
2010 125,00$

Matrix Laboratories Limited (524794) - Financial and Strategic Analysis Review

Matrix Laboratories Limited (524794) - Financial and Strategic Analysis Review / / Summary / / Matrix Laboratories Limited (Matr
2010 125,00$

Mead Johnson Nutrition Company (MJN) - Financial and Strategic Analysis Review

Mead Johnson Nutrition Company (MJN) - Financial and Strategic Analysis Review / / Summary / / Mead Johnson Nutrition Company (M
2010 125,00$

Meda AB (MEDA A) - Financial and Strategic Analysis Review

Meda AB (MEDA A) - Financial and Strategic Analysis Review / / Summary / / Meda AB is a Sweden-based specialty pharmaceutical co
2010 125,00$

Medical Staffing Network Holdings, Inc. (MSNW) - Financial and Strategic Analysis Review

Medical Staffing Network Holdings, Inc. (MSNW) - Financial and Strategic Analysis Review / / Summary / / Medical Staffing Networ
2010 125,00$

MediPal Holdings Corporation (7459) - Financial and Strategic Analysis Review

MediPal Holdings Corporation (7459) - Financial and Strategic Analysis Review / / Summary / / MediPal Holdings Corporation (Medi
2010 125,00$

The Medicines Company (MDCO) - Financial and Strategic Analysis Review

The Medicines Company (MDCO) - Financial and Strategic Analysis Review / / Summary / / The Medicines Company is an US based phar
2010 125,00$

Mediclin AG (MED) - Financial and Strategic Analysis Review

Mediclin AG (MED) - Financial and Strategic Analysis Review / / Summary / / Mediclin AG (Mediclin) is a German medical services
2010 125,00$

Medi-Clinic Corporation Limited (MDC) - Financial and Strategic Analysis Review

Medi-Clinic Corporation Limited (MDC) - Financial and Strategic Analysis Review / / Summary / / Medi-Clinic Corporation Limited
2010 125,00$

Metropolitan Health Networks, Inc. (MDF) - Financial and Strategic Analysis Review

Metropolitan Health Networks, Inc. (MDF) - Financial and Strategic Analysis Review / / Summary / / Metropolitan Health Networks,
2010 125,00$

Mettler-Toledo International Inc (MTD) - Financial and Strategic Analysis Review

Mettler-Toledo International Inc (MTD) - Financial and Strategic Analysis Review / / Summary / / Mettler-Toledo International In
2010 125,00$

Molina Healthcare, Inc. (MOH) - Financial and Strategic Analysis Review

Molina Healthcare, Inc. (MOH) - Financial and Strategic Analysis Review / / Summary / / Molina Healthcare, Inc (Molina) is an US
2010 125,00$

National HealthCare Corporation (NHC) - Financial and Strategic Analysis Review

National HealthCare Corporation (NHC) - Financial and Strategic Analysis Review / / Summary / / National HealthCare Corporation
2010 125,00$

Netcare Limited (NTC) - Financial and Strategic Analysis Review

Netcare Limited (NTC) - Financial and Strategic Analysis Review / / Summary / / Netcare Limited (Netcare) is an investment holdi
2010 125,00$

Nichii Gakkan Co., Inc. (9792) - Financial and Strategic Analysis Review

Nichii Gakkan Co., Inc. (9792) - Financial and Strategic Analysis Review / / Summary / / Nichii Gakkan Co., Inc. (Nichii Gakkan)
2010 125,00$

Noevir Co. Ltd. (4916) - Financial and Strategic Analysis Review

Noevir Co. Ltd. (4916) - Financial and Strategic Analysis Review / / Summary / / Noevir Co., Ltd. (Noevir) is Japnese company pr
2010 125,00$

Novozymes A/S (NZYM B) - Financial and Strategic Analysis Review

Novozymes A/S (NZYM B) - Financial and Strategic Analysis Review / / Summary / / Novozymes AS (Novozymes) is a Denmark based bio
2010 125,00$

Odyssey HealthCare, Inc. (ODSY) - Financial and Strategic Analysis Review

Odyssey HealthCare, Inc. (ODSY) - Financial and Strategic Analysis Review / / Summary / / Odyssey HealthCare, Inc. (Odyssey) is
2010 125,00$

Parkway Holdings Limited (P27) - Financial and Strategic Analysis Review

Parkway Holdings Limited (P27) - Financial and Strategic Analysis Review / / Summary / / Parkway Holdings Limited (Parkway) is a
2010 125,00$

Pharmaniaga Berhad (PHARMA) - Financial and Strategic Analysis Review

Pharmaniaga Berhad (PHARMA) - Financial and Strategic Analysis Review / / Summary / / Pharmaniaga Berhad (Pharmaniaga) is an int
2010 125,00$

Phibro Animal Health Corporation (PAHC) - Financial and Strategic Analysis Review

Phibro Animal Health Corporation (PAHC) - Financial and Strategic Analysis Review / / Summary / / Phibro Animal Health Corporati
2010 125,00$

PIGEON CORPORATION (7956) - Financial and Strategic Analysis Review

PIGEON CORPORATION (7956) - Financial and Strategic Analysis Review / / Summary / / Pigeon Corporation (Pigeon) is a Japanese co
2010 125,00$

PLIVA d.d. (PLVA-R-A) - Financial and Strategic Analysis Review

PLIVA d.d. (PLVA-R-A) - Financial and Strategic Analysis Review / / Summary / / PLIVA d.d.( PLIVA), is a joint stock company, wh
2010 125,00$

Podravka d.d. (PODR-R-A) - Financial and Strategic Analysis Review

Podravka d.d. (PODR-R-A) - Financial and Strategic Analysis Review / / Summary / / Podravka d.d. is involved in providing food p
2010 125,00$

Prestige Brands Holdings, Inc. (PBH) - Financial and Strategic Analysis Review

Prestige Brands Holdings, Inc. (PBH) - Financial and Strategic Analysis Review / / Summary / / Prestige Brands Holdings, Inc. (P
2010 125,00$

Primary Health Care Ltd (PRY) - Financial and Strategic Analysis Review

Primary Health Care Ltd (PRY) - Financial and Strategic Analysis Review / / Summary / / Primary Health Care Ltd (PHC) is a healt
2010 125,00$

Psychiatric Solutions, Inc. (PSYS) - Financial and Strategic Analysis Review

Psychiatric Solutions, Inc. (PSYS) - Financial and Strategic Analysis Review / / Summary / / Psychiatric Solutions, Inc (PSI) is
2010 125,00$

Ranbaxy Laboratories Limited (500359) - Financial and Strategic Analysis Review

Ranbaxy Laboratories Limited (500359) - Financial and Strategic Analysis Review / / Summary / / Ranbaxy Laboratories Limited (Ra
2010 125,00$

Recordati S.p.A. (REC) - Financial and Strategic Analysis Review

Recordati S.p.A. (REC) - Financial and Strategic Analysis Review / / Summary / / Recordati S.p.A (Recordati) is an Italy-based c
2010 125,00$

Rhon-Klinikum AG (RHK) - Financial and Strategic Analysis Review

Rhon-Klinikum AG (RHK) - Financial and Strategic Analysis Review / / Summary / / RHÖN-KLINIKUM AG (RHÖN-KLINIKUM) is a healthcar
2010 125,00$

Rural/Metro Corporation (RURL) - Financial and Strategic Analysis Review

Rural/Metro Corporation (RURL) - Financial and Strategic Analysis Review / / Summary / / Rural/Metro Corporation (Rural/Metro) i
2010 125,00$

Sartorius AG (SRT) - Financial and Strategic Analysis Review

Sartorius AG (SRT) - Financial and Strategic Analysis Review / / Summary / / Sartorius AG (Sartorius) is a German company which
2010 125,00$

Shasun Chemicals & Drugs Ltd. (524552) - Financial and Strategic Analysis Review

Shasun Chemicals & Drugs Ltd. (524552) - Financial and Strategic Analysis Review / / Summary / / Shasun Chemicals & Drugs Ltd. (
2010 125,00$

Siegfried Holding AG (SFZN) - Financial and Strategic Analysis Review

Siegfried Holding AG (SFZN) - Financial and Strategic Analysis Review / / Summary / / Siegfried Holding AG (Siegfried) is a Swit
2010 125,00$

Sino Biopharmaceutical Limited (1177) - Financial and Strategic Analysis Review

Sino Biopharmaceutical Limited (1177) - Financial and Strategic Analysis Review / / Summary / / Sino Biopharmaceutical Limited (
2010 125,00$

Sonic Healthcare Limited (SHL) - Financial and Strategic Analysis Review

Sonic Healthcare Limited (SHL) - Financial and Strategic Analysis Review / / Summary / / Sonic Healthcare Limited (Sonic Healthc
2010 125,00$

Strides Arcolab Limited (532531) - Financial and Strategic Analysis Review

Strides Arcolab Limited (532531) - Financial and Strategic Analysis Review / / Summary / / Strides Arcolab Limited (Strides Arco
2010 125,00$

Sud-Chemie AG (SUC) - Financial and Strategic Analysis Review

Sud-Chemie AG (SUC) - Financial and Strategic Analysis Review / / Summary / / Sud-Chemie AG (Sud-Chemie) is one of the Germany’s
2010 125,00$

Sunrise Senior Living, Inc. (SRZ) - Financial and Strategic Analysis Review

Sunrise Senior Living, Inc. (SRZ) - Financial and Strategic Analysis Review / / Summary / / Sunrise Senior Living, Inc. (Sunrise
2010 125,00$

Suzuken Co., Ltd. (9987) - Financial and Strategic Analysis Review

Suzuken Co., Ltd. (9987) - Financial and Strategic Analysis Review / / Summary / / Suzuken Co., Ltd. (Suzuken) is a Japanese pha
2010 125,00$

Symbion Health Limited (SYHTY) - Financial and Strategic Analysis Review

Symbion Health Limited (SYHTY) - Financial and Strategic Analysis Review / / Summary / / Symbion Health Limited (Symbion Health)
2010 125,00$

Taro Pharmaceuticals Industries Ltd. (TAROF) - Financial and Strategic Analysis Review

Taro Pharmaceuticals Industries Ltd. (TAROF) - Financial and Strategic Analysis Review / / Summary / / Taro Pharmaceuticals Indu
2010 125,00$

Tecan Group Ltd (TECN) - Financial and Strategic Analysis Review

Tecan Group Ltd (TECN) - Financial and Strategic Analysis Review / / Summary / / Tecan Group (Tecan) is engaged in the developme
2010 125,00$

Tiger Brands Ltd (TBS) - Financial and Strategic Analysis Review

Tiger Brands Ltd (TBS) - Financial and Strategic Analysis Review / / Summary / / Tiger Brands Limited (Tiger) is engaged in prov
2010 125,00$

TLC Vision Corporation (TLC) - Financial and Strategic Analysis Review

TLC Vision Corporation (TLC) - Financial and Strategic Analysis Review / / Summary / / TLC Vision Corporation (TLC Vision) is an
2010 125,00$

USANA Health Sciences, Inc. (USNA) - Financial and Strategic Analysis Review

USANA Health Sciences, Inc. (USNA) - Financial and Strategic Analysis Review / / Summary / / USANA Health Sciences, Inc. (USANA)
2010 125,00$

WebMD Health Corp (WBMD) - Financial and Strategic Analysis Review

WebMD Health Corp (WBMD) - Financial and Strategic Analysis Review / / Summary / / WebMD Health Corp. (WebMD) is a US based phar
2010 125,00$

WellCare Health Plans, Inc (WCG) - Financial and Strategic Analysis Review

WellCare Health Plans, Inc (WCG) - Financial and Strategic Analysis Review / / Summary / / WellCare Health Plans, Inc. (WellCare
2010 125,00$

Wockhardt Limited (532300) - Financial and Strategic Analysis Review

Wockhardt Limited (532300) - Financial and Strategic Analysis Review / / Summary / / Wockhardt Limited (Wockhardt) is an India-b
2010 125,00$

Zynex Medical, Inc. (ZYXI) - Financial and Strategic Analysis Review

Zynex Medical, Inc. (ZYXI) - Financial and Strategic Analysis Review / / Summary / / Zynex Medical, Inc. (Zynex) is a publicly h
2010 250,00$

YaSheng Group Ltd. (YHGG ) - Financial and Strategic Analysis Review

YaSheng Group Ltd. (YHGG ) - Financial and Strategic Analysis Review / / Summary / / YaSheng Group Ltd. is a US based holding co
2010 125,00$

Zentiva NV (BAAZEN) - Financial and Strategic Analysis Review

Zentiva NV (BAAZEN) - Financial and Strategic Analysis Review / / Summary / / Zentiva NV is a leading pharmaceutical company in
2010 125,00$

Zeria Pharmaceutical Co Ltd (4559) - Financial and Strategic Analysis Review

Zeria Pharmaceutical Co Ltd (4559) - Financial and Strategic Analysis Review / / Summary / / Zeria pharmceutical co., Ltd. (Zeri
2010 125,00$

Zydus Cadila Healthcare Limited (532321) - Financial and Strategic Analysis Review

Zydus Cadila Healthcare Limited (532321) - Financial and Strategic Analysis Review / / Summary / / Zydus Cadila Healthcare Limit
2010 125,00$

Kobayashi Pharmaceutical Co Ltd (4967) - Financial and Strategic Analysis Review

Kobayashi Pharmaceutical Co Ltd (4967) - Financial and Strategic Analysis Review / / Summary / / Kobayashi Pharmaceutical Co Ltd
2010 125,00$

ROHTO Pharmaceutical Co.,Ltd. (4527) - Financial and Strategic Analysis Review

ROHTO Pharmaceutical Co.,Ltd. (4527) - Financial and Strategic Analysis Review / / Summary / / ROHTO Pharmaceutical Co., Ltd. (R
2010 125,00$

Allion Healthcare, Inc. (ALLI) - Financial and Strategic Analysis Review

Allion Healthcare, Inc. (ALLI) - Financial and Strategic Analysis Review / / Summary / / Allion Healthcare, Inc. (Allion) is one
2010 125,00$

InSight Health Services Holdings Corp. (ISGT) - Financial and Strategic Analysis Review

InSight Health Services Holdings Corp. (ISGT) - Financial and Strategic Analysis Review / / Summary / / InSight Health Services
2010 125,00$

Chemical Company of Malaysia Berhad (CCM) - Financial and Strategic Analysis Review

Chemical Company of Malaysia Berhad (CCM) - Financial and Strategic Analysis Review / / Summary / / Chemical Company of Malaysia
2010 125,00$

PT Kalbe Farma Tbk (KLBF) - Financial and Strategic Analysis Review

PT Kalbe Farma Tbk (KLBF) - Financial and Strategic Analysis Review / / Summary / / PT Kalbe Farma Tbk is involved in the develo
2010 125,00$

Sun Pharmaceutical Industries Limited (524715) - Financial and Strategic Analysis Review

Sun Pharmaceutical Industries Limited (524715) - Financial and Strategic Analysis Review / / Summary / / Sun Pharmaceutical Indu
2010 125,00$

Apollo Hospitals Enterprise Limited (508869) - Financial and Strategic Analysis Review

Apollo Hospitals Enterprise Limited (508869) - Financial and Strategic Analysis Review / / Summary / / Apollo Hospitals Enterpri
2010 125,00$

Stone Group Holdings Limited (409) - Financial and Strategic Analysis Review

Stone Group Holdings Limited (409) - Financial and Strategic Analysis Review / / Summary / / Stone Group Holdings Limited (Stone
2010 250,00$

Eurofins Scientific SE (ERF) - Financial and Strategic Analysis Review

Eurofins Scientific SE (ERF) - Financial and Strategic Analysis Review / / Summary / / Eurofins Scientific (ES) is a pharmaceuti
2010 125,00$

Lavipharm Group (LAVI) - Financial and Strategic Analysis Review

Lavipharm Group (LAVI) - Financial and Strategic Analysis Review / / Summary / / Lavipharm Group (Lavipharm) is one of the large
2010 125,00$

Axon Holdings S.A. (AXON) - Financial and Strategic Analysis Review

Axon Holdings S.A. (AXON) - Financial and Strategic Analysis Review / / Summary / / Axon Holdings S.A (Axon) is a Greece-based h
2010 125,00$

Guangzhou Pharmaceutical Company Limited (600332) - Financial and Strategic Analysis Review

Guangzhou Pharmaceutical Company Limited (600332) - Financial and Strategic Analysis Review / / Summary / / Guangzhou Pharmaceut
2010 125,00$

Albert David Limited (524075) - Financial and Strategic Analysis Review

Albert David Limited (524075) - Financial and Strategic Analysis Review / / Summary / / Albert David Limited (ADL) is an India b
2010 250,00$

Parenteral Drug India Ltd. (524689) - Financial and Strategic Analysis Review

Parenteral Drug India Ltd. (524689) - Financial and Strategic Analysis Review / / Summary / / Parenteral Drug India Ltd. (PDPL)
2010 250,00$

Dharamsi Morarji Chemical Co Ltd (506405) - Financial and Strategic Analysis Review

Dharamsi Morarji Chemical Co Ltd (506405) - Financial and Strategic Analysis Review / / Summary / / Dharamsi Morarji Chemical Co
2010 250,00$

Venus Remedies Limited (526953) - Financial and Strategic Analysis Review

Venus Remedies Limited (526953) - Financial and Strategic Analysis Review / / Summary / / Venus Remedies Limited (Venus) is a pu
2010 250,00$

Neuland Laboratories Limited (524558) - Financial and Strategic Analysis Review

Neuland Laboratories Limited (524558) - Financial and Strategic Analysis Review / / Summary / / Neuland Laboratories Limited (Ne
2010 250,00$

Trimeris, Inc. (TRMS) - Financial and Strategic Analysis Review

Trimeris, Inc. (TRMS) - Financial and Strategic Analysis Review / / Summary / / Trimeris, Inc. (Trimeris) is a publicly held bio
2010 250,00$

Nanosonics Limited (NAN) - Financial and Strategic Analysis Review

Nanosonics Limited (NAN) - Financial and Strategic Analysis Review / / Summary / / Nanosonics Limited (Nanosonics) is a publicly
2010 250,00$

Talecris Biotherapeutics Holdings Corp (TLCR) - Financial and Strategic Analysis Review

Talecris Biotherapeutics Holdings Corp (TLCR) - Financial and Strategic Analysis Review / / Summary / / Talecris Biotherapeutics
2010 125,00$

Jerini AG (JI4) - Financial and Strategic Analysis Review

Jerini AG (JI4) - Financial and Strategic Analysis Review / / Summary / / Jerini AG (Jerini) is a publicly held pharmaceutical c
2010 250,00$

Silence Therapeutics plc. (SLN) - Financial and Strategic Analysis Review

Silence Therapeutics plc. (SLN) - Financial and Strategic Analysis Review / / Summary / / Silence Therapeutics plc. (Silence The
2010 250,00$

Optimer Pharmaceuticals, Inc. (OPTR) - Financial and Strategic Analysis Review

Optimer Pharmaceuticals, Inc. (OPTR) - Financial and Strategic Analysis Review / / Summary / / Optimer Pharmaceuticals, Inc. (Op
2010 250,00$

Sangui BioTech International, Inc. (SGBI) - Financial and Strategic Analysis Review

Sangui BioTech International, Inc. (SGBI) - Financial and Strategic Analysis Review / / Summary / / Sangui Biotech International
2010 250,00$

Cyclacel Pharmaceuticals Inc. (CYCC) - Financial and Strategic Analysis Review

Cyclacel Pharmaceuticals Inc. (CYCC) - Financial and Strategic Analysis Review / / Summary / / Cyclacel Pharmaceuticals, Inc. (C
2010 250,00$

United American Healthcare Corporation (UAHC) - Financial and Strategic Analysis Review

United American Healthcare Corporation (UAHC) - Financial and Strategic Analysis Review / / Summary / / United American Healthca
2010 250,00$

AES Chemunex SA (AESCH) - Financial and Strategic Analysis Review

AES Chemunex SA (AESCH) - Financial and Strategic Analysis Review / / Summary / / AES Chemunex SA (AES Chemunex) is a publicly
2010 250,00$

Global Clean Energy Holdings, LLC (GCEH) - Financial and Strategic Analysis Review

Global Clean Energy Holdings, LLC (GCEH) - Financial and Strategic Analysis Review / / Summary / / Global Clean Energy Holdings,
2010 250,00$

Arvind Remedies Ltd (531823) - Financial and Strategic Analysis Review

Arvind Remedies Ltd (531823) - Financial and Strategic Analysis Review / / Summary / / Arvind Remedies Ltd (Arvind Remedies) is
2010 250,00$

Tapestry Pharmaceuticals, Inc. (TPPHQ) - Financial and Strategic Analysis Review

Tapestry Pharmaceuticals, Inc. (TPPHQ) - Financial and Strategic Analysis Review / / Summary / / Tapestry Pharmaceuticals, Inc.,
2010 125,00$

OPKO Health, Inc. (OPK) - Financial and Strategic Analysis Review

OPKO Health, Inc. (OPK) - Financial and Strategic Analysis Review / / Summary / / OPKO Health, Inc. (OPKO) is a publicly held U
2010 250,00$

BrainStorm Cell Therapeutics Inc. (BCLI) - Financial and Strategic Analysis Review

BrainStorm Cell Therapeutics Inc. (BCLI) - Financial and Strategic Analysis Review / / Summary / / BrainStorm Cell Therapeutics
2010 250,00$

XTL Biopharmaceuticals Ltd. (XTLBY) - Financial and Strategic Analysis Review

XTL Biopharmaceuticals Ltd. (XTLBY) - Financial and Strategic Analysis Review / / Summary / / XTL Biopharmaceuticals Ltd. (XTL)
2010 250,00$

Healthscreen Solutions Inc. (MDU) - Financial and Strategic Analysis Review

Healthscreen Solutions Inc. (MDU) - Financial and Strategic Analysis Review / / Summary / / Healthscreen Solutions Inc. (Healths
2010 125,00$

MedCom USA, Inc. (EMED) - Financial and Strategic Analysis Review

MedCom USA, Inc. (EMED) - Financial and Strategic Analysis Review / / Summary / / MedCom USA, Inc. (MedCom USA) a publicly held
2010 250,00$

Shilpa Medicare Limited (530549) - Financial and Strategic Analysis Review

Shilpa Medicare Limited (530549) - Financial and Strategic Analysis Review / / Summary / / Shilpa Medicare Limited (Shilpa Medic
2010 250,00$

Alembic Limited (506235) - Financial and Strategic Analysis Review

Alembic Limited (506235) - Financial and Strategic Analysis Review / / Summary / / Alembic Limited (Alembic) is a publicly held
2010 125,00$

Transcat, Inc. (TRNS) - Financial and Strategic Analysis Review

Transcat, Inc. (TRNS) - Financial and Strategic Analysis Review / / Summary / / Transcat, Inc. (Transcat) is a publicly held US-
2010 250,00$

Bone Medical Limited (BNE) - Financial and Strategic Analysis Review

Bone Medical Limited (BNE) - Financial and Strategic Analysis Review / / Summary / / Bone Medical Limited (Bone Medical) is a pu
2010 250,00$

Transgenomic, Inc. (TBIO) - Financial and Strategic Analysis Review

Transgenomic, Inc. (TBIO) - Financial and Strategic Analysis Review / / Summary / / Transgenomic, Inc.(Transgenomic) is a public
2010 250,00$

ALDA Pharmaceuticals Corp. (APH) - Financial and Strategic Analysis Review

ALDA Pharmaceuticals Corp. (APH) - Financial and Strategic Analysis Review / / Summary / / ALDA Pharmaceuticals Corp. (ALDA) is
2010 125,00$

Genera Biosystems Limited (GBI) - Financial and Strategic Analysis Review

Genera Biosystems Limited (GBI) - Financial and Strategic Analysis Review / / Summary / / Genera Biosystems Limited (Genera) is
2010 125,00$

Genesis Research and Development Corporation Ltd. (GEN) - Financial and Strategic Analysis Review

Genesis Research and Development Corporation Ltd. (GEN) - Financial and Strategic Analysis Review / / Summary / / Genesis Resear
2010 250,00$

GelStat Corporation (GSAC) - Financial and Strategic Analysis Review

GelStat Corporation (GSAC) - Financial and Strategic Analysis Review / / Summary / / GelStat Corporation (GelStat) is a publicly
2010 125,00$

Genoptix, Inc. (GXDX) - Financial and Strategic Analysis Review

Genoptix, Inc. (GXDX) - Financial and Strategic Analysis Review / / Summary / / Genoptix, Inc (Genoptix) is a specialized labora
2010 125,00$

HearUSA, Inc. (EAR) - Financial and Strategic Analysis Review

HearUSA, Inc. (EAR) - Financial and Strategic Analysis Review / / Summary / / HearUSA, Inc. (HearUSA) is a publicly held company
2010 250,00$

Advitech Inc. (AVI) - Financial and Strategic Analysis Review

Advitech Inc. (AVI) - Financial and Strategic Analysis Review / / Summary / / Advitech Inc. (Advitech) is a publicly held pharma
2010 250,00$

IBEX Technologies Inc. (IBT) - Financial and Strategic Analysis Review

IBEX Technologies Inc. (IBT) - Financial and Strategic Analysis Review / / Summary / / IBEX Technologies, Inc. (IBEX) is a publi
2010 250,00$

iCo Therapeutics Inc. (ICO) - Financial and Strategic Analysis Review

iCo Therapeutics Inc. (ICO) - Financial and Strategic Analysis Review / / Summary / / iCo Therapeutics Inc. (iCo) is a publicly
2010 250,00$

Humet Nyrt. (HUMET) - Financial and Strategic Analysis Review

Humet Nyrt. (HUMET) - Financial and Strategic Analysis Review / / Summary / / Humet Nyrt. (Humet) is a privately held specialty
2010 250,00$

Pressure BioSciences, Inc. (PBIO) - Financial and Strategic Analysis Review

Pressure BioSciences, Inc. (PBIO) - Financial and Strategic Analysis Review / / Summary / / Pressure BioSciences, Inc. (PBI) is
2010 250,00$

Genitope Corporation (GTOP) - Financial and Strategic Analysis Review

Genitope Corporation (GTOP) - Financial and Strategic Analysis Review / / Summary / / Genitope Corporation (Genitope) is a publi
2010 125,00$

ValiRx Plc (VAL) - Financial and Strategic Analysis Review

ValiRx Plc (VAL) - Financial and Strategic Analysis Review / / Summary / / ValiRx Plc (ValiRx) is a publicly held biopharmaceuti
2010 250,00$

Neuralstem, Inc. (CUR) - Financial and Strategic Analysis Review

Neuralstem, Inc. (CUR) - Financial and Strategic Analysis Review / / Summary / / Neuralstem, Inc. (Neuralstem) is a publicly hel
2010 250,00$

IMMUNOSYN CORPORATION (IMYN) - Financial and Strategic Analysis Review

IMMUNOSYN CORPORATION (IMYN) - Financial and Strategic Analysis Review / / Summary / / Immunosyn Corporation (Immunosyn) is a pu
2010 250,00$

AIDA Pharmaceuticals, Inc. (AIDA) - Financial and Strategic Analysis Review

AIDA Pharmaceuticals, Inc. (AIDA) - Financial and Strategic Analysis Review / / Summary / / Aida Pharmaceuticals is a pharmaceut
2010 125,00$

Integrated BioPharma, Inc. (INBP) - Financial and Strategic Analysis Review

Integrated BioPharma, Inc. (INBP) - Financial and Strategic Analysis Review / / Summary / / Integrated BioPharma, Inc. (Integrat
2010 250,00$

IntelGenx Technologies Corp. (IGXT) - Financial and Strategic Analysis Review

IntelGenx Technologies Corp. (IGXT) - Financial and Strategic Analysis Review / / Summary / / IntelGenx Technologies Corp. (Inte
2010 125,00$

Genfit (ALGFT) - Financial and Strategic Analysis Review

Genfit (ALGFT) - Financial and Strategic Analysis Review / / Summary / / Genfit (Genfit) is a publicly held biopharmaceutical co
2010 250,00$

Antibiotice SA (ATB) - Financial and Strategic Analysis Review

Antibiotice SA (ATB) - Financial and Strategic Analysis Review / / Summary / / Antibiotice SA (Antibiotice) is a publicly held R
2010 250,00$

Apex Healthcare Berhad (AHEALTH) - Financial and Strategic Analysis Review

Apex Healthcare Berhad (AHEALTH) - Financial and Strategic Analysis Review / / Summary / / Apex Healthcare Berhad (APEX) is a pu
2010 250,00$

Can-Fite BioPharma Ltd. (CFBI) - Financial and Strategic Analysis Review

Can-Fite BioPharma Ltd. (CFBI) - Financial and Strategic Analysis Review / / Summary / / Can-Fite BioPharma Ltd.(Can-Fite) is a
2010 250,00$

ICSGlobal Limited (ICS) - Financial and Strategic Analysis Review

ICSGlobal Limited (ICS) - Financial and Strategic Analysis Review / / Summary / / ICSGlobal Limited (ICSGlobal) is a medical ban
2010 125,00$

Ascent Pharmahealth Limited (APH) - Financial and Strategic Analysis Review

Ascent Pharmahealth Limited (APH) - Financial and Strategic Analysis Review / / Summary / / Ascent Pharmahealth Limited (Ascent)
2010 250,00$

International Stem Cell Corporation (ISCO) - Financial and Strategic Analysis Review

International Stem Cell Corporation (ISCO) - Financial and Strategic Analysis Review / / Summary / / International Stem Cell Cor
2010 250,00$

IsoRay, Inc. (ISR) - Financial and Strategic Analysis Review

IsoRay, Inc. (ISR) - Financial and Strategic Analysis Review / / Summary / / IsoRay, Inc., (IsoRay) is a publicly traded US-base
2010 250,00$

Arrowhead Research Corporation (ARWR) - Financial and Strategic Analysis Review

Arrowhead Research Corporation (ARWR) - Financial and Strategic Analysis Review / / Summary / / Arrowhead Research Corporation (
2010 250,00$

Krka d.d. Novo Mesto (KRKG) - Financial and Strategic Analysis Review

Krka d.d. Novo Mesto (KRKG) - Financial and Strategic Analysis Review / / Summary / / Krka d.d. Novo Mesto (Krka) is a pharmaceu
2010 125,00$

LAB Research Inc (LRI) - Financial and Strategic Analysis Review

LAB Research Inc (LRI) - Financial and Strategic Analysis Review / / Summary / / LAB Research Inc. (LAB Research) is a publicly
2010 250,00$

Livzon Pharmaceutical Group Inc. (200513) - Financial and Strategic Analysis Review

Livzon Pharmaceutical Group Inc. (200513) - Financial and Strategic Analysis Review / / Summary / / Livzon Pharmaceutical Group
2010 125,00$

Marshall Edwards, Inc. (MSHL) - Financial and Strategic Analysis Review

Marshall Edwards, Inc. (MSHL) - Financial and Strategic Analysis Review / / Summary / / Marshall Edwards Inc. (MEI) is a publicl
2010 250,00$

AVAX Technologies, Inc. (AVXT) - Financial and Strategic Analysis Review

AVAX Technologies, Inc. (AVXT) - Financial and Strategic Analysis Review / / Summary / / AVAX Technologies, Inc. (AVAX) is a pub
2010 125,00$

Avastra Sleep Centres Limited (AVS) - Financial and Strategic Analysis Review

Avastra Sleep Centres Limited (AVS) - Financial and Strategic Analysis Review / / Summary / / Avastra Sleep Centres Limited (Ava
2010 250,00$

Medical Therapies Limited (CDY) - Financial and Strategic Analysis Review

Medical Therapies Limited (CDY) - Financial and Strategic Analysis Review / / Summary / / Medical Therapies Limited (Medical The
2010 250,00$

Medicure Inc. (MPH) - Financial and Strategic Analysis Review

Medicure Inc. (MPH) - Financial and Strategic Analysis Review / / Summary / / Medicure Inc. (Medicure), is a publicly held bio-p
2010 250,00$

Basilea Pharmaceutica Ltd. (BSLN) - Financial and Strategic Analysis Review

Basilea Pharmaceutica Ltd. (BSLN) - Financial and Strategic Analysis Review / / Summary / / Basilea Pharmaceutica Ltd. (Basilea)
2010 250,00$

MediSolution Ltd. (MSH) - Financial and Strategic Analysis Review

MediSolution Ltd. (MSH) - Financial and Strategic Analysis Review / / Summary / / MediSolution Ltd. is a healthcare and public s
2010 125,00$

Medivir AB (MVIRB) - Financial and Strategic Analysis Review

Medivir AB (MVIRB) - Financial and Strategic Analysis Review / / Summary / / Medivir AB (Medivir) is a research focused pharmace
2010 125,00$

Benda Pharmaceutical, Inc. (BPMA) - Financial and Strategic Analysis Review

Benda Pharmaceutical, Inc. (BPMA) - Financial and Strategic Analysis Review / / Summary / / Benda Pharmaceutical, Inc. (Benda) i
2010 250,00$

BioForce Nanosciences Holdings, Inc. (BFNH) - Financial and Strategic Analysis Review

BioForce Nanosciences Holdings, Inc. (BFNH) - Financial and Strategic Analysis Review / / Summary / / BioForce Nanosciences Hold
2010 125,00$

Calzada Limited (MBP) - Financial and Strategic Analysis Review

Calzada Limited (MBP) - Financial and Strategic Analysis Review / / Summary / / Metabolic Pharmaceuticals Limited is an Australi
2010 125,00$

Microbix Biosystems Inc. (MBX) - Financial and Strategic Analysis Review

Microbix Biosystems Inc. (MBX) - Financial and Strategic Analysis Review / / Summary / / Microbix Biosystems Inc. is a Canada-ba
2010 125,00$

BioMS Medical Corp. (MS) - Financial and Strategic Analysis Review

BioMS Medical Corp. (MS) - Financial and Strategic Analysis Review / / Summary / / BioMS Medical Corp. (BioMS) is a publicly hel
2010 250,00$

Bionomics Limited - Financial and Strategic Analysis Review

Bionomics Limited - Financial and Strategic Analysis Review / / Summary / / Bionomics Limited is a pharmaceuticals company engag
2010 125,00$

MIGENIX Inc. (MGI) - Financial and Strategic Analysis Review

MIGENIX Inc. (MGI) - Financial and Strategic Analysis Review / / Summary / / MIGENIX Inc. (MIGENIX) is a publicly held bio-pharm
2010 125,00$

Biosignal Limited (BOSDA) - Financial and Strategic Analysis Review

Biosignal Limited (BOSDA) - Financial and Strategic Analysis Review / / Summary / / Biosignal Limited (Biosignal) is a publicly
2010 250,00$

BIOTON S.A. (BIO) - Financial and Strategic Analysis Review

BIOTON S.A. (BIO) - Financial and Strategic Analysis Review / / Summary / / BIOTON S.A.(BIOTON) is a publicly held biotechnologi
2010 250,00$

Blackmores Limited (BKL) - Financial and Strategic Analysis Review

Blackmores Limited (BKL) - Financial and Strategic Analysis Review / / Summary / / Blackmores Limited (Blackmores) is a publicly
2010 125,00$

BMP Sunstone Corp. (BJGP) - Financial and Strategic Analysis Review

BMP Sunstone Corp. (BJGP) - Financial and Strategic Analysis Review / / Summary / / BMP Sunstone Corp. (BMP Sunstone) is a publi
2010 250,00$

Neurobiological Technologies, Inc. (NTII) - Financial and Strategic Analysis Review

Neurobiological Technologies, Inc. (NTII) - Financial and Strategic Analysis Review / / Summary / / Neurobiological Technologies
2010 250,00$

NeuroDiscovery Ltd (NDL) - Financial and Strategic Analysis Review

NeuroDiscovery Ltd (NDL) - Financial and Strategic Analysis Review / / Summary / / NeuroDiscovery Ltd (NeuroDiscovery) is a publ
2010 250,00$

NeurogesX, Inc. (NGSX) - Financial and Strategic Analysis Review

NeurogesX, Inc. (NGSX) - Financial and Strategic Analysis Review / / Summary / / NeurogesX, Inc. (NeurogesX) is a publicly held
2010 250,00$

NicOx SA (COX) - Financial and Strategic Analysis Review

NicOx SA (COX) - Financial and Strategic Analysis Review / / Summary / / NicOx SA (NicOx) is a publicly held France-based biopha
2010 250,00$

NORTHFIELD LABORATORIES INC (NFLD) - Financial and Strategic Analysis Review

NORTHFIELD LABORATORIES INC (NFLD) - Financial and Strategic Analysis Review / / Summary / / Northfield Laboratories Inc. is pri
2010 250,00$

Northstar Healthcare Inc. (NHC) - Financial and Strategic Analysis Review

Northstar Healthcare Inc. (NHC) - Financial and Strategic Analysis Review / / Summary / / Northstar Healthcare Inc. (Northstar H
2010 250,00$

NovaBay Pharmaceuticals, Inc. (NBY) - Financial and Strategic Analysis Review

NovaBay Pharmaceuticals, Inc. (NBY) - Financial and Strategic Analysis Review / / Summary / / NovaBay Pharmaceuticals, Inc. (Nov
2010 250,00$

ChemGenex Pharmaceuticals Limited (CXS) - Financial and Strategic Analysis Review

ChemGenex Pharmaceuticals Limited (CXS) - Financial and Strategic Analysis Review / / Summary / / ChemGenex Pharmaceuticals Limi
2010 250,00$

Chemokine Therapeutics Corp. (CTI) - Financial and Strategic Analysis Review

Chemokine Therapeutics Corp. (CTI) - Financial and Strategic Analysis Review / / Summary / / Chemokine Therapeutics Corp. (Chemo
2010 125,00$

Chengzhi Co., Ltd (990) - Financial and Strategic Analysis Review

Chengzhi Co., Ltd (990) - Financial and Strategic Analysis Review / / Summary / / Chengzhi Co., Ltd (Chengzhi) is a publicly hel
2010 125,00$

Nuvo Research Inc. (NRI) - Financial and Strategic Analysis Review

Nuvo Research Inc. (NRI) - Financial and Strategic Analysis Review / / Summary / / Nuvo Research Inc. (Nuvo Research) is a publi
2010 250,00$

Chongqing Huapont Pharm. Co., Ltd. (2004) - Financial and Strategic Analysis Review

Chongqing Huapont Pharm. Co., Ltd. (2004) - Financial and Strategic Analysis Review / / Summary / / Chongqing Huapont Pharm. Co.
2010 250,00$

Circadian Technologies Limited (CIR) - Financial and Strategic Analysis Review

Circadian Technologies Limited (CIR) - Financial and Strategic Analysis Review / / Summary / / Circadian Technologies Limited (C
2010 250,00$

Cleveland BioLabs, Inc. (CBLI) - Financial and Strategic Analysis Review

Cleveland BioLabs, Inc. (CBLI) - Financial and Strategic Analysis Review / / Summary / / Cleveland BioLabs, Inc. (Cleveland) is
2010 250,00$

Omega Pharma NV (OME) - Financial and Strategic Analysis Review

Omega Pharma NV (OME) - Financial and Strategic Analysis Review / / Summary / / Omega Pharma NV (Omega Pharma) is a Belgium base
2010 125,00$

Oncothyreon Inc (ONTY) - Financial and Strategic Analysis Review

Oncothyreon Inc (ONTY) - Financial and Strategic Analysis Review / / Summary / / Oncothyreon Inc. (Oncothyreon), a publicly held
2010 250,00$

Opexa Therapeutics, Inc. (OPXA) - Financial and Strategic Analysis Review

Opexa Therapeutics, Inc. (OPXA) - Financial and Strategic Analysis Review / / Summary / / Opexa Therapeutics, Inc. (Opexa) is a
2010 250,00$

Compugen Ltd. (CGEN) - Financial and Strategic Analysis Review

Compugen Ltd. (CGEN) - Financial and Strategic Analysis Review / / Summary / / Compugen, Ltd. (Compugen) is a biotechnology comp
2010 250,00$

OPMEDIC Group Inc. (OMG) - Financial and Strategic Analysis Review

OPMEDIC Group Inc. (OMG) - Financial and Strategic Analysis Review / / Summary / / OPMEDIC Group Inc. (OPMEDIC Group) is a publi
2010 250,00$

Orbus Pharma Inc. (ORB) - Financial and Strategic Analysis Review

Orbus Pharma Inc. (ORB) - Financial and Strategic Analysis Review / / Summary / / Orbus Pharma Inc. (Orbus Pharma), formerly kno
2010 250,00$

Ore Pharmaceuticals Inc (ORXE) - Financial and Strategic Analysis Review

Ore Pharmaceuticals Inc (ORXE) - Financial and Strategic Analysis Review / / Summary / / Ore Pharmaceuticals Inc (Ore Pharmaceut
2010 250,00$

Osta Biotechnologies Inc. (OBI) - Financial and Strategic Analysis Review

Osta Biotechnologies Inc. (OBI) - Financial and Strategic Analysis Review / / Summary / / Osta Biotechnologies Inc. (Osta) is a
2010 250,00$

OXiGENE, Inc. (OXGN) - Financial and Strategic Analysis Review

OXiGENE, Inc. (OXGN) - Financial and Strategic Analysis Review / / Summary / / OXiGENE, Inc. (OXiGENE) is a publicly held US-bas
2010 250,00$

Pacgen Biopharmaceuticals Corporation (PGA) - Financial and Strategic Analysis Review

Pacgen Biopharmaceuticals Corporation (PGA) - Financial and Strategic Analysis Review / / Summary / / Pacgen Biopharmaceuticals
2010 250,00$

Pacific Biometrics, Inc. (PBMC) - Financial and Strategic Analysis Review

Pacific Biometrics, Inc. (PBMC) - Financial and Strategic Analysis Review / / Summary / / Pacific Biometrics, Inc. (PBI) is a pu
2010 250,00$

PAREXEL International Corporation (PRXL) - Financial and Strategic Analysis Review

PAREXEL International Corporation (PRXL) - Financial and Strategic Analysis Review / / Summary / / PAREXEL International Corpora
2010 125,00$

Patrys Limited (PAB) - Financial and Strategic Analysis Review

Patrys Limited (PAB) - Financial and Strategic Analysis Review / / Summary / / Patrys Limited (Patrys) is a publicly held Austra
2010 250,00$

ConjuChem Biotechnologies Inc. (CJB) - Financial and Strategic Analysis Review

ConjuChem Biotechnologies Inc. (CJB) - Financial and Strategic Analysis Review / / Summary / / ConjuChem Biotechnologies Inc. (C
2010 250,00$

Medigen Biotechnology Corp. (3176) - Financial and Strategic Analysis Review

Medigen Biotechnology Corp. (3176) - Financial and Strategic Analysis Review / / Summary / / Medigen Biotechnology Corp. (MBC) i
2010 250,00$

Cosmo Pharmaceuticals S.p.A (COPN) - Financial and Strategic Analysis Review

Cosmo Pharmaceuticals S.p.A (COPN) - Financial and Strategic Analysis Review / / Summary / / Cosmo Pharmaceuticals S.p.A (Cosmo)
2010 250,00$

Peplin, Inc. (PLI) - Financial and Strategic Analysis Review

Peplin, Inc. (PLI) - Financial and Strategic Analysis Review / / Summary / / Peplin, Inc. (Peplin) is a pharmaceutical company p
2010 250,00$

Peregrine Pharmaceuticals, Inc. (PPHM) - Financial and Strategic Analysis Review

Peregrine Pharmaceuticals, Inc. (PPHM) - Financial and Strategic Analysis Review / / Summary / / Peregrine Pharmaceuticals, Inc.
2010 250,00$

Critical Outcome Technologies Inc. (COT) - Financial and Strategic Analysis Review

Critical Outcome Technologies Inc. (COT) - Financial and Strategic Analysis Review / / Summary / / Critical Outcome Technologies
2010 250,00$

Pharmanet Group Ltd (PNO) - Financial and Strategic Analysis Review

Pharmanet Group Ltd (PNO) - Financial and Strategic Analysis Review / / Summary / / Pharmanet Group Limited (Pharmanet) is a bio
2010 250,00$

Pharmasset, Inc (VRUS) - Financial and Strategic Analysis Review

Pharmasset, Inc (VRUS) - Financial and Strategic Analysis Review / / Summary / / Pharmasset, Inc. (Pharmasset) is a publicly hel
2010 250,00$

PharmAthene, Inc. (PIP) - Financial and Strategic Analysis Review

PharmAthene, Inc. (PIP) - Financial and Strategic Analysis Review / / Summary / / PharmAthene, Inc. (PharmAthene), formerly know
2010 250,00$

PharmAust Limited (PAA) - Financial and Strategic Analysis Review

PharmAust Limited (PAA) - Financial and Strategic Analysis Review / / Summary / / PharmAust Limited (PharmAust) is an Australia-
2010 125,00$

Cytopia Limited (CYT) - Financial and Strategic Analysis Review

Cytopia Limited (CYT) - Financial and Strategic Analysis Review / / Summary / / Cytopia Limited (Cytopia) is a publicly held Aus
2010 250,00$

Pharmaxis Ltd. (PXS) - Financial and Strategic Analysis Review

Pharmaxis Ltd. (PXS) - Financial and Strategic Analysis Review / / Summary / / Pharmaxis Ltd. (Pharmaxis) is a publicly held Aus
2010 250,00$

Symyx Technologies, Inc. (SMMX) - Financial and Strategic Analysis Review

Symyx Technologies, Inc. (SMMX) - Financial and Strategic Analysis Review / / Summary / / Symyx Technologies, Inc. (Symyx) is a
2010 250,00$

Transcept Pharmaceuticals, Inc. (TSPT) - Financial and Strategic Analysis Review

Transcept Pharmaceuticals, Inc. (TSPT) - Financial and Strategic Analysis Review / / Summary / / Transcept Pharmaceuticals, Inc.
2010 250,00$

Stellar Pharmaceuticals Inc. (SLXCF) - Financial and Strategic Analysis Review

Stellar Pharmaceuticals Inc. (SLXCF) - Financial and Strategic Analysis Review / / Summary / / Stellar Pharmaceuticals Inc. (Ste
2010 250,00$

Gujarat Themis Biosyn Ltd. (506879) - Financial and Strategic Analysis Review

Gujarat Themis Biosyn Ltd. (506879) - Financial and Strategic Analysis Review / / Summary / / Gujarat Themis Biosyn Ltd. (Gujara
2010 250,00$

TopoTarget A/S (TOPO) - Financial and Strategic Analysis Review

TopoTarget A/S (TOPO) - Financial and Strategic Analysis Review / / Summary / / TopoTarget A/S (TopoTarget) is a biotechnology c
2010 250,00$

Phase Forward Incorporated (PFWD) - Financial and Strategic Analysis Review

Phase Forward Incorporated (PFWD) - Financial and Strategic Analysis Review / / Summary / / Phase Forward Incorporated (Phase Fo
2010 125,00$

Shandong Donge E-jiao Co.,Ltd (423) - Financial and Strategic Analysis Review

Shandong Donge E-jiao Co.,Ltd (423) - Financial and Strategic Analysis Review / / Summary / / Shandong Donge E-jiao Co.,Ltd (Sha
2010 125,00$

Hubei Guangji Pharmaceutical Co.,Ltd. (952) - Financial and Strategic Analysis Review

Hubei Guangji Pharmaceutical Co.,Ltd. (952) - Financial and Strategic Analysis Review / / Summary / / Hubei Guangji Pharmaceutic
2010 250,00$

Somaxon Pharmaceuticals, Inc. (SOMX) - Financial and Strategic Analysis Review

Somaxon Pharmaceuticals, Inc. (SOMX) - Financial and Strategic Analysis Review / / Summary / / Somaxon Pharmaceuticals, Inc. (So
2010 250,00$

XELR8, Inc (XELR) - Financial and Strategic Analysis Review

XELR8, Inc (XELR) - Financial and Strategic Analysis Review / / Summary / / XELR8, Inc (XELR8) is a publicly held US based pharm
2010 250,00$

Senetek PLC (SNKTY) - Financial and Strategic Analysis Review

Senetek PLC (SNKTY) - Financial and Strategic Analysis Review / / Summary / / Senetek PLC (Senetek) is a privately held biotechn
2010 250,00$

Puleva Biotech S.A. (BIO) - Financial and Strategic Analysis Review

Puleva Biotech S.A. (BIO) - Financial and Strategic Analysis Review / / Summary / / Puleva Biotech S.A. (Puleva) is a publicly h
2010 250,00$

VioQuest Pharmaceuticals, Inc. (VOQP) - Financial and Strategic Analysis Review

VioQuest Pharmaceuticals, Inc. (VOQP) - Financial and Strategic Analysis Review / / Summary / / VioQuest Pharmaceuticals is a pu
2010 125,00$

Suheung Capsule Co., Ltd. (8490) - Financial and Strategic Analysis Review

Suheung Capsule Co., Ltd. (8490) - Financial and Strategic Analysis Review / / Summary / / Suheung Capsule Co., Ltd. (Suheung) i
2010 125,00$

Orient Europharma Co., Ltd. (4120) - Financial and Strategic Analysis Review

Orient Europharma Co., Ltd. (4120) - Financial and Strategic Analysis Review / / Summary / / Orient Europharma Co., Ltd. (Orient
2010 250,00$

Quality Healthcare Asia Limited (593) - Financial and Strategic Analysis Review

Quality Healthcare Asia Limited (593) - Financial and Strategic Analysis Review / / Summary / / Quality Healthcare Asia Limited
2010 250,00$

China Yongxin Pharmaceuticals Inc. (CYXN) - Financial and Strategic Analysis Review

China Yongxin Pharmaceuticals Inc. (CYXN) - Financial and Strategic Analysis Review / / Summary / / China Yongxin Pharmaceutical
2010 125,00$

Lend Lease Primelife Group (LLP) - Financial and Strategic Analysis Review

Lend Lease Primelife Group (LLP) - Financial and Strategic Analysis Review / / Summary / / Lend Lease Primelife Group (LLPG) is
2010 250,00$

Zhejiang NHU Company Ltd. (2001) - Financial and Strategic Analysis Review

Zhejiang NHU Company Ltd. (2001) - Financial and Strategic Analysis Review / / Summary / / Zhejiang Nhu Company Ltd. (NHU), is a
2010 125,00$

Vinati Organics Limited (524200) - Financial and Strategic Analysis Review

Vinati Organics Limited (524200) - Financial and Strategic Analysis Review / / Summary / / Vinati Organics Ltd. (VOL) is publicl
2010 250,00$

Shanghai RAAS Blood Products Co., Ltd. (2252) - Financial and Strategic Analysis Review

Shanghai RAAS Blood Products Co., Ltd. (2252) - Financial and Strategic Analysis Review / / Summary / / Shanghai RAAS Blood Prod
2010 250,00$

RehabCare Group, Inc. (RHB) - Financial and Strategic Analysis Review

RehabCare Group, Inc. (RHB) - Financial and Strategic Analysis Review / / Summary / / RehabCare Group, Inc. (RehabCare) is one o
2010 125,00$

Longlife Group Holdings Limited (8037) - Financial and Strategic Analysis Review

Longlife Group Holdings Limited (8037) - Financial and Strategic Analysis Review / / Summary / / Longlife Group Holdings Limited
2010 250,00$

The Ensign Group, Inc. (ENSG) - Financial and Strategic Analysis Review

The Ensign Group, Inc. (ENSG) - Financial and Strategic Analysis Review / / Summary / / The Ensign Group, Inc. (Ensign Group) is
2010 125,00$

Nestor Healthcare Group plc (NSR) - Financial and Strategic Analysis Review

Nestor Healthcare Group plc (NSR) - Financial and Strategic Analysis Review / / Summary / / Nestor Healthcare Group plc (Nestor)
2010 125,00$

Aceto Corporation (ACET) - Financial and Strategic Analysis Review

Aceto Corporation (ACET) - Financial and Strategic Analysis Review / / Summary / / Aceto Corporation (Aceto) is one of the globa
2010 125,00$

Yungjin Pharm Ind. Co., Ltd. (3520) - Financial and Strategic Analysis Review

Yungjin Pharm Ind. Co., Ltd. (3520) - Financial and Strategic Analysis Review / / Summary / / Yungjin Pharm Ind. Co., Ltd. (Yung
2010 250,00$

Yuyu Pharma, Inc. (220) - Financial and Strategic Analysis Review

Yuyu Pharma, Inc. (220) - Financial and Strategic Analysis Review / / Summary / / Yuyu Pharma, Inc. (Yuyu) is a publicly held re
2010 250,00$

Zentiva S.A. (SCD) - Financial and Strategic Analysis Review

Zentiva S.A. (SCD) - Financial and Strategic Analysis Review / / Summary / / Zentiva S.A. (Zentiva) is a publicly held pharmaceu
2010 250,00$

Toho Holdings Company Ltd. (8129) - Financial and Strategic Analysis Review

Toho Holdings Company Ltd. (8129) - Financial and Strategic Analysis Review / / Summary / / Toho Holdings Company Ltd. (Toho Pha
2010 125,00$

Animal Health International, Inc. (AHII) - Financial and Strategic Analysis Review

Animal Health International, Inc. (AHII) - Financial and Strategic Analysis Review / / Summary / / Animal Health International,
2010 125,00$

ACI Global Corp. (ACGJ) - Financial and Strategic Analysis Review

ACI Global Corp. (ACGJ) - Financial and Strategic Analysis Review / / Summary / / ACI Global Corp. (ACI Global) is a publicly he
2010 125,00$

Sogo Clinical Holdings Co., Ltd. (2399) - Financial and Strategic Analysis Review

Sogo Clinical Holdings Co., Ltd. (2399) - Financial and Strategic Analysis Review / / Summary / / Sogo Clinical Holdings Co., Lt
2010 250,00$

Bioanalytical Systems, Inc. (BASI) - Financial and Strategic Analysis Review

Bioanalytical Systems, Inc. (BASI) - Financial and Strategic Analysis Review / / Summary / / Bioanalytical Systems, Inc. (BASi)
2010 250,00$

Health Management International Ltd. (588) - Financial and Strategic Analysis Review

Health Management International Ltd. (588) - Financial and Strategic Analysis Review / / Summary / / Health Management Internati
2010 250,00$

Procter & Gamble Hygiene & Health Care Limited (500459) - Financial and Strategic Analysis Review

Procter & Gamble Hygiene & Health Care Limited (500459) - Financial and Strategic Analysis Review / / Summary / / Procter & Gamb
2010 125,00$

Wanbury Limited (524212) - Financial and Strategic Analysis Review

Wanbury Limited (524212) - Financial and Strategic Analysis Review / / Summary / / Wanbury Limited (Wanbury) is a publicly held
2010 250,00$

Kilitch Drugs (India) Ltd. (524500) - Financial and Strategic Analysis Review

Kilitch Drugs (India) Ltd. (524500) - Financial and Strategic Analysis Review / / Summary / / Kilitch Drugs (India) Ltd. (Kilitc
2010 250,00$

VITA 34 International AG (V3V) - Financial and Strategic Analysis Review

VITA 34 International AG (V3V) - Financial and Strategic Analysis Review / / Summary / / Vita 34 International AG (Vita 34) is a
2010 250,00$

Wakamoto Pharmaceutical Co., Ltd. (4512) - Financial and Strategic Analysis Review

Wakamoto Pharmaceutical Co., Ltd. (4512) - Financial and Strategic Analysis Review / / Summary / / Wakamoto Pharmaceutical Co.,
2010 250,00$

Dishman Pharmaceuticals & Chemicals Ltd. (532526) - Financial and Strategic Analysis Review

Dishman Pharmaceuticals & Chemicals Ltd. (532526) - Financial and Strategic Analysis Review / / Summary / / Dishman Pharmaceutic
2010 125,00$

William Ransom & Son PLC (RNSM) - Financial and Strategic Analysis Review

William Ransom & Son PLC (RNSM) - Financial and Strategic Analysis Review / / Summary / / William Ransom & Son PLC (William Rans
2010 250,00$

Goldshield Group plc (GSD) - Financial and Strategic Analysis Review

Goldshield Group plc (GSD) - Financial and Strategic Analysis Review / / Summary / / Goldshield Group Plc (Goldshield) is a publ
2010 125,00$

Sinclair Pharma Plc (SPH) - Financial and Strategic Analysis Review

Sinclair Pharma Plc (SPH) - Financial and Strategic Analysis Review / / Summary / / Sinclair Pharma Plc (Sinclair) is a public c
2010 250,00$

ADL plc (AD.) - Financial and Strategic Analysis Review

ADL plc (AD.) - Financial and Strategic Analysis Review / / Summary / / ADL plc (ADL) is a publicly held UK based company, that
2010 250,00$

PharmaNet Development Group Inc. (PDGI) - Financial and Strategic Analysis Review

PharmaNet Development Group Inc. (PDGI) - Financial and Strategic Analysis Review / / Summary / / PharmaNet Development Group In
2010 125,00$

Yamane Medical Co., Ltd. (2144) - Financial and Strategic Analysis Review

Yamane Medical Co., Ltd. (2144) - Financial and Strategic Analysis Review / / Summary / / Yamane Medical Co., Ltd. (Yamane Medic
2010 250,00$

PT Bristol-Myers Squibb Indonesia Tbk (SQBI) - Financial and Strategic Analysis Review

PT Bristol-Myers Squibb Indonesia Tbk (SQBI) - Financial and Strategic Analysis Review / / Summary / / PT Bristol-Myers Squibb I
2010 250,00$

Y.S.P. Southeast Asia Holding Berhad (YSPSAH) - Financial and Strategic Analysis Review

Y.S.P. Southeast Asia Holding Berhad (YSPSAH) - Financial and Strategic Analysis Review / / Summary / / Y.S.P. Southeast Asia Ho
2010 250,00$

Dynacq Healthcare, Inc. (DYII) - Financial and Strategic Analysis Review

Dynacq Healthcare, Inc. (DYII) - Financial and Strategic Analysis Review / / Summary / / Dynacq Healthcare, Inc. (DHI) is a publ
2010 250,00$

HYGEIA Hospital S.A. (HYGEIA) - Financial and Strategic Analysis Review

HYGEIA Hospital S.A. (HYGEIA) - Financial and Strategic Analysis Review / / Summary / / Hygeia Diagnostic & Therapeutic Center (
2010 125,00$

Shanghai Pharmaceutical Co., Ltd. (600849) - Financial and Strategic Analysis Review

Shanghai Pharmaceutical Co., Ltd. (600849) - Financial and Strategic Analysis Review / / Summary / / Shanghai Pharmaceutical Co.
2010 125,00$

Guangzhou Baiyunshan Pharmaceutical Co., Ltd. (522) - Financial and Strategic Analysis Review

Guangzhou Baiyunshan Pharmaceutical Co., Ltd. (522) - Financial and Strategic Analysis Review / / Summary / / Guangzhou Baiyunsh
2010 125,00$

Manchester International Hlgs Unltd Corp (MIHB) - Financial and Strategic Analysis Review

Manchester International Hlgs Unltd Corp (MIHB) - Financial and Strategic Analysis Review / / Summary / / Manchester Internation
2010 250,00$

EASY BIO System, Inc. (35810) - Financial and Strategic Analysis Review

EASY BIO System, Inc. (35810) - Financial and Strategic Analysis Review / / Summary / / EASY BIO System, Inc. (EASY BIO System)
2010 125,00$

KOLON LIFE SCIENCE INC. (102940) - Financial and Strategic Analysis Review

KOLON LIFE SCIENCE INC. (102940) - Financial and Strategic Analysis Review / / Summary / / KOLON LIFE SCIENCE INC. (KOLON) is a
2010 250,00$

OAO VEROPHARM (VRPH) - Financial and Strategic Analysis Review

OAO VEROPHARM (VRPH) - Financial and Strategic Analysis Review / / Summary / / OAO VEROPHARM (Verofarm) is a publicly held Russi
2010 125,00$

WhanIn Pharmaceutical Co., Ltd. (16580) - Financial and Strategic Analysis Review

WhanIn Pharmaceutical Co., Ltd. (16580) - Financial and Strategic Analysis Review / / Summary / / WhanIn Pharmaceutical Co., Ltd
2010 250,00$

Wooridul Life Sciences Ltd (4720) - Financial and Strategic Analysis Review

Wooridul Life Sciences Ltd (4720) - Financial and Strategic Analysis Review / / Summary / / Wooridul Life Sciences Ltd (Wooridul
2010 250,00$

Cipla Medpro South Africa Limited (CMP) - Financial and Strategic Analysis Review

Cipla Medpro South Africa Limited (CMP) - Financial and Strategic Analysis Review / / Summary / / Cipla Medpro South Africa Limi
2010 250,00$

Midelfart Sonesson AB (MSON B) - Financial and Strategic Analysis Review

Midelfart Sonesson AB (MSON B) - Financial and Strategic Analysis Review / / Summary / / Midelfart Sonesson AB (Midelfart Sones
2010 125,00$

Krungdhon Hospital Public Company Ltd. (KDH) - Financial and Strategic Analysis Review

Krungdhon Hospital Public Company Ltd. (KDH) - Financial and Strategic Analysis Review / / Summary / / Krungdhon Hospital Public
2010 250,00$

Wattana Karnpaet PCL (NEW) - Financial and Strategic Analysis Review

Wattana Karnpaet PCL (NEW) - Financial and Strategic Analysis Review / / Summary / / Wattana Karnpaet PCL (Wattana) is a publicl
2010 250,00$

Vibhavadi Medical Center Public Co. Ltd. (VIBHA) - Financial and Strategic Analysis Review

Vibhavadi Medical Center Public Co. Ltd. (VIBHA) - Financial and Strategic Analysis Review / / Summary / / Vibhavadi Medical Cen
2010 250,00$

Ramkhamhaeng Hospital (RAM) - Financial and Strategic Analysis Review

Ramkhamhaeng Hospital (RAM) - Financial and Strategic Analysis Review / / Summary / / Ramkhamhaeng Hospital (Ramkhamhaeng) is pu
2010 250,00$

Nonthavej Hospital Public Company Ltd. (NTV) - Financial and Strategic Analysis Review

Nonthavej Hospital Public Company Ltd. (NTV) - Financial and Strategic Analysis Review / / Summary / / Nonthavej Hospital Public
2010 250,00$

TECHNE Corporation (TECH) - Financial and Strategic Analysis Review

TECHNE Corporation (TECH) - Financial and Strategic Analysis Review / / Summary / / TECHNE Corporation (TECHNE) is involved in t
2010 125,00$

Davi Skin, Inc. (DAVN) - Financial and Strategic Analysis Review

Davi Skin, Inc. (DAVN) - Financial and Strategic Analysis Review / / Summary / / Davi Skin, Inc. (Davi Skin) is a publicly held
2010 125,00$

Medical Care Service Company Inc. (2494) - Financial and Strategic Analysis Review

Medical Care Service Company Inc. (2494) - Financial and Strategic Analysis Review / / Summary / / Medical Care Service Company
2010 250,00$

J. Bridge Corp. (9318) - Financial and Strategic Analysis Review

J. Bridge Corp. (9318) - Financial and Strategic Analysis Review / / Summary / / J. Bridge Corp. (J. Bridge) is a Japan based pu
2010 250,00$

Khimiko-farmats. komb. Akrikhin OAO (P) (AKPH) - Financial and Strategic Analysis Review

Khimiko-farmats. komb. Akrikhin OAO (P) (AKPH) - Financial and Strategic Analysis Review / / Summary / / Khimiko-farmats. komb.
2010 250,00$

Selcuk Ecza Deposu Ticaret ve Sanayi A.S (SELEC) - Financial and Strategic Analysis Review

Selcuk Ecza Deposu Ticaret ve Sanayi A.S (SELEC) - Financial and Strategic Analysis Review / / Summary / / Selcuk Ecza Deposu Ti
2010 125,00$

HemaCare Corporation (HEMA) - Financial and Strategic Analysis Review

HemaCare Corporation (HEMA) - Financial and Strategic Analysis Review / / Summary / / HemaCare Corporation (HemaCare) is a publi
2010 250,00$

Igene Biotechnology, Inc. (IGNE) - Financial and Strategic Analysis Review

Igene Biotechnology, Inc. (IGNE) - Financial and Strategic Analysis Review / / Summary / / Igene Biotechnology, Inc. (Igene) is
2010 250,00$

IGI Laboratories, Inc. (IG) - Financial and Strategic Analysis Review

IGI Laboratories, Inc. (IG) - Financial and Strategic Analysis Review / / Summary / / IGI Laboratories, Inc. (IGI) is publicly h
2010 250,00$

Natural Alternatives International, Inc. (NAII) - Financial and Strategic Analysis Review

Natural Alternatives International, Inc. (NAII) - Financial and Strategic Analysis Review / / Summary / / Natural Alternatives I
2010 250,00$

Poniard Pharmaceuticals, Inc. (PARD) - Financial and Strategic Analysis Review

Poniard Pharmaceuticals, Inc. (PARD) - Financial and Strategic Analysis Review / / Summary / / Poniard Pharmaceuticals, Inc. (Po
2010 250,00$

Psychemedics Corporation (PMD) - Financial and Strategic Analysis Review

Psychemedics Corporation (PMD) - Financial and Strategic Analysis Review / / Summary / / Psychemedics Corporation (Psychemedics)
2010 125,00$

Repligen Corporation (RGEN) - Financial and Strategic Analysis Review

Repligen Corporation (RGEN) - Financial and Strategic Analysis Review / / Summary / / Repligen Corporation (Repligen) is a publi
2010 250,00$

ATC Healthcare Services Inc. (AHNA) - Financial and Strategic Analysis Review

ATC Healthcare Services Inc. (AHNA) - Financial and Strategic Analysis Review / / Summary / / ATC Healthcare Services Inc. (ATC)
2010 125,00$

HST Global Inc. (HSTC) - Financial and Strategic Analysis Review

HST Global Inc. (HSTC) - Financial and Strategic Analysis Review / / Summary / / HST Global, Inc. (HST Global) is publicly held
2010 250,00$

Zhejiang Medicine Co.,Ltd. (600216) - Financial and Strategic Analysis Review

Zhejiang Medicine Co.,Ltd. (600216) - Financial and Strategic Analysis Review / / Summary / / Zhejiang Medicine Co., Ltd. (Zheji
2010 125,00$

Champions Biotechnology, Inc. (CSBR) - Financial and Strategic Analysis Review

Champions Biotechnology, Inc. (CSBR) - Financial and Strategic Analysis Review / / Summary / / Champions Biotechnology, Inc. (Ch
2010 250,00$

U.S. Physical Therapy, Inc. (USPH) - Financial and Strategic Analysis Review

U.S. Physical Therapy, Inc. (USPH) - Financial and Strategic Analysis Review / / Summary / / U.S. Physical Therapy, Inc. (USPh)
2010 125,00$

Repros Therapeutics Inc. (RPRX) - Financial and Strategic Analysis Review

Repros Therapeutics Inc. (RPRX) - Financial and Strategic Analysis Review / / Summary / / Repros Therapeutics, Inc., (Repros) is
2010 250,00$

Advocat Inc. (AVCA) - Financial and Strategic Analysis Review

Advocat Inc. (AVCA) - Financial and Strategic Analysis Review / / Summary / / Advocat Inc. (Advocat) is a US based company offer
2010 125,00$

NeoStem, Inc. (NBS) - Financial and Strategic Analysis Review

NeoStem, Inc. (NBS) - Financial and Strategic Analysis Review / / Summary / / NeoStem, Inc. (NeoStem), is a US based company act
2010 250,00$

Oncogenex Pharmaceuticals, Inc. (OGXI) - Financial and Strategic Analysis Review

Oncogenex Pharmaceuticals, Inc. (OGXI) - Financial and Strategic Analysis Review / / Summary / / Oncogenex Pharmaceuticals, Inc.
2010 250,00$

Health Fitness Corporation (FIT) - Financial and Strategic Analysis Review

Health Fitness Corporation (FIT) - Financial and Strategic Analysis Review / / Summary / / Health Fitness Corporation (HealthFit
2010 250,00$

Conmed Healthcare Management, Inc. (CONM) - Financial and Strategic Analysis Review

Conmed Healthcare Management, Inc. (CONM) - Financial and Strategic Analysis Review / / Summary / / Conmed Healthcare Management
2010 250,00$

Cadus Corporation (KDUS) - Financial and Strategic Analysis Review

Cadus Corporation (KDUS) - Financial and Strategic Analysis Review / / Summary / / Cadus Corporation (Cadus) is the US based pha
2010 250,00$

Nanobac Pharmaceuticals, Inc. (NNBP) - Financial and Strategic Analysis Review

Nanobac Pharmaceuticals, Inc. (NNBP) - Financial and Strategic Analysis Review / / Summary / / Nanobac Pharmaceuticals, Inc (Nan
2010 125,00$

PHC, Inc. (PHC) - Financial and Strategic Analysis Review

PHC, Inc. (PHC) - Financial and Strategic Analysis Review / / Summary / / PHC, Inc., (Pioneer Behavioral Health) is a healthcare
2010 250,00$

Titan Pharmaceuticals, Inc. (TTNP) - Financial and Strategic Analysis Review

Titan Pharmaceuticals, Inc. (TTNP) - Financial and Strategic Analysis Review / / Summary / / Titan Pharmaceuticals, Inc. (Titan
2010 250,00$

Continucare Corporation (CNU) - Financial and Strategic Analysis Review

Continucare Corporation (CNU) - Financial and Strategic Analysis Review / / Summary / / Continucare Corporation (Continucare) is
2010 125,00$

Symbollon Pharmaceuticals, Inc. (SYMBA) - Financial and Strategic Analysis Review

Symbollon Pharmaceuticals, Inc. (SYMBA) - Financial and Strategic Analysis Review / / Summary / / Symbollon Pharmaceuticals, Inc
2010 250,00$

UCI Medical Affiliates, Inc. (UCIA) - Financial and Strategic Analysis Review

UCI Medical Affiliates, Inc. (UCIA) - Financial and Strategic Analysis Review / / Summary / / UCI Medical Affiliates, Inc. (UCI
2010 250,00$

Orthometrix, Inc. (OMRX) - Financial and Strategic Analysis Review

Orthometrix, Inc. (OMRX) - Financial and Strategic Analysis Review / / Summary / / Orthometrix, Inc. (Orthometrix) is a pharmace
2010 125,00$

Synovics Pharmaceuticals, Inc. (SYVC) - Financial and Strategic Analysis Review

Synovics Pharmaceuticals, Inc. (SYVC) - Financial and Strategic Analysis Review / / Summary / / Synovics Pharmaceuticals, Inc. (
2010 250,00$

Encorium Group, Inc. (ENCO) - Financial and Strategic Analysis Review

Encorium Group, Inc. (ENCO) - Financial and Strategic Analysis Review / / Summary / / Encorium Group, Inc. (Encorium) is a full-
2010 250,00$

Capital Senior Living Corporation (CSU) - Financial and Strategic Analysis Review

Capital Senior Living Corporation (CSU) - Financial and Strategic Analysis Review / / Summary / / Capital Senior Living Corporat
2010 125,00$

SIGA Technologies, Inc. (SIGA) - Financial and Strategic Analysis Review

SIGA Technologies, Inc. (SIGA) - Financial and Strategic Analysis Review / / Summary / / SIGA Technologies, Inc. (SIGA) is a pub
2010 250,00$

Sanguine Corporation (SGUI) - Financial and Strategic Analysis Review

Sanguine Corporation (SGUI) - Financial and Strategic Analysis Review / / Summary / / Sanguine Corporation (Sanguine) is a pharm
2010 250,00$

Diapulse Corporation of America (DIAC) - Financial and Strategic Analysis Review

Diapulse Corporation of America (DIAC) - Financial and Strategic Analysis Review / / Summary / / Diapulse Corporation of America
2010 125,00$

CRYO-CELL International, Inc. (CCEL) - Financial and Strategic Analysis Review

CRYO-CELL International, Inc. (CCEL) - Financial and Strategic Analysis Review / / Summary / / Cryo-Cell International, Inc. (Cr
2010 250,00$

Birner Dental Management Services, Inc. (BDMS) - Financial and Strategic Analysis Review

Birner Dental Management Services, Inc. (BDMS) - Financial and Strategic Analysis Review / / Summary / / Birner Dental Managemen
2010 250,00$

Mera Pharmaceuticals, Inc. (MRPI) - Financial and Strategic Analysis Review

Mera Pharmaceuticals, Inc. (MRPI) - Financial and Strategic Analysis Review / / Summary / / Mera Pharmaceuticals, Inc. (Mera) is
2010 250,00$

Proteonomix, Inc. (PROT) - Financial and Strategic Analysis Review

Proteonomix, Inc. (PROT) - Financial and Strategic Analysis Review / / Summary / / Proteonomix, Inc. (Proteonomix) is a start-up
2010 250,00$

Protalix BioTherapeutics, Inc. (PLX) - Financial and Strategic Analysis Review

Protalix BioTherapeutics, Inc. (PLX) - Financial and Strategic Analysis Review / / Summary / / Protalix BioTherapeutics, Inc. (P
2010 250,00$

PhytoMedical Technologies, Inc. (PYTO) - Financial and Strategic Analysis Review

PhytoMedical Technologies, Inc. (PYTO) - Financial and Strategic Analysis Review / / Summary / / PhytoMedical Technologies, Inc.
2010 250,00$

Herborium Group, Inc. (HBRM) - Financial and Strategic Analysis Review

Herborium Group, Inc. (HBRM) - Financial and Strategic Analysis Review / / Summary / / Herborium Group, Inc. (Herborium) is a no
2010 125,00$

Sharps Compliance Corp. (SMED) - Financial and Strategic Analysis Review

Sharps Compliance Corp. (SMED) - Financial and Strategic Analysis Review / / Summary / / Sharps Compliance Corp. (Sharps) is eng
2010 250,00$

GeneThera, Inc. (GTHR) - Financial and Strategic Analysis Review

GeneThera, Inc. (GTHR) - Financial and Strategic Analysis Review / / Summary / / GeneThera, Inc. (GeneThera) is a biotechnology
2010 250,00$

U.S. Neurosurgical, Inc. (USNU) - Financial and Strategic Analysis Review

U.S. Neurosurgical, Inc. (USNU) - Financial and Strategic Analysis Review / / Summary / / U.S. NeuroSurgical, Inc., (USN) is a m
2010 250,00$

Deltagen, Inc. (DGEN) - Financial and Strategic Analysis Review

Deltagen, Inc. (DGEN) - Financial and Strategic Analysis Review / / Summary / / Deltagen, Inc. (Deltagen) is a pharmaceutical co
2010 250,00$

Tikcro Technologies, Ltd. (TIKRF) - Financial and Strategic Analysis Review

Tikcro Technologies, Ltd. (TIKRF) - Financial and Strategic Analysis Review / / Summary / / Tikcro Technologies Ltd. (Tikcro) is
2010 250,00$

Renhuang Pharmaceuticals, Inc. (RHGP) - Financial and Strategic Analysis Review

Renhuang Pharmaceuticals, Inc. (RHGP) - Financial and Strategic Analysis Review / / Summary / / Renhuang Pharmaceuticals, Inc. (
2010 250,00$

Dynavax Technologies Corporation (DVAX) - Financial and Strategic Analysis Review

Dynavax Technologies Corporation (DVAX) - Financial and Strategic Analysis Review / / Summary / / Dynavax Technologies Corporati
2010 250,00$

Senomyx, Inc. (SNMX) - Financial and Strategic Analysis Review

Senomyx, Inc. (SNMX) - Financial and Strategic Analysis Review / / Summary / / Senomyx, Inc. (Senomyx) is a publicly traded chem
2010 250,00$

Epicore BioNetworks Inc. (EBN) - Financial and Strategic Analysis Review

Epicore BioNetworks Inc. (EBN) - Financial and Strategic Analysis Review / / Summary / / Epicore BioNetworks Inc. (Epicore BioNe
2010 250,00$

ProMetic Life Sciences Inc. (PLI) - Financial and Strategic Analysis Review

ProMetic Life Sciences Inc. (PLI) - Financial and Strategic Analysis Review / / Summary / / ProMetic Life Sciences Inc. (ProMeti
2010 250,00$

Phytopharm Plc (PYM) - Financial and Strategic Analysis Review

Phytopharm Plc (PYM) - Financial and Strategic Analysis Review / / Summary / / Phytopharm plc (Phytopharm) is a public company i
2010 250,00$

Indo Internacional SA (IDO) - Financial and Strategic Analysis Review

Indo Internacional SA (IDO) - Financial and Strategic Analysis Review / / Summary / / Indo Internacional SA (Indo) engages in th
2010 250,00$

Source BioScience Plc. (SBS) - Financial and Strategic Analysis Review

Source BioScience Plc. (SBS) - Financial and Strategic Analysis Review / / Summary / / Source BioScience Plc. (Source BioScience
2010 250,00$

Reliance GeneMedix Plc. (GMX) - Financial and Strategic Analysis Review

Reliance GeneMedix Plc. (GMX) - Financial and Strategic Analysis Review / / Summary / / Reliance GeneMedix Plc. (Reliance GeneMe
2010 250,00$

FuturaGene, Plc. (FGN) - Financial and Strategic Analysis Review

FuturaGene, Plc. (FGN) - Financial and Strategic Analysis Review / / Summary / / FuturaGene, Plc. (Futuragene) is a UK based bio
2010 250,00$

Asterand plc. (ATD) - Financial and Strategic Analysis Review

Asterand plc. (ATD) - Financial and Strategic Analysis Review / / Summary / / Asterand plc. (Asterand) is a biotechnology compan
2010 250,00$

Fulcrum Pharma plc (FUL) - Financial and Strategic Analysis Review

Fulcrum Pharma plc (FUL) - Financial and Strategic Analysis Review / / Summary / / Fulcrum Pharma plc (Fulcrum Pharma) is a serv
2010 250,00$

MWG-Biotech AG (NWU) - Financial and Strategic Analysis Review

MWG-Biotech AG (NWU) - Financial and Strategic Analysis Review / / Summary / / MWG-Biotech AG (MWG) is a biotechnology company e
2010 250,00$

LVL Medical Groupe SA (LVL) - Financial and Strategic Analysis Review

LVL Medical Groupe SA (LVL) - Financial and Strategic Analysis Review / / Summary / / LVL Medical Groupe SA (LVL Medical) is a h
2010 125,00$

Semperit AG Holding (SEM) - Financial and Strategic Analysis Review

Semperit AG Holding (SEM) - Financial and Strategic Analysis Review / / Summary / / Semperit AG Holding is a holding company, op
2010 125,00$

Audika SA (ADI) - Financial and Strategic Analysis Review

Audika SA (ADI) - Financial and Strategic Analysis Review / / Summary / / Audika SA (Audika) is engaged in providing hearing cor
2010 250,00$

MorphoSys AG (MOR) - Financial and Strategic Analysis Review

MorphoSys AG (MOR) - Financial and Strategic Analysis Review / / Summary / / MorphoSys AG (MorphoSys) is a biotechnology company
2010 250,00$

Aker BioMarine ASA (AKBM) - Financial and Strategic Analysis Review

Aker BioMarine ASA (AKBM) - Financial and Strategic Analysis Review / / Summary / / Aker BioMarine ASA (Aker BioMarine) is an in
2010 250,00$

Fornix BioSciences N.V. (FORBI) - Financial and Strategic Analysis Review

Fornix BioSciences N.V. (FORBI) - Financial and Strategic Analysis Review / / Summary / / Fornix BioSciences N.V. (Fornix) is a
2010 250,00$

Athens Medical C.S.A. (IATR) - Financial and Strategic Analysis Review

Athens Medical C.S.A. (IATR) - Financial and Strategic Analysis Review / / Summary / / Athens Medical C.S.A. (Athens Medical) is
2010 125,00$

GeneScan Europe AG (GEP1) - Financial and Strategic Analysis Review

GeneScan Europe AG (GEP1) - Financial and Strategic Analysis Review / / Summary / / GeneScan Europe AG (GeneScan) is a German co
2010 250,00$

IASO S.A. (IASO) - Financial and Strategic Analysis Review

IASO S.A. (IASO) - Financial and Strategic Analysis Review / / Summary / / IASO S.A. (IASO) is a pharmaceutical company engaged
2010 125,00$

Green Cross Holdings Corporation (5250) - Financial and Strategic Analysis Review

Green Cross Holdings Corporation (5250) - Financial and Strategic Analysis Review / / Summary / / Green Cross Holdings Corporati
2010 125,00$

Eu Yan Sang International Ltd. (E02) - Financial and Strategic Analysis Review

Eu Yan Sang International Ltd. (E02) - Financial and Strategic Analysis Review / / Summary / / Eu Yan Sang International Ltd. (E
2010 250,00$

Kwang Dong Pharmaceutical Co., Ltd. (9290) - Financial and Strategic Analysis Review

Kwang Dong Pharmaceutical Co., Ltd. (9290) - Financial and Strategic Analysis Review / / Summary / / Kwang Dong Pharmaceutical C
2010 125,00$

PT Tempo Scan Pacific Tbk. (TSPC) - Financial and Strategic Analysis Review

PT Tempo Scan Pacific Tbk. (TSPC) - Financial and Strategic Analysis Review / / Summary / / PT Tempo Scan Pacific Tbk. (TSP), fo
2010 125,00$

Macrogen Incorporation (38290) - Financial and Strategic Analysis Review

Macrogen Incorporation (38290) - Financial and Strategic Analysis Review / / Summary / / Macrogen Incorporation (Macrogen) is en
2010 250,00$

EXCON Co.,Ltd. (38120) - Financial and Strategic Analysis Review

EXCON Co.,Ltd. (38120) - Financial and Strategic Analysis Review / / Summary / / EXCON Co., Ltd., (EXCON) previously known as RI
2010 250,00$

Hepahope Korea, Inc. (39350) - Financial and Strategic Analysis Review

Hepahope Korea, Inc. (39350) - Financial and Strategic Analysis Review / / Summary / / Hepahope Korea, Inc. (Hepahope) is a biot
2010 250,00$

DOV Pharmaceutical, Inc. (DOVP) - Financial and Strategic Analysis Review

DOV Pharmaceutical, Inc. (DOVP) - Financial and Strategic Analysis Review / / Summary / / DOV Pharmaceutical, Inc. (DOV) is a ph
2010 125,00$

Starpharma Holdings Limited (SPL) - Financial and Strategic Analysis Review

Starpharma Holdings Limited (SPL) - Financial and Strategic Analysis Review / / Summary / / Starpharma Holdings Limited (Starpha
2010 250,00$

Ryman Healthcare Ltd. (RYM) - Financial and Strategic Analysis Review

Ryman Healthcare Ltd. (RYM) - Financial and Strategic Analysis Review / / Summary / / Ryman Healthcare Ltd. (Ryman Healthcare)
2010 250,00$

Raffles Medical Group (R01) - Financial and Strategic Analysis Review

Raffles Medical Group (R01) - Financial and Strategic Analysis Review / / Summary / / Raffles Medical Group Ltd. (RMG) is a spec
2010 250,00$

Transgene SA (TNG) - Financial and Strategic Analysis Review

Transgene SA (TNG) - Financial and Strategic Analysis Review / / Summary / / Transgene SA (Transgene) is a publicly held bio pha
2010 250,00$

SYGNIS Pharma AG (LIO) - Financial and Strategic Analysis Review

SYGNIS Pharma AG (LIO) - Financial and Strategic Analysis Review / / Summary / / SYGNIS Pharma AG (SYGNIS) is a publicly held ph
2010 250,00$

Senesco Technologies, Inc. (SNT) - Financial and Strategic Analysis Review

Senesco Technologies, Inc. (SNT) - Financial and Strategic Analysis Review / / Summary / / Senesco Technologies, Inc. (Senesco)
2010 250,00$

China Agrotech Holdings Limited (1073) - Financial and Strategic Analysis Review

China Agrotech Holdings Limited (1073) - Financial and Strategic Analysis Review / / Summary / / China Agrotech Holdings Limited
2010 125,00$

Prana Biotechnology Limited (PBT) - Financial and Strategic Analysis Review

Prana Biotechnology Limited (PBT) - Financial and Strategic Analysis Review / / Summary / / Prana Biotechnology Limited (Prana B
2010 250,00$

Sawai Pharmaceutical Co., Ltd. (4555) - Financial and Strategic Analysis Review

Sawai Pharmaceutical Co., Ltd. (4555) - Financial and Strategic Analysis Review / / Summary / / Sawai Pharmaceutical Co., Ltd. (
2010 125,00$

Feelgood Svenska AB (FEEL) - Financial and Strategic Analysis Review

Feelgood Svenska AB (FEEL) - Financial and Strategic Analysis Review / / Summary / / Feelgood Svenska AB (Feelgood) is a health
2010 250,00$

Probiomics Ltd. (PCC) - Financial and Strategic Analysis Review

Probiomics Ltd. (PCC) - Financial and Strategic Analysis Review / / Summary / / Probiomics Ltd. (Probiomics), formerly known as
2010 250,00$

Forest Place Group Limited (FPG) - Financial and Strategic Analysis Review

Forest Place Group Limited (FPG) - Financial and Strategic Analysis Review / / Summary / / Forest Place Group Limited (Forest Pl
2010 250,00$

Prima BioMed Limited (PRR) - Financial and Strategic Analysis Review

Prima BioMed Limited (PRR) - Financial and Strategic Analysis Review / / Summary / / Prima BioMed Limited (Prima) is a publicly
2010 250,00$

Oral Hammaslaakarit Oyj (ORA1V) - Financial and Strategic Analysis Review

Oral Hammaslaakarit Oyj (ORA1V) - Financial and Strategic Analysis Review / / Summary / / Oral Hammaslaakarit Oyj (Oral Hammasla
2010 250,00$

Dragon Pharmaceuticals Inc. (DDD) - Financial and Strategic Analysis Review

Dragon Pharmaceuticals Inc. (DDD) - Financial and Strategic Analysis Review / / Summary / / Dragon Pharmaceutical Inc. (Dragon P
2010 250,00$

Immuron Limited (IMC) - Financial and Strategic Analysis Review

Immuron Limited (IMC) - Financial and Strategic Analysis Review / / Summary / / Immuron Limited (Immuron) is a biotechnology com
2010 125,00$

Nissui Pharmaceutical Co., Ltd. (4550) - Financial and Strategic Analysis Review

Nissui Pharmaceutical Co., Ltd. (4550) - Financial and Strategic Analysis Review / / Summary / / Nissui Pharmaceutical Co., Ltd.
2010 250,00$

MATERNUS Kliniken AG (MAK) - Financial and Strategic Analysis Review

MATERNUS Kliniken AG (MAK) - Financial and Strategic Analysis Review / / Summary / / MATERNUS Kliniken AG (MATERNUS) is a German
2010 250,00$

Nippon Chemiphar Co., Ltd. (4539) - Financial and Strategic Analysis Review

Nippon Chemiphar Co., Ltd. (4539) - Financial and Strategic Analysis Review / / Summary / / Nippon Chemiphar Co., Ltd. (Nippon C
2010 125,00$

Eifelhoehen-Klinik AG (EIF) - Financial and Strategic Analysis Review

Eifelhoehen-Klinik AG (EIF) - Financial and Strategic Analysis Review / / Summary / / Eifelhoehen-Klinik AG (Eifelhoehen-Klinik)
2010 250,00$

Prim S.A. (PRIM) - Financial and Strategic Analysis Review

Prim S.A. (PRIM) - Financial and Strategic Analysis Review / / Summary / / Prim S.A. (Prim) is a pharmaceutical provider service
2010 250,00$

Kopran Limited (524280) - Financial and Strategic Analysis Review

Kopran Limited (524280) - Financial and Strategic Analysis Review / / Summary / / Kopran Limited (Kopran) is a pharmaceutical co
2010 250,00$

Pfizer Limited (500680) - Financial and Strategic Analysis Review

Pfizer Limited (500680) - Financial and Strategic Analysis Review / / Summary / / Pfizer Limited (Pfizer) is a research based ph
2010 125,00$

Tokiwa Yakuhin Co., Ltd. (7644) - Financial and Strategic Analysis Review

Tokiwa Yakuhin Co., Ltd. (7644) - Financial and Strategic Analysis Review / / Summary / / Tokiwa Yakuhin Co., Ltd. (Tokiwa Yakuh
2010 125,00$

Fulford (India) Limited (506803) - Financial and Strategic Analysis Review

Fulford (India) Limited (506803) - Financial and Strategic Analysis Review / / Summary / / Fulford (India) Limited (Fulford) is
2010 250,00$

Lyka Labs Limited (500259) - Financial and Strategic Analysis Review

Lyka Labs Limited (500259) - Financial and Strategic Analysis Review / / Summary / / Lyka Labs Limited (Lyka Labs), a publicly-h
2010 250,00$

JAPAN CARE SERVICE GROUP CORPORATION (7566) - Financial and Strategic Analysis Review

JAPAN CARE SERVICE GROUP CORPORATION (7566) - Financial and Strategic Analysis Review / / Summary / / Japan Care Service Group C
2010 125,00$

Unichem Laboratories Ltd. (506690) - Financial and Strategic Analysis Review

Unichem Laboratories Ltd. (506690) - Financial and Strategic Analysis Review / / Summary / / Unichem Laboratories Limited (Unich
2010 250,00$

Torrent Pharmaceuticals Limited (500420) - Financial and Strategic Analysis Review

Torrent Pharmaceuticals Limited (500420) - Financial and Strategic Analysis Review / / Summary / / Torrent Pharmaceuticals Limit
2010 125,00$

Merck Limited (500126) - Financial and Strategic Analysis Review

Merck Limited (500126) - Financial and Strategic Analysis Review / / Summary / / Merck Limited (Merck) is a publicly held compan
2010 250,00$

Progen Pharmaceuticals Limited (PGL) - Financial and Strategic Analysis Review

Progen Pharmaceuticals Limited (PGL) - Financial and Strategic Analysis Review / / Summary / / Progen Pharmaceuticals Limited (P
2010 250,00$

Metlifecare Limited (MET) - Financial and Strategic Analysis Review

Metlifecare Limited (MET) - Financial and Strategic Analysis Review / / Summary / / Metlifecare Limited (Metlifecare) is a healt
2010 250,00$

PainCare Holdings, Inc. (PRXZ) - Financial and Strategic Analysis Review

PainCare Holdings, Inc. (PRXZ) - Financial and Strategic Analysis Review / / Summary / / PainCare Holdings, Inc. (PainCare), is
2010 125,00$

FDC Limited (531599) - Financial and Strategic Analysis Review

FDC Limited (531599) - Financial and Strategic Analysis Review / / Summary / / FDC Limited (FDC) is a pharmaceuticals manufactur
2010 250,00$

Katakura Industries Co., Ltd. (3001) - Financial and Strategic Analysis Review

Katakura Industries Co., Ltd. (3001) - Financial and Strategic Analysis Review / / Summary / / Katakura Industries Co., Ltd. (Ka
2010 125,00$

IPCA Laboratories Limited (524494) - Financial and Strategic Analysis Review

IPCA Laboratories Limited (524494) - Financial and Strategic Analysis Review / / Summary / / IPCA Laboratories Limited (IPCA) is
2010 125,00$

Amrutanjan Health Care Ltd. (590006) - Financial and Strategic Analysis Review

Amrutanjan Health Care Ltd. (590006) - Financial and Strategic Analysis Review / / Summary / / Amrutanjan Health Care Ltd. (Amru
2010 250,00$

Novartis India Limited (500672) - Financial and Strategic Analysis Review

Novartis India Limited (500672) - Financial and Strategic Analysis Review / / Summary / / Novartis India Limited (Novartis India
2010 250,00$

MATSUDA SANGYO Co., Ltd. (7456) - Financial and Strategic Analysis Review

MATSUDA SANGYO Co., Ltd. (7456) - Financial and Strategic Analysis Review / / Summary / / Matsuda Sangyo Co., Ltd. (Matsuda) is
2010 125,00$

Lipoxen PLC (LPX) - Financial and Strategic Analysis Review

Lipoxen PLC (LPX) - Financial and Strategic Analysis Review / / Summary / / Lipoxen PLC (Lipoxen) is a biopharmaceutical company
2010 250,00$

Extrawell Pharmaceutical Holdings Limited (858) - Financial and Strategic Analysis Review

Extrawell Pharmaceutical Holdings Limited (858) - Financial and Strategic Analysis Review / / Summary / / Extrawell Pharmaceutic
2010 250,00$

Torii Pharmaceutical Co., Ltd. (4551) - Financial and Strategic Analysis Review

Torii Pharmaceutical Co., Ltd. (4551) - Financial and Strategic Analysis Review / / Summary / / Torii Pharmaceutical Co., Ltd. (
2010 125,00$

Telesso Technologies Limited (TEO) - Financial and Strategic Analysis Review

Telesso Technologies Limited (TEO) - Financial and Strategic Analysis Review / / Summary / / Telesso Technologies Limited (Teles
2010 250,00$

Daewoong Co., Ltd. (3090) - Financial and Strategic Analysis Review

Daewoong Co., Ltd. (3090) - Financial and Strategic Analysis Review / / Summary / / Daewoong Co., Ltd. (Daewoong) is a diversifi
2010 125,00$

Biotika, a.s. (1BSL01A) - Financial and Strategic Analysis Review

Biotika, a.s. (1BSL01A) - Financial and Strategic Analysis Review / / Summary / / Biotika, a.s. (Biotika) is a pharmaceutical co
2010 250,00$

Bukwang Pharmaceutical Co., Ltd. (3000) - Financial and Strategic Analysis Review

Bukwang Pharmaceutical Co., Ltd. (3000) - Financial and Strategic Analysis Review / / Summary / / Bukwang Pharmaceutical Co., Lt
2010 250,00$

TapImmune Inc. (TPIV) - Financial and Strategic Analysis Review

TapImmune Inc. (TPIV) - Financial and Strategic Analysis Review / / Summary / / TapImmune Inc. (Taplummune) is engaged in the de
2010 250,00$

BIOFERMIN PHARMACEUTICAL CO., LTD. (4517) - Financial and Strategic Analysis Review

BIOFERMIN PHARMACEUTICAL CO., LTD. (4517) - Financial and Strategic Analysis Review / / Summary / / BIOFERMIN PHARMACEUTICAL CO.
2010 250,00$

Choongwae Pharma Corp (1060) - Financial and Strategic Analysis Review

Choongwae Pharma Corp (1060) - Financial and Strategic Analysis Review / / Summary / / Choongwae Holdings Co., Ltd (Choongwae) i
2010 125,00$

HANDOK Pharmaceuticals Co., Ltd. (2390) - Financial and Strategic Analysis Review

HANDOK Pharmaceuticals Co., Ltd. (2390) - Financial and Strategic Analysis Review / / Summary / / HANDOK Pharmaceuticals Co., Lt
2010 125,00$

ILSUNG PHARMACEUTICAL CO.,LTD (3120) - Financial and Strategic Analysis Review

ILSUNG PHARMACEUTICAL CO.,LTD (3120) - Financial and Strategic Analysis Review / / Summary / / ILSUNG PHARMACEUTICAL CO.,LTD (IL
2010 250,00$

Dongwha Pharm Co., Ltd. (20) - Financial and Strategic Analysis Review

Dongwha Pharm Co., Ltd. (20) - Financial and Strategic Analysis Review / / Summary / / Dongwha Pharm Co., Ltd. (Dongwha) is a pu
2010 125,00$

Boryung Pharmaceutical Co., Ltd. (3850) - Financial and Strategic Analysis Review

Boryung Pharmaceutical Co., Ltd. (3850) - Financial and Strategic Analysis Review / / Summary / / Boryung Pharmaceutical Co., Lt
2010 250,00$

Samil Pharmaceutical Co., Ltd. (520) - Financial and Strategic Analysis Review

Samil Pharmaceutical Co., Ltd. (520) - Financial and Strategic Analysis Review / / Summary / / Samil Pharmaceutical Co., Ltd. (S
2010 250,00$

Samjin Pharmaceutical Co., Ltd. (5500) - Financial and Strategic Analysis Review

Samjin Pharmaceutical Co., Ltd. (5500) - Financial and Strategic Analysis Review / / Summary / / Samjin Pharmaceutical Co., Ltd.
2010 250,00$

Fuji Pharma Co., Ltd. (4554) - Financial and Strategic Analysis Review

Fuji Pharma Co., Ltd. (4554) - Financial and Strategic Analysis Review / / Summary / / Fuji Pharma Co., Ltd. (Fuji Pharma) is a
2010 125,00$

IVF Hartmann Holding AG (VBSN) - Financial and Strategic Analysis Review

IVF Hartmann Holding AG (VBSN) - Financial and Strategic Analysis Review / / Summary / / IVF Hartmann Holding AG (IVF) is a Swit
2010 250,00$

Chongkundang Corp. (1630) - Financial and Strategic Analysis Review

Chongkundang Corp. (1630) - Financial and Strategic Analysis Review / / Summary / / Chong Kun Dang Pharmaceutical Corp. (Chong K
2010 125,00$

Sun Biomedical Limited (SBN) - Financial and Strategic Analysis Review

Sun Biomedical Limited (SBN) - Financial and Strategic Analysis Review / / Summary / / Sun Biomedical Limited (Sun Biomedical) i
2010 250,00$

KunWha Pharmaceutical Co., Ltd. (2250) - Financial and Strategic Analysis Review

KunWha Pharmaceutical Co., Ltd. (2250) - Financial and Strategic Analysis Review / / Summary / / KunWha Pharmaceutical Co., Ltd.
2010 250,00$

Ilyang Pharmaceutical Co., Ltd (7570) - Financial and Strategic Analysis Review

Ilyang Pharmaceutical Co., Ltd (7570) - Financial and Strategic Analysis Review / / Summary / / Ilyang Pharmaceutical Co., Ltd (
2010 250,00$

Miraca Holdings Inc. (4544) - Financial and Strategic Analysis Review

Miraca Holdings Inc. (4544) - Financial and Strategic Analysis Review / / Summary / / Miraca Holdings Inc. (Miraca) is a publicl
2010 125,00$

J. B. Chemicals & Pharmaceuticals Ltd. (506943) - Financial and Strategic Analysis Review

J. B. Chemicals & Pharmaceuticals Ltd. (506943) - Financial and Strategic Analysis Review / / Summary / / J. B. Chemicals & Phar
2010 125,00$

IMI Co., Ltd. (7503) - Financial and Strategic Analysis Review

IMI Co., Ltd. (7503) - Financial and Strategic Analysis Review / / Summary / / IMI Co., Ltd. (IMI) is a publicly held specialty
2010 250,00$

Solvay Pharma India Ltd. (532447) - Financial and Strategic Analysis Review

Solvay Pharma India Ltd. (532447) - Financial and Strategic Analysis Review / / Summary / / Solvay Pharma India Ltd. (Solvay), a
2010 250,00$

Dar Al Dawa Development & Investment Co. Ltd. (DADI) - Financial and Strategic Analysis Review

Dar Al Dawa Development & Investment Co. Ltd. (DADI) - Financial and Strategic Analysis Review / / Summary / / Dar Al Dawa Devel
2010 250,00$

Shinpoong Pharmaceutical Co., Ltd. (19170) - Financial and Strategic Analysis Review

Shinpoong Pharmaceutical Co., Ltd. (19170) - Financial and Strategic Analysis Review / / Summary / / Shinpoong Pharmaceutical Co
2010 125,00$

Green Cross Corporation (6280) - Financial and Strategic Analysis Review

Green Cross Corporation (6280) - Financial and Strategic Analysis Review / / Summary / / Green Cross Corporation (Green Cross) i
2010 125,00$

Pacific Pharmaceutical Co., Ltd. (16570) - Financial and Strategic Analysis Review

Pacific Pharmaceutical Co., Ltd. (16570) - Financial and Strategic Analysis Review / / Summary / / Pacific Pharmaceutical Co., L
2010 250,00$

Hanall Pharmaceutical Co., Ltd. (9420) - Financial and Strategic Analysis Review

Hanall Pharmaceutical Co., Ltd. (9420) - Financial and Strategic Analysis Review / / Summary / / Hanall Pharmaceutical Co., Ltd.
2010 250,00$

KAINOS Laboratories, Inc. (4556) - Financial and Strategic Analysis Review

KAINOS Laboratories, Inc. (4556) - Financial and Strategic Analysis Review / / Summary / / Kainos Laboratories, Inc. (Kainos), i
2010 250,00$

Shenzhen Accord Pharmaceutical Co., Ltd. (200028) - Financial and Strategic Analysis Review

Shenzhen Accord Pharmaceutical Co., Ltd. (200028) - Financial and Strategic Analysis Review / / Summary / / Shenzhen Accord Phar
2010 125,00$

Samsung Pharmaceutical Industry Corporation Limited. (1360) - Financial and Strategic Analysis Review

Samsung Pharmaceutical Industry Corporation Limited. (1360) - Financial and Strategic Analysis Review / / Summary / / Samsung Ph
2010 250,00$

Kukje Pharmaceutical Industry Co., Ltd. (2720) - Financial and Strategic Analysis Review

Kukje Pharmaceutical Industry Co., Ltd. (2720) - Financial and Strategic Analysis Review / / Summary / / Kukje Pharmaceutical In
2010 250,00$

Pro-Pharmaceuticals, Inc. (PRWP) - Financial and Strategic Analysis Review

Pro-Pharmaceuticals, Inc. (PRWP) - Financial and Strategic Analysis Review / / Summary / / Pro-Pharmaceuticals, Inc.( Pro-Pharma
2010 250,00$

MOLOGEN AG (MGN) - Financial and Strategic Analysis Review

MOLOGEN AG (MGN) - Financial and Strategic Analysis Review / / Summary / / MOLOGEN AG (Mologen) is biotechnology company, that i
2010 250,00$

Searainbow Holding Co., Ltd (503) - Financial and Strategic Analysis Review

Searainbow Holding Co., Ltd (503) - Financial and Strategic Analysis Review / / Summary / / Searainbow Holding Co., Ltd (Searain
2010 250,00$

JCR Pharmaceuticals Co., Ltd. (4552) - Financial and Strategic Analysis Review

JCR Pharmaceuticals Co., Ltd. (4552) - Financial and Strategic Analysis Review / / Summary / / JCR Pharmaceuticals Co., Ltd. (JC
2010 250,00$

TOWA PHARMACEUTICAL CO., LTD. (4553) - Financial and Strategic Analysis Review

TOWA PHARMACEUTICAL CO., LTD. (4553) - Financial and Strategic Analysis Review / / Summary / / Towa Pharmaceutical Co. Ltd (Towa
2010 125,00$

Nanoen Tek, Inc. (39860) - Financial and Strategic Analysis Review

Nanoen Tek, Inc. (39860) - Financial and Strategic Analysis Review / / Summary / / Nanoen Tek, Inc. (Nanoen Tek) is a publicly
2010 250,00$

Kyung Dong Pharmaceutical Co., Ltd. (11040) - Financial and Strategic Analysis Review

Kyung Dong Pharmaceutical Co., Ltd. (11040) - Financial and Strategic Analysis Review / / Summary / / Kyung Dong Pharmaceutical
2010 250,00$

Ahn-Gook Pharmaceutical Co., Ltd. (1540) - Financial and Strategic Analysis Review

Ahn-Gook Pharmaceutical Co., Ltd. (1540) - Financial and Strategic Analysis Review / / Summary / / Ahn-Gook Pharmaceutical Co.,
2010 250,00$

New York Health Care, Inc. (BBAL) - Financial and Strategic Analysis Review

New York Health Care, Inc. (BBAL) - Financial and Strategic Analysis Review / / Summary / / wNew York Health Care, Inc. (New Yor
2010 125,00$

Nichi-Iko Pharmaceutical Co., Ltd. (4541) - Financial and Strategic Analysis Review

Nichi-Iko Pharmaceutical Co., Ltd. (4541) - Financial and Strategic Analysis Review / / Summary / / Nichi-Iko Pharmaceutical Co.
2010 125,00$

PT Indofarma (Persero) Tbk (INAF) - Financial and Strategic Analysis Review

PT Indofarma (Persero) Tbk (INAF) - Financial and Strategic Analysis Review / / Summary / / Pt Indofarma (Persero) Tbk (Indofarm
2010 250,00$

PT Kimia Farma (Persero) Tbk (KAEF) - Financial and Strategic Analysis Review

PT Kimia Farma (Persero) Tbk (KAEF) - Financial and Strategic Analysis Review / / Summary / / PT Kimia Farma Tbk (Kimia Farma) i
2010 125,00$

TTY Biopharm Company Limited (4105) - Financial and Strategic Analysis Review

TTY Biopharm Company Limited (4105) - Financial and Strategic Analysis Review / / Summary / / TTY Biopharm Company Limited (TTY)
2010 250,00$

Standard Chemical & Pharmaceutical Co. (1720) - Financial and Strategic Analysis Review

Standard Chemical & Pharmaceutical Co. (1720) - Financial and Strategic Analysis Review / / Summary / / Standard Chemical & Phar
2010 250,00$

PhytoHealth Corporation (4108) - Financial and Strategic Analysis Review

PhytoHealth Corporation (4108) - Financial and Strategic Analysis Review / / Summary / / PhytoHealth Corporation (PhytoHealth) i
2010 250,00$

Pihsiang Machinery Mfg. Co., Ltd. (1729) - Financial and Strategic Analysis Review

Pihsiang Machinery Mfg. Co., Ltd. (1729) - Financial and Strategic Analysis Review / / Summary / / Pihsiang Machinery Mfg. Co.,
2010 250,00$

HYUNDAI PHARM. CO., LTD. (4310) - Financial and Strategic Analysis Review

HYUNDAI PHARM. CO., LTD. (4310) - Financial and Strategic Analysis Review / / Summary / / HYUNDAI PHARM. CO., LTD. (Hyundai Phar
2010 250,00$

Chi Sheng Chemical Corporation (4111) - Financial and Strategic Analysis Review

Chi Sheng Chemical Corporation (4111) - Financial and Strategic Analysis Review / / Summary / / Chi Sheng Chemical Corporation (
2010 250,00$

LG Life Sciences, Ltd (68870) - Financial and Strategic Analysis Review

LG Life Sciences, Ltd (68870) - Financial and Strategic Analysis Review / / Summary / / LG Life Sciences, Ltd. (LGLS) is a pharm
2010 250,00$

CCM Duopharma Biotech Bhd. (DBIOTEC) - Financial and Strategic Analysis Review

CCM Duopharma Biotech Bhd. (DBIOTEC) - Financial and Strategic Analysis Review / / Summary / / CCM Duopharma Biotech Bhd. (CCM D
2010 250,00$

China Chemical & Pharmaceutical Co. Ltd. (1701) - Financial and Strategic Analysis Review

China Chemical & Pharmaceutical Co. Ltd. (1701) - Financial and Strategic Analysis Review / / Summary / / China Chemical & Pharm
2010 250,00$

Polska Grupa Farmaceutyczna S.A. (PGF) - Financial and Strategic Analysis Review

Polska Grupa Farmaceutyczna S.A. (PGF) - Financial and Strategic Analysis Review / / Summary / / Polska Grupa Farmaceutyczna S.A
2010 125,00$

CMIC Co., Ltd. (2309) - Financial and Strategic Analysis Review

CMIC Co., Ltd. (2309) - Financial and Strategic Analysis Review / / Summary / / CMIC Co., Ltd. (CMIC) is a publicly held healthc
2010 125,00$

Ohki Co., Ltd. (8120) - Financial and Strategic Analysis Review

Ohki Co., Ltd. (8120) - Financial and Strategic Analysis Review / / Summary / / Ohki Co Ltd. (Ohki) is a publicly held pharmaceu
2010 125,00$

Shigematsu Works Co., Ltd. (7980) - Financial and Strategic Analysis Review

Shigematsu Works Co., Ltd. (7980) - Financial and Strategic Analysis Review / / Summary / / Shigematsu Works Co., Ltd. (Shigemat
2010 250,00$

Hua Han Bio-Pharmaceutical Holdings Ltd. (587) - Financial and Strategic Analysis Review

Hua Han Bio-Pharmaceutical Holdings Ltd. (587) - Financial and Strategic Analysis Review / / Summary / / Hua Han Bio-Pharmaceuti
2010 250,00$

Tong Ren Tang Technologies Co., Ltd. (8069) - Financial and Strategic Analysis Review

Tong Ren Tang Technologies Co., Ltd. (8069) - Financial and Strategic Analysis Review / / Summary / / Tong Ren Tang Technologies
2010 125,00$

Deva Holding A.S. (DEVA) - Financial and Strategic Analysis Review

Deva Holding A.S. (DEVA) - Financial and Strategic Analysis Review / / Summary / / Deva Holding A.S. (Deva) is a pharmaceutical
2010 125,00$

PT Darya-Varia Laboratoria Tbk (DVLA) - Financial and Strategic Analysis Review

PT Darya-Varia Laboratoria Tbk (DVLA) - Financial and Strategic Analysis Review / / Summary / / Pt Darya-Varia Laboratoria Tbk (
2010 250,00$

LONGLIFE HOLDING Co., Ltd. (4355) - Financial and Strategic Analysis Review

LONGLIFE HOLDING Co., Ltd. (4355) - Financial and Strategic Analysis Review / / Summary / / LONGLIFE HOLDING Co., Ltd. (LHCL) is
2010 250,00$

Sapporo Clinical Laboratory Inc. (9776) - Financial and Strategic Analysis Review

Sapporo Clinical Laboratory Inc. (9776) - Financial and Strategic Analysis Review / / Summary / / Sapporo Clinical Laboratory In
2010 250,00$

Medical System Network Co., Ltd. (4350) - Financial and Strategic Analysis Review

Medical System Network Co., Ltd. (4350) - Financial and Strategic Analysis Review / / Summary / / Medical System Network Co., Lt
2010 125,00$

Biotie Therapies Corp. (BTH1V) - Financial and Strategic Analysis Review

Biotie Therapies Corp. (BTH1V) - Financial and Strategic Analysis Review / / Summary / / Biotie Therapies Corp. (Biotie) is a bi
2010 250,00$

Abano Healthcare Group Limited (ABA) - Financial and Strategic Analysis Review

Abano Healthcare Group Limited (ABA) - Financial and Strategic Analysis Review / / Summary / / Abano Healthcare Group Limited (A
2010 250,00$

Euro-Med Laboratories Phil., Inc. (EURO) - Financial and Strategic Analysis Review

Euro-Med Laboratories Phil., Inc. (EURO) - Financial and Strategic Analysis Review / / Summary / / Euro-Med Laboratories Phil.,
2010 250,00$

ALKALOID AD - Skopje (ALK) - Financial and Strategic Analysis Review

ALKALOID AD - Skopje (ALK) - Financial and Strategic Analysis Review / / Summary / / ALKALOID AD Skopje (ALKALOID) is a pharmace
2010 250,00$

Sam Chun Dang Pharm Co., Ltd. (250) - Financial and Strategic Analysis Review

Sam Chun Dang Pharm Co., Ltd. (250) - Financial and Strategic Analysis Review / / Summary / / Sam Chun Dang Pharm Co., Ltd. (Sam
2010 250,00$

Schnell Biopharmaceuticals, Inc. (3060) - Financial and Strategic Analysis Review

Schnell Biopharmaceuticals, Inc. (3060) - Financial and Strategic Analysis Review / / Summary / / Schnell Biopharmaceuticals, In
2010 250,00$

Daewon Pharmaceutical Co., Ltd. (3220) - Financial and Strategic Analysis Review

Daewon Pharmaceutical Co., Ltd. (3220) - Financial and Strategic Analysis Review / / Summary / / Daewon Pharmaceutical Co., Ltd.
2010 250,00$

Les Trois Chenes SA (MLTRC) - Financial and Strategic Analysis Review

Les Trois Chenes SA (MLTRC) - Financial and Strategic Analysis Review / / Summary / / Les Trois Chenes SA (Les Trois) is a Franc
2010 250,00$

ICP Biotechnology Limited (BIO) - Financial and Strategic Analysis Review

ICP Biotechnology Limited (BIO) - Financial and Strategic Analysis Review / / Summary / / ICP Biotechnology Limited (ICP) is a b
2010 125,00$

Innocell Corporation (31390) - Financial and Strategic Analysis Review

Innocell Corporation (31390) - Financial and Strategic Analysis Review / / Summary / / Innocell Corporation (Innocell) is a biot
2010 250,00$

BLIS Technologies Ltd (BLT) - Financial and Strategic Analysis Review

BLIS Technologies Ltd (BLT) - Financial and Strategic Analysis Review / / Summary / / BLIS Technologies Ltd (BLIS) is a publicly
2010 250,00$

Botry-Zen Limited (BOZ) - Financial and Strategic Analysis Review

Botry-Zen Limited (BOZ) - Financial and Strategic Analysis Review / / Summary / / Botry-Zen Limited (Botry-Zen) is a biotechnolo
2010 250,00$

BioPhausia AB (BIOP) - Financial and Strategic Analysis Review

BioPhausia AB (BIOP) - Financial and Strategic Analysis Review / / Summary / / BioPhausia AB (BioPhausia) is a specialty pharmac
2010 250,00$

Komipharm International Co., Ltd. (41960) - Financial and Strategic Analysis Review

Komipharm International Co., Ltd. (41960) - Financial and Strategic Analysis Review / / Summary / / Komipharm International Co.,
2010 250,00$

Jin Yang Pharmaceutical Co., Ltd. (7370) - Financial and Strategic Analysis Review

Jin Yang Pharmaceutical Co., Ltd. (7370) - Financial and Strategic Analysis Review / / Summary / / Jin Yang Pharmaceutical Co.,
2010 250,00$

PharmswellBio Co., Ltd. (43090) - Financial and Strategic Analysis Review

PharmswellBio Co., Ltd. (43090) - Financial and Strategic Analysis Review / / Summary / / PharmswellBio Co., Ltd. (PharmswellBio
2010 250,00$

F. Reichelt AG (RCH) - Financial and Strategic Analysis Review

F. Reichelt AG (RCH) - Financial and Strategic Analysis Review / / Summary / / F. Reichelt AG (Reichelt) is a pharmaceutical who
2010 250,00$

Korea United Pharm, Inc. (33270) - Financial and Strategic Analysis Review

Korea United Pharm, Inc. (33270) - Financial and Strategic Analysis Review / / Summary / / Korea United Pharm, Inc., is a South
2010 250,00$

Sam-A Pharm. Co., Ltd. (9300) - Financial and Strategic Analysis Review

Sam-A Pharm. Co., Ltd. (9300) - Financial and Strategic Analysis Review / / Summary / / Sam-A Pharm. Co., Ltd. (Sam-A) is princi
2010 250,00$

Eagle Veterinary Technology Co., Ltd. (44960) - Financial and Strategic Analysis Review

Eagle Veterinary Technology Co., Ltd. (44960) - Financial and Strategic Analysis Review / / Summary / / Eagle Veterinary Technol
2010 250,00$

CHO-A PHARM.Co.,LTD. (34940) - Financial and Strategic Analysis Review

CHO-A PHARM.Co.,LTD. (34940) - Financial and Strategic Analysis Review / / Summary / / CHO-A PHARM.Co.,LTD. (CHO-A) is a publicl
2010 250,00$

Medica Sur SAB de CV (MEDICA) - Financial and Strategic Analysis Review

Medica Sur SAB de CV (MEDICA) - Financial and Strategic Analysis Review / / Summary / / Medica Sur SAB de CV (Medica) is a non-g
2010 250,00$

Supermax Corporation Berhad (SUPERMX) - Financial and Strategic Analysis Review

Supermax Corporation Berhad (SUPERMX) - Financial and Strategic Analysis Review / / Summary / / Supermax Corporation Berhad (Sup
2010 125,00$

Dawnrays Pharmaceutical (Holdings) Limited (2348) - Financial and Strategic Analysis Review

Dawnrays Pharmaceutical (Holdings) Limited (2348) - Financial and Strategic Analysis Review / / Summary / / Dawnrays Pharmaceuti
2010 250,00$

NitroMed, Inc. (NTMD) - Financial and Strategic Analysis Review

NitroMed, Inc. (NTMD) - Financial and Strategic Analysis Review / / Summary / / NitroMed, Inc. (NitroMed) is a development stage
2010 250,00$

MEDINET Co., Ltd. (2370) - Financial and Strategic Analysis Review

MEDINET Co., Ltd. (2370) - Financial and Strategic Analysis Review / / Summary / / MEDINET Co., Ltd. (Medinet) is a publicly hel
2010 250,00$

AquaCarotene Limited (AQL) - Financial and Strategic Analysis Review

AquaCarotene Limited (AQL) - Financial and Strategic Analysis Review / / Summary / / AquaCarotene Limited (AquaCarotene) is enga
2010 250,00$

Daesung Microbiological Labs, Co., Ltd. (36480) - Financial and Strategic Analysis Review

Daesung Microbiological Labs, Co., Ltd. (36480) - Financial and Strategic Analysis Review / / Summary / / Daesung Microbiologica
2010 250,00$

Cheil Bio Co., Ltd. (52670) - Financial and Strategic Analysis Review

Cheil Bio Co., Ltd. (52670) - Financial and Strategic Analysis Review / / Summary / / Cheil Bio Co., Ltd. (Cheil Bio Co) is enga
2010 250,00$

Daehan New Pharm Co., Ltd. (54670) - Financial and Strategic Analysis Review

Daehan New Pharm Co., Ltd. (54670) - Financial and Strategic Analysis Review / / Summary / / Daehan New Pharm Co., Ltd. (Daehan)
2010 250,00$

CTCBIO INC. (60590) - Financial and Strategic Analysis Review

CTCBIO INC. (60590) - Financial and Strategic Analysis Review / / Summary / / CTCBIO INC (CTCBIO) is a publicly held pharmaceuti
2010 250,00$

Skynewpharm Inc. (58820) - Financial and Strategic Analysis Review

Skynewpharm Inc. (58820) - Financial and Strategic Analysis Review / / Summary / / Skynewpharm Inc. (Skynewpharm) is a pharmaceu
2010 250,00$

CKD Bio Corporation (63160) - Financial and Strategic Analysis Review

CKD Bio Corporation (63160) - Financial and Strategic Analysis Review / / Summary / / CKD Bio Corporation (CKD Bio) is a publicl
2010 250,00$

Dai Han Pharmaceutical Co., Ltd. (23910) - Financial and Strategic Analysis Review

Dai Han Pharmaceutical Co., Ltd. (23910) - Financial and Strategic Analysis Review / / Summary / / Dai Han Pharmaceutical Co., L
2010 250,00$

Hwail Pharma Co., Ltd. (61250) - Financial and Strategic Analysis Review

Hwail Pharma Co., Ltd. (61250) - Financial and Strategic Analysis Review / / Summary / / Hwail Pharma Co., Ltd. (Hwail) is a pha
2010 250,00$

DAE HWA Pharm Co., Ltd. (67080) - Financial and Strategic Analysis Review

DAE HWA Pharm Co., Ltd. (67080) - Financial and Strategic Analysis Review / / Summary / / DAE HWA Pharm. Co., Ltd. (Daehwa) is a
2010 250,00$

HS BIO PHARM (53950) - Financial and Strategic Analysis Review

HS BIO PHARM (53950) - Financial and Strategic Analysis Review / / Summary / / HS BIO PHARM (HS BIO) is a pharmaceutical company
2010 250,00$

Soiken Holdings Inc. (2385) - Financial and Strategic Analysis Review

Soiken Holdings Inc. (2385) - Financial and Strategic Analysis Review / / Summary / / Soiken Holdings Inc. (Soiken Holdings) is
2010 250,00$

Shinil Pharmaceutical Co., Ltd. (12790) - Financial and Strategic Analysis Review

Shinil Pharmaceutical Co., Ltd. (12790) - Financial and Strategic Analysis Review / / Summary / / Shinil Pharmaceutical Co., Ltd
2010 250,00$

Seoul Pharma Co., Ltd. (18680) - Financial and Strategic Analysis Review

Seoul Pharma Co., Ltd. (18680) - Financial and Strategic Analysis Review / / Summary / / Seoul Pharma Co., Ltd. (Seoul Pharma) i
2010 250,00$

Korean Drug Co., Ltd. (14570) - Financial and Strategic Analysis Review

Korean Drug Co., Ltd. (14570) - Financial and Strategic Analysis Review / / Summary / / Korean Drug Co., Ltd. (KDC) is pharmace
2010 250,00$

OncoTherapy Science, Inc. (4564) - Financial and Strategic Analysis Review

OncoTherapy Science, Inc. (4564) - Financial and Strategic Analysis Review / / Summary / / OncoTherapy Science, Inc. (OTS) is a
2010 250,00$

Goldis Berhad (GOLDIS) - Financial and Strategic Analysis Review

Goldis Berhad (GOLDIS) - Financial and Strategic Analysis Review / / Summary / / Goldis Berhad (Goldis) is a publicly held inves
2010 250,00$

Joincare Pharmaceutical Group Industry Co., Ltd. (600380) - Financial and Strategic Analysis Review

Joincare Pharmaceutical Group Industry Co., Ltd. (600380) - Financial and Strategic Analysis Review / / Summary / / Joincare Pha
2010 125,00$

Stirling Products Limited (STI) - Financial and Strategic Analysis Review

Stirling Products Limited (STI) - Financial and Strategic Analysis Review / / Summary / / Stirling Products Limited (Stirling) i
2010 250,00$

EstechPharma Co., Ltd. (41910) - Financial and Strategic Analysis Review

EstechPharma Co., Ltd. (41910) - Financial and Strategic Analysis Review / / Summary / / EstechPharma Co., Ltd. (EstechPharma) i
2010 250,00$

Select Vaccines Limited (SLT) - Financial and Strategic Analysis Review

Select Vaccines Limited (SLT) - Financial and Strategic Analysis Review / / Summary / / Select Vaccines Limited (SVL) is a publi
2010 250,00$

SciGen Limited (SIE) - Financial and Strategic Analysis Review

SciGen Limited (SIE) - Financial and Strategic Analysis Review / / Summary / / SciGen Limited (SciGen) is a bio-pharmaceutical c
2010 250,00$

Transition Therapeutics Inc. (TTHI) - Financial and Strategic Analysis Review

Transition Therapeutics Inc. (TTHI) - Financial and Strategic Analysis Review / / Summary / / Transition Therapeutics Inc. (Tran
2010 250,00$

Beijing Double-Crane Pharmaceutical Co., Ltd. (600062) - Financial and Strategic Analysis Review

Beijing Double-Crane Pharmaceutical Co., Ltd. (600062) - Financial and Strategic Analysis Review / / Summary / / Beijing Double-
2010 125,00$

Acibadem Saglik Hizmetleri ve Ticaret AS (ACIBD) - Financial and Strategic Analysis Review

Acibadem Saglik Hizmetleri ve Ticaret AS (ACIBD) - Financial and Strategic Analysis Review / / Summary / / Acibadem Saglik Hizme
2010 125,00$

Bio-Treat Technology Ltd. (B22) - Financial and Strategic Analysis Review

Bio-Treat Technology Ltd. (B22) - Financial and Strategic Analysis Review / / Summary / / Bio-Treat Technology Ltd. (Bio-Treat)
2010 250,00$

Sanjiu Medical & Pharmaceutical Co., Ltd. (999) - Financial and Strategic Analysis Review

Sanjiu Medical & Pharmaceutical Co., Ltd. (999) - Financial and Strategic Analysis Review / / Summary / / Sanjiu Medical & Pharm
2010 125,00$

DNA Chip Research Inc. (2397) - Financial and Strategic Analysis Review

DNA Chip Research Inc. (2397) - Financial and Strategic Analysis Review / / Summary / / DNA Chip Research Inc. (DNA Chip) is a p
2010 250,00$

ChoongAng Vaccine Laboratory (72020) - Financial and Strategic Analysis Review

ChoongAng Vaccine Laboratory (72020) - Financial and Strategic Analysis Review / / Summary / / ChoongAng Vaccine Laboratory (Cho
2010 250,00$

GuiZhou YiBai Pharmaceutical Co., Ltd. (600594) - Financial and Strategic Analysis Review

GuiZhou YiBai Pharmaceutical Co., Ltd. (600594) - Financial and Strategic Analysis Review / / Summary / / GuiZhou YiBai Pharmace
2010 125,00$

PharmaGap Inc. (GAP) - Financial and Strategic Analysis Review

PharmaGap Inc. (GAP) - Financial and Strategic Analysis Review / / Summary / / Pharmagap Inc. (Pharmagap) is biotechnology compa
2010 250,00$

DR. Chip Biotech Inc. (4131) - Financial and Strategic Analysis Review

DR. Chip Biotech Inc. (4131) - Financial and Strategic Analysis Review / / Summary / / Dr. Chip Biotechnology, Inc. (Dr. Chip) i
2010 250,00$

TSUKUI CORPORATION (2398) - Financial and Strategic Analysis Review

TSUKUI CORPORATION (2398) - Financial and Strategic Analysis Review / / Summary / / Tsukui Corporation (Tsukui) is a publicly he
2010 125,00$

Hythiam, Inc. (HYTM) - Financial and Strategic Analysis Review

Hythiam, Inc. (HYTM) - Financial and Strategic Analysis Review / / Summary / / Hythiam, Inc. (Hythiam) is a managed healthcare s
2010 250,00$

Jack Chia Industries (Thailand) PCL (JCT) - Financial and Strategic Analysis Review

Jack Chia Industries (Thailand) PCL (JCT) - Financial and Strategic Analysis Review / / Summary / / Jack Chia Industries (Thaila
2010 250,00$

Allon Therapeutics Inc. (NPC) - Financial and Strategic Analysis Review

Allon Therapeutics Inc. (NPC) - Financial and Strategic Analysis Review / / Summary / / Allon Therapeutics Inc. (Allon), formerl
2010 250,00$

Medtecs International Corporation Limited (546) - Financial and Strategic Analysis Review

Medtecs International Corporation Limited (546) - Financial and Strategic Analysis Review / / Summary / / MEDTECS INTERNATIONAL
2010 250,00$

Praxitelio Hospital S.A. (PRAXC) - Financial and Strategic Analysis Review

Praxitelio Hospital S.A. (PRAXC) - Financial and Strategic Analysis Review / / Summary / / Praxitelio Hospital S.A. (Praxitelio)
2010 250,00$

Sopharma AD Sofia (3JR) - Financial and Strategic Analysis Review

Sopharma AD Sofia (3JR) - Financial and Strategic Analysis Review / / Summary / / Sopharma AD Sofia (Sopharma), is a public shar
2010 125,00$

AS Olainfarm (OLF1R) - Financial and Strategic Analysis Review

AS Olainfarm (OLF1R) - Financial and Strategic Analysis Review / / Summary / / AS Olainfarm (Olainfarm) is a joint stock company
2010 250,00$

Adcock Ingram Holdings Limited (AIPJ) - Financial and Strategic Analysis Review

Adcock Ingram Holdings Limited (AIPJ) - Financial and Strategic Analysis Review / / Summary / / Adcock Ingram Holdings Limited (
2010 125,00$

Bangkok Dusit Medical Services PCL (BGH) - Financial and Strategic Analysis Review

Bangkok Dusit Medical Services PCL (BGH) - Financial and Strategic Analysis Review / / Summary / / Bangkok Dusit Medical Service
2010 125,00$

Prasit Patana Public Company Limited (PYT) - Financial and Strategic Analysis Review

Prasit Patana Public Company Limited (PYT) - Financial and Strategic Analysis Review / / Summary / / Prasit Patana Public Compan
2010 250,00$

Samitivej PCL (SVH) - Financial and Strategic Analysis Review

Samitivej PCL (SVH) - Financial and Strategic Analysis Review / / Summary / / Samitivej PCL (Samitivej) is a publicly held healt
2010 250,00$

Sikarin PCL (SKR) - Financial and Strategic Analysis Review

Sikarin PCL (SKR) - Financial and Strategic Analysis Review / / Summary / / Sikarin PCL (Sikarin) is a publicly held healthcare
2010 250,00$

Jinling Pharmaceutical Co., Ltd. (919) - Financial and Strategic Analysis Review

Jinling Pharmaceutical Co., Ltd. (919) - Financial and Strategic Analysis Review / / Summary / / Jinling Pharmaceutical Co., Ltd
2010 125,00$

Medical Facilities Corporation (DR.UN) - Financial and Strategic Analysis Review

Medical Facilities Corporation (DR.UN) - Financial and Strategic Analysis Review / / Summary / / Medical Facilities Corporation
2010 125,00$

Message Co., Ltd. (2400) - Financial and Strategic Analysis Review

Message Co., Ltd. (2400) - Financial and Strategic Analysis Review / / Summary / / Message Co., Ltd. (Message Co.) is a health c
2010 125,00$

Chiang Mai Ram Medical Business PCL (CMR) - Financial and Strategic Analysis Review

Chiang Mai Ram Medical Business PCL (CMR) - Financial and Strategic Analysis Review / / Summary / / Chiang Mai Ram Medical Busin
2010 250,00$

Quest PharmaTech Inc. (QPT) - Financial and Strategic Analysis Review

Quest PharmaTech Inc. (QPT) - Financial and Strategic Analysis Review / / Summary / / Quest PharmaTech Inc. (Quest) is a Canada
2010 250,00$

Imagin Molecular Corporation (IMGM) - Financial and Strategic Analysis Review

Imagin Molecular Corporation (IMGM) - Financial and Strategic Analysis Review / / Summary / / Imagin Molecular Corporation (Imag
2010 250,00$

MaYinglong Pharmaceutical Group Co., Ltd (600993) - Financial and Strategic Analysis Review

MaYinglong Pharmaceutical Group Co., Ltd (600993) - Financial and Strategic Analysis Review / / Summary / / MaYinglong Pharmaceu
2010 250,00$

PT Merck Tbk (MERK) - Financial and Strategic Analysis Review

PT Merck Tbk (MERK) - Financial and Strategic Analysis Review / / Summary / / PT Merck Tbk is engaged in the manufacture of pres
2010 250,00$

Pluristem Therapeutics Inc. (PSTI) - Financial and Strategic Analysis Review

Pluristem Therapeutics Inc. (PSTI) - Financial and Strategic Analysis Review / / Summary / / Pluristem Therapeutics Inc. (Pluris
2010 250,00$

PT Schering Plough Indonesia Tbk - Financial and Strategic Analysis Review

PT Schering Plough Indonesia Tbk - Financial and Strategic Analysis Review / / Summary / / PT Schering Plough Indonesia Tbk (PT
2010 250,00$

A-motion Co.,Ltd. (31860) - Financial and Strategic Analysis Review

A-motion Co.,Ltd. (31860) - Financial and Strategic Analysis Review / / Summary / / A-motion Co.,Ltd. (A-motion Co) is principal
2010 250,00$

MIV Therapeutics Inc (MIVI) - Financial and Strategic Analysis Review

MIV Therapeutics Inc (MIVI) - Financial and Strategic Analysis Review / / Summary / / MIV Therapeutics Inc. (MIVT) is an advance
2010 250,00$

China Biopharma, Inc. (CHBO) - Financial and Strategic Analysis Review

China Biopharma, Inc. (CHBO) - Financial and Strategic Analysis Review / / Summary / / China Biopharma Inc. (CBI) is a biopharma
2010 250,00$

Mahachai Hospital Public Company Limited (M-CHAI) - Financial and Strategic Analysis Review

Mahachai Hospital Public Company Limited (M-CHAI) - Financial and Strategic Analysis Review / / Summary / / Mahachai Hospital Pu
2010 250,00$

Gesundheitswelt Chiemgau AG (JTH) - Financial and Strategic Analysis Review

Gesundheitswelt Chiemgau AG (JTH) - Financial and Strategic Analysis Review / / Summary / / Gesundheitswelt Chiemgau AG (GCAG) i
2010 250,00$

Theravance, Inc. (THRX) - Financial and Strategic Analysis Review

Theravance, Inc. (THRX) - Financial and Strategic Analysis Review / / Summary / / Theravance, Inc. (Theravance) is engaged in th
2010 250,00$

Resverlogix Corp. (RVX) - Financial and Strategic Analysis Review

Resverlogix Corp. (RVX) - Financial and Strategic Analysis Review / / Summary / / Resverlogix Corp. (Resverlogix) is a publicly
2010 250,00$

Ondine Biopharma Corporation (OBP) - Financial and Strategic Analysis Review

Ondine Biopharma Corporation (OBP) - Financial and Strategic Analysis Review / / Summary / / Ondine Biopharma Corporation (Ondin
2010 250,00$

Bangkok Chain Hospital Public Co. Ltd. (KH) - Financial and Strategic Analysis Review

Bangkok Chain Hospital Public Co. Ltd. (KH) - Financial and Strategic Analysis Review / / Summary / / Bangkok Chain Hospital Pub
2010 250,00$

Aikchol Hospital Public Company Limited (AHC) - Financial and Strategic Analysis Review

Aikchol Hospital Public Company Limited (AHC) - Financial and Strategic Analysis Review / / Summary / / Aikchol Hospital Public
2010 250,00$

Propharex (PROP) - Financial and Strategic Analysis Review

Propharex (PROP) - Financial and Strategic Analysis Review / / Summary / / Propharex is a specialty pharmaceutical company spec
2010 125,00$

LTT Bio-Pharma Co., Ltd. (4566) - Financial and Strategic Analysis Review

LTT Bio-Pharma Co., Ltd. (4566) - Financial and Strategic Analysis Review / / Summary / / LTT Bio-Pharma Co., Ltd. (LTT Bio-Phar
2010 250,00$

Care Service Co., Ltd. (2425) - Financial and Strategic Analysis Review

Care Service Co., Ltd. (2425) - Financial and Strategic Analysis Review / / Summary / / Care Service Co., Ltd. (CSC) is a health
2010 250,00$

Takara Bio Inc. (4974) - Financial and Strategic Analysis Review

Takara Bio Inc. (4974) - Financial and Strategic Analysis Review / / Summary / / Takara Bio Inc. (Takara) is a biotechnological
2010 125,00$

Henan Topfond Pharmaceutical Co., Ltd (600253) - Financial and Strategic Analysis Review

Henan Topfond Pharmaceutical Co., Ltd (600253) - Financial and Strategic Analysis Review / / Summary / / Henan Topfond Pharmaceu
2010 125,00$

Jiangsu Hengrui Medicine Co., Ltd. (600276) - Financial and Strategic Analysis Review

Jiangsu Hengrui Medicine Co., Ltd. (600276) - Financial and Strategic Analysis Review / / Summary / / Jiangsu Hengrui Medicine C
2010 125,00$

Threshold Pharmaceuticals, Inc. (THLD) - Financial and Strategic Analysis Review

Threshold Pharmaceuticals, Inc. (THLD) - Financial and Strategic Analysis Review / / Summary / / Threshold Pharmaceuticals, Inc.
2010 250,00$

Provectus Pharmaceuticals, Inc. (PVCT) - Financial and Strategic Analysis Review

Provectus Pharmaceuticals, Inc. (PVCT) - Financial and Strategic Analysis Review / / Summary / / Provectus Pharmaceuticals, Inc.
2010 250,00$

Tianjin Tianyao Pharmaceutical Co., Ltd (600488) - Financial and Strategic Analysis Review

Tianjin Tianyao Pharmaceutical Co., Ltd (600488) - Financial and Strategic Analysis Review / / Summary / / Tianjin Tianyao Pharm
2010 250,00$

JiLin AoDong Medicine Industry Group Co., Ltd. (623) - Financial and Strategic Analysis Review

JiLin AoDong Medicine Industry Group Co., Ltd. (623) - Financial and Strategic Analysis Review / / Summary / / JiLin AoDong Medi
2010 250,00$

Guangxi Beisheng Pharmaceutical Co., Ltd (600556) - Financial and Strategic Analysis Review

Guangxi Beisheng Pharmaceutical Co., Ltd (600556) - Financial and Strategic Analysis Review / / Summary / / Guangxi Beisheng Pha
2010 250,00$

Care Twentyone Corporation (2373) - Financial and Strategic Analysis Review

Care Twentyone Corporation (2373) - Financial and Strategic Analysis Review / / Summary / / Care Twentyone Corporation (Care 21)
2010 250,00$

CEDAR Co., Ltd. (2435) - Financial and Strategic Analysis Review

CEDAR Co., Ltd. (2435) - Financial and Strategic Analysis Review / / Summary / / CEDAR. Co., Ltd. (Cedar) is a healthcare compan
2010 250,00$

Indoco Remedies Limited (532612) - Financial and Strategic Analysis Review

Indoco Remedies Limited (532612) - Financial and Strategic Analysis Review / / Summary / / Indoco Remedies Limited (Indoco Remed
2010 250,00$

United Envirotech Ltd. (U19) - Financial and Strategic Analysis Review

United Envirotech Ltd. (U19) - Financial and Strategic Analysis Review / / Summary / / United Envirotech Ltd (United Envirotech)
2010 250,00$

Hovid Berhad (HOVID) - Financial and Strategic Analysis Review

Hovid Berhad (HOVID) - Financial and Strategic Analysis Review / / Summary / / Hovid Berhad (Hovid) is a pharmaceutical company
2010 250,00$

Taiko Pharmaceutical Co.,Ltd. (4574) - Financial and Strategic Analysis Review

Taiko Pharmaceutical Co.,Ltd. (4574) - Financial and Strategic Analysis Review / / Summary / / Taiko Pharmaceutical Co.,Ltd. (Ta
2010 250,00$

Swissmed Centrum Zdrowia S.A. (SWD) - Financial and Strategic Analysis Review

Swissmed Centrum Zdrowia S.A. (SWD) - Financial and Strategic Analysis Review / / Summary / / Swissmed Centrum Zdrowia SA (Swiss
2010 250,00$

TORFARM S.A. (TFM) - Financial and Strategic Analysis Review

TORFARM S.A. (TFM) - Financial and Strategic Analysis Review / / Summary / / Torfarm SA (Torfarm) is a publicly held pharmaceuti
2010 125,00$

Essex Bio-Technology Limited (8151) - Financial and Strategic Analysis Review

Essex Bio-Technology Limited (8151) - Financial and Strategic Analysis Review / / Summary / / Essex Bio-Technology Limited (Esse
2010 250,00$

LifeVantage Corporation (LFVN) - Financial and Strategic Analysis Review

LifeVantage Corporation (LFVN) - Financial and Strategic Analysis Review / / Summary / / LifeVantage Corporation (LifeVantage) i
2010 250,00$

Lipidviro Tech, Inc. (LPVO) - Financial and Strategic Analysis Review

Lipidviro Tech, Inc. (LPVO) - Financial and Strategic Analysis Review / / Summary / / LipidViro Tech, Inc. (LTI) was engaged in
2010 250,00$

PT. Pyridam Farma Tbk. (PYFA) - Financial and Strategic Analysis Review

PT. Pyridam Farma Tbk. (PYFA) - Financial and Strategic Analysis Review / / Summary / / PT. Pyridam Farma Tbk. (Pyridam) is a ph
2010 250,00$

SemBiosys Genetics Inc. (SBS) - Financial and Strategic Analysis Review

SemBiosys Genetics Inc. (SBS) - Financial and Strategic Analysis Review / / Summary / / SemBioSys Genetics Inc. (SemBioSys) is a
2010 250,00$

Pharmesis International Ltd. (P31) - Financial and Strategic Analysis Review

Pharmesis International Ltd. (P31) - Financial and Strategic Analysis Review / / Summary / / Pharmesis International Ltd. (Pharm
2010 250,00$

Suven Life Sciences Ltd. (530239) - Financial and Strategic Analysis Review

Suven Life Sciences Ltd. (530239) - Financial and Strategic Analysis Review / / Summary / / Suven Life Sciences Ltd. (Suven) is
2010 250,00$

Galapagos NV (GLPGA) - Financial and Strategic Analysis Review

Galapagos NV (GLPGA) - Financial and Strategic Analysis Review / / Summary / / Galapagos NV (Galapagos) is a publicly held resea
2010 250,00$

EMC Instytut Medyczny SA (EMCINSMED) - Financial and Strategic Analysis Review

EMC Instytut Medyczny SA (EMCINSMED) - Financial and Strategic Analysis Review / / Summary / / EMC Instytut Medyczny SA (EMC) is
2010 250,00$

Uni-Bio Science Group Ltd. (690) - Financial and Strategic Analysis Review

Uni-Bio Science Group Ltd. (690) - Financial and Strategic Analysis Review / / Summary / / Uni-Bio Science Group Limited (Uni-Bi
2010 250,00$

Ruyan Group (Holdings) Limited (329) - Financial and Strategic Analysis Review

Ruyan Group (Holdings) Limited (329) - Financial and Strategic Analysis Review / / Summary / / Ruyan Group (Holdings) Limited (R
2010 250,00$

Thomson Medical Centre Limited (5FV) - Financial and Strategic Analysis Review

Thomson Medical Centre Limited (5FV) - Financial and Strategic Analysis Review / / Summary / / Thomson Medical Centre Limited (T
2010 250,00$

Apollo Consolidated Limited (AOP) - Financial and Strategic Analysis Review

Apollo Consolidated Limited (AOP) - Financial and Strategic Analysis Review / / Summary / / Apollo Consolidated Limited (Apollo)
2010 250,00$

Broad Intelligence International Pharmaceutical Holdings Limited (1149) - Financial and Strategic Analysis Review

Broad Intelligence International Pharmaceutical Holdings Limited (1149) - Financial and Strategic Analysis Review / / Summary /
2010 250,00$

Jiwa Bio-Pharm Holdings Limited (2327) - Financial and Strategic Analysis Review

Jiwa Bio-Pharm Holdings Limited (2327) - Financial and Strategic Analysis Review / / Summary / / Jiwa Bio-Pharm Holdings Limited
2010 250,00$

INS Bioscience Berhad (INSBIO) - Financial and Strategic Analysis Review

INS Bioscience Berhad (INSBIO) - Financial and Strategic Analysis Review / / Summary / / INS Bioscience Berhad (INSBio) is a pub
2010 250,00$

Hualan Biological Engineering, Inc. (2007) - Financial and Strategic Analysis Review

Hualan Biological Engineering, Inc. (2007) - Financial and Strategic Analysis Review / / Summary / / Hualan Biological Engineeri
2010 250,00$

MediPost Co., Ltd. (78160) - Financial and Strategic Analysis Review

MediPost Co., Ltd. (78160) - Financial and Strategic Analysis Review / / Summary / / Medipost Co, Ltd. (Medipost) is a publicly
2010 250,00$

Clearant, Inc. (CLRA) - Financial and Strategic Analysis Review

Clearant, Inc. (CLRA) - Financial and Strategic Analysis Review / / Summary / / Clearant, Inc. (Clearant) is a publicly trading
2010 250,00$

Byotrol Plc (BYOT) - Financial and Strategic Analysis Review

Byotrol Plc (BYOT) - Financial and Strategic Analysis Review / / Summary / / Byotrol plc (Byotrol) is a publicly held biotechnol
2010 250,00$

Medi-Flex Limited (5FF) - Financial and Strategic Analysis Review

Medi-Flex Limited (5FF) - Financial and Strategic Analysis Review / / Summary / / Medi-Flex Limited (Medi-Flex) is a publicly he
2010 250,00$

Fuhua Group Co. Ltd. Zhuhai S.E.Z. (507) - Financial and Strategic Analysis Review

Fuhua Group Co. Ltd. Zhuhai S.E.Z. (507) - Financial and Strategic Analysis Review / / Summary / / Fuhua Group Co. Ltd. Zhuhai
2010 125,00$

Carotech Bhd. (CAROTEC) - Financial and Strategic Analysis Review

Carotech Bhd. (CAROTEC) - Financial and Strategic Analysis Review / / Summary / / Carotech Berhad (Carotech) publicly held compa
2010 250,00$

TMC Life Sciences Berhad (TMCLIFE) - Financial and Strategic Analysis Review

TMC Life Sciences Berhad (TMCLIFE) - Financial and Strategic Analysis Review / / Summary / / TMC Life Sciences Berhad (TMC Life)
2010 250,00$

Jiuzhitang Co.,Ltd. (989) - Financial and Strategic Analysis Review

Jiuzhitang Co.,Ltd. (989) - Financial and Strategic Analysis Review / / Summary / / Jiuzhitang Co., Ltd. (Jiuzhitang) is a China
2010 125,00$

HENAN TALOPH PHARMACEUTICAL STOCK CO., LTD (600222) - Financial and Strategic Analysis Review

HENAN TALOPH PHARMACEUTICAL STOCK CO., LTD (600222) - Financial and Strategic Analysis Review / / Summary / / HENAN TALOPH PHARM
2010 250,00$

Reyoung Pharmaceutical Holdings Limited (R12) - Financial and Strategic Analysis Review

Reyoung Pharmaceutical Holdings Limited (R12) - Financial and Strategic Analysis Review / / Summary / / Reyoung Pharmaceutical H
2010 250,00$

Topsun Science and Technology Co., Ltd. (600771) - Financial and Strategic Analysis Review

Topsun Science and Technology Co., Ltd. (600771) - Financial and Strategic Analysis Review / / Summary / / Topsun Science and Te
2010 250,00$

C & O Pharmaceutical Technology (Holdings) Limited (COPT) - Financial and Strategic Analysis Review

C & O Pharmaceutical Technology (Holdings) Limited (COPT) - Financial and Strategic Analysis Review / / Summary / / C & O Pharma
2010 250,00$

CareTech Holdings PLC (CTH) - Financial and Strategic Analysis Review

CareTech Holdings PLC (CTH) - Financial and Strategic Analysis Review / / Summary / / CareTech Holdings PLC (CareTech) is a pub
2010 250,00$

Sichuan Joint-Wit Med. & Pharm. Ind. (809) - Financial and Strategic Analysis Review

Sichuan Joint-Wit Med. & Pharm. Ind. (809) - Financial and Strategic Analysis Review / / Summary / / Sichuan Joint-Wit Med. & Ph
2010 250,00$

Henan Lingrui Pharmaceutical Co., Ltd. (600285) - Financial and Strategic Analysis Review

Henan Lingrui Pharmaceutical Co., Ltd. (600285) - Financial and Strategic Analysis Review / / Summary / / Henan Lingrui Pharmace
2010 250,00$

Guilinjiqi Pharmaceutical Co., Ltd. (750) - Financial and Strategic Analysis Review

Guilinjiqi Pharmaceutical Co., Ltd. (750) - Financial and Strategic Analysis Review / / Summary / / Guilinjiqi Pharmaceutical Co
2010 250,00$

Angel Biotechnology Holdings plc. (ABH) - Financial and Strategic Analysis Review

Angel Biotechnology Holdings plc. (ABH) - Financial and Strategic Analysis Review / / Summary / / Angel is attending BIO 2010 th
2010 250,00$

Sanitas AB (SAN1L) - Financial and Strategic Analysis Review

Sanitas AB (SAN1L) - Financial and Strategic Analysis Review / / Summary / / Sanitas AB (Sanitas) is a publicly held pharmaceuti
2010 125,00$

Qinghai Gelatin Company Limited (606) - Financial and Strategic Analysis Review

Qinghai Gelatin Company Limited (606) - Financial and Strategic Analysis Review / / Summary / / Qinghai Gelatin Company Limited
2010 250,00$

Beximco Pharmaceuticals Ltd. (BXP) - Financial and Strategic Analysis Review

Beximco Pharmaceuticals Ltd. (BXP) - Financial and Strategic Analysis Review / / Summary / / Beximco Pharmaceuticals Ltd. (Bexim
2010 250,00$

S&P Pharmaceutical Co., Ltd. (600869) - Financial and Strategic Analysis Review

S&P Pharmaceutical Co., Ltd. (600869) - Financial and Strategic Analysis Review / / Summary / / S&P Pharmaceutical Co., Ltd. (S&
2010 250,00$

Mebix, Inc. (3780) - Financial and Strategic Analysis Review

Mebix, Inc. (3780) - Financial and Strategic Analysis Review / / Summary / / Mebix, Inc. (Mebix) is a publicly held pharmaceutic
2010 250,00$

Medicare Group QSC (MCGS) - Financial and Strategic Analysis Review

Medicare Group QSC (MCGS) - Financial and Strategic Analysis Review / / Summary / / Medicare Group QSC (Medicare Group) is engag
2010 250,00$

Sichuan Di Kang Sci&Tech Pharm. Ind. Co. (600466) - Financial and Strategic Analysis Review

Sichuan Di Kang Sci&Tech Pharm. Ind. Co. (600466) - Financial and Strategic Analysis Review / / Summary / / Sichuan Dikang Sci&T
2010 250,00$

Clinica Las Condes S.A. (LASCONDES) - Financial and Strategic Analysis Review

Clinica Las Condes S.A. (LASCONDES) - Financial and Strategic Analysis Review / / Summary / / Clinica Las Condes S.A. (CLC) oper
2010 125,00$

Summit Corporation plc (SUMM) - Financial and Strategic Analysis Review

Summit Corporation plc (SUMM) - Financial and Strategic Analysis Review / / Summary / / Summit Corporation plc (Summit Corp) is
2010 250,00$

SeouLin Bioscience Co., Ltd. (38070) - Financial and Strategic Analysis Review

SeouLin Bioscience Co., Ltd. (38070) - Financial and Strategic Analysis Review / / Summary / / SeouLin Bioscience Co., Ltd. (Seo
2010 250,00$

CrystalGenomics, Inc. (83790) - Financial and Strategic Analysis Review

CrystalGenomics, Inc. (83790) - Financial and Strategic Analysis Review / / Summary / / CrystalGenomics, Inc. (CrystalGenomics)
2010 250,00$

Gulf Pharmaceutical Industries PSC (JULPHUR) - Financial and Strategic Analysis Review

Gulf Pharmaceutical Industries PSC (JULPHUR) - Financial and Strategic Analysis Review / / Summary / / Gulf Pharmaceutical Indus
2010 125,00$

Tibet Rhodiola Pharmaceutical Holding Co., Ltd. (600211) - Financial and Strategic Analysis Review

Tibet Rhodiola Pharmaceutical Holding Co., Ltd. (600211) - Financial and Strategic Analysis Review / / Summary / / Tibet Rhodiol
2010 250,00$

Ginwa Enterprise (Group) Inc. (600080) - Financial and Strategic Analysis Review

Ginwa Enterprise (Group) Inc. (600080) - Financial and Strategic Analysis Review / / Summary / / Ginwa Enterprise (Group) Inc. (
2010 250,00$

Hainan Hai Pharmaceutical Co., Ltd. (566) - Financial and Strategic Analysis Review

Hainan Hai Pharmaceutical Co., Ltd. (566) - Financial and Strategic Analysis Review / / Summary / / Hainan Haiyao Co., Ltd. (Hai
2010 250,00$

Pharco Pharmaceuticals (PHPC) - Financial and Strategic Analysis Review

Pharco Pharmaceuticals (PHPC) - Financial and Strategic Analysis Review / / Summary / / Pharco Pharmaceuticals (Pharco Pharma) i
2010 125,00$

Biofarm S.A. (BIO) - Financial and Strategic Analysis Review

Biofarm S.A. (BIO) - Financial and Strategic Analysis Review / / Summary / / Biofarm S.A. (Biofarm) is a specialty pharmaceutica
2010 250,00$

Sanjiu Yigong Biopharmaceutical & Chem - Financial and Strategic Analysis Review

Sanjiu Yigong Biopharmaceutical & Chem - Financial and Strategic Analysis Review / / Summary / / Sanjiu Yigong Biopharmaceutical
2010 250,00$

Tonghua Golden-Horse Pharmaceutical Industry Co. Ltd. (766) - Financial and Strategic Analysis Review

Tonghua Golden-Horse Pharmaceutical Industry Co. Ltd. (766) - Financial and Strategic Analysis Review / / Summary / / Tonghua Go
2010 250,00$

Unisplendour Guhan Group Corporation Ltd (590) - Financial and Strategic Analysis Review

Unisplendour Guhan Group Corporation Ltd (590) - Financial and Strategic Analysis Review / / Summary / / Unisplendour Guhan Grou
2010 250,00$

Jiangzhong Pharmaceutical Co.,Ltd (600750) - Financial and Strategic Analysis Review

Jiangzhong Pharmaceutical Co.,Ltd (600750) - Financial and Strategic Analysis Review / / Summary / / Jiangzhong Pharmaceutical C
2010 125,00$

Guangxi Wuzhou Zhongheng Group Co.,Ltd (600252) - Financial and Strategic Analysis Review

Guangxi Wuzhou Zhongheng Group Co.,Ltd (600252) - Financial and Strategic Analysis Review / / Summary / / Guangxi Wuzhou Zhonghe
2010 250,00$

Along Tibet Co., Ltd. PLC (600773) - Financial and Strategic Analysis Review

Along Tibet Co., Ltd. PLC (600773) - Financial and Strategic Analysis Review / / Summary / / Along Tibet Co., Ltd. PLC (Along Ti
2010 250,00$

Chang An Info Industry (Group) Co.,Ltd (600706) - Financial and Strategic Analysis Review

Chang An Info Industry (Group) Co.,Ltd (600706) - Financial and Strategic Analysis Review / / Summary / / Chang An Info Industry
2010 250,00$

NextGen Group PLC (NGG) - Financial and Strategic Analysis Review

NextGen Group PLC (NGG) - Financial and Strategic Analysis Review / / Summary / / NextGen Group PLC (NextGen) is a biotechnology
2010 250,00$

Jilin Pharmaceutical Co., Ltd (545) - Financial and Strategic Analysis Review

Jilin Pharmaceutical Co., Ltd (545) - Financial and Strategic Analysis Review / / Summary / / Jilin Pharmaceutical Co., Ltd. (Ji
2010 250,00$

Renhe Pharmacy Co., Ltd. (650) - Financial and Strategic Analysis Review

Renhe Pharmacy Co., Ltd. (650) - Financial and Strategic Analysis Review / / Summary / / Renhe Pharmacy Co., Ltd. (RPCL) is a pu
2010 250,00$

Sihuan Pharmaceutical Co.,Ltd. (605) - Financial and Strategic Analysis Review

Sihuan Pharmaceutical Co.,Ltd. (605) - Financial and Strategic Analysis Review / / Summary / / Sihuan Pharmaceutical Co., Ltd. (
2010 250,00$

Kotra Industries Berhad (KOTRA) - Financial and Strategic Analysis Review

Kotra Industries Berhad (KOTRA) - Financial and Strategic Analysis Review / / Summary / / Kotra Industries Berhad (Kotra) is an
2010 250,00$

DongGuan Fangda Renew Reso Indu Co., Ltd (600656) - Financial and Strategic Analysis Review

DongGuan Fangda Renew Reso Indu Co., Ltd (600656) - Financial and Strategic Analysis Review / / Summary / / DongGuan Fangda Rene
2010 250,00$

Anhui Koyo (Group) Co., Ltd. (979) - Financial and Strategic Analysis Review

Anhui Koyo (Group) Co., Ltd. (979) - Financial and Strategic Analysis Review / / Summary / / Anhui Koyo (Group) Co., Ltd. (Koyo)
2010 250,00$

Latvijas Juras medicinas centrs AS (LJM1R) - Financial and Strategic Analysis Review

Latvijas Juras medicinas centrs AS (LJM1R) - Financial and Strategic Analysis Review / / Summary / / Latvijas Juras medicinas ce
2010 250,00$

Clinica de Marly S.A. (CDM) - Financial and Strategic Analysis Review

Clinica de Marly S.A. (CDM) - Financial and Strategic Analysis Review / / Summary / / Clinica de Marly S.A. (Clinica de Marly) m
2010 250,00$

Hikal Limited (524735) - Financial and Strategic Analysis Review

Hikal Limited (524735) - Financial and Strategic Analysis Review / / Summary / / Hikal Limited (Hikal), a China-based public sha
2010 125,00$

Adinotec AG (N1N) - Financial and Strategic Analysis Review

Adinotec AG (N1N) - Financial and Strategic Analysis Review / / Summary / / Adinotec AG (Adinotec) is engaged in the development
2010 250,00$

Rigas Farmaceitiska Fabrika AS (FRM1R) - Financial and Strategic Analysis Review

Rigas Farmaceitiska Fabrika AS (FRM1R) - Financial and Strategic Analysis Review / / Summary / / Rigas Farmaceitiska Fabrika AS
2010 250,00$

Nectar Lifesciences Ltd. (532649) - Financial and Strategic Analysis Review

Nectar Lifesciences Ltd. (532649) - Financial and Strategic Analysis Review / / Summary / / Nectar Lifesciences Ltd (NecLife) is
2010 250,00$

Amoun Pharmaceutical Co. SAE (AMUN) - Financial and Strategic Analysis Review

Amoun Pharmaceutical Co. SAE (AMUN) - Financial and Strategic Analysis Review / / Summary / / Amoun Pharmaceutical Co. SAE (Amou
2010 250,00$

Celestial Labs Limited (532871) - Financial and Strategic Analysis Review

Celestial Labs Limited (532871) - Financial and Strategic Analysis Review / / Summary / / Celestial Labs Limited (CLL) is a bio
2010 250,00$

Golden House Ltd. (GOHO) - Financial and Strategic Analysis Review

Golden House Ltd. (GOHO) - Financial and Strategic Analysis Review / / Summary / / Golden House Ltd. (Golden House) is a public
2010 250,00$

Glaxo SmithKline S.A.E. (BIOC) - Financial and Strategic Analysis Review

Glaxo SmithKline S.A.E. (BIOC) - Financial and Strategic Analysis Review / / Summary / / Glaxo SmithKline S.A.E. is an Egypt bas
2010 250,00$

AdCare Health Systems, Inc. (ADK) - Financial and Strategic Analysis Review

AdCare Health Systems, Inc. (ADK) - Financial and Strategic Analysis Review / / Summary / / AdCare Health Systems, Inc. (AdCare)
2010 250,00$

STAR Pharmaceutical Limited (X64) - Financial and Strategic Analysis Review

STAR Pharmaceutical Limited (X64) - Financial and Strategic Analysis Review / / Summary / / STAR Pharmaceutical Limited (STAR Ph
2010 250,00$

Plethora Solutions Holdings plc (PLE) - Financial and Strategic Analysis Review

Plethora Solutions Holdings plc (PLE) - Financial and Strategic Analysis Review / / Summary / / Plethora Solutions Holdings plc
2010 250,00$

Phynova Group Ltd (PYN) - Financial and Strategic Analysis Review

Phynova Group Ltd (PYN) - Financial and Strategic Analysis Review / / Summary / / Phynova Group Ltd (Phynova) is a pharmaceutica
2010 250,00$

Entelos, Inc. (ENTL) - Financial and Strategic Analysis Review

Entelos, Inc. (ENTL) - Financial and Strategic Analysis Review / / Summary / / Entelos, Inc. (Entelos) is the US based life scie
2010 125,00$

Aqua Bounty Technologies, Inc. (ABTX ) - Financial and Strategic Analysis Review

Aqua Bounty Technologies, Inc. (ABTX ) - Financial and Strategic Analysis Review / / Summary / / Aqua Bounty Technologies, Inc.
2010 250,00$

Millet Innovation SA (ALINN) - Financial and Strategic Analysis Review

Millet Innovation SA (ALINN) - Financial and Strategic Analysis Review / / Summary / / Millet Innovation SA (Millet Innovation)
2010 250,00$

Renovo Group Plc (RNVO) - Financial and Strategic Analysis Review

Renovo Group Plc (RNVO) - Financial and Strategic Analysis Review / / Summary / / Renovo Group Plc (Renovo) is a publicly held b
2010 250,00$

Protalex, Inc. (PRTX) - Financial and Strategic Analysis Review

Protalex, Inc. (PRTX) - Financial and Strategic Analysis Review / / Summary / / Protalex, Inc. (Protalex) is a publicly traded d
2010 250,00$

Plethico Pharmaceuticals Limited (532739) - Financial and Strategic Analysis Review

Plethico Pharmaceuticals Limited (532739) - Financial and Strategic Analysis Review / / Summary / / Plethico Pharmaceuticals Lim
2010 125,00$

Pierrel S.p.A. (PRL) - Financial and Strategic Analysis Review

Pierrel S.p.A. (PRL) - Financial and Strategic Analysis Review / / Summary / / Pierrel S.P.A. (Pierrel) principally operates in
2010 250,00$

PCB SA (PCBB) - Financial and Strategic Analysis Review

PCB SA (PCBB) - Financial and Strategic Analysis Review / / Summary / / PCB SA (PCB) is engaged in the distribution of pharmaceu
2010 125,00$

Clavis Pharma ASA (CLAVIS) - Financial and Strategic Analysis Review

Clavis Pharma ASA (CLAVIS) - Financial and Strategic Analysis Review / / Summary / / Clavis Pharma ASA (Clavis) is a publicly he
2010 250,00$

Pharma Foods International Co., Ltd. (2929) - Financial and Strategic Analysis Review

Pharma Foods International Co., Ltd. (2929) - Financial and Strategic Analysis Review / / Summary / / Pharma Foods International
2010 250,00$

Geneart AG (G6A) - Financial and Strategic Analysis Review

Geneart AG (G6A) - Financial and Strategic Analysis Review / / Summary / / Geneart AG (Geneart) is a service provider that offer
2010 250,00$

atect corporation (4241) - Financial and Strategic Analysis Review

atect corporation (4241) - Financial and Strategic Analysis Review / / Summary / / Atect corporation (Atect) is a public company
2010 250,00$

Oriola-KD Oyj (OKDBV) - Financial and Strategic Analysis Review

Oriola-KD Oyj (OKDBV) - Financial and Strategic Analysis Review / / Summary / / Oriola-KD Oyj (Oriola-KD) is a publicly held pha
2010 125,00$

Pharco SA (PHAR) - Financial and Strategic Analysis Review

Pharco SA (PHAR) - Financial and Strategic Analysis Review / / Summary / / Pharco SA (Pharco) is principally engaged in the area
2010 125,00$

OncoMethylome Sciences S.A. (ONCOB) - Financial and Strategic Analysis Review

OncoMethylome Sciences S.A. (ONCOB) - Financial and Strategic Analysis Review / / Summary / / OncoMethylome Sciences S.A. (OncoM
2010 250,00$

Curalogic A/S (CUR) - Financial and Strategic Analysis Review

Curalogic A/S (CUR) - Financial and Strategic Analysis Review / / Summary / / Curalogic A/S, (Curalogic) is a development stage
2010 250,00$

Le Noble Age S.A. (LNA) - Financial and Strategic Analysis Review

Le Noble Age S.A. (LNA) - Financial and Strategic Analysis Review / / Summary / / Le Noble Age S.A. (Le Noble Age) is a France-b
2010 125,00$

JVM Co., Ltd. (54950) - Financial and Strategic Analysis Review

JVM Co., Ltd. (54950) - Financial and Strategic Analysis Review / / Summary / / JVM Co., Ltd. (JVM Co) is a health care IT compa
2010 250,00$

Granules India Limited. (532482) - Financial and Strategic Analysis Review

Granules India Limited. (532482) - Financial and Strategic Analysis Review / / Summary / / Granules India Ltd. (Granules) is a p
2010 250,00$

CAPS Holdings Limited (CAPS) - Financial and Strategic Analysis Review

CAPS Holdings Limited (CAPS) - Financial and Strategic Analysis Review / / Summary / / CAPS Holdings Limited (CAPS) is one of Af
2010 125,00$

Starwin Products Limited (SPL) - Financial and Strategic Analysis Review

Starwin Products Limited (SPL) - Financial and Strategic Analysis Review / / Summary / / Starwin Products Limited (SPL) is a pha
2010 250,00$

Bradmer Pharmaceuticals Inc. (BMR) - Financial and Strategic Analysis Review

Bradmer Pharmaceuticals Inc. (BMR) - Financial and Strategic Analysis Review / / Summary / / Bradmer Pharmaceuticals Inc. (Bradm
2010 250,00$

COLTENE Holding AG (CLTN) - Financial and Strategic Analysis Review

COLTENE Holding AG (CLTN) - Financial and Strategic Analysis Review / / Summary / / COLTENE Holding AG (COLTENE) is specialized
2010 250,00$

NascaCell Technologies AG (N7C) - Financial and Strategic Analysis Review

NascaCell Technologies AG (N7C) - Financial and Strategic Analysis Review / / Summary / / Nascacell Technologies AG (Nascacell)
2010 250,00$

OraSolv AB (OS) - Financial and Strategic Analysis Review

OraSolv AB (OS) - Financial and Strategic Analysis Review / / Summary / / OraSolv AB (OraSolv) is engaged in acquisition, develo
2010 250,00$

BioXell S.p.A. (BXLN) - Financial and Strategic Analysis Review

BioXell S.p.A. (BXLN) - Financial and Strategic Analysis Review / / Summary / / BioXell S.p.A. is a biopharmaceutical company fo
2010 125,00$

Microbio Co., Ltd. (4128) - Financial and Strategic Analysis Review

Microbio Co., Ltd. (4128) - Financial and Strategic Analysis Review / / Summary / / Microbio Co., Ltd. (Microbio) is a botanical
2010 250,00$

Marksans Pharma Limited (524404) - Financial and Strategic Analysis Review

Marksans Pharma Limited (524404) - Financial and Strategic Analysis Review / / Summary / / Marksans Pharma Limited (Marksans Pha
2010 250,00$

Sucampo Pharmaceuticals, Inc. (SCMP) - Financial and Strategic Analysis Review

Sucampo Pharmaceuticals, Inc. (SCMP) - Financial and Strategic Analysis Review / / Summary / / Sucampo Pharmaceuticals, Inc. (Su
2010 250,00$

ThromboGenics NV (THR) - Financial and Strategic Analysis Review

ThromboGenics NV (THR) - Financial and Strategic Analysis Review / / Summary / / ThromboGenics NV (ThromboGenics) is a publicly
2010 250,00$

Innate Pharma SA (IPH) - Financial and Strategic Analysis Review

Innate Pharma SA (IPH) - Financial and Strategic Analysis Review / / Summary / / Innate Pharma SA (Innate Pharma), is a biopharm
2010 250,00$

HumanOptics AG (H9O) - Financial and Strategic Analysis Review

HumanOptics AG (H9O) - Financial and Strategic Analysis Review / / Summary / / HumanOptics AG (HumanOptics) is a specialty pharm
2010 250,00$

Phylogica Limited (PYC) - Financial and Strategic Analysis Review

Phylogica Limited (PYC) - Financial and Strategic Analysis Review / / Summary / / Phylogica Limited (Phylogica) is a pharmaceuti
2010 250,00$

Curidium Medica plc (CUR) - Financial and Strategic Analysis Review

Curidium Medica plc (CUR) - Financial and Strategic Analysis Review / / Summary / / Curidium Medica plc (Curidium) is a personal
2010 125,00$

MedCap AB (MCAP) - Financial and Strategic Analysis Review

MedCap AB (MCAP) - Financial and Strategic Analysis Review / / Summary / / MedCap AB (MedCap), formerly New Science Svenska AB,
2010 250,00$

Conpharm AB (CONP A) - Financial and Strategic Analysis Review

Conpharm AB (CONP A) - Financial and Strategic Analysis Review / / Summary / / Conpharm AB (Conpharm) is a pharmaceutical compan
2010 250,00$

Oman Medical Projects Company SAOG (OMPS) - Financial and Strategic Analysis Review

Oman Medical Projects Company SAOG (OMPS) - Financial and Strategic Analysis Review / / Summary / / Oman Medical Projects Compan
2010 250,00$

IDL Biotech AB (publ) (IDL B) - Financial and Strategic Analysis Review

IDL Biotech AB (publ) (IDL B) - Financial and Strategic Analysis Review / / Summary / / IDL Biotech AB (publ) (IDL) is a biotech
2010 250,00$

Creative Antibiotics Sweden AB (INPH) - Financial and Strategic Analysis Review

Creative Antibiotics Sweden AB (INPH) - Financial and Strategic Analysis Review / / Summary / / Creative Antibiotics Sweden AB (
2010 250,00$

Proximagen Neuroscience plc. (PRX) - Financial and Strategic Analysis Review

Proximagen Neuroscience plc. (PRX) - Financial and Strategic Analysis Review / / Summary / / Proximagen Neuroscience plc. (Proxi
2010 250,00$

Immunotec Inc. (IMM) - Financial and Strategic Analysis Review

Immunotec Inc. (IMM) - Financial and Strategic Analysis Review / / Summary / / Immunotec Inc. (Immunotec) is engaged in the deve
2010 250,00$

Kamada Ltd. (KMDA) - Financial and Strategic Analysis Review

Kamada Ltd. (KMDA) - Financial and Strategic Analysis Review / / Summary / / Kamada Ltd. (Kamada) is a publicly traded, biopharm
2010 250,00$

Affymax, Inc. (AFFY) - Financial and Strategic Analysis Review

Affymax, Inc. (AFFY) - Financial and Strategic Analysis Review / / Summary / / Affymax, Inc.(Affymax) is a biopharmaceutical com
2010 250,00$

Personalized Nursing Services SA (PNSB) - Financial and Strategic Analysis Review

Personalized Nursing Services SA (PNSB) - Financial and Strategic Analysis Review / / Summary / / Personalized Nursing Services
2010 250,00$

Khimfarm AO (CHFM) - Financial and Strategic Analysis Review

Khimfarm AO (CHFM) - Financial and Strategic Analysis Review / / Summary / / Khimfarm AO (Khimfarm) is a pharmaceutical company,
2010 250,00$

Luis Cassanello SAICECA (CAS) - Financial and Strategic Analysis Review

Luis Cassanello SAICECA (CAS) - Financial and Strategic Analysis Review / / Summary / / Luis Cassanello SAICECA (Luis Cassanello
2010 250,00$

Al-Bilad Medical Services Co. (ABMS) - Financial and Strategic Analysis Review

Al-Bilad Medical Services Co. (ABMS) - Financial and Strategic Analysis Review / / Summary / / Al-Bilad Medical Services Co. (Al
2010 250,00$

Arab Center for Pharmaceutical and Chemical Industries Co. (APHC) - Financial and Strategic Analysis Review

Arab Center for Pharmaceutical and Chemical Industries Co. (APHC) - Financial and Strategic Analysis Review / / Summary / / Arab
2010 250,00$

Hayat Pharmaceutical Industries (HPIC) - Financial and Strategic Analysis Review

Hayat Pharmaceutical Industries (HPIC) - Financial and Strategic Analysis Review / / Summary / / Hayat Pharmaceutical Industries
2010 250,00$

Pinnacle Staffing Group plc (PCL) - Financial and Strategic Analysis Review

Pinnacle Staffing Group plc (PCL) - Financial and Strategic Analysis Review / / Summary / / Pinnacle Staffing Group plc (Pinnacl
2010 250,00$

Tien Liang BioTech Co., Ltd. (4127) - Financial and Strategic Analysis Review

Tien Liang BioTech Co., Ltd. (4127) - Financial and Strategic Analysis Review / / Summary / / Tien Liang BioTech Co., Ltd. (Tien
2010 250,00$

Nang Kuang Pharmaceutical Co., Ltd. (1752) - Financial and Strategic Analysis Review

Nang Kuang Pharmaceutical Co., Ltd. (1752) - Financial and Strategic Analysis Review / / Summary / / Nang Kuang Pharmaceutical C
2010 250,00$

Avonova Sverige AB (AVON) - Financial and Strategic Analysis Review

Avonova Sverige AB (AVON) - Financial and Strategic Analysis Review / / Summary / / Avonova Sverige AB (Avonova, formerly known
2010 250,00$

Biosensor Applications Sweden AB (BIAP A) - Financial and Strategic Analysis Review

Biosensor Applications Sweden AB (BIAP A) - Financial and Strategic Analysis Review / / Summary / / Biosensor Applications Swede
2010 250,00$

Ocean Bright Co., Ltd. (3266) - Financial and Strategic Analysis Review

Ocean Bright Co., Ltd. (3266) - Financial and Strategic Analysis Review / / Summary / / Ocean Bright Co., Ltd. (Ocean Bright) is
2010 250,00$

Genovate Biotechnology Co., LTD. (4130) - Financial and Strategic Analysis Review

Genovate Biotechnology Co., LTD. (4130) - Financial and Strategic Analysis Review / / Summary / / Genovate Biotechnology Co., Lt
2010 250,00$

SCI Pharmtech, Inc. (4119) - Financial and Strategic Analysis Review

SCI Pharmtech, Inc. (4119) - Financial and Strategic Analysis Review / / Summary / / SCI Pharmtech, Inc. ( SCI) is a pharmaceuti
2010 250,00$

Syn-Tech Chem. & Pharm. Co., Ltd. (1777) - Financial and Strategic Analysis Review

Syn-Tech Chem. & Pharm. Co., Ltd. (1777) - Financial and Strategic Analysis Review / / Summary / / Syn-Tech Chem. & Pharm. Co.,
2010 250,00$

Panion & Bf Biotech Inc. (1760) - Financial and Strategic Analysis Review

Panion & Bf Biotech Inc. (1760) - Financial and Strategic Analysis Review / / Summary / / Panion & Bf Biotech Inc. (Panion) is a
2010 250,00$

Replek AD Skopje (REPL) - Financial and Strategic Analysis Review

Replek AD Skopje (REPL) - Financial and Strategic Analysis Review / / Summary / / Replek AD Skopje (Replek AD) is a healthcare c
2010 250,00$

Sagittarius Life Science Corp. (3205) - Financial and Strategic Analysis Review

Sagittarius Life Science Corp. (3205) - Financial and Strategic Analysis Review / / Summary / / Sagittarius Life Science Corp. (
2010 250,00$

OctoPlus N.V. (OCTO) - Financial and Strategic Analysis Review

OctoPlus N.V. (OCTO) - Financial and Strategic Analysis Review / / Summary / / OctoPlus N.V. (OctoPlus) operates as a drug deliv
2010 250,00$

Asiri Surgical Hospital PLC (AMSLN) - Financial and Strategic Analysis Review

Asiri Surgical Hospital PLC (AMSLN) - Financial and Strategic Analysis Review / / Summary / / Asiri Surgical Hospital PLC (Asiri
2010 250,00$

Center Laboratories, Inc. (4123) - Financial and Strategic Analysis Review

Center Laboratories, Inc. (4123) - Financial and Strategic Analysis Review / / Summary / / Center Laboratories, Inc. (Center Lab
2010 250,00$

Level Biotechnology Inc. (3118) - Financial and Strategic Analysis Review

Level Biotechnology Inc. (3118) - Financial and Strategic Analysis Review / / Summary / / Level Biotechnology Inc., (LBI) is a b
2010 250,00$

BIONET Corp. (1784) - Financial and Strategic Analysis Review

BIONET Corp. (1784) - Financial and Strategic Analysis Review / / Summary / / BIONET Corp. (BIONET) is a publicly held stem cell
2010 250,00$

GenMont Biotech Inc. (3164) - Financial and Strategic Analysis Review

GenMont Biotech Inc. (3164) - Financial and Strategic Analysis Review / / Summary / / Genmont Biotech Inc. (Genmont Biotech) is
2010 250,00$

Trident Medical Corp. (4116) - Financial and Strategic Analysis Review

Trident Medical Corp. (4116) - Financial and Strategic Analysis Review / / Summary / / Trident Medical Corp. (Trident Medical) i
2010 250,00$

ChronTech Pharma AB (CTEC) - Financial and Strategic Analysis Review

ChronTech Pharma AB (CTEC) - Financial and Strategic Analysis Review / / Summary / / ChronTech Pharma AB (ChronTech Pharma), for
2010 250,00$

NeutraHealth Plc (NUT) - Financial and Strategic Analysis Review

NeutraHealth Plc (NUT) - Financial and Strategic Analysis Review / / Summary / / NeutraHealth Plc is a UK based holding company.
2010 250,00$

Probiotec Limited (PBP) - Financial and Strategic Analysis Review

Probiotec Limited (PBP) - Financial and Strategic Analysis Review / / Summary / / Probiotec Limited (Probiotec) is engaged in th
2010 250,00$

CytoTools AG (T5O) - Financial and Strategic Analysis Review

CytoTools AG (T5O) - Financial and Strategic Analysis Review / / Summary / / CytoTools AG (CytoTools) is an investment and holdi
2010 250,00$

Fortis Healthcare Limited (532843) - Financial and Strategic Analysis Review

Fortis Healthcare Limited (532843) - Financial and Strategic Analysis Review / / Summary / / Fortis Healthcare Limited (Fortis)
2010 250,00$

China Pharma Holdings, Inc. (CPHI) - Financial and Strategic Analysis Review

China Pharma Holdings, Inc. (CPHI) - Financial and Strategic Analysis Review / / Summary / / China Pharma Holdings, Inc. (China
2010 250,00$

Advanta India Limited (532840) - Financial and Strategic Analysis Review

Advanta India Limited (532840) - Financial and Strategic Analysis Review / / Summary / / Advanta India Limited (AIL) is a resear
2010 250,00$

Astek Group Plc (AKG) - Financial and Strategic Analysis Review

Astek Group Plc (AKG) - Financial and Strategic Analysis Review / / Summary / / Astek Group plc (Astek) is engaged in the manufa
2010 250,00$

China-Biotics, Inc. (CHBT) - Financial and Strategic Analysis Review

China-Biotics, Inc. (CHBT) - Financial and Strategic Analysis Review / / Summary / / China-Biotics Inc. (China-Biotics) is engag
2010 250,00$

Bosnalijek d.d. Sarajevo (BSNLR) - Financial and Strategic Analysis Review

Bosnalijek d.d. Sarajevo (BSNLR) - Financial and Strategic Analysis Review / / Summary / / Bosnalijek d.d. Sarajevo (Bosnalijek)
2010 250,00$

Synopsis Ltd. (SYNO) - Financial and Strategic Analysis Review

Synopsis Ltd. (SYNO) - Financial and Strategic Analysis Review / / Summary / / Synopsis Ltd. (Synopsis) is an Israel-based healt
2010 250,00$

T.R.D. Instrum Ltd. (TRD) - Financial and Strategic Analysis Review

T.R.D. Instrum Ltd. (TRD) - Financial and Strategic Analysis Review / / Summary / / T.R.D. Instrum Ltd. (TRD) is engaged in deve
2010 250,00$

InterCure Ltd. (INCR) - Financial and Strategic Analysis Review

InterCure Ltd. (INCR) - Financial and Strategic Analysis Review / / Summary / / InterCure Ltd. (InterCure) is a medical device c
2010 250,00$

Societe des Industries Pharmaceutiques de Tunisie S.A. (SIPHA) - Financial and Strategic Analysis Review

Societe des Industries Pharmaceutiques de Tunisie S.A. (SIPHA) - Financial and Strategic Analysis Review / / Summary / / Societe
2010 250,00$

Sothema (SOT) - Financial and Strategic Analysis Review

Sothema (SOT) - Financial and Strategic Analysis Review / / Summary / / Sothema is a publicly traded pharmaceutical company that
2010 250,00$

Oasmia Pharmaceutical AB (OASM A) - Financial and Strategic Analysis Review

Oasmia Pharmaceutical AB (OASM A) - Financial and Strategic Analysis Review / / Summary / / Oasmia Pharmaceutical AB (Oasmia Pha
2010 250,00$

RayClinic AB (RCLN B) - Financial and Strategic Analysis Review

RayClinic AB (RCLN B) - Financial and Strategic Analysis Review / / Summary / / RayClinic AB (RayClinic) is a pharmaceutical com
2010 250,00$

Huons Co., Ltd. (84110) - Financial and Strategic Analysis Review

Huons Co., Ltd. (84110) - Financial and Strategic Analysis Review / / Summary / / Huons Co., Ltd. (Huons) is a specialty pharmac
2010 250,00$

Hebi Health Care AB (HEBI B) - Financial and Strategic Analysis Review

Hebi Health Care AB (HEBI B) - Financial and Strategic Analysis Review / / Summary / / Hebi Health Care AB (Hebi Health Care), t
2010 250,00$

European Lifecare Group A/S (DLVS) - Financial and Strategic Analysis Review

European Lifecare Group A/S (DLVS) - Financial and Strategic Analysis Review / / Summary / / European Lifecare Group A/S (Europe
2010 250,00$

Taihua plc (TAIH) - Financial and Strategic Analysis Review

Taihua plc (TAIH) - Financial and Strategic Analysis Review / / Summary / / Taihua plc (Taihua) is an investment holding company
2010 250,00$

Cyclopharm Limited (CYC) - Financial and Strategic Analysis Review

Cyclopharm Limited (CYC) - Financial and Strategic Analysis Review / / Summary / / Cyclopharm Limited (CL) is a medical and heal
2010 250,00$

Imexpharm Pharmaceutical JSC (IMP) - Financial and Strategic Analysis Review

Imexpharm Pharmaceutical JSC (IMP) - Financial and Strategic Analysis Review / / Summary / / Imexpharm Pharmaceutical JSC (Imexp
2010 250,00$

Norwood Immunology Limited (AIM) - Financial and Strategic Analysis Review

Norwood Immunology Limited (AIM) - Financial and Strategic Analysis Review / / Summary / / Norwood Immunology Ltd. (Norwood) is
2010 250,00$

Orexigen Therapeutics, Inc. (OREX) - Financial and Strategic Analysis Review

Orexigen Therapeutics, Inc. (OREX) - Financial and Strategic Analysis Review / / Summary / / Orexigen Therapeutics, Inc. (Orexig
2010 250,00$

Ferozsons Laboratories Limited (FEROZ) - Financial and Strategic Analysis Review

Ferozsons Laboratories Limited (FEROZ) - Financial and Strategic Analysis Review / / Summary / / Ferozsons Laboratories Limited
2010 250,00$

Shifa International Hospitals Limited (SHFA) - Financial and Strategic Analysis Review

Shifa International Hospitals Limited (SHFA) - Financial and Strategic Analysis Review / / Summary / / Shifa International Hospi
2010 250,00$

DiaMedica Inc. (DMA) - Financial and Strategic Analysis Review

DiaMedica Inc. (DMA) - Financial and Strategic Analysis Review / / Summary / / DiaMedica Inc. (DiaMedica) is a publicly held bio
2010 250,00$

Nawaloka Hospitals Private Limited (NHL) - Financial and Strategic Analysis Review

Nawaloka Hospitals Private Limited (NHL) - Financial and Strategic Analysis Review / / Summary / / Nawaloka Hospitals Private Li
2010 250,00$

New Nordic Healthbrands AB (NNH) - Financial and Strategic Analysis Review

New Nordic Healthbrands AB (NNH) - Financial and Strategic Analysis Review / / Summary / / New Nordic Healthbrands AB (New Nordi
2010 250,00$

Oscotec Inc. (39200) - Financial and Strategic Analysis Review

Oscotec Inc. (39200) - Financial and Strategic Analysis Review / / Summary / / Oscotec Inc. (Oscotec) is a publicly held pharmac
2010 250,00$

Cremer SA (CREM3) - Financial and Strategic Analysis Review

Cremer SA (CREM3) - Financial and Strategic Analysis Review / / Summary / / Cremer SA (Cremer) is a manufacturing and distributi
2010 125,00$

Hikari Heights-Varus Co., Ltd. (2137) - Financial and Strategic Analysis Review

Hikari Heights-Varus Co., Ltd. (2137) - Financial and Strategic Analysis Review / / Summary / / Hikari Heights-Varus Co., Ltd. (
2010 250,00$

OPC Pharmaceutical Joint Stock Company (OPC) - Financial and Strategic Analysis Review

OPC Pharmaceutical Joint Stock Company (OPC) - Financial and Strategic Analysis Review / / Summary / / OPC Pharmaceutical Joint
2010 250,00$

Immuno-Biological Laboratories Co., Ltd. (4570) - Financial and Strategic Analysis Review

Immuno-Biological Laboratories Co., Ltd. (4570) - Financial and Strategic Analysis Review / / Summary / / Immuno-Biological Labo
2010 250,00$

Jilin Zixin Pharmaceutical Ind. Co., Ltd (2118) - Financial and Strategic Analysis Review

Jilin Zixin Pharmaceutical Ind. Co., Ltd (2118) - Financial and Strategic Analysis Review / / Summary / / Jilin Zixin Pharmaceut
2010 250,00$

Aptilon Corporation (APZ) - Financial and Strategic Analysis Review

Aptilon Corporation (APZ) - Financial and Strategic Analysis Review / / Summary / / Aptilon Corporation (Aptilon) is a Canada-ba
2010 250,00$

Clinica Baviera SA (CBAV) - Financial and Strategic Analysis Review

Clinica Baviera SA (CBAV) - Financial and Strategic Analysis Review / / Summary / / Clinica Baviera SA (Clinica Baviera) is a Sp
2010 250,00$

Servizi Italia S.p.A. (SRI) - Financial and Strategic Analysis Review

Servizi Italia S.p.A. (SRI) - Financial and Strategic Analysis Review / / Summary / / Servizi Italia S.p.A. (Servizi Italia) is
2010 125,00$

Simcere Pharmaceutical Group (SCR) - Financial and Strategic Analysis Review

Simcere Pharmaceutical Group (SCR) - Financial and Strategic Analysis Review / / Summary / / Simcere Pharmaceutical Group (Simce
2010 125,00$

Ankur Drugs and Pharma Ltd. (531683) - Financial and Strategic Analysis Review

Ankur Drugs and Pharma Ltd. (531683) - Financial and Strategic Analysis Review / / Summary / / Ankur Drugs and Pharma Ltd. (Anku
2010 125,00$

Transgene Biotek Limited (526139) - Financial and Strategic Analysis Review

Transgene Biotek Limited (526139) - Financial and Strategic Analysis Review / / Summary / / Transgene Biotek Limited. (TBL) is a
2010 250,00$

Jupiter Bioscience Limited (524826) - Financial and Strategic Analysis Review

Jupiter Bioscience Limited (524826) - Financial and Strategic Analysis Review / / Summary / / Jupiter Bioscience Limited. (Jupit
2010 250,00$

Themis Medicare Ltd. (530199) - Financial and Strategic Analysis Review

Themis Medicare Ltd. (530199) - Financial and Strategic Analysis Review / / Summary / / Themis Medicare Ltd. (Themis Medicare) i
2010 125,00$

DHG Pharmaceutical JSC (DHG) - Financial and Strategic Analysis Review

DHG Pharmaceutical JSC (DHG) - Financial and Strategic Analysis Review / / Summary / / DHG Pharmaceutical JSC (DHG) is a publicl
2010 250,00$

Protox Therapeutics Inc. (PRX) - Financial and Strategic Analysis Review

Protox Therapeutics Inc. (PRX) - Financial and Strategic Analysis Review / / Summary / / Protox Therapeutics Inc. (Protox) is a
2010 250,00$

MetrioPharm AG (MP5) - Financial and Strategic Analysis Review

MetrioPharm AG (MP5) - Financial and Strategic Analysis Review / / Summary / / MetrioPharm AG (MetrioPharm) is a pharmaceutical
2010 250,00$

Aureum Realwert AG (TRH) - Financial and Strategic Analysis Review

Aureum Realwert AG (TRH) - Financial and Strategic Analysis Review / / Summary / / Aureum Realwert AG, (formerly known as HELIO
2010 250,00$

Skilled Healthcare Group, Inc. (SKH) - Financial and Strategic Analysis Review

Skilled Healthcare Group, Inc. (SKH) - Financial and Strategic Analysis Review / / Summary / / Skilled Healthcare Group, Inc. (S
2010 125,00$

Domesco Medical Import-Export JS Corp (DMC) - Financial and Strategic Analysis Review

Domesco Medical Import-Export JS Corp (DMC) - Financial and Strategic Analysis Review / / Summary / / Domesco Medical Import-Exp
2010 250,00$

DONGKOOK Pharmaceutical Co., Ltd. (86450) - Financial and Strategic Analysis Review

DONGKOOK Pharmaceutical Co., Ltd. (86450) - Financial and Strategic Analysis Review / / Summary / / DONGKOOK Pharmaceutical Co.,
2010 250,00$

Medical Nutrition USA, Inc. (MDNU) - Financial and Strategic Analysis Review

Medical Nutrition USA, Inc. (MDNU) - Financial and Strategic Analysis Review / / Summary / / Medical Nutrition USA, Inc. (MNI) i
2010 250,00$

Farmstandart OAO (PHST) - Financial and Strategic Analysis Review

Farmstandart OAO (PHST) - Financial and Strategic Analysis Review / / Summary / / Farmstandart OAO (Farmstandart) is a publicly
2010 125,00$

Avvaa World Health Care Products, Inc. (AVVH) - Financial and Strategic Analysis Review

Avvaa World Health Care Products, Inc. (AVVH) - Financial and Strategic Analysis Review / / Summary / / Avvaa World Health Care
2010 250,00$

Eternal Technologies Group, Inc. (ETLT) - Financial and Strategic Analysis Review

Eternal Technologies Group, Inc. (ETLT) - Financial and Strategic Analysis Review / / Summary / / Eternal Technologies Group, In
2010 125,00$

Genex Pharmaceutical, Inc. (GENX) - Financial and Strategic Analysis Review

Genex Pharmaceutical, Inc. (GENX) - Financial and Strategic Analysis Review / / Summary / / Genex Pharmaceutical, Inc. (Genex Ph
2010 125,00$

Upstream Biosciences Inc. (UPBS) - Financial and Strategic Analysis Review

Upstream Biosciences Inc. (UPBS) - Financial and Strategic Analysis Review / / Summary / / Upstream Biosciences Inc. (Upstream B
2010 250,00$

Huifeng BioPharmaceutical Technology Inc. (HFGB) - Financial and Strategic Analysis Review

Huifeng BioPharmaceutical Technology Inc. (HFGB) - Financial and Strategic Analysis Review / / Summary / / Huifeng BioPharmaceut
2010 250,00$

Cord Blood America, Inc. (CBAI) - Financial and Strategic Analysis Review

Cord Blood America, Inc. (CBAI) - Financial and Strategic Analysis Review / / Summary / / Cord Blood America, Inc. (Cord Blood)
2010 250,00$

Sinobiomed, Inc. (SOBM) - Financial and Strategic Analysis Review

Sinobiomed, Inc. (SOBM) - Financial and Strategic Analysis Review / / Summary / / Sinobiomed, Inc. (Sinobiomed) is a biotechnolo
2010 125,00$

Raptor Pharmaceuticals Corp. (RPTP) - Financial and Strategic Analysis Review

Raptor Pharmaceuticals Corp. (RPTP) - Financial and Strategic Analysis Review / / Summary / / Raptor Pharmaceuticals Corp. (Rapt
2010 250,00$

Pacer Health Corporation (PHLH) - Financial and Strategic Analysis Review

Pacer Health Corporation (PHLH) - Financial and Strategic Analysis Review / / Summary / / Pacer Health Corporation (Pacer Health
2010 125,00$

Choongwae Holdings Co., Ltd (96760) - Financial and Strategic Analysis Review

Choongwae Holdings Co., Ltd (96760) - Financial and Strategic Analysis Review / / Summary / / Choongwae Holdings Co., Ltd (Choon
2010 125,00$

ReSearch Pharmaceutical Services, Inc. (RPSE) - Financial and Strategic Analysis Review

ReSearch Pharmaceutical Services, Inc. (RPSE) - Financial and Strategic Analysis Review / / Summary / / ReSearch Pharmaceutical
2010 125,00$

Ost Japan Group Inc. (2757) - Financial and Strategic Analysis Review

Ost Japan Group Inc. (2757) - Financial and Strategic Analysis Review / / Summary / / Ost Japan Group Inc. (Ost Japan) is a publ
2010 250,00$

Redpoint Bio Corporation (RPBC) - Financial and Strategic Analysis Review

Redpoint Bio Corporation (RPBC) - Financial and Strategic Analysis Review / / Summary / / Redpoint Bio Corporation (Redpoint) is
2010 250,00$

Societe Adwya SA (ADWYA) - Financial and Strategic Analysis Review

Societe Adwya SA (ADWYA) - Financial and Strategic Analysis Review / / Summary / / Societe Adwya SA (Societe Adwya) is engaged i
2010 250,00$

Sunway Global Inc. (SUWG) - Financial and Strategic Analysis Review

Sunway Global Inc. (SUWG) - Financial and Strategic Analysis Review / / Summary / / Sunway Global Inc. (Sunway Global) is a medi
2010 250,00$

Guilin Layn Natural Ingredients Corp. (2166) - Financial and Strategic Analysis Review

Guilin Layn Natural Ingredients Corp. (2166) - Financial and Strategic Analysis Review / / Summary / / Guilin Layn Natural Ingre
2010 250,00$

IPC The Hospitalist Company, Inc. (IPCM) - Financial and Strategic Analysis Review

IPC The Hospitalist Company, Inc. (IPCM) - Financial and Strategic Analysis Review / / Summary / / IPC The Hospitalist Company,
2010 125,00$

Aqua Bio Technology ASA (ATB) - Financial and Strategic Analysis Review

Aqua Bio Technology ASA (ATB) - Financial and Strategic Analysis Review / / Summary / / Aqua Bio Technology ASA (ABT) is a Norwa
2010 250,00$

Biotoxtech Co., Ltd (86040) - Financial and Strategic Analysis Review

Biotoxtech Co., Ltd (86040) - Financial and Strategic Analysis Review / / Summary / / Biotoxtech Co., Ltd (Biotoxtech) is a publ
2010 250,00$

China Kangtai Cactus Bio-Tech Inc. (CKGT) - Financial and Strategic Analysis Review

China Kangtai Cactus Bio-Tech Inc. (CKGT) - Financial and Strategic Analysis Review / / Summary / / China Kangtai Cactus Bio-Tec
2010 250,00$

Highnoon Laboratories Limited (HINOON) - Financial and Strategic Analysis Review

Highnoon Laboratories Limited (HINOON) - Financial and Strategic Analysis Review / / Summary / / Highnoon Laboratories Limited (
2010 250,00$

Sun Pharma Advanced Research Company (532872) - Financial and Strategic Analysis Review

Sun Pharma Advanced Research Company (532872) - Financial and Strategic Analysis Review / / Summary / / Sun Pharma Advanced Rese
2010 250,00$

Imuniti Holdings Limited (IMU) - Financial and Strategic Analysis Review

Imuniti Holdings Limited (IMU) - Financial and Strategic Analysis Review / / Summary / / Imuniti Holdings Limited (Imuniti) is a
2010 250,00$

Stem Cell Therapeutics Corp. (SSS) - Financial and Strategic Analysis Review

Stem Cell Therapeutics Corp. (SSS) - Financial and Strategic Analysis Review / / Summary / / Stem Cell Therapeutics Corp. (SCT)
2010 250,00$

Neimeth International Pharmaceutical PLC (NEIMETH) - Financial and Strategic Analysis Review

Neimeth International Pharmaceutical PLC (NEIMETH) - Financial and Strategic Analysis Review / / Summary / / Neimeth Internation
2010 250,00$

CPEX Pharmaceuticals, Inc. (CPEX) - Financial and Strategic Analysis Review

CPEX Pharmaceuticals, Inc. (CPEX) - Financial and Strategic Analysis Review / / Summary / / CPEX Pharmaceuticals, Inc. (CPEX) is
2010 250,00$

MIC Medical Corporation (2166) - Financial and Strategic Analysis Review

MIC Medical Corporation (2166) - Financial and Strategic Analysis Review / / Summary / / MIC Medical Corporation (MIC Medical) i
2010 250,00$

RXi Pharmaceuticals Corporation (RXII) - Financial and Strategic Analysis Review

RXi Pharmaceuticals Corporation (RXII) - Financial and Strategic Analysis Review / / Summary / / RXi Pharmaceuticals Corporation
2010 250,00$

ProMD Biotech Co., Ltd. (4731) - Financial and Strategic Analysis Review

ProMD Biotech Co., Ltd. (4731) - Financial and Strategic Analysis Review / / Summary / / ProMD Biotech Co., Ltd. (ProMD) is a ph
2010 250,00$

Nattopharma ASA (NATTO) - Financial and Strategic Analysis Review

Nattopharma ASA (NATTO) - Financial and Strategic Analysis Review / / Summary / / Nattopharma ASA (Nattopharma) is a publicly he
2010 250,00$

PharmaFarm SA (NAFA) - Financial and Strategic Analysis Review

PharmaFarm SA (NAFA) - Financial and Strategic Analysis Review / / Summary / / PharmaFarm SA is a pharmaceutical distribution co
2010 125,00$

Hybrigenics S.A. (ALHYG) - Financial and Strategic Analysis Review

Hybrigenics S.A. (ALHYG) - Financial and Strategic Analysis Review / / Summary / / Hybrigenics S.A. is a France based bio-pharma
2010 125,00$

Nepentes SA (NEP) - Financial and Strategic Analysis Review

Nepentes SA (NEP) - Financial and Strategic Analysis Review / / Summary / / Nepentes S.A. (Nepentes) is a publicly held pharmace
2010 250,00$

Transdermal Cosmetics Plc (TRCP) - Financial and Strategic Analysis Review

Transdermal Cosmetics Plc (TRCP) - Financial and Strategic Analysis Review / / Summary / / Transdermal Cosmetics Plc (Transderma
2010 250,00$

Japan Tissue Engineering Co., Ltd. (7774) - Financial and Strategic Analysis Review

Japan Tissue Engineering Co., Ltd. (7774) - Financial and Strategic Analysis Review / / Summary / / Japan Tissue Engineering Co.
2010 250,00$

EastPharma Ltd. (EAST) - Financial and Strategic Analysis Review

EastPharma Ltd. (EAST) - Financial and Strategic Analysis Review / / Summary / / EastPharma Ltd. (EastPharma) is a publicly held
2010 125,00$

B.M.P. Pharma Trading AG (BMP) - Financial and Strategic Analysis Review

B.M.P. Pharma Trading AG (BMP) - Financial and Strategic Analysis Review / / Summary / / B.M.P. Pharma Trading AG (B.M.P) is eng
2010 250,00$

NatureWise Biotech & Medicals Corp (4732) - Financial and Strategic Analysis Review

NatureWise Biotech & Medicals Corp (4732) - Financial and Strategic Analysis Review / / Summary / / NatureWise Biotech & Medical
2010 250,00$

InfuSystem Holdings, Inc. (INHI) - Financial and Strategic Analysis Review

InfuSystem Holdings, Inc. (INHI) - Financial and Strategic Analysis Review / / Summary / / InfuSystem Holdings, Inc. (InfuSystem
2010 250,00$

Aoxing Pharmaceutical Company, Inc (AXN) - Financial and Strategic Analysis Review

Aoxing Pharmaceutical Company, Inc (AXN) - Financial and Strategic Analysis Review / / Summary / / Aoxing Pharmaceutical Company
2010 250,00$

Skystar Bio-Pharmaceutical Company (SKBI) - Financial and Strategic Analysis Review

Skystar Bio-Pharmaceutical Company (SKBI) - Financial and Strategic Analysis Review / / Summary / / Skystar Bio-Pharmaceutical C
2010 250,00$

Global Pharmatech, Inc. (GBLP) - Financial and Strategic Analysis Review

Global Pharmatech, Inc. (GBLP) - Financial and Strategic Analysis Review / / Summary / / Global Pharmatech, Inc. (Global Pharmat
2010 125,00$

China Health Resource, Inc. (CHRI) - Financial and Strategic Analysis Review

China Health Resource, Inc. (CHRI) - Financial and Strategic Analysis Review / / Summary / / China Health Resource, Inc. (CHR) i
2010 250,00$

Gansu Duyiwei Biological Pharmaceutical Co., Ltd. (2219) - Financial and Strategic Analysis Review

Gansu Duyiwei Biological Pharmaceutical Co., Ltd. (2219) - Financial and Strategic Analysis Review / / Summary / / Gansu Duyiwei
2010 250,00$

NanoCarrier Co., Ltd. (4571) - Financial and Strategic Analysis Review

NanoCarrier Co., Ltd. (4571) - Financial and Strategic Analysis Review / / Summary / / NanoCarrier Co., Ltd. (NanoCarrier) is a
2010 250,00$

Lotus Eye Care Hospital Limited (532998) - Financial and Strategic Analysis Review

Lotus Eye Care Hospital Limited (532998) - Financial and Strategic Analysis Review / / Summary / / Lotus Eye Care Hospital Limit
2010 250,00$

Carna Biosciences, Inc. (4572) - Financial and Strategic Analysis Review

Carna Biosciences, Inc. (4572) - Financial and Strategic Analysis Review / / Summary / / Carna Biosciences, Inc. (Carna Bioscien
2010 250,00$

ER Urgent Care Holdings, Inc. (ERUC) - Financial and Strategic Analysis Review

ER Urgent Care Holdings, Inc. (ERUC) - Financial and Strategic Analysis Review / / Summary / / ER Urgent Care Holdings, Inc. (ER
2010 125,00$

Senzime AB (SEZI) - Financial and Strategic Analysis Review

Senzime AB (SEZI) - Financial and Strategic Analysis Review / / Summary / / Senzime AB (Senzime) is a Sweden-based biotechnology
2010 250,00$

R-Tech Ueno, Ltd. (4573) - Financial and Strategic Analysis Review

R-Tech Ueno, Ltd. (4573) - Financial and Strategic Analysis Review / / Summary / / R-Tech Ueno, Ltd. (R-Tech) is principally eng
2010 250,00$

Hartalega Holdings Berhad (HARTA) - Financial and Strategic Analysis Review

Hartalega Holdings Berhad (HARTA) - Financial and Strategic Analysis Review / / Summary / / Hartalega Holdings Berhad (Hartalega
2010 250,00$

G&E Herbal Biotechnology Co., Ltd. (4911) - Financial and Strategic Analysis Review

G&E Herbal Biotechnology Co., Ltd. (4911) - Financial and Strategic Analysis Review / / Summary / / G&E Herbal Biotechnology Co.
2010 250,00$

Ambalal Sarabhai Enterprises Limited (500009) - Financial and Strategic Analysis Review

Ambalal Sarabhai Enterprises Limited (500009) - Financial and Strategic Analysis Review / / Summary / / Ambalal Sarabhai Enterpr
2010 250,00$

Rexahn Pharmaceuticals, Inc. (RNN) - Financial and Strategic Analysis Review

Rexahn Pharmaceuticals, Inc. (RNN) - Financial and Strategic Analysis Review / / Summary / / Rexahn Pharmaceuticals, Inc., (Rexa
2010 250,00$

Myungmoon pharmaceutical Co.,Ltd. (17180) - Financial and Strategic Analysis Review

Myungmoon pharmaceutical Co.,Ltd. (17180) - Financial and Strategic Analysis Review / / Summary / / Myungmoon pharmaceutical Co.
2010 250,00$

NeuroVive Pharmaceutical AB (NVP) - Financial and Strategic Analysis Review

NeuroVive Pharmaceutical AB (NVP) - Financial and Strategic Analysis Review / / Summary / / NeuroVive Pharmaceutical AB (NeuroVi
2010 250,00$

Piramal Life Sciences Limited (532979) - Financial and Strategic Analysis Review

Piramal Life Sciences Limited (532979) - Financial and Strategic Analysis Review / / Summary / / Piramal Life Sciences Limited (
2010 250,00$

Abnova Corporation (4133) - Financial and Strategic Analysis Review

Abnova Corporation (4133) - Financial and Strategic Analysis Review / / Summary / / Abnova Corporation (Abnova) is a biotechnolo
2010 250,00$

Unipharm AD (59X) - Financial and Strategic Analysis Review

Unipharm AD (59X) - Financial and Strategic Analysis Review / / Summary / / Unipharm AD (Unipharm) is engaged in the manufacturi
2010 250,00$

Ina Research Inc. (2176) - Financial and Strategic Analysis Review

Ina Research Inc. (2176) - Financial and Strategic Analysis Review / / Summary / / Ina Research Inc. (INA) is a public traded, c
2010 250,00$

Genomma Lab Internacional SAB de CV (LABB) - Financial and Strategic Analysis Review

Genomma Lab Internacional SAB de CV (LABB) - Financial and Strategic Analysis Review / / Summary / / Genomma Lab Internacional,
2010 125,00$

Healthway Medical Corporation Limited (5NG) - Financial and Strategic Analysis Review

Healthway Medical Corporation Limited (5NG) - Financial and Strategic Analysis Review / / Summary / / Healthway Medical Corporat
2010 250,00$

Qualitas Medical Group Sdn Bhd. (5NN) - Financial and Strategic Analysis Review

Qualitas Medical Group Sdn Bhd. (5NN) - Financial and Strategic Analysis Review / / Summary / / Qualitas Medical Group Sdn Bhd.
2010 250,00$

Jiangsu Nhwa Pharma Corporation (2262) - Financial and Strategic Analysis Review

Jiangsu Nhwa Pharma Corporation (2262) - Financial and Strategic Analysis Review / / Summary / / Jiangsu Nhwa Pharma Corporation
2010 125,00$

Enervit S.p.A. (ENV) - Financial and Strategic Analysis Review

Enervit S.p.A. (ENV) - Financial and Strategic Analysis Review / / Summary / / Enervit S.p.A. (Enervit) is a healthcare company
2010 250,00$

Growell Holdings Co., Ltd. (3141) - Financial and Strategic Analysis Review

Growell Holdings Co., Ltd. (3141) - Financial and Strategic Analysis Review / / Summary / / Growell Holdings Co., Ltd. (Growell)
2010 125,00$

Gamma Pharmaceuticals Inc. (GMPM) - Financial and Strategic Analysis Review

Gamma Pharmaceuticals Inc. (GMPM) - Financial and Strategic Analysis Review / / Summary / / Gamma Pharmaceuticals Inc. (Gamma Ph
2010 250,00$

PuraMed BioScience Inc. (PMBS) - Financial and Strategic Analysis Review

PuraMed BioScience Inc. (PMBS) - Financial and Strategic Analysis Review / / Summary / / PuraMed BioScience Inc. (PuraMed) is a
2010 250,00$

Fluorotechnics Limited (FLS) - Financial and Strategic Analysis Review

Fluorotechnics Limited (FLS) - Financial and Strategic Analysis Review / / Summary / / Fluorotechnics Limited (Fluorotechnics) i
2010 250,00$

Medizone International, Inc. (MZEI) - Financial and Strategic Analysis Review

Medizone International, Inc. (MZEI) - Financial and Strategic Analysis Review / / Summary / / Medizone International, Inc. (Medi
2010 250,00$

Merrion Pharmaceuticals Plc (3MP) - Financial and Strategic Analysis Review

Merrion Pharmaceuticals Plc (3MP) - Financial and Strategic Analysis Review / / Summary / / Merrion Pharmaceuticals Plc (Merrion
2010 250,00$

Scancell Holdings Plc (SCLP) - Financial and Strategic Analysis Review

Scancell Holdings Plc (SCLP) - Financial and Strategic Analysis Review / / Summary / / Scancell Holdings plc (Scancell) is a bio
2010 250,00$

Sunzen Biotech Berhad (SUNZEN) - Financial and Strategic Analysis Review

Sunzen Biotech Berhad (SUNZEN) - Financial and Strategic Analysis Review / / Summary / / Sunzen Biotech Berhad (Sunzen Biotech)
2010 250,00$

Clinique du Rond-Point des Champs Elysees SA (MLCRP) - Financial and Strategic Analysis Review

Clinique du Rond-Point des Champs Elysees SA (MLCRP) - Financial and Strategic Analysis Review / / Summary / / Clinique du Rond-
2010 250,00$

Tiens Biotech Group (USA), Inc. (TBV) - Financial and Strategic Analysis Review

Tiens Biotech Group (USA), Inc. (TBV) - Financial and Strategic Analysis Review / / Summary / / Tiens Biotech Group (USA), Inc.
2010 250,00$

Kovai Medical Center & Hospital Limited (523323) - Financial and Strategic Analysis Review

Kovai Medical Center & Hospital Limited (523323) - Financial and Strategic Analysis Review / / Summary / / Kovai Medical Center
2010 250,00$

Indraprastha Medical Corporation Limited (532150) - Financial and Strategic Analysis Review

Indraprastha Medical Corporation Limited (532150) - Financial and Strategic Analysis Review / / Summary / / Indraprastha Medical
2010 250,00$

Malar Hospitals Ltd (523696) - Financial and Strategic Analysis Review

Malar Hospitals Ltd (523696) - Financial and Strategic Analysis Review / / Summary / / Malar Hospitals Ltd (Malar) is an Associa
2010 250,00$

Sanacorp Pharmaholding AG (SNC3) - Financial and Strategic Analysis Review

Sanacorp Pharmaholding AG (SNC3) - Financial and Strategic Analysis Review / / Summary / / Sanacorp Pharmaholding AG (formerly k
2010 250,00$

Gufic BioSciences Limited (509079) - Financial and Strategic Analysis Review

Gufic BioSciences Limited (509079) - Financial and Strategic Analysis Review / / Summary / / Gufic BioSciences Limited (Gufic Bi
2010 250,00$

Medicamen Biotech Limited (531146) - Financial and Strategic Analysis Review

Medicamen Biotech Limited (531146) - Financial and Strategic Analysis Review / / Summary / / Medicamen Biotech Limited (Medicame
2010 250,00$

Hester Biosciences Limited (524669) - Financial and Strategic Analysis Review

Hester Biosciences Limited (524669) - Financial and Strategic Analysis Review / / Summary / / Hester Biosciences Limited (Hester
2010 250,00$

Aventis Pharma Limited (AVENTIS) - Financial and Strategic Analysis Review

Aventis Pharma Limited (AVENTIS) - Financial and Strategic Analysis Review / / Summary / / Aventis Pharma Limited (Aventis) is a
2010 125,00$

Prospect Medical Holdings Inc (PZZ) - Financial and Strategic Analysis Review

Prospect Medical Holdings Inc (PZZ) - Financial and Strategic Analysis Review / / Summary / / Prospect Medical Holdings, Inc. (P
2010 125,00$

MiMedx Group, Inc (MDXG) - Financial and Strategic Analysis Review

MiMedx Group, Inc (MDXG) - Financial and Strategic Analysis Review / / Summary / / MiMedx Group, Inc.(MiMedx Group) is engaged i
2010 250,00$

Incitive Ltd. (ICV) - Financial and Strategic Analysis Review

Incitive Ltd. (ICV) - Financial and Strategic Analysis Review / / Summary / / Incitive Ltd. (Incitive) is a research focused bio
2010 250,00$

Genolier Swiss Medical Network SA (GSMN) - Financial and Strategic Analysis Review

Genolier Swiss Medical Network SA (GSMN) - Financial and Strategic Analysis Review / / Summary / / Genolier Swiss Medical Networ
2010 250,00$

Cumberland Pharmaceuticals, Inc. (CPIX) - Financial and Strategic Analysis Review

Cumberland Pharmaceuticals, Inc. (CPIX) - Financial and Strategic Analysis Review / / Summary / / Cumberland Pharmaceuticals, In
2010 250,00$

Logibec Groupe Informatique Ltd. (LGI) - Financial and Strategic Analysis Review

Logibec Groupe Informatique Ltd. (LGI) - Financial and Strategic Analysis Review / / Summary / / Logibec Groupe Informatique Ltd
2010 125,00$

Zandu Pharmaceutical Works Ltd. (506720) - Financial and Strategic Analysis Review

Zandu Pharmaceutical Works Ltd. (506720) - Financial and Strategic Analysis Review / / Summary / / Zandu Pharmaceutical Works Lt
2010 250,00$

Skin Health Spa PLC (SHS) - Financial and Strategic Analysis Review

Skin Health Spa PLC (SHS) - Financial and Strategic Analysis Review / / Summary / / Skin Health Spa PLC (Skin Health Spa) is an
2010 125,00$

Accura Animal Health Plc (ACPO) - Financial and Strategic Analysis Review

Accura Animal Health Plc (ACPO) - Financial and Strategic Analysis Review / / Summary / / Accura Animal Health Plc (Accura) is a
2010 250,00$

Verona Pharma Plc - Financial and Strategic Analysis Review

Verona Pharma Plc - Financial and Strategic Analysis Review / / Summary / / Verona Pharma Plc (Verona), formerly known as Isis R
2010 125,00$

HOV Services Limited (532761) - Financial and Strategic Analysis Review

HOV Services Limited (532761) - Financial and Strategic Analysis Review / / Summary / / HOV Services Limited (HOV) is engaged in
2010 125,00$

Magic Software Enterprises Ltd. (MGIC) - Financial and Strategic Analysis Review

Magic Software Enterprises Ltd. (MGIC) - Financial and Strategic Analysis Review / / Summary / / Magic Software Enterprises Ltd.
2010 125,00$

Dhanuka Agritech Ltd (507717) - Financial and Strategic Analysis Review

Dhanuka Agritech Ltd (507717) - Financial and Strategic Analysis Review / / Summary / / Dhanuka Agritech Ltd (DAL) is engaged in
2010 250,00$

PCI Biotech Holding ASA (PCIB) - Financial and Strategic Analysis Review

PCI Biotech Holding ASA (PCIB) - Financial and Strategic Analysis Review / / Summary / / PCI Biotech AS (PCI Biotech) is princip
2010 250,00$

The Avicena Group, Inc. (AVCEE) - Financial and Strategic Analysis Review

The Avicena Group, Inc. (AVCEE) - Financial and Strategic Analysis Review / / Summary / / The Avicena Group, Inc. (Avicena) is a
2010 125,00$

Grupo Estrella SA (QUES) - Financial and Strategic Analysis Review

Grupo Estrella SA (QUES) - Financial and Strategic Analysis Review / / Summary / / Grupo Estrella SA (Estrella) is focused on th
2010 250,00$

Instituto Rosenbusch S.A. (ROSE) - Financial and Strategic Analysis Review

Instituto Rosenbusch S.A. (ROSE) - Financial and Strategic Analysis Review / / Summary / / Instituto Rosenbusch S.A. (Instituto
2010 250,00$

Hypermarcas SA (HYPE3) - Financial and Strategic Analysis Review

Hypermarcas SA (HYPE3) - Financial and Strategic Analysis Review / / Summary / / Hypermarcas SA (Hypermarcas) is engaged in manu
2010 125,00$

Medical Union Pharmaceuticals Company (MEDU) - Financial and Strategic Analysis Review

Medical Union Pharmaceuticals Company (MEDU) - Financial and Strategic Analysis Review / / Summary / / Medical Union Pharmaceuti
2010 250,00$

Amreyah Pharmaceuticals Company (ARPP) - Financial and Strategic Analysis Review

Amreyah Pharmaceuticals Company (ARPP) - Financial and Strategic Analysis Review / / Summary / / Amreyah Pharmaceuticals Company
2010 250,00$

The Nile Co. for Pharm & Chemical Ind. (NIPH) - Financial and Strategic Analysis Review

The Nile Co. for Pharm & Chemical Ind. (NIPH) - Financial and Strategic Analysis Review / / Summary / / The Nile Co. for Pharm &
2010 250,00$

Cairo Pharmaceuticals and Chemical Industries (CPCI) - Financial and Strategic Analysis Review

Cairo Pharmaceuticals and Chemical Industries (CPCI) - Financial and Strategic Analysis Review / / Summary / / Cairo Pharmaceuti
2010 250,00$

Alexandria Pharmaceutical and Chemical Industries Company (AXPH) - Financial and Strategic Analysis Review

Alexandria Pharmaceutical and Chemical Industries Company (AXPH) - Financial and Strategic Analysis Review / / Summary / / Alexa
2010 250,00$

GlaxoSmithKline Pharmaceuticals Limited (500660) - Financial and Strategic Analysis Review

GlaxoSmithKline Pharmaceuticals Limited (500660) - Financial and Strategic Analysis Review / / Summary / / GlaxoSmithKline Pharm
2010 125,00$

Jagsonpal Pharmaceuticals Limited (507789) - Financial and Strategic Analysis Review

Jagsonpal Pharmaceuticals Limited (507789) - Financial and Strategic Analysis Review / / Summary / / Jagsonpal Pharmaceuticals L
2010 250,00$

Affitech A/S (AFFITECH) - Financial and Strategic Analysis Review

Affitech A/S (AFFITECH) - Financial and Strategic Analysis Review / / Summary / / Affitech A/S (Affitech) is a publicly held pha
2010 250,00$

Fresenius Kabi Oncology Limited (532545) - Financial and Strategic Analysis Review

Fresenius Kabi Oncology Limited (532545) - Financial and Strategic Analysis Review / / Summary / / Fresenius Kabi Oncology Limit
2010 250,00$

Wyeth Limited (500095) - Financial and Strategic Analysis Review

Wyeth Limited (500095) - Financial and Strategic Analysis Review / / Summary / / Wyeth Limited is a pharmaceutical company, enga
2010 250,00$

Sharon Bio-Medicine Ltd. (590034) - Financial and Strategic Analysis Review

Sharon Bio-Medicine Ltd. (590034) - Financial and Strategic Analysis Review / / Summary / / Sharon Bio-Medicine Ltd. (Sharon) is
2010 250,00$

Aarti Drugs Ltd. (524348) - Financial and Strategic Analysis Review

Aarti Drugs Ltd. (524348) - Financial and Strategic Analysis Review / / Summary / / Aarti Drugs Ltd. (Aarti Drugs) is an India b
2010 250,00$

Astrazeneca Pharma India Limited (506820) - Financial and Strategic Analysis Review

Astrazeneca Pharma India Limited (506820) - Financial and Strategic Analysis Review / / Summary / / AstraZeneca Pharma India Lim
2010 250,00$

Global Advanced Wound Management: Market Analysis and Opportunity Assessment

Introduction / / GlobalData’s “Global Advanced Wound Management: Market Analysis and Opportunity Assessment” report is an essen
2009 3.500,00$

Global Endoscopes Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s medical equipment report, “Global Endoscopes Equipment Pipeline Analysis, Opportunity Assessment an
2010 3.500,00$

Global Hospital Information Systems (HIS) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016

Introduction / / GlobalData’s medical equipment report, “Global Hospital Information Systems (HIS) Opportunity Assessment, Compet
2010 3.500,00$

Medtronic to Acquire ATS Medical

Introduction / / Medtronic, Inc., a medical device company, signed a definitive agreement to acquire ATS Medical, Inc., a cardiov
2010 500,00$

Brazil Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Brazil Cardiovascular Devices Market Outlook to 2016” provides key marke
2010 2.500,00$

Mexico Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Mexico Cardiovascular Devices Market Outlook to 2016” provides key marke
2010 2.500,00$

Israel Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Israel Cardiovascular Devices Market Outlook to 2016” provides key marke
2010 2.500,00$

United States Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “US Diagnostic Imaging Market Outlook to 2016” provides key market data o
2010 2.500,00$

United Kingdom Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “UK Diagnostic Imaging Market Outlook to 2016” provides key market data o
2010 2.500,00$

India Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “India Diagnostic Imaging Market Outlook to 2016” provides key market dat
2010 2.500,00$

China Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “China Diagnostic Imaging Market Outlook to 2016” provides key market dat
2010 2.500,00$

Canada Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Canada Diagnostic Imaging Market Outlook to 2016” provides key market da
2010 2.500,00$

Italy Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Italy Diagnostic Imaging Market Outlook to 2016” provides key market dat
2010 2.500,00$

Brazil Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Brazil Diagnostic Imaging Market Outlook to 2016” provides key market da
2010 2.500,00$

Netherlands Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Netherlands Diagnostic Imaging Market Outlook to 2016” provides key mark
2010 2.500,00$

Mexico Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Mexico Diagnostic Imaging Market Outlook to 2016” provides key market da
2010 2.500,00$

Taiwan Diagnostic Imaging Market Outlook to 2016

Introduction / / GlobalData’s medical equipment report, “Taiwan Diagnostic Imaging Market Outlook to 2016” provides key market da
2010 2.500,00$

The UK Medical Devices Industry: Increasing Incidence of Lifestyle Disorders Driving Growth

Introduction / / GlobalData’s report, “The UK Medical Devices Industry: Increasing Incidence of Lifestyle Disorders Driving Growt
2010 500,00$

Insulet and Ypsomed Sign Distribution Agreement for Europe: Ypsomed Expected to Expand Market for Insulin Pump Therapy

Introduction / / Insulet is a start up company in the insulin delivery market. The company’s product, the Omnipod, which is a dis
2010 500,00$

Canada Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “Canada Cardiovascular Devices Market Outlook to 2016” provides key market data on the
2010 2.500,00$

Germany Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “Germany Cardiovascular Devices Market Outlook to 2016” provides key market data on the
2010 2.500,00$

Spain Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “Spain Cardiovascular Devices Market Outlook to 2016” provides key market data on the S
2010 2.500,00$

Netherlands Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “Netherlands Cardiovascular Devices Market Outlook to 2016” provides key market data on
2010 2.500,00$

Belgium Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “Belgium Cardiovascular Devices Market Outlook to 2016” provides key market data on the
2010 2.500,00$

South Africa Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “South Africa Cardiovascular Devices Market Outlook to 2016” provides key market data o
2010 2.500,00$

United Kingdom Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “The UK Cardiovascular Devices Market Outlook to 2016” provides key market data on the
2010 2.500,00$

Japan Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “Japan Cardiovascular Devices Market Outlook to 2016” provides key market data on the J
2010 2.500,00$

United States Diabetes Care Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “US Diabetes Care Devices Market Outlook to 2016” provides key market data on the US di
2010 2.500,00$

United States Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s new report, “US Cardiovascular Devices Market Outlook to 2016” provides key market data on the US c
2010 2.500,00$

Medical Equipment Quarterly Deals Analysis: M&A and Investments Trends - Q1 2010

Introduction / / GlobalData's “Medical Equipment Quarterly Deals Analysis: M&A and Investments Trends - Q1 2010” report is an ess
2010 1.500,00$

Medical Equipment Monthly Deals Analysis: M&A and Investments Trends - May 2010

Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis: M&A and Investments Trends – May 2010” report is an esse
2010 1.000,00$

Vacuum Assisted Breast Biopsy Systems: A Market Snapshot

Introduction / / GlobalData’s report, “Vacuum Assisted Breast Biopsy Systems: A Market Snapshot” provides key data, information a
2010 500,00$

Healthcare Reform: Impact on Medical Device Industry

Introduction / / GlobalData’s report, “Healthcare Reform: Impact on Medical Device Industry” provides key insights, information a
2010 500,00$

European Union (EU) Medical Device Directive (MDD) Changes: Industry Impact Analysis

Introduction / / Medical devices are primarily used for a physical effect on the body and are overseen by regulatory systems for
2010 500,00$

Arteriotomy Closure Devices: A Market Snapshot

Introduction / / GlobalData’s report, “Arteriotomy Closure Devices: A Market Snapshot” provides key data, information and analysi
2010 500,00$

Platelet Rich Plasma: A Market Snapshot

Introduction / / GlobalData’s report, “Platelet Rich Plasma (PRP): Market Snapshot” provides key data, information on the US plat
2010 500,00$

Rigid Video Laryngoscopes: A Market Snapshot

Introduction / / GlobalData’s report, “Rigid Video Laryngoscopes: A Market Snapshot” provides key data, information and analysis
2010 500,00$

Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s medical device report offering, “Global Renal Dialysis Equipment Pipeline Analysis, Opportunity A
2010 3.500,00$

Israel Patient Monitoring Market Outlook to 2016

Introduction / / GlobalData’s medical device report offering, “Israel Patient Monitoring Market Outlook to 2016” provides key m
2010 2.500,00$

France Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s medical device report offering, “France Cardiovascular Devices Market Outlook to 2016” provides k
2010 2.500,00$

Italy Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s medical device report offering, “Italy Cardiovascular Devices Market Outlook to 2016” provides ke
2010 2.500,00$

Australia Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s medical device report offering, “Australia Cardiovascular Devices Market Outlook to 2016” provide
2010 2.500,00$

Argentina Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s medical device report offering, “Argentina Cardiovascular Devices Market Outlook to 2016” provide
2010 2.500,00$

Republic of Korea Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s medical device report offering, “Republic of Korea Cardiovascular Devices Market Outlook to 2016”
2010 2.500,00$

Taiwan Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s medical device report offering, “Taiwan Cardiovascular Devices Market Outlook to 2016” provides k
2010 2.500,00$

India Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s medical device report offering, “India Cardiovascular Devices Market Outlook to 2016” provides ke
2010 2.500,00$

China Cardiovascular Devices Market Outlook to 2016

Introduction / / GlobalData’s medical device report offering, “China Cardiovascular Devices Market Outlook to 2016” provides ke
2010 2.500,00$

Spain Diabetes Care Devices Market Outlook to 2016

Introduction / / GlobalData’s medical device report offering, “Spain Diabetes Care Devices Market Outlook to 2016” provides key
2010 2.500,00$

Argentina Diabetes Care Devices Market Outlook to 2016

Introduction / / GlobalData’s medical device report offering, “Argentina Diabetes Care Devices Market Outlook to 2016” provides
2010 2.500,00$

Israel Diabetes Care Devices Market Outlook to 2016

Introduction / / GlobalData’s medical device report offering, “Israel Diabetes Care Devices Market Outlook to 2016” provides ke
2010 2.500,00$

Global Infusion Systems Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s new report, “Global Infusion Systems Pipeline Analysis, Opportunity Assessment and Market Forecas
2010 3.500,00$

Angiotech Pharma Acquires Product Candidates and Technology Assets from Haemacure Corporation

Introduction / / Angiotech Pharmaceuticals, Inc. a specialty pharmaceutical and medical device company, announced the closing o
2010 500,00$

United Kingdom Diabetes Care Devices Market Outlook to 2016

Introduction / / GlobalData's medical equipment offering - “The UK Diabetes Care Devices Market Outlook to 2016” provides key m
2010 2.500,00$

Canada Diabetes Care Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment offering, “Canada Diabetes Care Devices Market Outlook to 2016” provides key ma
2010 2.500,00$

Germany Diabetes Care Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment offering, “Germany Diabetes Care Devices Market Outlook to 2016” provides key m
2010 2.500,00$

France Diabetes Care Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment offering, “France Diabetes Care Devices Market Outlook to 2016” provides key ma
2010 2.500,00$

Italy Diabetes Care Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment offering, “Italy Diabetes Care Devices Market Outlook to 2016” provides key mar
2010 2.500,00$

Australia Diabetes Care Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment offering, “Australia Diabetes Care Devices Market Outlook to 2016” provides key
2010 2.500,00$

Brazil Diabetes Care Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment offering, “Brazil Diabetes Care Devices Market Outlook to 2016” provides key ma
2010 2.500,00$

Netherlands Diabetes Care Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment offering, “Netherlands Diabetes Care Devices Market Outlook to 2016” provides k
2010 2.500,00$

Belgium Diabetes Care Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment offering, “Belgium Diabetes Care Devices Market Outlook to 2016” provides key m
2010 2.500,00$

Mexico Diabetes Care Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment offering, “Mexico Diabetes Care Devices Market Outlook to 2016” provides key ma
2010 2.500,00$

South Africa Diabetes Care Devices Market Outlook to 2016

Introduction / / GlobalData’s medical equipment offering, “South Africa Diabetes Care Devices Market Outlook to 2016” provides
2010 2.500,00$

Hepatitis C - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData has released a pharmaceutical and healthcare report, “hepatitis C – Drug Pipeline Analysis and Mark
2010 2.000,00$

Pneumonia - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData’s pharmaceutical and healthcare report offering, “Pneumonia - Drug Pipeline Analysis and Market For
2010 2.000,00$

Germany Patient Monitoring Market Outlook to 2016

Market size and company share data for seven patient monitoring market categories – Multiparameter Patient Monitoring, Remote Pati
2010 2.500,00$

Belgium Patient Monitoring Market Outlook to 2016

Market size and company share data for seven patient monitoring market categories – Multiparameter Patient Monitoring, Remote Pati
2010 2.500,00$

Republic of Korea Patient Monitoring Market Outlook to 2016

Market size and company share data for seven patient monitoring market categories – Multiparameter Patient Monitoring, Remote Pati
2010 2.500,00$

Taiwan Patient Monitoring Market Outlook to 2016

Market size and company share data for seven patient monitoring market categories – Multiparameter Patient Monitoring, Remote Pati
2010 2.500,00$

South Africa Patient Monitoring Market Outlook to 2016

Market size and company share data for seven patient monitoring market categories – Multiparameter Patient Monitoring, Remote Pati
2010 2.500,00$

Japan Diabetes Care Devices Market Outlook to 2016

Market size and company share data for two diabetes care devices market categories – Glucose Monitoring and Insulin Delivery. / A
2010 2.500,00$

India Diabetes Care Devices Market Outlook to 2016

Market size and company share data for two diabetes care devices market categories – Glucose Monitoring and Insulin Delivery. / A
2010 2.500,00$

China Diabetes Care Devices Market Outlook to 2016

Market size and company share data for two diabetes care devices market categories – Glucose Monitoring and Insulin Delivery. / A
2010 2.500,00$

Republic of Korea Diabetes Care Devices Market Outlook to 2016

Market size and company share data for two diabetes care devices market categories – Glucose Monitoring and Insulin Delivery. / A
2010 2.500,00$

Taiwan Diabetes Care Devices Market Outlook to 2016

Market size and company share data for two diabetes care devices market categories – Glucose Monitoring and Insulin Delivery. / A
2010 2.500,00$

Anemia - Drug Pipeline Analysis and Market Forecasts to 2016

Annualized global anemia market revenues data from 2001 to 2009, forecast forward for seven years to 2016. / Geographies covered
2010 2.000,00$

Canada Patient Monitoring Market Outlook to 2016

Introduction / / GlobalData’s new report, “Canada Patient Monitoring Market Outlook to 2016” provides key market data on the Ca
2010 2.500,00$

France Patient Monitoring Market Outlook to 2016

Introduction / / GlobalData’s new report, “France Patient Monitoring Market Outlook to 2016” provides key market data on the Fr
2010 2.500,00$

Italy Patient Monitoring Market Outlook to 2016

Introduction / / GlobalData’s new report, “Italy Patient Monitoring Market Outlook to 2016” provides key market data on the Ita
2010 2.500,00$

Australia Patient Monitoring Market Outlook to 2016

Introduction / / GlobalData’s new report, “Australia Patient Monitoring Market Outlook to 2016” provides key market data on the
2010 2.500,00$

Brazil Patient Monitoring Market Outlook to 2016

Introduction / / GlobalData’s new report, “Brazil Patient Monitoring Market Outlook to 2016” provides key market data on the Br
2010 2.500,00$

Netherlands Patient Monitoring Market Outlook to 2016

Introduction / / GlobalData’s new report, “Netherlands Patient Monitoring Market Outlook to 2016” provides key market data on t
2010 2.500,00$

Argentina Patient Monitoring Market Outlook to 2016

Introduction / / GlobalData’s new report, “Argentina Patient Monitoring Market Outlook to 2016” provides key market data on the
2010 2.500,00$

Mexico Patient Monitoring Market Outlook to 2016

Introduction / / GlobalData’s new report, “Mexico Patient Monitoring Market Outlook to 2016” provides key market data on the Me
2010 2.500,00$

Healthcare Information and Management Systems Society (HIMSS) 2010 - Conference Review and Analysis

Introduction / / GlobalData’s “Healthcare Information and Management Systems Society (HIMSS) 2010: Conference Review and Analys
2010 1.000,00$

United Kingdom Patient Monitoring Market Outlook to 2016

Introduction / / GlobalData’s new report, “The UK Patient Monitoring Market Outlook to 2016” provides key market data on the Un
2010 2.500,00$

Japan Patient Monitoring Market Outlook to 2016

Introduction / / GlobalData’s new report, “Japan Patient Monitoring Market Outlook to 2016” provides key market data on the Jap
2010 2.500,00$

India Patient Monitoring Market Outlook to 2016

Introduction / / GlobalData’s new report, “India Patient Monitoring Market Outlook to 2016” provides key market data on the Ind
2010 2.500,00$

China Patient Monitoring Market Outlook to 2016

Introduction / / GlobalData’s new report, “China Patient Monitoring Market Outlook to 2016” provides key market data on the Chi
2010 2.500,00$

Global Orthopedic Devices Pipeline Landscape: Analysis of Key Upcoming Products and Technologies

Introduction / / While the leading orthopedic device manufacturers continue to be impacted by economic and regulatory challenge
2010 3.500,00$

Hepatitis B - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData\'s report, “Hepatitis B – Drug Pipeline Analysis and Market Forecasts to 2016” is an essential sour
2010 2.000,00$

Candidiasis - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData’s report, “Candidiasis - Drug Pipeline Analysis and Market Forecasts to 2016”, provides an essentia
2010 2.000,00$

Dysmenorrhea - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData’s report, “Dysmenorrhea - Drug Pipeline Analysis and Market Forecasts to 2016” is an essential sour
2010 2.000,00$

Global Drug Eluting Balloons (DEB) Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Introduction / / GlobalData’s report, “Global Drug Eluting Balloons (DEB) Pipeline Analysis, Opportunity Assessment and Market
2010 3.500,00$

American Academy of Orthopedic Surgeons (AAOS) 2010: Conference Review and Analysis

Introduction / / GlobalData’s “American Academy of Orthopedic Surgeons (AAOS) 2010: Conference Review and Analysis” report is a
2010 1.000,00$

HIV/AIDS - Drug Pipeline Analysis and Market Forecasts to 2016

Annualized global HIV/AIDS market revenues data from 2001 to 2009, forecast for seven years to 2016. / Geographies covered in th
2010 2.000,00$

Nonalcoholic Steatohepatitis - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData's report, “Nonalcoholic Steatohepatitis (NASH)– Drug Pipeline Analysis and Market Forecasts to 2016
2010 2.000,00$

Bristol-Myers Squibb Company (BMY) SWOT Profile

Bristol-Myers Squibb Company (BMY) SWOT Profile / / Summary / / GlobalData’s Bristol-Myers Squibb Company (BMY) SWOT Profile is
2010 150,00$

Genzyme Corporation (GENZ) SWOT Profile

Genzyme Corporation (GENZ) SWOT Profile / / Summary / / GlobalData’s Genzyme Corporation (GENZ) SWOT Profile is a comprehensive
2010 150,00$

Aethlon Medical, Inc. (AEMD) SWOT Profile

Aethlon Medical, Inc. (AEMD) SWOT Profile / / Summary / / GlobalData’s Aethlon Medical, Inc. (AEMD) SWOT Profile is a comprehens
2010 150,00$

Abraxis BioScience, Inc. (ABII) SWOT Profile

Abraxis BioScience, Inc. (ABII) SWOT Profile / / Summary / / GlobalData’s Abraxis BioScience, Inc. (ABII) SWOT Profile is a comp
2010 150,00$

Affymetrix, Inc. (AFFX) SWOT Profile

Affymetrix, Inc. (AFFX) SWOT Profile / / Summary / / GlobalData’s Affymetrix, Inc. (AFFX) SWOT Profile is a comprehensive busine
2010 150,00$

AtriCure, Inc. (ATRC) SWOT Profile

AtriCure, Inc. (ATRC) SWOT Profile / / Summary / / GlobalData’s AtriCure, Inc. (ATRC) SWOT Profile is a comprehensive business,
2010 150,00$

Endologix, Inc. (ELGX) SWOT Profile

Endologix, Inc. (ELGX) SWOT Profile / / Summary / / GlobalData’s Endologix, Inc. (ELGX) SWOT Profile is a comprehensive business
2010 150,00$

bioMerieux S.A. (BIM) SWOT Profile

bioMerieux S.A. (BIM) SWOT Profile / / Summary / / GlobalData’s bioMerieux S.A. (BIM) SWOT Profile is a comprehensive business,
2010 150,00$

Sonova Holding AG (SOON) SWOT Profile

Sonova Holding AG (SOON) SWOT Profile / / Summary / / GlobalData’s Sonova Holding AG (SOON) SWOT Profile is a comprehensive busi
2010 150,00$

ev3 Inc. (EVVV) SWOT Profile

ev3 Inc. (EVVV) SWOT Profile / / Summary / / GlobalData’s ev3 Inc. (EVVV) SWOT Profile is a comprehensive business, functional a
2010 150,00$

Eli Lilly and Company (LLY) SWOT Profile

Eli Lilly and Company (LLY) SWOT Profile / / Summary / / GlobalData’s Eli Lilly and Company (LLY) SWOT Profile is a comprehensiv
2010 150,00$

Universal Biosensors, Inc. (UBI) SWOT Profile

Universal Biosensors, Inc. (UBI) SWOT Profile / / Summary / / GlobalData’s Universal Biosensors, Inc. (UBI) SWOT Profile is a co
2010 150,00$

iSOFT Group Limited (ISF) SWOT Profile

Universal Biosensors, Inc. (UBI) SWOT Profile / / Summary / / GlobalData’s Universal Biosensors, Inc. (UBI) SWOT Profile is a co
2010 150,00$

Texas Instruments Incorporated (TXN) SWOT Profile

Texas Instruments Incorporated (TXN) SWOT Profile / / Summary / / GlobalData’s Texas Instruments Incorporated (TXN) SWOT Profile
2010 150,00$

Sepracor Inc. (BAACEZ) SWOT Profile

Sepracor Inc. (BAACEZ) SWOT Profile / / Summary / / GlobalData’s Sepracor Inc. (BAACEZ) SWOT Profile is a comprehensive business
2010 150,00$

Koninklijke Philips Electronics N.V. (PHIA) SWOT Profile

Koninklijke Philips Electronics N.V. (PHIA) SWOT Profile / / Summary / / GlobalData’s Koninklijke Philips Electronics N.V. (PHIA
2010 150,00$

Illumina, Inc. (ILMN) SWOT Profile

Illumina, Inc. (ILMN) SWOT Profile / / Summary / / GlobalData’s Illumina, Inc. (ILMN) SWOT Profile is a comprehensive business,
2010 150,00$

AlphaRx, Inc. (ALRX) SWOT Profile

AlphaRx, Inc. (ALRX) SWOT Profile / / Summary / / GlobalData’s AlphaRx, Inc. (ALRX) SWOT Profile is a comprehensive business, fu
2010 150,00$

Valeant Pharmaceuticals International (VRX) SWOT Profile

Valeant Pharmaceuticals International (VRX) SWOT Profile / / Summary / / GlobalData’s Valeant Pharmaceuticals International (VRX
2010 150,00$

Neoprobe Corporation (NEOP) SWOT Profile

Neoprobe Corporation (NEOP) SWOT Profile / / Summary / / GlobalData’s Neoprobe Corporation (NEOP) SWOT Profile is a comprehensiv
2010 150,00$

Antares Pharma, Inc. (AIS) SWOT Profile

Antares Pharma, Inc. (AIS) SWOT Profile / / Summary / / GlobalData’s Antares Pharma, Inc. (AIS) SWOT Profile is a comprehensive
2010 150,00$

Sanofi-Aventis (SAN) SWOT Profile

Sanofi-Aventis (SAN) SWOT Profile / / Summary / / GlobalData’s Sanofi-Aventis (SAN) SWOT Profile is a comprehensive business, fu
2010 150,00$

Agilent Technologies Inc. (A) SWOT Profile

Agilent Technologies, Inc. (A) SWOT Profile / / Summary / / GlobalData’s Agilent Technologies, Inc. (A) SWOT Profile is a compre
2010 150,00$

GlaxoSmithKline plc (GSK) SWOT Profile

GlaxoSmithKline plc (GSK) SWOT Profile / / Summary / / GlobalData’s GlaxoSmithKline plc (GSK) SWOT Profile is a comprehensive bu
2010 150,00$

Bioniche Life Sciences, Inc. (BNC) SWOT Profile

Bioniche Life Sciences, Inc. (BNC) SWOT Profile / / Summary / / GlobalData’s Bioniche Life Sciences, Inc. (BNC) SWOT Profile is
2010 150,00$

Millipore Corporation (MIL) SWOT Profile

Millipore Corporation (MIL) SWOT Profile / / Summary / / GlobalData’s Millipore Corporation (MIL) SWOT Profile is a comprehensiv
2010 150,00$

Alkermes, Inc. (ALKS) SWOT Profile

Alkermes, Inc. (ALKS) SWOT Profile / / Summary / / GlobalData’s Alkermes, Inc. (ALKS) SWOT Profile is a comprehensive business,
2010 150,00$

E. I. du Pont de Nemours and Company (DD) SWOT Profile

E. I. du Pont de Nemours and Company (DD) SWOT Profile / / Summary / / GlobalData’s E. I. du Pont de Nemours and Company (DD) SW
2010 150,00$

Myriad Genetics, Inc. (MYGN) SWOT Profile

Myriad Genetics, Inc. (MYGN) SWOT Profile / / Summary / / GlobalData’s Myriad Genetics, Inc. (MYGN) SWOT Profile is a comprehens
2010 150,00$

Novo Nordisk A/S (NOVO B) SWOT Profile

Novo Nordisk A/S (NOVO B) SWOT Profile / / Summary / / GlobalData’s Novo Nordisk A/S (NOVO B) SWOT Profile is a comprehensive bu
2010 150,00$

Cepheid (CPHD) SWOT Profile

Cepheid (CPHD) SWOT Profile / / Summary / / GlobalData’s Cepheid (CPHD) SWOT Profile is a comprehensive business, functional and
2010 150,00$

CK Life Sciences Int'l., (Holdings) Inc. (0775) SWOT Profile

CK Life Sciences Int'l., (Holdings) Inc. (0775) SWOT Profile / / Summary / / GlobalData’s CK Life Sciences Int'l., (Holdings) In
2010 150,00$

Healthscope Limited (HSP) SWOT Profile

Healthscope Limited (HSP) SWOT Profile / / Summary / / GlobalData’s Healthscope Limited (HSP) SWOT Profile is a comprehensive bu
2010 150,00$

IMS Health Incorporated (RX) SWOT Profile

IMS Health Incorporated (RX) SWOT Profile / / Summary / / GlobalData’s IMS Health Incorporated (RX) SWOT Profile is a comprehens
2010 150,00$

InterMune, Inc. (ITMN) SWOT Profile

InterMune, Inc. (ITMN) SWOT Profile / / Summary / / GlobalData’s InterMune, Inc. (ITMN) SWOT Profile is a comprehensive business
2010 150,00$

Kindred Healthcare, Inc. (KND) SWOT Profile

Kindred Healthcare, Inc. (KND) SWOT Profile / / Summary / / GlobalData’s Kindred Healthcare, Inc. (KND) SWOT Profile is a compre
2010 150,00$

King Pharmaceuticals, Inc. (KG) SWOT Profile

King Pharmaceuticals, Inc. (KG) SWOT Profile / / Summary / / GlobalData’s King Pharmaceuticals, Inc. (KG) SWOT Profile is a comp
2010 150,00$

KV Pharmaceutical Company (KV.A) SWOT Profile

KV Pharmaceutical Company (KV.A) SWOT Profile / / Summary / / GlobalData’s KV Pharmaceutical Company (KV.A) SWOT Profile is a co
2010 150,00$

Magellan Health Services, Inc. (MGLN) SWOT Profile

Magellan Health Services, Inc. (MGLN) SWOT Profile / / Summary / / GlobalData’s Magellan Health Services, Inc. (MGLN) SWOT Profi
2010 150,00$

Novavax, Inc. (NVAX) SWOT Profile

Novavax, Inc. (NVAX) SWOT Profile / / Summary / / GlobalData’s Novavax, Inc. (NVAX) SWOT Profile is a comprehensive business, fu
2010 150,00$

Acura Pharmaceuticals, Inc. (ACUR) SWOT Profile

Acura Pharmaceuticals, Inc. (ACUR) SWOT Profile / / Summary / / GlobalData’s Acura Pharmaceuticals, Inc. (ACUR) SWOT Profile is
2010 150,00$

Hikma Pharmaceuticals PLC (HIK) SWOT Profile

Hikma Pharmaceuticals PLC (HIK) SWOT Profile / / Summary / / GlobalData’s Hikma Pharmaceuticals PLC (HIK) SWOT Profile is a comp
2010 150,00$

Enzo Biochem, Inc. (ENZ) SWOT Profile

Enzo Biochem, Inc. (ENZ) SWOT Profile / / Summary / / GlobalData’s Enzo Biochem, Inc. (ENZ) SWOT Profile is a comprehensive busi
2010 150,00$

Imugene Limited (IMU) SWOT Profile

Imugene Limited (IMU) SWOT Profile / / Summary / / GlobalData’s Imugene Limited (IMU) SWOT Profile is a comprehensive business,
2010 150,00$

Active Biotech AB (ACTI) SWOT Profile

Active Biotech AB (ACTI) SWOT Profile / / Summary / / GlobalData’s Active Biotech AB (ACTI) SWOT Profile is a comprehensive busi
2010 150,00$

AEterna Zentaris Inc. (AEZ) SWOT Profile

AEterna Zentaris Inc. (AEZ) SWOT Profile / / Summary / / GlobalData’s AEterna Zentaris Inc. (AEZ) SWOT Profile is a comprehensiv
2010 150,00$

Immtech Pharmaceuticals, Inc. (IMMP) SWOT Profile

Immtech Pharmaceuticals, Inc. (IMMP) SWOT Profile / / Summary / / GlobalData’s Immtech Pharmaceuticals, Inc. (IMMP) SWOT Profile
2010 150,00$

Amicus Therapeutics, Inc. (FOLD) SWOT Profile

Amicus Therapeutics, Inc. (FOLD) SWOT Profile / / Summary / / GlobalData’s Amicus Therapeutics, Inc. (FOLD) SWOT Profile is a co
2010 150,00$

IMMUNOMEDICS, INC (IMMU) SWOT Profile

IMMUNOMEDICS, INC (IMMU) SWOT Profile / / Summary / / GlobalData’s IMMUNOMEDICS, INC (IMMU) SWOT Profile is a comprehensive busi
2010 150,00$

Ardea Biosciences, Inc. (RDEA) SWOT Profile

Ardea Biosciences, Inc. (RDEA) SWOT Profile / / Summary / / GlobalData’s Ardea Biosciences, Inc. (RDEA) SWOT Profile is a compre
2010 150,00$

Insmed Incorporated (INSM) SWOT Profile

Insmed Incorporated (INSM) SWOT Profile / / Summary / / GlobalData’s Insmed Incorporated (INSM) SWOT Profile is a comprehensive
2010 150,00$

Takeda Pharmaceutical Company Limited SWOT Profile

Takeda Pharmaceutical Company Limited SWOT Profile / / Summary / / GlobalData’s Takeda Pharmaceutical Company Limited SWOT Profi
2010 150,00$

Medical Equipment Monthly Deals Analysis: M&A and Investments Trends – April 2010

Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis M&A and Investments Trends – April 2010” report is an e
2010 1.000,00$

Liver Cancer - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Liver Cancer - Drug Pipeline Analysis and Market F
2010 2.000,00$

Cyanoacrylates Tissue Adhesives - A Market Snapshot

Introduction / / GlobalData’s report, “Cyanoacrylates Tissue Adhesives: A Market Snapshot” provides key data, information and a
2010 500,00$

Gastroesophageal Reflux Disease - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Gastroesophageal Reflux Disease (GERD) – Drug Pipe
2010 2.000,00$

Polycystic Ovarian Syndrome - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Polycystic Ovarian Syndrome– Drug Pipeline Analysi
2010 2.000,00$

Medical Equipment Monthly Deals Analysis: M&A and Investments Trends - March 2010

Introduction / / "GlobalData's “Medical Equipment Monthly Deals Analysis M&A and Investments Trends – March 2010” report is an es
2010 1.000,00$

Huntington's Disease - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData’s report on the pharmaceutical and healthcare industry - “Huntington’s disease – Drug Pipeline Analys
2010 2.000,00$

Global Spinal Surgery Devices: Market Analysis and Opportunity Assessment

Introduction / / GlobalData’s “Global Spinal Surgery Devices: Market Analysis and Opportunity Assessment report is an essential s
2009 3.500,00$

Healthcare IT: A Market Poised for Strong Growth in the Future

Introduction / / GlobalData’s report, “Healthcare IT: A Market Poised for Strong Growth in the Future” provides key data, informa
2010 500,00$

Investment Opportunities in the Medical Devices Sector

Introduction / / GlobalData’s report, “Investment Opportunities in the Medical Device Sector” provides key insights, information
2010 500,00$

Sterilization Wraps: A Market Snapshot

Introduction / / GlobalData’s report, “Sterilization Wraps: A Market Snapshot” provides key data, information and analysis on the
2010 500,00$

Lyme Disease - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Lyme Disease – Drug Pipeline Analysis and Market For
2010 2.000,00$

Acute Heart Failure - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Acute Heart Failure – Drug Pipeline Analysis and Mar
2010 2.000,00$

Meningitis - Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData’s report, “Meningitis – Pipeline Analysis and Market Forecasts to 2016” is an essential source of inf
2010 2.000,00$

Amyotrophic Lateral Sclerosis (Lou Gehrig's) - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData’s report, “Amyotrophic lateral sclerosis (Lou Gehrigs) - Drug Pipeline Analysis and Market Forecasts
2010 2.000,00$

Medical Equipment Annual Deals Analysis 2010

Introduction / / "GlobalData's “Medical Equipment Annual Deals Analysis 2010” report is an essential source of data and trend ana
2010 3.500,00$

Medical Equipment Monthly Deals Analysis - February 2010

Introduction / / "GlobalData's “Medical Equipment Monthly Deals Analysis – February 2010” report is an essential source of data a
2010 1.000,00$

Asian Oil Companies Looking To Capitalize On the Opportunity in the Canadian Oil Sands Industry

Introduction / / The decline in oil reserves worldwide is challenging oil and gas companies to seek new fields in order to mainta
2010 500,00$

Medical Equipment Quarterly Deals Analysis Q4 2009

Introduction / / GlobalData's “Medical Equipment Quarterly Deal Analysis Q4 2009” report is an essential source of data and tre
2010 1.500,00$

Dyslipidemia - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Dyslipidemia - Drug Pipeline Analysis and Market F
2010 2.000,00$

Pulmonary Arterial Hypertension (PAH) - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Pulmonary Arterial Hypertension (PAH) - Drug Pipel
2010 2.000,00$

Anti-hypertension - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Anti-Hypertension - Drug Pipeline Analysis and Mar
2010 2.000,00$

Autism - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Autism - Drug Pipeline Analysis and Market Forecas
2010 2.000,00$

Bone Morphogenic Proteins: Future Therapeutic Applications

Introduction / / Stimulating the human body to generate and repair bone, reliably and quickly has been one of the greatest challe
2010 500,00$

Diagnostic Imaging in Developing Economies: A Closer Look at Accessibility

Introduction / / Patient access to diagnostic imaging in emerging economies varies across different economic regions within the s
2010 500,00$

Dystonia - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Dystonia - Drug Pipeline Analysis and Market Forecas
2010 2.000,00$

Venous Thromboembolism - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Venous Thromboembolism - Drug Pipeline Analysis and
2010 2.000,00$

Global Cardiovascular Devices Pipeline Landscape: Analysis of Key Upcoming Products and Technologies

Introduction / / While the leading cardiovascular device manufacturers continue to be impacted by economic and regulatory challen
2010 2.000,00$

Outsourcing in the Global Medical Equipment Industry - The Market Expected to Register High Growth in the Future

Introduction / / GlobalData’s new report, “Outsourcing in the Global Medical Equipment Industry - The Market Expected to Register
2010 3.500,00$

Chronic Obstructive Pulmonary Disease (COPD) - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist, has released a new report, “Chronic Obstructive Pulmonary Disease
2010 2.000,00$

Global Peritoneal Dialysis Market: Strategic Analysis and Opportunity Assessment

The report provides market size data and information on the global peritoneal dialysis market. / - Annualized market revenues data
2010 3.500,00$

US Hip and Knee Implants: Strategic Market Analysis and Insight to 2015

Introduction / / GlobalData has released its latest research on a key segment within the medical equipment industry. The “US Hip
2009 3.500,00$

UK Orthopedic Devices Market Analysis and Forecasts to 2015

Introduction / / GlobalData’s “UK Orthopedic Devices Market Analysis and Forecasts to 2015” report provides key data, information
2010 3.500,00$

Medical Equipment Monthly Deals Analysis – January 2010

Introduction / / "GlobalData's “Medical Equipment Monthly Deals Analysis – January 2010” report is an essential source of data an
2010 1.000,00$

US Computed Tomography (CT) Systems Market: Strategic Analysis and Opportunity Assessment to 2015

Introduction / / GlobalData has released its latest research on a key segment within the medical equipment industry. The “US Comp
2009 3.500,00$

Europe Nuclear Imaging Equipment: Market Analysis and Opportunity Assessment

Introduction / / GlobalData has released its latest research on a key segment within the medical equipment industry. The “Europe
2009 3.500,00$

Flexible Endoscope Pipeline Technology and Market Forecasts to 2015

Introduction / / GlobalData’s “Flexible Endoscope Pipeline Technology and Market Forecasts to 2015” report is an essential source
2009 2.000,00$

US Surgical Sutures Market: Surgical Procedures Growth to Drive Demand

Introduction / / GlobalData’s “US Surgical Sutures Market: Surgical Procedures Growth to Drive Demand” report is an essential sou
2009 3.500,00$

Europe Picture Archiving and Communication Systems (PACS) Market: Market Analysis and Opportunity Assessment

Introduction / / GlobalData’s “Europe Picture Archiving and Communication Systems (PACS) Market: Increasing Adoption to Drive Gro
2009 3.500,00$

Contrast Media: A Market Snapshot

Introduction / / The global contrast media market was valued at $5.4 billion in 2008, and is expected to grow to $7.9 billion in
2009 500,00$

Small Medium Enterprises: The Powerhouse of Innovation for Medical Device Industry

Introduction / / Rapid innovation is a pre-condition for survival of medical device companies, given the quick turnaround time of
2009 500,00$

Trocars: A Market Snapshot

Introduction / / The global market for trocars was valued at $800m in 2008. Increasing use of trocars in laparoscopic surgeries i
2009 500,00$

The US Cardiac Resynchronization Therapy Market: Positive Clinical Trial Results to Boost Growth

Introduction / / Cardiac Resynchronization Therapy (CRT) devices have been studied clinically since 1998, and have been on the US
2009 500,00$

The US Neurology Devices Market to Present Opportunities for Growth

Introduction / / Some of the major markets like cardiovascular and orthopedic devices have witnessed immense innovation over the
2009 500,00$

Australia Medical Equipment Market Analysis and Forecasts to 2015

Introduction / / GlobalData’s “Australia Medical Equipment Market Analysis and Forecasts to 2015” report provides key data, infor
2009 3.500,00$

Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Introduction / / This Medical Device report is an essential source for key information and data relating to the global Anesthesia
2009 4.000,00$

Global Cardiovascular Devices Market Analysis & Forecasts to 2015

Introduction / / This Medical Device report is an essential source for key information and data relating to the global Cardiovasc
2009 4.000,00$

Global Dental Devices Market Analysis and Forecasts to 2015

Introduction / / This Medical Device report is an essential source for key information and data relating to the global dental dev
2009 4.000,00$

Global Orthopedic Devices Market Analysis & Forecasts to 2015

Introduction / / This Medical Device report is an essential source for key information and data relating to the global Orthopedic
2009 4.000,00$

Global Wound Care Management Market Analysis and Forecasts to 2015

Introduction / / This Medical Device report is an essential source for key information and data relating to the global Wound Care
2009 4.000,00$

Brazil Medical Equipment Market Analysis and Forecasts to 2015

Introduction / / GlobalData’s “Brazil Medical Equipment Market Analysis and Forecasts to 2015” report provides key data, informat
2009 3.500,00$

US Small Joint Implants Market: The Underlying Demand Drivers Remain in Place

Introduction / / GlobalData’s “US Small Joint Implants Market: The Underlying Demand Drivers Remain in Place” report is an essent
2009 3.500,00$

India Ultrasound Systems Market: Strategic Market Analysis and Insight

Introduction / / GlobalData’s “India Ultrasound Systems Market: Strategic Market Analysis and Insight” report is an essential sou
2009 3.500,00$

Drug Eluting Stents (DES) Pipeline Technology and Market Forecasts to 2016

Introduction / / GlobalData’s “Drug Eluting Stents (DES) Pipeline Technology and Market Forecasts to 2016” report is an essential
2009 2.000,00$

Medical Equipment Monthly Deals Analysis – December 2009

Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis – December 2009 ” report is an essential source of data a
2009 1.000,00$

US Spinal Surgery Devices Market: Increasing Procedures to Drive Growth

Introduction / / GlobalData’s “US Spinal Surgery Devices Market: Increasing Procedures to Drive Growth” report is an essential
2009 3.500,00$

Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016

Introduction / / GlobalData’s “Negative Pressure Wound Therapy (NPWT)Pipeline Technology and Market Forecasts to 2016” report i
2009 2.000,00$

23rd European Association for Cardio-Thoracic Surgeons (EACTS) Annual Meeting: Conference Review and Analysis

Introduction / / GlobalData’s “23rd European Association for Cardio-Thoracic Surgeons (EACTS) Annual Meeting: Conference Review a
2009 1.000,00$

Glucose Monitoring Systems Pipeline Technology and Market Forecasts to 2015

Introduction / / GlobalData’s “Glucose monitoring systems Pipeline Technology and Market Forecasts to 2015” report is an essentia
2009 2.000,00$

Attention Deficit Hyperactivity Disorder (ADHD) - Drug Pipeline Analysis and Market Forecasts to 2015

Introduction / / GlobalData, the industry analysis specialist’s new report, “Attention Deficit Hyperactivity Disorder – Drug Pipe
2009 2.000,00$

Major Depressive Disorder (MDD) - Drug Pipeline Analysis and Market Forecasts to 2015

Introduction / / GlobalData, the industry analysis specialist’s new report, “Major Depressive Disorder – Drug Pipeline Analysis a
2009 2.000,00$

Rheumatoid Arthritis - Drug Pipeline Analysis and Market Forecasts to 2015

Introduction / / GlobalData, the industry analysis specialist, has released a new report, “Rheumatoid Arthritis – Drug Pipeline A
2009 2.000,00$

Crohn's Disease - Drug Pipeline Analysis and Market Forecasts to 2015

Introduction / / GlobalData, the industry analysis specialist’s new report, “Crohn’s Disease – Drug Pipeline Analysis and Marke
2009 2.000,00$

Alzheimer’s Disease - Drug Pipeline Analysis and Market Forecasts to 2015

Introduction / / GlobalData, the industry analysis specialist’s new report, “Alzheimer’s Disease – Drug Pipeline Analysis and Mar
2009 2.000,00$

Parkinson's Disease - Drug Pipeline Analysis and Market Forecasts to 2015

Introduction / / GlobalData, the industry analysis specialist’s new report, “Parkinson’s Disease – Drug Pipeline Analysis and Mar
2009 2.000,00$

Insomnia - Drug Pipeline Analysis and Market Forecasts to 2015

Introduction / / GlobalData, the industry analysis specialist’s new report, “Insomnia – Drug Pipeline Analysis and Market Forecas
2009 2.000,00$

Schizophrenia - Drug Pipeline Analysis and Market Forecasts to 2015

Introduction / / GlobalData, the industry analysis specialist, has released a new report, “Schizophrenia – Drug Pipeline Analysis
2009 2.000,00$

Bipolar Disorder - Drug Pipeline Analysis and Market Forecasts to 2015

Introduction / / GlobalData, the industry analysis specialist’s new report, “Bipolar Disorder – Drug Pipeline Analysis and Market
2009 2.000,00$

Addiction Control - Drug Pipeline Analysis and Market Forecasts to 2015

Introduction / / GlobalData, the industry analysis specialist, has released a new report “Addiction Control – Drug Pipeline Analy
2009 2.000,00$

Acute Ischemic Stroke - Drug Pipeline Analysis and Market Forecasts to 2015

Introduction / / GlobalData, the industry analysis specialist’s new report, “Acute Ischemic Stroke – Drug Pipeline Analysis and M
2009 2.000,00$

Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015

Introduction / / GlobalData, the industry analysis specialist’s new report, “Systemic Lupus Erythematosus – Drug Pipeline Analysi
2009 2.000,00$

Non-Hodgkin's Lymphoma (NHL) - Drug Pipeline Analysis and Market Forecasts to 2015

Introduction / / GlobalData, the industry analysis specialist’s new report, “Non-Hodgkin's Lymphoma – Drug Pipeline Analysis and
2010 2.000,00$

Ulcerative Colitis - Drug Pipeline Analysis and Market Forecasts to 2015

Introduction / / GlobalData, the industry analysis specialist’s new report, “Ulcerative Colitis – Drug Pipeline Analysis and Mark
2010 2.000,00$

Angina Pectoris - Drug Pipeline Analysis and Market Forecasts to 2015

Introduction / / GlobalData, the industry analysis specialist’s new report, “Angina Pectoris – Drug Pipeline Analysis and Market
2010 2.000,00$

Renal Cancer - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Renal Cancer – Drug Pipeline Analysis and Market For
2010 2.000,00$

Head and Neck Cancer - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Head and Neck Cancer – Drug Pipeline Analysis and Ma
2010 2.000,00$

Breast Cancer - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Breast Cancer – Drug Pipeline Analysis and Market Fo
2010 2.000,00$

Brain Tumor - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Brain Tumour – Drug Pipeline Analysis and Market For
2010 2.000,00$

Cancer Vaccines - Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Cancer Vaccines – Pipeline Analysis and Market Forec
2010 2.000,00$

Influenza Vaccines - Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Influenza Vaccines – Pipeline Analysis and Market Fo
2010 2.000,00$

Type 1 Diabetes - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Type 1 Diabetes – Drug Pipeline Analysis and Market
2010 2.000,00$

Atopic Dermatitis - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Atopic Dermatitis – Drug Pipeline Analysis and Marke
2010 2.000,00$

Macular Oedema - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Macular Oedema – Drug Pipeline Analysis and Market F
2010 2.000,00$

Asthma - Drug Pipeline Analysis and Market Forecasts to 2016

Introduction / / GlobalData, the industry analysis specialist’s new report, “Asthma – Drug Pipeline Analysis and Market Forecasts
2010 2.000,00$

North American Spine Society Annual Meeting 2009 – Post Conference Review

Introduction / / GlobalData’s “North American Spine Society (NASS) 24th Annual Meeting: Conference Review and Analysis” report is
2009 1.000,00$

American Society of Anesthesiologists Annual Meeting 2009 – Post Conference Review

Introduction / / GlobalData’s “American Society of Anesthesiologists (2009 Annual Meeting): Conference Review and Analysis” repor
2009 1.000,00$

3M Health Care Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

A&D Medical Lifesource Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Abbott Medical Optics, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

ABIOMED, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Accuray Incorporated Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

ACUTRONIC Medical Systems AG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

A-dec Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Advanced Bionics Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Advanced Medical Solutions Group plc Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Aerogen (Ireland) Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Agfa-Gevaert N.V. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

AIR LIQUIDE Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

ALCARE Co., Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Allengers Medical Systems Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Allosource Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Aloka Co., Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Alpha Bio GmbH Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Animas Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Ansell Limited Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Anthogyr S.A. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Apex Biotechnology Corp. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

ARKRAY, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Arthrex, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Arthrocare Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

ASAHI ROENTGEN IND.CO., LTD. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Asia Pacific Microsystems, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Astro-Med, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Atricure, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

AViTA Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

B. Braun Melsungen AG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

BASKO HEALTHCARE Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Bauerfeind AG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Baxter International Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Bayer HealthCare AG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Becton, Dickinson and Company Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Beijing Aerospace Changfeng Co., Ltd Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Bioject Medical Technologies Inc Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Biomet, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

BIONIME Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

BIOTRONIK GmbH & Co. KG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Boehringer Ingelheim GmbH Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Boss Instruments, Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Boston Scientific Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Bovie Medical Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

BREG Incorporated Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

BSN medical GmbH Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

CAMLOG Biotechnologies AG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Card Guard AG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Cardiac Science Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Cardinal Health, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Carestream Health, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Carl Zeiss AG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Cerner Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

CIBA Vision Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

CLINICARE Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Cochlear Limited Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Codman & Shurtleff, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Coloplast A/S Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

CompuGROUP Holding AG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Compumedics Limited Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Computer Programs and Systems, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Conexao Sistemas de Protese Ltda. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

CONMED Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Consort Medical plc Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

ConvaTec Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

CooperVision, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Cordis Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Criticare Systems, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Cryolife, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Custom Ultrasonics Company Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Cyberonics, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

DEKA M.E.L.A. s.r.l. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

DePuy, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

DeRoyal Industries, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

DiaSorin S.p.A Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Digene Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Digene Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Dornier MedTech GmbH Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Edwards Lifesciences Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Elekta AB Medical Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Eli Lilly and Company Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Embla Systems Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

ERBE Elektromedizin GmbH Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

ESAOTE S.p.A Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Essilor International Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Ethicon, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

ev3 Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

F. Hoffmann-La Roche Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Fanem Ltda Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Fleming Medical Ltd Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

FUJIFILM Medical Systems USA, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Fujinon Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Fujitsu Limited Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Gambro AB Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

GE Healthcare Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

GE Sensing & Inspection Technologies Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Geistlich Pharma AG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Gendex Dental Systems Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Gen-Probe Incorporated Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Genzyme Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Getinge AB Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Ginevri s.r.l. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

GN ReSound A/S Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

HAMILTON MEDICAL AG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Hanger Orthopedic Group, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Healthphone Solutions Limited Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

HealthTronics, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Hindustan Syringes & Medical Devices Ltd Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Hitachi Medical Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Hologic, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Hospira, Inc Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

HOYA ConBio Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Hoya Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

iMDsoft Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

IMECO S.A. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Instrumentarium Dental Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Intersurgical Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Invacare Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Invatec S.r.l. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

iSOFT Group PLC Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Ivens S.A Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Ivoclar Vivadent AG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Jackson Allison Medical & Surgical Ltd Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Japan Medical Materials Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Johnson & Johnson Vision Care, Inc Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

K. Takaoka Industria e Comercio Ltda. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

KARL STORZ GmbH & Co. KG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Kimberly-Clark Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Kinetic Concepts, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

King Systems Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Klockner Implant System Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

KLS Martin, L.P. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Lamprecht AG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Larsen & Turbo Medical Equipment & Systems Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

LifeScan, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

LMA International N.V. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

MAQUET GmbH & Co. KG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Masimo Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Matrix I.T. Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

McKesson Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

MED-EL Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Medical Information Technology, Inc Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

MEDICON eG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Medline Industries, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Medtronic CryoCath, LP. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Medtronic, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Mennen Medical Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Metaltronica S.r.l. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Microlife Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Midmark Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Minntech Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Misys Healthcare Systems, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Morepen Laboratories Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Nakanishi Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Natus Medical Incorporated Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

NEC Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Neodent S.A. Company Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Neurelec Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Nightingale Informatix Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Nihon Kohden Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

NIPRO CORPORATION Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Nobel Biocare Holding AG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Noritake Co., Limited Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Novartis Medical Nutrition Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Novo Nordisk A/S Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

NxStage Medical, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

OLYMPUS CORPORATION Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

OMRON HEALTHCARE Co., Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

ONTEX International N.V. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Oridion Systems Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Ortho-Clinical Diagnostics Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

OSI Systems, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

OSSTEM IMPLANT Co., Ltd Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Ossur hf. Medical Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Owandy S.A.S Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Parker Healthcare Pty Ltd Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Pelton & Crane Company Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Penlon Limited Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Perlong Medical Equipment Co., Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Philips Healthcare Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Planmeca Oy Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Planmed Oy Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

PRAXIM medivision Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Profdoc ASA Market Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

PSP Corporation Company Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

QHR Technologies Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Qiagen N.V. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

ResMed Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Rossmax International Co.Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Rothacher & Partner Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

San Meditech(Huzhou)Co.,Ltd Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Sanofi- Aventis Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Scanlan International, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Schick Technologies, Inc. Company Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Schiller AG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Sectra AB Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

SEIKO OPTICAL PRODUCTS CO., LTD. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Sepracor Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Shanghai Medical Instruments Co., Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Shaoxing Haitian Medical Device Co.,Ltd Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Shimadzu Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Shree Pacetronix Ltd., Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Siemens Healthcare Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Sklar Instruments Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Smith & Nephew Plc Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Smiths Medical Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Sonic Innovations, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

SonoSite, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Sorin S.p.A. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Spectrum Surgical Instruments Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

SSM Sterile Health Products Inc Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

St. Jude Medical, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

STAAR Surgical Company Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Starkey Laboratories, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

STERIS Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

STORZ MEDICAL AG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Stryker Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Sunrise Medical Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Sutures India Private Limited Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Svenska Cellulosa Aktiebolaget SCA Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Sweden & Martina S.P.A. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Synergetics USA, Inc Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Synthes, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Taema Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Teleflex Incorporated Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Terumo Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Thoratec Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Thuasne Cr, S.R.O. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

TietoEnator Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

TOSHIBA Medical Systems Corporation Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

TRACOE medical GmbH Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

TrakHealth Pty Limited Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Transasia Bio-Medicals Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

VEPRO AG Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Vissco Rehabilitation Aids Pvt. Ltd Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

VITA In-Ceram Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Widex A/S Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

William Demant Holding A/S Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Wright Medical Group, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Zimmer Holdings, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Heinen + Löwenstein GmbH Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Ambu A/S Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

dbMotion Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Given Imaging Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Shinhung Co., Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Orthofix International N.V. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Mindray Medical International Limited Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

GlaxoSmithKline plc Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Draegerwerk AG & Co. KGaA Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Global Health Pty Ltd Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Abbott Laboratories Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Alcon, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

All Pro Oxygen Masks Co., Ltd. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Bausch & Lomb Incorporated Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Beckman Coulter, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

bioMerieux S.A. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Biosense Webster, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

C. R. Bard, Inc. Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Fresenius Medical Care AG & Co. KGaA Market Share Analysis

Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business
2009 1.000,00$

Spain Orthopedic Devices Market Analysis and Forecasts to 2015

Introduction / / This report is an essential source for in-depth information and data relating to the Spain orthopedic devices ma
2009 3.500,00$

South and Central America Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Introduction / / This report is an essential source for in-depth information and data relating to the the South and Central Ameri
2009 3.500,00$

China Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Introduction / / This report is an essential source for in-depth information and data relating to the the China anesthesia & resp
2009 3.500,00$

Japan Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Introduction / / This report is an essential source for in-depth information and data relating to the the Japan anesthesia & resp
2009 3.500,00$

France Anesthesia and Respiratory Devices Market Analysis & Forecasts to 2015

Introduction / / This report is an essential source for in-depth information and data relating to the the France anesthesia & res
2009 3.500,00$

North America Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Introduction / / This report is an essential source for in-depth information and data relating to the the North America anesthesi
2009 3.500,00$

Global In Vitro Diagnostics Market Analysis and Forecasts to 2015

Introduction / / GlobalData’s “Global In Vitro Diagnostics (IVD) Market Analysis and Forecasts to 2015” report provides key data,
2009 4.000,00$

US Prosthetic Heart Valves Market: Tissue Valves to Emerge as the Largest Segment

Introduction / / GlobalData’s “US Prosthetic Heart Valves Market: Tissue Valves to Emerge as the Largest Segment” report is an es
2009 3.500,00$

Medical Weekly Deals Summaries 27 July 2009

Introduction / / Global Data’s Medical Equipment weekly deals summary is an excellent source providing detailed information on Me
2009 125,00$

Medical Weekly Deals Summaries 03 August 2009

Introduction / / Global Data’s Medical Equipment weekly deals summary is an excellent source providing detailed information on Me
2009 125,00$

Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth

Introduction / / GlobalData’s “Global Self Monitoring Blood Glucose (SMBG) Market: Increasing Adoption to Drive Growth” report is
2009 3.500,00$

Global Automated External Defibrillators (AED) Market: Demand to Drive Growth

Introduction / / GlobalData’s “Global Automated External Defibrillators (AED) Market: Demand to Drive Growth” report is an essent
2009 3.500,00$

Germany Diabetes Care Devices Market Analysis & Forecasts to 2015

Introduction / / This report is an essential source for in-depth information and data relating to the Germany diabetes care devic
2009 3.500,00$

Intra Ocular Lenses Pipeline Technology and Market Forecasts to 2015

Introduction / / GlobalData’s “Intra Ocular Lens (IOL) Pipeline Technology and Market Forecasts to 2015” report is an essential s
2009 2.000,00$

Global Diagnostic Imaging Market Analysis & Forecasts to 2015

Key Companies GE Healthcare, Philips Healthcare, Siemens Medical Solutions, TOSHIBA Medical Systems Corporation, and Hitachi Medic
2009 4.000,00$

Italy Orthopedic Devices Market Analysis and Forecasts to 2015

Introduction / / This report is an essential source for in-depth information and data relating to the Italy orthopedic devices ma
2009 3.500,00$

Japan Orthopedic Devices Market Analysis and Forecasts to 2015

Introduction / / This report is an essential source for in-depth information and data relating to the Japan orthopedic devices ma
2009 3.500,00$

Italy Cardiovascular Devices Market Analysis and Forecasts to 2015

Introduction / / GlobalData’s “Italy Cardiovascular Devices Market Analysis and Forecasts to 2015” report provides key data, info
2009 3.500,00$

Mergers & Acquisitions and Financing Trends in Medical Equipment Q2 2009

Introduction / / GlobalData's Medical Equipment Quarterly M&A and Financing Trends Report Q2 2009 is an excellent source providin
2009 1.500,00$

Spain Cardiovascular Devices Market Analysis and Forecasts to 2015

Introduction / / GlobalData’s “Spain Cardiovascular Devices Market Analysis and Forecasts to 2015” report provides key data, info
2009 3.500,00$

Infusion Systems Pipeline Technology and Market Forecasts to 2015

Introduction / / GlobalData’s “Infusion Systems Pipeline Technology and Market Forecasts to 2015” report is an essential source o
2009 2.000,00$

Medical Equipment Monthly Deals Analysis – November 2009

Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis – November 2009 ” report is an essential source of data a
2009 1.000,00$

Transcatheter Cardiovascular Therapeutics (TCT) 2009: Conference Review and Analysis

Introduction / / GlobalData’s “Transcatheter Therapeutics (TCT) 2009: Conference Review and Analysis” report is an essentially so
2009 1.000,00$

Cardiac Markers Pipeline Technology and Market Forecasts to 2015

Introduction / / GlobalData’s “Cardiac Markers Pipeline Technology and Market Forecasts to 2015” report is an essential source of
2009 2.000,00$

India Medical Equipment Market Analysis and Forecasts to 2015

Introduction / / GlobalData’s “India Medical Equipment Market Analysis and Forecasts to 2015” report provides key data, informati
2009 3.500,00$

Medical Equipment Quarterly Deals Analysis Q3 2009

Introduction / / GlobalData's “Medical Equipment Quarterly Deal Analysis Q3 2009” report is an essential source of data and trend
2009 1.500,00$

Cardiac Resynchronization Therapy (CRT) Devices Pipeline Technology and Market Forecasts to 2015

Introduction / / GlobalData’s “Cardiac Resynchronization Therapy (CRT) Devices Pipeline Technology and Market Forecasts to 2015”
2009 2.000,00$

Insulin Delivery Devices Pipeline Technology and Market Forecasts to 2015

Introduction / / GlobalData’s “Insulin Delivery Devices Pipeline Technology and Market Forecasts to 2015” report is an essential
2009 2.000,00$

Japan Interventional Cardiology Devices: Coronary Stents to Drive Growth

Introduction / / GlobalData’s “Japan Interventional Cardiology Devices Market: Coronary Stents to Drive Growth” report is an esse
2009 3.500,00$

Global Medical Devices Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery

Introduction / / “Global Medical Devices Industry Outlook to 2010: Marketing & Sales Strategies and the Impact of Recession and R
2009 2.000,00$

Germany Wound Care Management Market Analysis and Forecasts to 2015

Introduction / / GlobalData’s “Germany Wound Care Management Market Analysis and Forecasts to 2015” report provides key data, inf
2009 3.500,00$

China Medical Equipment Market Analysis and Forecasts to 2015

Introduction / / GlobalData’s “China Medical Equipment Market Analysis and Forecasts to 2015” report provides key data, informati
2009 3.500,00$

US Mammography Equipment Market: Product Innovations to Drive Growth

Introduction / / GlobalData’s “US Mammography Equipment Market: Product Innovations to Drive Growth” report is an essential sourc
2009 3.500,00$

Brazil Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Introduction / / This report is an essential source for in-depth information and data relating to the the Brazil anesthesia &
2009 3.500,00$

Canada Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Introduction / / This report is an essential source for in-depth information and data relating to the the Canada anesthesia &
2009 3.500,00$

Germany Diagnostic Imaging Market Analysis and Forecasts to 2015

Introduction / / GlobalData’s “Germany Diagnostic Imaging Market Analysis and Forecasts to 2015” report provides key data, inform
2009 3.500,00$

Italy Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Introduction / / This report is an essential source for in-depth information and data relating to the the Italy anesthesia &
2009 3.500,00$

Medical Equipment Industry Deals Analysis – September 2009

Introduction / / GlobalData's “Medical Equipment Industry Deals Analysis – September 2009” report is an essential source of data
2009 1.000,00$

Spain Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Introduction / / This report is an essential source for in-depth information and data relating to the the Spain anesthesia &
2009 3.500,00$

Spain Medical Equipment Market Analysis and Forecasts to 2015

Introduction / / GlobalData’s “Spain Medical Equipment Market Analysis and Forecasts to 2015” report provides key data, informati
2009 3.500,00$

UK Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Introduction / / This report is an essential source for in-depth information and data relating to the the UK anesthesia & res
2009 3.500,00$

Europe Remote Patient Monitoring Market: Strategic Analysis and Opportunity Assessment

Introduction / / GlobalData’s “Europe Remote Patient Monitoring Market: Strategic Analysis and Opportunity Assessment” report is
2009 3.500,00$

Global Diabetes Care Devices Market Analysis and Forecasts to 2015

Key Companies F. Hoffmann-La Roche, LifeScan, Bayer HealthCare, Abbott Laboratories, and Medtronic / It gives key company share i
2009 3.500,00$

Japan Dental Devices Market Analysis and Forecasts to 2015

Introduction / / GlobalData’s “Japan Dental Devices Market Analysis and Forecasts to 2015” report provides key data, information
2009 3.500,00$

Medical Weekly Deals Summaries 17 August 2009

Introduction / / Global Data’s Medical Equipment weekly deals summary is an excellent source providing detailed information on Me
2009 125,00$

Medical Weekly Deals Summaries 24 August 2009

Introduction / / Global Data’s Medical Equipment weekly deals summary is an excellent source providing detailed information on Me
2009 125,00$

UK Diagnostic Imaging Market Analysis and Forecasts to 2015

Introduction / / GlobalData’s “UK Diagnostic Imaging Market Analysis and Forecasts to 2015” report provides key data, information
2009 3.500,00$

Areva in a Global Expansion Mode

GlobalData viewpoints cover the latest key events or important developments in the nuclear energy industry and provide our in-dept
2009 500,00$

Canada Diabetes Care Devices Market Analysis and Forecasts to 2015

Forecasts & Analysis of the Canada diabetes care devices market to 2015. Market segmentation by glucose monitoring and insulin del
2009 3.500,00$

Canada Orthopedic Devices Market Analysis and Forecasts to 2015

and latest news, financial deals and pipeline products information of each of the key sub-segments of the orthopedic devices marke
2009 3.500,00$

Cardiac Assist Devices Pipeline Technology and Market Forecasts to 2015

Annualized global cardiac assist devices market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. Updated com
2009 2.000,00$

China Orthopedic Devices Market Analysis and Forecasts to 2015

and latest news, financial deals and pipeline products information of each of the key sub-segments of the orthopedic devices marke
2009 3.500,00$

Computer Assisted Radiology and Surgery (CARS) 2009 Conference Review and Analysis

The report covers information and analysis on product and technology launched at the conference. The report provides market size d
2009 1.000,00$

Intra Ocular Lens Pipeline Technology and Market Forecasts to 2015

Annualized global IOLs market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. Updated company shares data f
2009 2.000,00$

Medical Weekly Deals Summaries 20 July 2009

Summary of Medical Equipment deals by segment during the week Information on rumored and upcoming deals before they occur Any upd
2009 125,00$

Merger & Acquisition Deal Analysis - Bonavista Energy Trust To Acquire Non-Core Alberta Properties From EnCana Corporation

In depth analysis of the latest and the most important Mergers and Acquisitions deal
2009 500,00$

International Society of Arthroscopy, Knee Surgery & Orthopedic Sports Medicine 2009 – Conference Review And Analysis

The report covers information and analysis on product and technology launched at the conference. / The report provides market size
2009 1.000,00$

The Dawn Of Consolidation In The Spinal Surgery Market: Nuvasive To Acquire Cervitech

In depth analysis of the latest and the most important Mergers and Acquisitions deal; / Analysis of the operations of the companie
2009 500,00$

Japan Diabetes Care Devices Market Analysis and Forecasts to 2015

The report provides Diabetes care devices market information broken down into detailed categories and segments in Japan. / Total
2009 3.500,00$

United States Diabetes Care Devices Market Analysis & Forecasts to 2015

The report provides Diabetes care devices market information broken down into detailed categories and segments in the US. / Total
2009 3.500,00$

Dental Implants Pipeline Technology and Market Forecasts to 2015

Annualized global dental implants market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. / Analysis and rev
2009 2.000,00$

Medical Weekly Deals Summaries 27 April 2009

Summary of Medical Equipment deals by segment during the week / Information on rumored and upcoming deals before they occur / Any
2009 125,00$

Medical Device Clinical Trials: Destination India

Viewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m
2009 500,00$

Stem Cell Research and Tissue Engineering: A Boon for Dental Tissue Regeneration

Viewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m
2009 500,00$

Bioject Medical Technologies Inc. - Healthcare - Medical Equipment SWOT Report

Critical appraisal of the company’s positioning using SWOT analysis. / Company information, including business descriptions, com
2008 125,00$

Biliary Stents: Off – Label Use to Drive Growth

Viewpoints are a source of realtime and frequent updates on key events in the medical equipment sectors and provide insights on ma
2009 500,00$

Medical Weekly Deals Summaries 01 June 2009

Summary of Medical Equipment deals by segment during the week / Information on rumored and upcoming deals before they occur / A
2009 125,00$

Medical Weekly Deals Summaries 25 May 2009

Summary of Medical Equipment deals by segment during the week / Information on rumored and upcoming deals before they occur / A
2009 125,00$

The Medical Device Reprocessing Industry: Increasing Hospital Sustainability

Viewpoints are a source of realtime and frequent updates on key events in the medical equipment sectors and provide insights on ma
2009 500,00$

US Electrophysiology Devices Market: Opportunity Analysis and Market Assessment to 2015

The report provides market size data and information on three electrophysiology devices market categories – Electrophysiology Lab
2009 3.500,00$

Global X-Ray Systems Market: Strategic Market Analysis and Insight to 2015

The report covers data and analysis on the x-ray systems market in the leading geographies of the world – United States, Canada, U
2009 3.500,00$

SWOT Review of the Key Orthopedic Device Companies

Viewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m
2009 500,00$

Transcatheter Cardiovascular Therapeutics 2008 – Post Conference Review

The report covers information and analysis on product and technology launched at the conference / The report provides market size
2009 1.000,00$

Medtronic to Acquire Ablation Frontiers: A Move to Strengthen Stake in the Atrial Fibrillation Market

In depth profiling of the latest and the most important Mergers & Acquisitions deal; / Historical deal analysis of the compani
2009 500,00$

Cardiovascular Surgery Pipeline Technology and Market Forecasts To 2015

Annualized global cardiovascular surgery market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. / Analysis
2009 2.000,00$

Global Patient Monitoring Investment Opportunities, Analysis and Forecasts to 2012

This report provides detailed global, regional countries (United States, Germany, United Kingdom, France, Italy, Spain, Japan, Can
2009 3.500,00$

United States Patient Monitoring Investment Opportunities, Analysis and Forecasts to 2015

The report provides patient monitoring devices information broken down into detailed categories and segments in United States. /
2009 3.500,00$

Aesthetics Devices Pipeline Product and Technology Analysis Report

Analysis and review of the key pipeline devices that are likely to impact the treatment landscape globally; / Independent analysis
2009 2.000,00$

Neurostimulation Devices Pipeline Product and Technology Analysis Report

Analysis and review of the key pipeline devices that are likely to impact the treatment landscape globally; / Independent analysis
2009 2.000,00$

Digital Mammography Pipeline Technology and Market Forecasts To 2015

Analysis and review of the key pipeline devices that are likely to impact the treatment landscape globally; / Independent analysis
2009 2.000,00$

Mergers & Acquisitions and Financing Trends in Medical Equipment Industry Q4 2008

Comprehensive summary of Medical Equipment deals globally in the last four quarters / Trend analysis of deals by segments, region,
2009 1.500,00$

Cell Therapy - A New Lease of Life for the Heart

Viewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m
2009 500,00$

Combination Products - Evolution of the Medical Equipment Industry

Viewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m
2009 500,00$

Small Joints - Big Innovations

Viewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m
2009 500,00$

Key M&A Events in the Spinal Surgery Market in 2008

Viewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m
2009 500,00$

Orthopedic Devices Pipeline Product Analysis and Technology Report

Analysis and review of the key pipeline devices that are likely to impact the treatment landscape globally; / Independent analysi
2008 2.000,00$

Peripheral Vascular Devices Pipeline Product Analysis and Technology Report

Analysis and review of the key pipeline devices that are likely to impact the treatment landscape globally; / Independent analysi
2008 2.000,00$

Wound Care Management Pipeline Product Analysis and Technology Report

Analysis and review of the key pipeline devices that are likely to impact the treatment landscape globally; / Independent analysi
2008 2.000,00$

Medical Equipment Mergers & Acquisitions Trends – April 2009

Comprehensive summary of Medical Equipment deals globally in the last six months / Trend analysis of deals by sector and type /
2009 1.000,00$

Global X-Ray Systems Market: Strategic Market Analysis and Insight to 2015

The report covers data and analysis on the xray systems market in the leading geographies of the world – United States, Canada, UK
2009 3.500,00$

Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth

The report provides market size data and information on two global Self Monitoring Blood Glucose (SMBG) market categories – blood
2009 3.500,00$

US Cardiac Rhythm Management Devices Market: Strategic Market Analysis and Insight to 2015

The report provides market size data and information on three US cardiac rhythm management devices market categories – Cardiac Res
2009 3.500,00$

Ultrasound Systems Pipeline Technology and Market Forecasts to 2015

Annualized global ultrasound systems market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. / Analysis and
2009 2.000,00$

Electrosurgical Devices Pipeline Technology and Market Forecasts to 2015

Develop business strategies by understanding the trends shaping and driving the global electrosurgical devices market. / Identify
2009 2.000,00$

Mergers & Acquisitions and Financing Trends in Medical Equipment, 2008

Comprehensive summary of Medical Equipment deals globally in the last four years / Trend analysis of deals by segments, region, an
2009 3.500,00$

Italy’s nuclear renaissance helps the country to meet the electricity demand

GlobalData viewpoints cover the latest key events or important developments in the nuclear energy industry and provide our indepth
2009 500,00$

Middle East Will Drive Growth in the Global Refining Industry in the Next Five Years

GlobalData viewpoints cover the latest events or important trends in the global oil and gas industry and provide our in-depth anal
2009 500,00$

US Electrophysiology Devices Market: Opportunity Analysis and Market Assessment to 2015

The report provides market size data and information on three electrophysiology devices market categories – Electrophysiology Lab
2009 3.500,00$

Global X-Ray Systems Market: Strategic Market Analysis and Insight to 2015

The report covers data and analysis on the x-ray systems market in the leading geographies of the world – United States, Canada, U
2009 3.500,00$

SWOT Review of the Key Orthopedic Device Companies

Viewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m
2009 500,00$

United States Medical Equipment Market Analysis & Forecasts to 2015

The report provides an overview of the medical equipment industry in the US and provides data and information on each of the key i
2009 4.000,00$

Mexico Orthopedic Devices Market Analysis & Forecasts to 2015

The report provides orthopedic devices information broken down into detailed categories and segments in Mexico. / Total revenues,
2009 3.500,00$

Global Patient Monitoring Market Analysis & Forecasts to 2015

Key Companies Philips Healthcare, GE Healthcare, OMRON HEALTHCARE, Draegerwerk Aktiengesellschaft, and OSI Systems. / It gives ke
2009 4.000,00$

United States Patient Monitoring Market Analysis & Forecasts to 2015

The report provides patient monitoring devices information broken down into detailed categories and segments in United States. /
2009 3.500,00$

United Kingdom Cardiovascular Devices Market Analysis & Forecasts to 2015

The report provides cardiovascular devices market information broken down into detailed categories and segments in UK. / Total re
2009 3.500,00$

US Anesthesia and Respiratory Devices Market Analysis & Forecasts to 2015

The report provides canesthesia & respiratory devices market information broken down into detailed categories and segments in
2009 3.500,00$

United States Cardiovascular Devices Market Analysis & Forecasts to 2015

The report provides cardiovascular devices market information broken down into detailed categories and segments in the US. / Tota
2009 3.500,00$

United States Diagnostic Imaging Market Analysis & Forecasts to 2015

The report provides diagnostic imaging market information broken down into detailed categories and segments in the US. / Total re
2009 3.500,00$

Japan Patient Monitoring Market Analysis & Forecasts to 2015

The report provides patient monitoring market information broken down into detailed categories and segments in Japan. / Total rev
2009 3.500,00$

Germany Cardiovascular Devices Market Analysis & Forecasts to 2015

The report provides cardiovascular devices market information broken down into detailed categories and segments in Germany. / Tot
2009 3.500,00$

United States Orthopedic Devices Market Analysis & Forecasts to 2015

The report provides orthopedic devices market information broken down into detailed categories and segments in the US. / Total re
2009 3.500,00$

Japan Cardiovascular Devices Market Analysis & Forecasts to 2015

The report provides cardiovascular devices market information broken down into detailed categories and segments in Japan. / Total
2009 3.500,00$

Dynamic Stabilization Pipeline Technology and Market Forecasts to 2015

Annualized global dynamic stabilization market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. / Analysis a
2009 2.000,00$

India Cardiovascular Devices Market Analysis & Forecasts to 2015

The report provides cardiovascular devices market information broken down into detailed categories and segments in India. / Total
2009 3.500,00$

Capsule Endoscopy: Small is Effective

Viewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m
2009 500,00$

Kyphoplasty: Driving Growth in the Vertebral Compression Fracture Treatment Market in the US

Viewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m
2009 500,00$

Medical Equipment M&A Trends - October 2008

Comprehensive summary of Medical Equipment deals globally in the last six months / Trend analysis of deals by sector and type /
2008 1.000,00$

US Electrophysiology Devices Market: Strategic Market Analysis and Insight to 2015

The report provides market size data and information on three electrophysiology devices market categories – Electrophysiology Lab
2009 3.500,00$

US Dental Implants Market: Growth Driver for the Dental Equipment Sector

The report provides market size data and information on two US dental implants market categories – Titanium Dental Implants, Zirco
2009 3.500,00$

Dental Aesthetics Pipeline Technology and Market Forecasts to 2015

Annualized global dental aesthetics market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. / Analysis and
2009 2.000,00$

Wound Closure Devices Pipeline Technology and Market Forecasts to 2015

Annualized global wound closure devices market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. / Analysis
2009 2.000,00$

Medical Weekly Deals Summaries 06 April 2009

Summary of Medical Equipment deals by segment during the week / Information on rumored and upcoming deals before they occur / A
2009 125,00$

In Vitro Diagnostics Market - A Hotspot For Venture Capital Funding

Viewpoints are a source of realtime and frequent updates on key events in the medical equipment sectors and provide insights on ma
2009 500,00$

US Ophthalmic Devices Market Analysis & Forecasts to 2015

The report provides ophthalmic devices market information broken down into detailed categories and segments in the US. / Total r
2009 3.500,00$

Knee Replacement Pipeline Technology and Market Forecasts to 2015

Annualized global knee replacement market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. / Analysis and r
2009 2.000,00$

Global Respiratory Devices Market: The Home and Self Care Products to Drive Growth

The report provides market size data and information on six respiratory devices market categories – Anesthesia Disposables, Anesth
2009 3.500,00$

Germany Diabetes Care Devices Market Analysis & Forecasts to 2015

The report provides Diabetes care devices market information broken down into detailed categories and segments in Germany. / Tot
2009 3.500,00$

China Cardiovascular Devices Market Analysis & Forecasts to 2015

The report provides cardiovascular devices market information broken down into detailed categories and segments in China. / Tota
2009 3.500,00$

Europe Electrophysiology Devices Market: Increasing Demand to Drive Growth

The report provides market size data and information on four Europe electrophysiology devices market categories – electrophysiolog
2009 3.500,00$

Global Electrocardiogram (ECG) Data Management Systems Market: Increasing Demand to Drive Growth

The report covers data and analysis on the ECG data management systems market in the leading geographies of the world – US, Canada
2009 3.500,00$

Global Cardiopulmonary Stress Testing Systems: Market Opportunity Assessment and Insight to 2015

The report covers data and analysis on the cardiopulmonary stress testing systems market in the leading geographies of the world –
2009 3.500,00$

Global X-Ray Systems Market: Strategic Market Analysis and Insight to 2015

The report covers data and analysis on the x-ray systems market in the leading geographies of the world – United States, Canada, U
2009 3.500,00$